{
  "98": {
    "report_string": "# Genomic Variants and Obesity\n\nThe community revolves around genomic variants, particularly those associated with obesity and related traits. Key entities include genomic variants in the FTO gene, which are linked to obesity phenotypes, BMI, and LMI. Other important entities are physiological processes like Hardy-Weinberg Equilibrium and statistical concepts like Odds Ratio. These entities are interconnected through their roles in genetic associations, disease susceptibility, and phenotypic variance.\n\n## Genomic variants in the FTO gene and obesity risk\n\nGenomic variants in the FTO gene, such as rs56137030, are associated with an increased risk of obesity. These variants are linked to obesity phenotypes, including BMI and waist circumference. The FTO gene is a key player in obesity genetics, and its variants can influence obesity risk.\n\n## Relationship between genomic variants and BMI\n\nGenomic variants in the FTO gene are associated with BMI variation. The relationship between genomic variants and BMI is complex, and multiple genetic and environmental factors contribute to BMI. However, genomic variants in the FTO gene have been consistently linked to BMI variation.\n\n## Role of Hardy-Weinberg Equilibrium in genetic association studies\n\nHardy-Weinberg Equilibrium (HWE) is a physiological process used to assess the genetic equilibrium of a population. HWE is used to test for deviations in the study group and filter SNPs. It is an essential concept in genetic association studies, including those investigating genomic variants and obesity risk.\n\n## Genomic variants and LMI\n\nGenomic variants in the FTO gene are linked to LMI. LMI is a condition associated with variants in the FTO gene. The relationship between genomic variants and LMI highlights the importance of considering genetic factors in disease susceptibility.\n\n## Impact of genomic variants on phenotypic variance\n\nGenomic variants can affect phenotypic variance, including traits like BMI and obesity risk. The relationship between genomic variants and phenotypic variance is complex, and multiple genetic and environmental factors contribute to phenotypic traits.",
    "report_json": {
      "title": "Genomic Variants and Obesity",
      "summary": "The community revolves around genomic variants, particularly those associated with obesity and related traits. Key entities include genomic variants in the FTO gene, which are linked to obesity phenotypes, BMI, and LMI. Other important entities are physiological processes like Hardy-Weinberg Equilibrium and statistical concepts like Odds Ratio. These entities are interconnected through their roles in genetic associations, disease susceptibility, and phenotypic variance.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genomic variants on obesity risk and related traits.",
      "findings": [
        {
          "summary": "Genomic variants in the FTO gene and obesity risk",
          "explanation": "Genomic variants in the FTO gene, such as rs56137030, are associated with an increased risk of obesity. These variants are linked to obesity phenotypes, including BMI and waist circumference. The FTO gene is a key player in obesity genetics, and its variants can influence obesity risk."
        },
        {
          "summary": "Relationship between genomic variants and BMI",
          "explanation": "Genomic variants in the FTO gene are associated with BMI variation. The relationship between genomic variants and BMI is complex, and multiple genetic and environmental factors contribute to BMI. However, genomic variants in the FTO gene have been consistently linked to BMI variation."
        },
        {
          "summary": "Role of Hardy-Weinberg Equilibrium in genetic association studies",
          "explanation": "Hardy-Weinberg Equilibrium (HWE) is a physiological process used to assess the genetic equilibrium of a population. HWE is used to test for deviations in the study group and filter SNPs. It is an essential concept in genetic association studies, including those investigating genomic variants and obesity risk."
        },
        {
          "summary": "Genomic variants and LMI",
          "explanation": "Genomic variants in the FTO gene are linked to LMI. LMI is a condition associated with variants in the FTO gene. The relationship between genomic variants and LMI highlights the importance of considering genetic factors in disease susceptibility."
        },
        {
          "summary": "Impact of genomic variants on phenotypic variance",
          "explanation": "Genomic variants can affect phenotypic variance, including traits like BMI and obesity risk. The relationship between genomic variants and phenotypic variance is complex, and multiple genetic and environmental factors contribute to phenotypic traits."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 98",
    "edges": [
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HWE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"HARDY-WEINBERG EQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OR\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HAPLOTYPE\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PARENTAL ORIGIN\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"INTRON1 PROMOTER FLANKING\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"P-VALUE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID SEQUENCING TECHNOLOGY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY PHENOTYPE\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LD BLOCK\""
      ],
      [
        "\"DBSNP DATABASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HARDY-WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"DBSNP\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"TAQMAN ASSAY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MULTIPLE TESTING\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE ANALYSIS\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GOLDENGATE ARRAY\""
      ],
      [
        "\"CI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"HWE\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"OR\"",
      "\"INTRON1 PROMOTER FLANKING\"",
      "\"HWE\"",
      "\"CI\"",
      "\"GENOMIC VARIANT\"",
      "\"HARDY-WEINBERG EQUILIBRIUM\"",
      "\"PARENTAL ORIGIN\"",
      "\"LMI\"",
      "\"MULTIPLE TESTING\"",
      "\"WALKING PACE\"",
      "\"GOLDENGATE ARRAY\"",
      "\"LINKAGE ANALYSIS\"",
      "\"TAQMAN ASSAY\"",
      "\"LD BLOCK\"",
      "\"DBSNP DATABASE\"",
      "\"OBESITY PHENOTYPE\"",
      "\"SOLID\"",
      "\"SOLID SEQUENCING TECHNOLOGY\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.47058823529411764,
    "sub_communities": []
  },
  "84": {
    "report_string": "# BMI and Genetic Factors in Obesity\n\nThe community revolves around Body Mass Index (BMI) and its associations with genetic factors, particularly the FTO gene and its variants. BMI is a measure of body fatness influenced by both genetic and environmental factors. The FTO gene, and specific SNPs within it, are linked to BMI variation and obesity risk. This community highlights the interplay between genetics, BMI, and obesity-related traits.\n\n## BMI as a measure of body fatness\n\nBMI is a widely used physiological measure to assess body fatness and weight status. It is influenced by both genetic and environmental factors, including genetic variants in the FTO gene. BMI is associated with various health outcomes, such as obesity, cardiovascular disease, and type2 diabetes.\n\n## The FTO gene and BMI\n\nThe FTO gene is significantly associated with BMI and body composition. Variants within the FTO gene, such as rs9939609, rs3751812, and rs7185735, are linked to BMI variation. These genetic associations highlight the role of genetics in influencing body mass index and obesity risk.\n\n## Genomic variants and BMI\n\nSpecific genomic variants, such as rs17818902, rs17818920, and rs56137030, within the FTO gene are associated with BMI variation. These variants contribute to the genetic component of BMI and obesity risk, illustrating the complex interplay between genetics and body mass index.\n\n## BMI and obesity-related traits\n\nBMI is associated with various obesity-related traits, including body shape, waist-hip ratio, and obesity rate. These relationships emphasize the utility of BMI as a measure for assessing health risks associated with body fatness and obesity.\n\n## Educational attainment and BMI\n\nEducational attainment is a complex trait that can be influenced by genetic and environmental factors, similar to BMI. There is a genetic correlation between educational attainment and BMI, suggesting that factors influencing one may impact the other.\n\n## TDH gene and BMI\n\nThe TDH gene is associated with BMI and type2 diabetes (DM2). This association highlights the potential link between genetic factors influencing BMI and metabolic health outcomes.",
    "report_json": {
      "title": "BMI and Genetic Factors in Obesity",
      "summary": "The community revolves around Body Mass Index (BMI) and its associations with genetic factors, particularly the FTO gene and its variants. BMI is a measure of body fatness influenced by both genetic and environmental factors. The FTO gene, and specific SNPs within it, are linked to BMI variation and obesity risk. This community highlights the interplay between genetics, BMI, and obesity-related traits.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors, particularly the FTO gene, on BMI and obesity risk.",
      "findings": [
        {
          "summary": "BMI as a measure of body fatness",
          "explanation": "BMI is a widely used physiological measure to assess body fatness and weight status. It is influenced by both genetic and environmental factors, including genetic variants in the FTO gene. BMI is associated with various health outcomes, such as obesity, cardiovascular disease, and type2 diabetes."
        },
        {
          "summary": "The FTO gene and BMI",
          "explanation": "The FTO gene is significantly associated with BMI and body composition. Variants within the FTO gene, such as rs9939609, rs3751812, and rs7185735, are linked to BMI variation. These genetic associations highlight the role of genetics in influencing body mass index and obesity risk."
        },
        {
          "summary": "Genomic variants and BMI",
          "explanation": "Specific genomic variants, such as rs17818902, rs17818920, and rs56137030, within the FTO gene are associated with BMI variation. These variants contribute to the genetic component of BMI and obesity risk, illustrating the complex interplay between genetics and body mass index."
        },
        {
          "summary": "BMI and obesity-related traits",
          "explanation": "BMI is associated with various obesity-related traits, including body shape, waist-hip ratio, and obesity rate. These relationships emphasize the utility of BMI as a measure for assessing health risks associated with body fatness and obesity."
        },
        {
          "summary": "Educational attainment and BMI",
          "explanation": "Educational attainment is a complex trait that can be influenced by genetic and environmental factors, similar to BMI. There is a genetic correlation between educational attainment and BMI, suggesting that factors influencing one may impact the other."
        },
        {
          "summary": "TDH gene and BMI",
          "explanation": "The TDH gene is associated with BMI and type2 diabetes (DM2). This association highlights the potential link between genetic factors influencing BMI and metabolic health outcomes."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 84",
    "edges": [
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ],
      [
        "\"BMI\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"BMI\"",
        "\"DURBIN-HAUSMAN TEST\""
      ],
      [
        "\"BMI\"",
        "\"BODY COMPOSITION\""
      ],
      [
        "\"BMI\"",
        "\"RS56137030\""
      ],
      [
        "\"BMI\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"LEPTIN\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"BMI\"",
        "\"RS9939609\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE\""
      ],
      [
        "\"BMI\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"BMI\"",
        "\"EXTREME OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 3\""
      ],
      [
        "\"BMI\"",
        "\"MAFLD\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BMI\"",
        "\"EDUCATIONAL ATTAINMENT\""
      ],
      [
        "\"BMI\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"MINOR ALLELES\""
      ],
      [
        "\"BMI\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"BMI\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BMI\"",
        "\"RS17818902\""
      ],
      [
        "\"AGE\"",
        "\"BMI\""
      ],
      [
        "\"NUTRITIONAL INTERVENTION\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"BMI\"",
        "\"CARDIOVASCULAR DISEASE\""
      ],
      [
        "\"BMI\"",
        "\"RS17818920\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"BODY FATNESS\""
      ],
      [
        "\"FTO GENE\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"BMI\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"TDH\""
      ],
      [
        "\"BMI\"",
        "\"WAIST-HIP RATIO\""
      ],
      [
        "\"BMI\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"MC4R SNPS\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 2\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY RATE\""
      ],
      [
        "\"BMI\"",
        "\"GENOME-WIDE SNPS\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"RS7185735\""
      ],
      [
        "\"BMI\"",
        "\"GENOTYPE\""
      ]
    ],
    "nodes": [
      "\"RS17818902\"",
      "\"INTRON 2\"",
      "\"RS56137030\"",
      "\"EDUCATIONAL ATTAINMENT\"",
      "\"OBESITY RATE\"",
      "\"MC4R SNPS\"",
      "\"TDH\"",
      "\"BODY COMPOSITION\"",
      "\"RS7185735\"",
      "\"INTRON 1\"",
      "\"TBFAT (KG)\"",
      "\"INTRON 3\"",
      "\"RS17818920\"",
      "\"WAIST-HIP RATIO\"",
      "\"BMI\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.7794117647058824,
    "sub_communities": []
  },
  "93": {
    "report_string": "# Genetic and Environmental Factors in Obesity\n\nThe community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include genes such as FTO, ADIPOQ, and LEPR, nutrients like dietary fiber and energy intake, and environmental factors like educational level and physical activity. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk, with variants like rs9939609 and rs3751812 linked to increased risk. The FTO gene's role in fat mass and obesity highlights the genetic component of the disease.\n\n## ADIPOQ gene and insulin sensitivity\n\nThe ADIPOQ gene is associated with insulin sensitivity and glucose homeostasis through adiponectin production. Variants in ADIPOQ have been linked to obesity and type 2 diabetes risk.\n\n## Dietary fiber and obesity risk\n\nDietary fiber intake is important for maintaining a healthy weight and reducing obesity risk. A high-fiber diet can help mitigate the effects of genetic variants associated with obesity.\n\n## LEPR gene and leptin signaling\n\nThe LEPR gene encodes the leptin receptor, crucial for energy balance and body weight regulation. Variants in LEPR have been associated with obesity phenotypes and metabolic disorders.\n\n## Genetic variants and obesity risk in different populations\n\nThe impact of genetic variants on obesity risk can vary across different populations. For example, FTO SNPs show significant associations with obesity traits in Caucasians, while other populations may have different genetic risk factors.\n\n## Obesity and chronic disease risk\n\nObesity is a risk factor for various chronic diseases, including type 2 diabetes, colorectal cancer, and thyroid cancer. The relationships between obesity and these diseases highlight the importance of addressing obesity in public health strategies.\n\n## Environmental factors and obesity risk\n\nEnvironmental factors like educational level, physical activity, and energy intake can influence obesity risk. These factors can interact with genetic variants to affect an individual's susceptibility to obesity.\n\n## Obesity and BMI\n\nBMI is a measure used to assess obesity risk and classify individuals into case and control groups. The relationship between BMI and obesity highlights the importance of monitoring body mass index in public health.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity",
      "summary": "The community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include genes such as FTO, ADIPOQ, and LEPR, nutrients like dietary fiber and energy intake, and environmental factors like educational level and physical activity. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity risk and its association with various chronic diseases.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk, with variants like rs9939609 and rs3751812 linked to increased risk. The FTO gene's role in fat mass and obesity highlights the genetic component of the disease."
        },
        {
          "summary": "ADIPOQ gene and insulin sensitivity",
          "explanation": "The ADIPOQ gene is associated with insulin sensitivity and glucose homeostasis through adiponectin production. Variants in ADIPOQ have been linked to obesity and type 2 diabetes risk."
        },
        {
          "summary": "Dietary fiber and obesity risk",
          "explanation": "Dietary fiber intake is important for maintaining a healthy weight and reducing obesity risk. A high-fiber diet can help mitigate the effects of genetic variants associated with obesity."
        },
        {
          "summary": "LEPR gene and leptin signaling",
          "explanation": "The LEPR gene encodes the leptin receptor, crucial for energy balance and body weight regulation. Variants in LEPR have been associated with obesity phenotypes and metabolic disorders."
        },
        {
          "summary": "Genetic variants and obesity risk in different populations",
          "explanation": "The impact of genetic variants on obesity risk can vary across different populations. For example, FTO SNPs show significant associations with obesity traits in Caucasians, while other populations may have different genetic risk factors."
        },
        {
          "summary": "Obesity and chronic disease risk",
          "explanation": "Obesity is a risk factor for various chronic diseases, including type 2 diabetes, colorectal cancer, and thyroid cancer. The relationships between obesity and these diseases highlight the importance of addressing obesity in public health strategies."
        },
        {
          "summary": "Environmental factors and obesity risk",
          "explanation": "Environmental factors like educational level, physical activity, and energy intake can influence obesity risk. These factors can interact with genetic variants to affect an individual's susceptibility to obesity."
        },
        {
          "summary": "Obesity and BMI",
          "explanation": "BMI is a measure used to assess obesity risk and classify individuals into case and control groups. The relationship between BMI and obesity highlights the importance of monitoring body mass index in public health."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 93",
    "edges": [
      [
        "\"MEC\"",
        "\"OBESITY\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"META-ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"NPY\"",
        "\"OBESITY\""
      ],
      [
        "\"MDS\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO UPSTREAM REGION\"",
        "\"OBESITY\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"MULTIVITAMINS\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI VALUE\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1558902\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PFKFB3\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"LEPTIN\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SEX\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"LDL CHOLESTEROL\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PPARG\""
      ],
      [
        "\"CABP5\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"T2DM\""
      ],
      [
        "\"FTO SNPS\"",
        "\"OBESITY\""
      ],
      [
        "\"FISHER'S EXACT TEST\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"OBESITY\"",
        "\"POLISH ADULT SUBJECTS\""
      ],
      [
        "\"IRX5 RS12444481\"",
        "\"OBESITY\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"OBESITY\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1421085\"",
        "\"OBESITY\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"IRX3 RS4270172\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"TRIGLYCERIDE\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9930506\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"RS9939609\""
      ],
      [
        "\"ENERGY AND MACRONUTRIENT INTAKES\"",
        "\"OBESITY\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"OBESITY\""
      ],
      [
        "\"EDUCATIONAL LEVEL\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"OBESITY\""
      ],
      [
        "\"LOCI\"",
        "\"OBESITY\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"OBESITY\""
      ],
      [
        "\"IRX5 RS4435250\"",
        "\"OBESITY\""
      ],
      [
        "\"NEGR1\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"HUMAN FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"CREB1\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"AGE\"",
        "\"OBESITY\""
      ],
      [
        "\"GWAS\"",
        "\"OBESITY\""
      ],
      [
        "\"DIETARY FIBER\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"OBESITY\""
      ],
      [
        "\"CEBPB\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"ENERGY AND MACRONUTRIENT INTAKES\"",
      "\"CTNNBL1\"",
      "\"BMI VALUE\"",
      "\"IRX5 RS4435250\"",
      "\"MEC\"",
      "\"IRX5 RS12444481\"",
      "\"FTO RS9930506\"",
      "\"FTO UPSTREAM REGION\"",
      "\"POLISH ADULT SUBJECTS\"",
      "\"HUMAN FTO GENE\"",
      "\"LEPR\"",
      "\"MULTIVITAMINS\"",
      "\"DIETARY FIBER\"",
      "\"OBESITY\"",
      "\"PPARG\"",
      "\"LOCI\"",
      "\"PFKFB3\"",
      "\"TRIGLYCERIDE\"",
      "\"LDL CHOLESTEROL\"",
      "\"CEBPB\"",
      "\"IRX3 RS4270172\"",
      "\"NPY\"",
      "\"CAUCASIANS\"",
      "\"FISHER'S EXACT TEST\"",
      "\"EDUCATIONAL LEVEL\"",
      "\"ADIPOQ\"",
      "\"CABP5\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.6764705882352942,
    "sub_communities": []
  },
  "102": {
    "report_string": "# Genetic Regulation Community\n\nThe community consists of entities related to genetic regulation, including genes, molecular interactions like microRNA (MIRNA), and tools like MAGMA. These entities are interconnected through their roles in gene expression, variant identification, and complex trait association.\n\n## Genes and their role in heredity\n\nGenes are units of heredity passed from one generation to the next. They play a crucial role in determining traits and susceptibility to diseases. The entity 'GENE' in the community represents this concept.\n\n## MicroRNA (MIRNA) and gene regulation\n\nMIRNA is a type of molecular interaction that regulates gene expression by binding to target mRNAs. This process is vital for fine-tuning gene expression and is represented in the community as a relationship between 'GENE' and 'MIRNA'.\n\n## MAGMA and complex trait association\n\nMAGMA is a tool used to identify genes associated with complex traits. The community includes a relationship between 'GENE' and 'MAGMA', highlighting the importance of genetic analysis in understanding disease susceptibility.\n\n## Relationship between genes and SNPs\n\nSNPs (Single Nucleotide Polymorphisms) are genomic variants located within or near genes. The community acknowledges this relationship, indicating the significance of genetic variation in understanding disease mechanisms.",
    "report_json": {
      "title": "Genetic Regulation Community",
      "summary": "The community consists of entities related to genetic regulation, including genes, molecular interactions like microRNA (MIRNA), and tools like MAGMA. These entities are interconnected through their roles in gene expression, variant identification, and complex trait association.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the fundamental role of genes and molecular interactions in regulating biological processes.",
      "findings": [
        {
          "summary": "Genes and their role in heredity",
          "explanation": "Genes are units of heredity passed from one generation to the next. They play a crucial role in determining traits and susceptibility to diseases. The entity 'GENE' in the community represents this concept."
        },
        {
          "summary": "MicroRNA (MIRNA) and gene regulation",
          "explanation": "MIRNA is a type of molecular interaction that regulates gene expression by binding to target mRNAs. This process is vital for fine-tuning gene expression and is represented in the community as a relationship between 'GENE' and 'MIRNA'."
        },
        {
          "summary": "MAGMA and complex trait association",
          "explanation": "MAGMA is a tool used to identify genes associated with complex traits. The community includes a relationship between 'GENE' and 'MAGMA', highlighting the importance of genetic analysis in understanding disease susceptibility."
        },
        {
          "summary": "Relationship between genes and SNPs",
          "explanation": "SNPs (Single Nucleotide Polymorphisms) are genomic variants located within or near genes. The community acknowledges this relationship, indicating the significance of genetic variation in understanding disease mechanisms."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 102",
    "edges": [
      [
        "\"GENE\"",
        "\"MIRNA\""
      ],
      [
        "\"GENE\"",
        "\"MAGMA\""
      ],
      [
        "\"GENE\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"GENE\"",
      "\"MIRNA\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-521bed5210a0e902e5e59f17fccc1452"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "99": {
    "report_string": "# Carbohydrate Intake and Genomic Variants\n\nThe community revolves around carbohydrate intake and its associations with various genomic variants. Key entities include nutrient carbohydrate intake, and genomic variants such as SNP RS2815752 and SNP RS368794. These entities are interconnected through their roles in energy intake, obesity risk, and genetic influences on dietary behaviors.\n\n## Association between carbohydrate intake and genomic variants\n\nCarbohydrate intake is a nutrient associated with various genetic variants. Specifically, SNP rs2815752 and SNP rs368794 are genomic variants linked to carbohydrate intake. These associations suggest that genetic factors can influence dietary behaviors, potentially impacting obesity risk and energy intake.\n\n## SNP RS2815752 and carbohydrate intake\n\nSNP rs2815752 is a genomic variant associated with lower total energy intake. This variant's link to carbohydrate intake highlights the potential for genetic factors to influence nutrient intake and metabolism.\n\n## SNP RS368794 and carbohydrate intake\n\nSNP rs368794 is a genomic variant associated with higher carbohydrate intake. This association underscores the role of genetic factors in shaping dietary preferences and potentially influencing obesity risk.\n\n## Carbohydrate intake and obesity risk\n\nCarbohydrate intake is a nutrient associated with obesity risk. The connections between carbohydrate intake, genomic variants, and obesity risk emphasize the importance of considering genetic factors in dietary recommendations for obesity prevention and management.\n\n## Genetic influences on dietary behaviors\n\nThe relationships between carbohydrate intake, genomic variants, and energy intake illustrate the complex interplay between genetic and environmental factors in shaping dietary behaviors. Understanding these interactions can inform personalized nutrition approaches and obesity prevention strategies.",
    "report_json": {
      "title": "Carbohydrate Intake and Genomic Variants",
      "summary": "The community revolves around carbohydrate intake and its associations with various genomic variants. Key entities include nutrient carbohydrate intake, and genomic variants such as SNP RS2815752 and SNP RS368794. These entities are interconnected through their roles in energy intake, obesity risk, and genetic influences on dietary behaviors.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the associations between carbohydrate intake and genetic variants influencing energy intake and obesity risk.",
      "findings": [
        {
          "summary": "Association between carbohydrate intake and genomic variants",
          "explanation": "Carbohydrate intake is a nutrient associated with various genetic variants. Specifically, SNP rs2815752 and SNP rs368794 are genomic variants linked to carbohydrate intake. These associations suggest that genetic factors can influence dietary behaviors, potentially impacting obesity risk and energy intake."
        },
        {
          "summary": "SNP RS2815752 and carbohydrate intake",
          "explanation": "SNP rs2815752 is a genomic variant associated with lower total energy intake. This variant's link to carbohydrate intake highlights the potential for genetic factors to influence nutrient intake and metabolism."
        },
        {
          "summary": "SNP RS368794 and carbohydrate intake",
          "explanation": "SNP rs368794 is a genomic variant associated with higher carbohydrate intake. This association underscores the role of genetic factors in shaping dietary preferences and potentially influencing obesity risk."
        },
        {
          "summary": "Carbohydrate intake and obesity risk",
          "explanation": "Carbohydrate intake is a nutrient associated with obesity risk. The connections between carbohydrate intake, genomic variants, and obesity risk emphasize the importance of considering genetic factors in dietary recommendations for obesity prevention and management."
        },
        {
          "summary": "Genetic influences on dietary behaviors",
          "explanation": "The relationships between carbohydrate intake, genomic variants, and energy intake illustrate the complex interplay between genetic and environmental factors in shaping dietary behaviors. Understanding these interactions can inform personalized nutrition approaches and obesity prevention strategies."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 99",
    "edges": [
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS368794\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"FGF21\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS2815752\""
      ]
    ],
    "nodes": [
      "\"SNP RS368794\"",
      "\"SNP RS2815752\"",
      "\"CARBOHYDRATE INTAKE\""
    ],
    "chunk_ids": [
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-7c36aa6b71801f70e3b21a56383ca249"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "87": {
    "report_string": "# FTO Gene and Obesity Risk\n\nThe community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and related metabolic disorders. The FTO gene interacts with various entities, including IRX3, IGF-1, and MYF5, in muscle development and glucose homeostasis. The gene is also linked to hypertension, hypercholesterolemia, and type2 diabetes (T2D).\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants of the FTO gene, such as rs8050136 and rs3751812, have been linked to increased obesity risk. The gene's association with obesity phenotypes, including self-reported walking pace and physical activity, highlights its importance in understanding the genetic factors underlying obesity.\n\n## FTO gene and metabolic disorders\n\nThe FTO gene is associated with various metabolic disorders, including type2 diabetes (T2D), hypertension, and hypercholesterolemia. The gene's interaction with glucose homeostasis and insulin sensitivity highlights its role in metabolic health. Variants of the FTO gene have been linked to increased risk of T2D and other metabolic disorders.\n\n## FTO gene and muscle development\n\nThe FTO gene interacts with various genes involved in muscle development, including IRX3, IGF-1, MYF5, MYF6, MYOD1, and MYOG. These interactions suggest a role for FTO in regulating muscle development and function, which may contribute to its association with obesity and metabolic disorders.\n\n## FTO gene and dietary intake\n\nThe FTO gene is associated with dietary intake, including energy intake and fat mass. Variants of the FTO gene may influence dietary preferences and obesity risk. The gene's interaction with dietary factors highlights the importance of considering genetic factors in nutrition and obesity prevention.\n\n## FTO gene and hypertension\n\nThe FTO gene is associated with hypertension, a condition characterized by high blood pressure. The gene's interaction with obesity and metabolic disorders suggests a complex relationship between FTO, blood pressure regulation, and cardiovascular health.",
    "report_json": {
      "title": "FTO Gene and Obesity Risk",
      "summary": "The community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and related metabolic disorders. The FTO gene interacts with various entities, including IRX3, IGF-1, and MYF5, in muscle development and glucose homeostasis. The gene is also linked to hypertension, hypercholesterolemia, and type2 diabetes (T2D).",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of the FTO gene on obesity risk and related metabolic disorders.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants of the FTO gene, such as rs8050136 and rs3751812, have been linked to increased obesity risk. The gene's association with obesity phenotypes, including self-reported walking pace and physical activity, highlights its importance in understanding the genetic factors underlying obesity."
        },
        {
          "summary": "FTO gene and metabolic disorders",
          "explanation": "The FTO gene is associated with various metabolic disorders, including type2 diabetes (T2D), hypertension, and hypercholesterolemia. The gene's interaction with glucose homeostasis and insulin sensitivity highlights its role in metabolic health. Variants of the FTO gene have been linked to increased risk of T2D and other metabolic disorders."
        },
        {
          "summary": "FTO gene and muscle development",
          "explanation": "The FTO gene interacts with various genes involved in muscle development, including IRX3, IGF-1, MYF5, MYF6, MYOD1, and MYOG. These interactions suggest a role for FTO in regulating muscle development and function, which may contribute to its association with obesity and metabolic disorders."
        },
        {
          "summary": "FTO gene and dietary intake",
          "explanation": "The FTO gene is associated with dietary intake, including energy intake and fat mass. Variants of the FTO gene may influence dietary preferences and obesity risk. The gene's interaction with dietary factors highlights the importance of considering genetic factors in nutrition and obesity prevention."
        },
        {
          "summary": "FTO gene and hypertension",
          "explanation": "The FTO gene is associated with hypertension, a condition characterized by high blood pressure. The gene's interaction with obesity and metabolic disorders suggests a complex relationship between FTO, blood pressure regulation, and cardiovascular health."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 87",
    "edges": [
      [
        "\"BODY SHAPE\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF6\""
      ],
      [
        "\"FTO\"",
        "\"MYOD1\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"FTO\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"RS17817964\""
      ],
      [
        "\"MAFLD\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"IGF-1\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"HYPERCHOLESTEROLEMIA\""
      ],
      [
        "\"FM\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYOG\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"GENETIC EPIDEMIOLOGY\""
      ],
      [
        "\"FTO\"",
        "\"META-ANALYSES\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"FTO\""
      ],
      [
        "\"CHROMOSOME16\"",
        "\"FTO\""
      ],
      [
        "\"IRX3\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"RS12595985\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"FTO\"",
        "\"SKELETAL ROBUSTNESS\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF5\""
      ],
      [
        "\"FTO\"",
        "\"IRX3\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"SEX\""
      ],
      [
        "\"FTO\"",
        "\"PBF\""
      ],
      [
        "\"FTO\"",
        "\"GLUCOSE HOMEOSTASIS\""
      ],
      [
        "\"CHROMOSOME 16\"",
        "\"FTO\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"HYPERTENSION\""
      ],
      [
        "\"FTO\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"OBESITY GWAS GENES\""
      ]
    ],
    "nodes": [
      "\"FTO\"",
      "\"MYF5\"",
      "\"GENETIC EPIDEMIOLOGY\"",
      "\"PBF\"",
      "\"RS17817964\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"FM\"",
      "\"HYPERTENSION\"",
      "\"HYPERCHOLESTEROLEMIA\"",
      "\"MYOG\"",
      "\"MYF6\"",
      "\"IRX3\"",
      "\"RS8050136\"",
      "\"GLUCOSE HOMEOSTASIS\"",
      "\"RS12595985\"",
      "\"MYOD1\"",
      "\"META-ANALYSES\"",
      "\"IGF-1\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.5882352941176471,
    "sub_communities": []
  },
  "100": {
    "report_string": "# Genetic Variants and Obesity\n\nThe community revolves around genetic variants, particularly Single Nucleotide Polymorphisms (SNPs), and their associations with obesity and related traits. Key entities include SNPs, genes such as FTO, and concepts like minor allele frequency (MAF) and genome-wide association studies (GWAS). These entities are interconnected through their roles in genetic research, disease risk, and anthropometric traits.\n\n## SNPs and their role in obesity\n\nSNPs are genetic variants associated with obesity, and various studies have identified SNPs in genes such as FTO that are linked to body mass index (BMI) and obesity. For example, SNPs in the FTO gene have been associated with BMI variation and obesity risk.\n\n## GWAS and SNP identification\n\nGenome-wide association studies (GWAS) are used to identify genetic variants, including SNPs, associated with diseases and traits. GWAS has identified multiple SNPs associated with obesity and related traits, highlighting the importance of genetic research in understanding disease risk.\n\n## Minor Allele Frequency (MAF) and SNP analysis\n\nMinor Allele Frequency (MAF) is a measure of the frequency of a particular allele in a population, used to analyze genetic associations. MAF is used to select SNPs for studies and to evaluate the genetic equilibrium of a population.\n\n## dbSNP and genetic variant database\n\ndbSNP is a database of known genetic variants, including SNPs and indels. It provides a comprehensive resource for genetic research and variant analysis.\n\n## Genetic variation and anthropometric traits\n\nSNPs are a type of genetic variation used to analyze genetic associations with anthropometric traits. They are associated with various traits, including body fatness and skeletal robustness.",
    "report_json": {
      "title": "Genetic Variants and Obesity",
      "summary": "The community revolves around genetic variants, particularly Single Nucleotide Polymorphisms (SNPs), and their associations with obesity and related traits. Key entities include SNPs, genes such as FTO, and concepts like minor allele frequency (MAF) and genome-wide association studies (GWAS). These entities are interconnected through their roles in genetic research, disease risk, and anthropometric traits.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants on obesity risk and related traits.",
      "findings": [
        {
          "summary": "SNPs and their role in obesity",
          "explanation": "SNPs are genetic variants associated with obesity, and various studies have identified SNPs in genes such as FTO that are linked to body mass index (BMI) and obesity. For example, SNPs in the FTO gene have been associated with BMI variation and obesity risk."
        },
        {
          "summary": "GWAS and SNP identification",
          "explanation": "Genome-wide association studies (GWAS) are used to identify genetic variants, including SNPs, associated with diseases and traits. GWAS has identified multiple SNPs associated with obesity and related traits, highlighting the importance of genetic research in understanding disease risk."
        },
        {
          "summary": "Minor Allele Frequency (MAF) and SNP analysis",
          "explanation": "Minor Allele Frequency (MAF) is a measure of the frequency of a particular allele in a population, used to analyze genetic associations. MAF is used to select SNPs for studies and to evaluate the genetic equilibrium of a population."
        },
        {
          "summary": "dbSNP and genetic variant database",
          "explanation": "dbSNP is a database of known genetic variants, including SNPs and indels. It provides a comprehensive resource for genetic research and variant analysis."
        },
        {
          "summary": "Genetic variation and anthropometric traits",
          "explanation": "SNPs are a type of genetic variation used to analyze genetic associations with anthropometric traits. They are associated with various traits, including body fatness and skeletal robustness."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 100",
    "edges": [
      [
        "\"MINOR ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"SNP\""
      ],
      [
        "\"HARDY-WEINBERG EQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"SNP\""
      ],
      [
        "\"GENE\"",
        "\"SNP\""
      ],
      [
        "\"GENETIC VARIATION\"",
        "\"SNP\""
      ],
      [
        "\"LINKAGE DISEQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"ADCY3\"",
        "\"SNP\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"TMEM18\""
      ],
      [
        "\"DBSNP\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"INDEL\"",
        "\"SNP\""
      ],
      [
        "\"GENOTYPE\"",
        "\"SNP\""
      ],
      [
        "\"CTSS\"",
        "\"SNP\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"LD PLOT\"",
        "\"SNP\""
      ],
      [
        "\"HWE\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"SNP\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"MAF\"",
        "\"SNP\""
      ],
      [
        "\"LEP\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"GENOTYPING\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELE FREQUENCY\"",
      "\"GENOTYPING\"",
      "\"GENETIC VARIATION\"",
      "\"UVAM\"",
      "\"MAF\"",
      "\"DBSNP\"",
      "\"SNP\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.39705882352941174,
    "sub_communities": []
  },
  "86": {
    "report_string": "# Genomic Variants and Population Stratification\n\nThe community consists of GENOME-WIDE SNPS and PRINCIPAL COMPONENTS, which are interconnected through their roles in controlling population stratification in genetic analysis. GENOME-WIDE SNPS are used to generate PRINCIPAL COMPONENTS, which in turn are used to adjust for genetic variation in studies.\n\n## GENOME-WIDE SNPS and their role in population stratification\n\nGENOME-WIDE SNPS are genomic variants used to control for population stratification. They are used as covariates to adjust for genetic variation in studies, which is essential for identifying true associations between genetic variants and traits like BMI.\n\n## Relationship between GENOME-WIDE SNPS and PRINCIPAL COMPONENTS\n\nGENOME-WIDE SNPS are used to generate PRINCIPAL COMPONENTS, which are a method used to control for population stratification. This highlights the importance of GENOME-WIDE SNPS in genetic analysis and their application in generating covariates for studies.\n\n## Role of PRINCIPAL COMPONENTS in genetic analysis\n\nPRINCIPAL COMPONENTS are used to adjust for genetic variation in studies and control for population structure in genetic analysis. This demonstrates their utility in refining the accuracy of genetic association studies.\n\n## GENOME-WIDE SNPS and BMI association\n\nGenome-wide SNPs can be used as covariates to control for population stratification in the association with BMI. This shows the practical application of GENOME-WIDE SNPS in studies examining the relationship between genetic variants and BMI.",
    "report_json": {
      "title": "Genomic Variants and Population Stratification",
      "summary": "The community consists of GENOME-WIDE SNPS and PRINCIPAL COMPONENTS, which are interconnected through their roles in controlling population stratification in genetic analysis. GENOME-WIDE SNPS are used to generate PRINCIPAL COMPONENTS, which in turn are used to adjust for genetic variation in studies.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited scope and degree of the entities and their relationships in the community.",
      "findings": [
        {
          "summary": "GENOME-WIDE SNPS and their role in population stratification",
          "explanation": "GENOME-WIDE SNPS are genomic variants used to control for population stratification. They are used as covariates to adjust for genetic variation in studies, which is essential for identifying true associations between genetic variants and traits like BMI."
        },
        {
          "summary": "Relationship between GENOME-WIDE SNPS and PRINCIPAL COMPONENTS",
          "explanation": "GENOME-WIDE SNPS are used to generate PRINCIPAL COMPONENTS, which are a method used to control for population stratification. This highlights the importance of GENOME-WIDE SNPS in genetic analysis and their application in generating covariates for studies."
        },
        {
          "summary": "Role of PRINCIPAL COMPONENTS in genetic analysis",
          "explanation": "PRINCIPAL COMPONENTS are used to adjust for genetic variation in studies and control for population structure in genetic analysis. This demonstrates their utility in refining the accuracy of genetic association studies."
        },
        {
          "summary": "GENOME-WIDE SNPS and BMI association",
          "explanation": "Genome-wide SNPs can be used as covariates to control for population stratification in the association with BMI. This shows the practical application of GENOME-WIDE SNPS in studies examining the relationship between genetic variants and BMI."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 86",
    "edges": [
      [
        "\"GENOME-WIDE SNPS\"",
        "\"PRINCIPAL COMPONENTS\""
      ],
      [
        "\"BMI\"",
        "\"GENOME-WIDE SNPS\""
      ]
    ],
    "nodes": [
      "\"GENOME-WIDE SNPS\"",
      "\"PRINCIPAL COMPONENTS\""
    ],
    "chunk_ids": [
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e"
    ],
    "occurrence": 0.04411764705882353,
    "sub_communities": []
  },
  "101": {
    "report_string": "# Anthropometric Traits and Genetic Associations\n\nThe community revolves around anthropometric traits, which are influenced by genetic and environmental factors such as gender. Key entities include anthropometric traits, genetic variants (SNPs), and environmental factors like gender. These entities are interconnected through their roles in metabolic health, obesity, and genetic associations.\n\n## Anthropometric Traits and Genetic Associations\n\nAnthropometric traits are physiological processes related to body measurements, and their analysis is crucial for assessing an individual's health and physical characteristics. Genetic associations with anthropometric traits are identified through GWAS and SNPs, highlighting the complex interplay between genetics and metabolic health.\n\n## Role of Gender in Anthropometric Traits\n\nGender is an environmental factor that affects BMI, obesity, and anthropometric measures. The relationship between gender and anthropometric traits underscores the importance of considering gender in health assessments and interventions.\n\n## Childhood Obesity and Anthropometric Traits\n\nChildhood obesity is related to anthropometric traits, and early intervention is crucial for preventing long-term metabolic consequences. The connection between childhood obesity and anthropometric traits highlights the need for monitoring and addressing obesity in early life.\n\n## Impact of Age on Anthropometric Traits\n\nAge affects anthropometric measures, and understanding these changes is essential for developing age-specific health guidelines. The relationship between age and anthropometric traits emphasizes the need for life-course approaches to health and wellness.\n\n## Genetic Variants and Anthropometric Traits\n\nSNPs are used to analyze genetic associations with anthropometric traits, providing insights into the genetic underpinnings of metabolic health. The study of genetic variants and their impact on anthropometric traits can inform personalized interventions and disease prevention strategies.",
    "report_json": {
      "title": "Anthropometric Traits and Genetic Associations",
      "summary": "The community revolves around anthropometric traits, which are influenced by genetic and environmental factors such as gender. Key entities include anthropometric traits, genetic variants (SNPs), and environmental factors like gender. These entities are interconnected through their roles in metabolic health, obesity, and genetic associations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on anthropometric traits and metabolic health.",
      "findings": [
        {
          "summary": "Anthropometric Traits and Genetic Associations",
          "explanation": "Anthropometric traits are physiological processes related to body measurements, and their analysis is crucial for assessing an individual's health and physical characteristics. Genetic associations with anthropometric traits are identified through GWAS and SNPs, highlighting the complex interplay between genetics and metabolic health."
        },
        {
          "summary": "Role of Gender in Anthropometric Traits",
          "explanation": "Gender is an environmental factor that affects BMI, obesity, and anthropometric measures. The relationship between gender and anthropometric traits underscores the importance of considering gender in health assessments and interventions."
        },
        {
          "summary": "Childhood Obesity and Anthropometric Traits",
          "explanation": "Childhood obesity is related to anthropometric traits, and early intervention is crucial for preventing long-term metabolic consequences. The connection between childhood obesity and anthropometric traits highlights the need for monitoring and addressing obesity in early life."
        },
        {
          "summary": "Impact of Age on Anthropometric Traits",
          "explanation": "Age affects anthropometric measures, and understanding these changes is essential for developing age-specific health guidelines. The relationship between age and anthropometric traits emphasizes the need for life-course approaches to health and wellness."
        },
        {
          "summary": "Genetic Variants and Anthropometric Traits",
          "explanation": "SNPs are used to analyze genetic associations with anthropometric traits, providing insights into the genetic underpinnings of metabolic health. The study of genetic variants and their impact on anthropometric traits can inform personalized interventions and disease prevention strategies."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 101",
    "edges": [
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"GENDER\"",
        "\"MAFLD\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GENDER\""
      ],
      [
        "\"AGE\"",
        "\"ANTHROPOMETRIC TRAITS\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GWAS\""
      ]
    ],
    "nodes": [
      "\"ANTHROPOMETRIC TRAITS\"",
      "\"GENDER\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "97": {
    "report_string": "# Thyroid Cancer Risk Factors and Genetic Associations\n\nThe community revolves around thyroid cancer and its associations with genetic variants, physiological processes, and risk factors such as obesity and overweight. Key entities include thyroid cancer, genetic variants like rs17817288, rs9937053, rs12149832, and rs1861867, and physiological processes like the codominant, dominant, and recessive models. These entities are interconnected through their roles in assessing and influencing thyroid cancer risk.\n\n## Genetic variants associated with thyroid cancer risk\n\nSeveral genetic variants, including rs17817288, rs9937053, rs12149832, and rs1861867, are associated with thyroid cancer risk. These variants have been identified through genome-wide association studies and are linked to increased risk, particularly in overweight and obese individuals.\n\n## Role of obesity and overweight in thyroid cancer risk\n\nObesity and overweight are significant risk factors for thyroid cancer. The relationship between body mass index (BMI) and thyroid cancer risk is well-established, with higher BMI values associated with increased risk. This highlights the importance of maintaining a healthy weight in reducing thyroid cancer risk.\n\n## Genetic models for assessing thyroid cancer risk\n\nThe codominant, dominant, and recessive models are statistical models used to assess the association between genetic variants and thyroid cancer risk. These models help researchers understand the genetic architecture of thyroid cancer and identify individuals at increased risk.\n\n## rs17817288 and its association with thyroid cancer risk\n\nThe rs17817288 SNP has a combined p-value of 5.441011 and predicted enhancer activity, indicating its potential role in regulating gene expression associated with thyroid cancer risk. This variant is particularly significant in overweight and obese individuals.\n\n## Importance of BMI in thyroid cancer risk assessment\n\nBMI is a critical factor in assessing thyroid cancer risk, with overweight and obesity increasing risk. This relationship underscores the need for lifestyle interventions aimed at weight management to reduce thyroid cancer risk.",
    "report_json": {
      "title": "Thyroid Cancer Risk Factors and Genetic Associations",
      "summary": "The community revolves around thyroid cancer and its associations with genetic variants, physiological processes, and risk factors such as obesity and overweight. Key entities include thyroid cancer, genetic variants like rs17817288, rs9937053, rs12149832, and rs1861867, and physiological processes like the codominant, dominant, and recessive models. These entities are interconnected through their roles in assessing and influencing thyroid cancer risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations between genetic variants, obesity, and thyroid cancer risk.",
      "findings": [
        {
          "summary": "Genetic variants associated with thyroid cancer risk",
          "explanation": "Several genetic variants, including rs17817288, rs9937053, rs12149832, and rs1861867, are associated with thyroid cancer risk. These variants have been identified through genome-wide association studies and are linked to increased risk, particularly in overweight and obese individuals."
        },
        {
          "summary": "Role of obesity and overweight in thyroid cancer risk",
          "explanation": "Obesity and overweight are significant risk factors for thyroid cancer. The relationship between body mass index (BMI) and thyroid cancer risk is well-established, with higher BMI values associated with increased risk. This highlights the importance of maintaining a healthy weight in reducing thyroid cancer risk."
        },
        {
          "summary": "Genetic models for assessing thyroid cancer risk",
          "explanation": "The codominant, dominant, and recessive models are statistical models used to assess the association between genetic variants and thyroid cancer risk. These models help researchers understand the genetic architecture of thyroid cancer and identify individuals at increased risk."
        },
        {
          "summary": "rs17817288 and its association with thyroid cancer risk",
          "explanation": "The rs17817288 SNP has a combined p-value of 5.441011 and predicted enhancer activity, indicating its potential role in regulating gene expression associated with thyroid cancer risk. This variant is particularly significant in overweight and obese individuals."
        },
        {
          "summary": "Importance of BMI in thyroid cancer risk assessment",
          "explanation": "BMI is a critical factor in assessing thyroid cancer risk, with overweight and obesity increasing risk. This relationship underscores the need for lifestyle interventions aimed at weight management to reduce thyroid cancer risk."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 97",
    "edges": [
      [
        "\"OVERWEIGHT\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"DOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"ORS\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS17817288\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS1861867\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS12149832\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"CODOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"SNP\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RECESSIVE MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS9937053\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ]
    ],
    "nodes": [
      "\"RS17817288\"",
      "\"RS1861867\"",
      "\"DOMINANT MODEL\"",
      "\"RS9937053\"",
      "\"RECESSIVE MODEL\"",
      "\"THYROID CANCER\"",
      "\"RS12149832\"",
      "\"OVERWEIGHT\"",
      "\"CODOMINANT MODEL\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "90": {
    "report_string": "# FTO SNPs and Obesity Risk\n\nThe community revolves around FTO SNPs, which are genetic variants associated with obesity risk. These variants are linked to BMI, abdominal obesity, and high waist-to-hip ratio (WHR), and their effects can be modulated by dietary patterns. The community includes various ethnic groups, such as African-Americans, Chinese, and Caucasians, who show different levels of association with FTO SNPs.\n\n## Association of FTO SNPs with Obesity Risk\n\nFTO SNPs are strongly associated with obesity risk, including BMI and abdominal obesity. These genetic variants have been linked to obesity traits in various populations, with significant associations in Caucasians and marginal associations in non-Caucasian populations.\n\n## FTO SNPs and Genetic Differentiation\n\nFTO SNPs show varying levels of genetic differentiation among populations, influencing obesity traits. This highlights the importance of considering population-specific genetic factors in obesity risk assessment.\n\n## Role of Dietary Patterns in Modulating FTO SNP Effects\n\nThe effects of FTO SNPs on obesity risk can be modulated by dietary patterns. This suggests that personalized dietary recommendations may be necessary to mitigate the risk of obesity in individuals with certain FTO SNP genotypes.\n\n## FTO SNPs and High WHR\n\nFTO SNPs are associated with high WHR risk, and their effects can be modulated by dietary patterns. High WHR is a disease characterized by a high waist-to-hip ratio, which can be influenced by genetic and environmental factors.\n\n## Population-Specific Associations of FTO SNPs\n\nFTO SNPs show different levels of association with obesity traits in various ethnic groups, including African-Americans, Chinese, and Caucasians. This highlights the importance of considering population-specific genetic factors in obesity risk assessment.",
    "report_json": {
      "title": "FTO SNPs and Obesity Risk",
      "summary": "The community revolves around FTO SNPs, which are genetic variants associated with obesity risk. These variants are linked to BMI, abdominal obesity, and high waist-to-hip ratio (WHR), and their effects can be modulated by dietary patterns. The community includes various ethnic groups, such as African-Americans, Chinese, and Caucasians, who show different levels of association with FTO SNPs.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of FTO SNPs with obesity risk and their potential modulation by dietary patterns.",
      "findings": [
        {
          "summary": "Association of FTO SNPs with Obesity Risk",
          "explanation": "FTO SNPs are strongly associated with obesity risk, including BMI and abdominal obesity. These genetic variants have been linked to obesity traits in various populations, with significant associations in Caucasians and marginal associations in non-Caucasian populations."
        },
        {
          "summary": "FTO SNPs and Genetic Differentiation",
          "explanation": "FTO SNPs show varying levels of genetic differentiation among populations, influencing obesity traits. This highlights the importance of considering population-specific genetic factors in obesity risk assessment."
        },
        {
          "summary": "Role of Dietary Patterns in Modulating FTO SNP Effects",
          "explanation": "The effects of FTO SNPs on obesity risk can be modulated by dietary patterns. This suggests that personalized dietary recommendations may be necessary to mitigate the risk of obesity in individuals with certain FTO SNP genotypes."
        },
        {
          "summary": "FTO SNPs and High WHR",
          "explanation": "FTO SNPs are associated with high WHR risk, and their effects can be modulated by dietary patterns. High WHR is a disease characterized by a high waist-to-hip ratio, which can be influenced by genetic and environmental factors."
        },
        {
          "summary": "Population-Specific Associations of FTO SNPs",
          "explanation": "FTO SNPs show different levels of association with obesity traits in various ethnic groups, including African-Americans, Chinese, and Caucasians. This highlights the importance of considering population-specific genetic factors in obesity risk assessment."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 90",
    "edges": [
      [
        "\"FTO SNPS\"",
        "\"HIGH WHR\""
      ],
      [
        "\"HIGH WHR\"",
        "\"MDS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"CHINESE\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"GENETIC DIFFERENTIATION\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"AFRICAN-AMERICANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HARDY WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MINOR ALLELE FREQUENCIES\""
      ],
      [
        "\"FTO SNPS\"",
        "\"TRAIT ANXIETY\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"OBESITY\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MDS\""
      ],
      [
        "\"EATING DISORDER\"",
        "\"FTO SNPS\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELE FREQUENCIES\"",
      "\"HARDY WEINBERG EQUILIBRIUM\"",
      "\"FTO SNPS\"",
      "\"TRAIT ANXIETY\"",
      "\"CHINESE\"",
      "\"AFRICAN-AMERICANS\"",
      "\"GENETIC DIFFERENTIATION\"",
      "\"HIGH WHR\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-6c935916492da41e4048751fc4c84348"
    ],
    "occurrence": 0.08823529411764706,
    "sub_communities": []
  },
  "92": {
    "report_string": "# Genetic Associations with Obesity in Hispanic-Americans\n\nThe community revolves around the genetic associations with obesity traits in Hispanic-Americans, specifically focusing on the FTO gene and its variant rs7201444. This variant shows marginally significant associations with obesity traits in this ethnic group.\n\n## FTO gene and its variant rs7201444 in Hispanic-Americans\n\nThe FTO gene is associated with obesity traits, and the variant rs7201444 is specifically noted in Hispanic-Americans. This SNP shows marginally significant associations with obesity traits, highlighting a potential genetic risk factor for this population.\n\n## Relationship between FTO SNPs and Hispanic-Americans\n\nFTO SNPs, including rs7201444, have been studied in Hispanic-Americans for their associations with obesity traits. This relationship underscores the importance of genetic factors in understanding obesity in this ethnic group.\n\n## Specificity of rs7201444 to Hispanic-Americans\n\nThe rs7201444 variant of the FTO gene is specifically mentioned in the context of Hispanic-Americans. This specificity suggests that genetic associations with obesity may vary by ethnic group, highlighting the need for population-specific studies.\n\n## Marginally significant associations with obesity traits\n\nThe associations between rs7201444 and obesity traits in Hispanic-Americans are described as marginally significant. This indicates that while there is some evidence supporting a link, further research is needed to fully understand the impact of this variant on obesity risk.\n\n## Implications for obesity risk in Hispanic-Americans\n\nThe identification of rs7201444 as a risk factor for obesity in Hispanic-Americans has implications for public health and personalized medicine. It suggests that genetic screening and tailored interventions may be beneficial in managing obesity risk in this population.",
    "report_json": {
      "title": "Genetic Associations with Obesity in Hispanic-Americans",
      "summary": "The community revolves around the genetic associations with obesity traits in Hispanic-Americans, specifically focusing on the FTO gene and its variant rs7201444. This variant shows marginally significant associations with obesity traits in this ethnic group.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but marginally significant associations of the FTO SNP rs7201444 with obesity traits in Hispanic-Americans.",
      "findings": [
        {
          "summary": "FTO gene and its variant rs7201444 in Hispanic-Americans",
          "explanation": "The FTO gene is associated with obesity traits, and the variant rs7201444 is specifically noted in Hispanic-Americans. This SNP shows marginally significant associations with obesity traits, highlighting a potential genetic risk factor for this population."
        },
        {
          "summary": "Relationship between FTO SNPs and Hispanic-Americans",
          "explanation": "FTO SNPs, including rs7201444, have been studied in Hispanic-Americans for their associations with obesity traits. This relationship underscores the importance of genetic factors in understanding obesity in this ethnic group."
        },
        {
          "summary": "Specificity of rs7201444 to Hispanic-Americans",
          "explanation": "The rs7201444 variant of the FTO gene is specifically mentioned in the context of Hispanic-Americans. This specificity suggests that genetic associations with obesity may vary by ethnic group, highlighting the need for population-specific studies."
        },
        {
          "summary": "Marginally significant associations with obesity traits",
          "explanation": "The associations between rs7201444 and obesity traits in Hispanic-Americans are described as marginally significant. This indicates that while there is some evidence supporting a link, further research is needed to fully understand the impact of this variant on obesity risk."
        },
        {
          "summary": "Implications for obesity risk in Hispanic-Americans",
          "explanation": "The identification of rs7201444 as a risk factor for obesity in Hispanic-Americans has implications for public health and personalized medicine. It suggests that genetic screening and tailored interventions may be beneficial in managing obesity risk in this population."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 92",
    "edges": [
      [
        "\"FTO SNPS\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"HISPANIC-AMERICANS\"",
        "\"RS7201444\""
      ]
    ],
    "nodes": [
      "\"RS7201444\"",
      "\"HISPANIC-AMERICANS\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-925f77b6b7102d795bffeed55b127dbf"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "89": {
    "report_string": "# Genetic and Physiological Factors in Obesity and Impulsivity\n\nThe community revolves around the FTO gene, impulsivity traits, and their associations with BMI, obesity risk, and MAFLD. Key entities include the RS3751812 genomic variant, impulsivity traits, and the FTO gene, which are interconnected through their roles in influencing BMI, impulsivity, and disease risk.\n\n## RS3751812 variant and its association with BMI and obesity\n\nThe RS3751812 variant in the FTO gene is associated with BMI and obesity risk. This genomic variant has a low allele frequency of 4.4% and is linked to increased risk of MAFLD. The FTO gene's role in obesity highlights the importance of genetic factors in metabolic health.\n\n## Impulsivity traits and their relationship with BMI and genetics\n\nImpulsivity traits are physiological processes associated with BMI and influenced by genetic factors, including the FTO gene. The relationship between impulsivity traits and BMI suggests that genetic variants like RS3751812 may contribute to both impulsivity and obesity risk.\n\n## FTO gene and its role in impulsivity traits and obesity\n\nThe FTO gene is associated with impulsivity traits, including delay discounting of rewards and negative urgency. This gene's link to RS3751812 and obesity risk underscores the complex interplay between genetic and physiological factors in metabolic health.\n\n## RS3751812 variant and its association with MAFLD\n\nThe T allele of RS3751812 is associated with increased risk of MAFLD, highlighting the potential impact of this genomic variant on liver health and metabolic disease risk.\n\n## Interplay between genetic and physiological factors in obesity and impulsivity\n\nThe community's entities are interconnected through their roles in influencing BMI, impulsivity, and disease risk. Understanding these relationships can inform personalized interventions for obesity and metabolic health, taking into account both genetic and physiological factors.",
    "report_json": {
      "title": "Genetic and Physiological Factors in Obesity and Impulsivity",
      "summary": "The community revolves around the FTO gene, impulsivity traits, and their associations with BMI, obesity risk, and MAFLD. Key entities include the RS3751812 genomic variant, impulsivity traits, and the FTO gene, which are interconnected through their roles in influencing BMI, impulsivity, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and physiological factors on obesity risk and impulsivity traits.",
      "findings": [
        {
          "summary": "RS3751812 variant and its association with BMI and obesity",
          "explanation": "The RS3751812 variant in the FTO gene is associated with BMI and obesity risk. This genomic variant has a low allele frequency of 4.4% and is linked to increased risk of MAFLD. The FTO gene's role in obesity highlights the importance of genetic factors in metabolic health."
        },
        {
          "summary": "Impulsivity traits and their relationship with BMI and genetics",
          "explanation": "Impulsivity traits are physiological processes associated with BMI and influenced by genetic factors, including the FTO gene. The relationship between impulsivity traits and BMI suggests that genetic variants like RS3751812 may contribute to both impulsivity and obesity risk."
        },
        {
          "summary": "FTO gene and its role in impulsivity traits and obesity",
          "explanation": "The FTO gene is associated with impulsivity traits, including delay discounting of rewards and negative urgency. This gene's link to RS3751812 and obesity risk underscores the complex interplay between genetic and physiological factors in metabolic health."
        },
        {
          "summary": "RS3751812 variant and its association with MAFLD",
          "explanation": "The T allele of RS3751812 is associated with increased risk of MAFLD, highlighting the potential impact of this genomic variant on liver health and metabolic disease risk."
        },
        {
          "summary": "Interplay between genetic and physiological factors in obesity and impulsivity",
          "explanation": "The community's entities are interconnected through their roles in influencing BMI, impulsivity, and disease risk. Understanding these relationships can inform personalized interventions for obesity and metabolic health, taking into account both genetic and physiological factors."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 89",
    "edges": [
      [
        "\"MAFLD\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"IMPULSIVITY TRAITS\"",
        "\"RS3751812\""
      ],
      [
        "\"OBESITY RISK\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"IMPULSIVITY TRAITS\""
      ]
    ],
    "nodes": [
      "\"IMPULSIVITY TRAITS\"",
      "\"RS3751812\""
    ],
    "chunk_ids": [
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.10294117647058823,
    "sub_communities": []
  },
  "96": {
    "report_string": "# Statistical Measures in Thyroid Cancer Association Studies\n\nThe community consists of entities related to statistical measures used in assessing associations between risk factors and thyroid cancer. The key entities are 'ORs' (Odds Ratios), '95% CIs' (Confidence Intervals), and their relationships to thyroid cancer. ORs are used to describe the association between risk factors and disease, while 95% CIs assess the precision of these estimates.\n\n## Role of ORs in assessing risk factors for thyroid cancer\n\nORs (Odds Ratios) are statistical measures used to assess the association between risk factors and thyroid cancer. They provide a quantitative measure of the strength of association between a particular risk factor and the occurrence of thyroid cancer.\n\n## Importance of 95% CIs in estimating precision\n\n95% CIs (Confidence Intervals) are used to assess the precision of OR estimates. A 95% CI that does not include 1 indicates a statistically significant association between the risk factor and thyroid cancer.\n\n## Relationship between ORs and 95% CIs\n\nThe relationship between ORs and 95% CIs is crucial in epidemiological studies. ORs provide the estimated effect size, while 95% CIs provide a range of plausible values for the true effect size, thereby offering insight into the precision of the estimates.",
    "report_json": {
      "title": "Statistical Measures in Thyroid Cancer Association Studies",
      "summary": "The community consists of entities related to statistical measures used in assessing associations between risk factors and thyroid cancer. The key entities are 'ORs' (Odds Ratios), '95% CIs' (Confidence Intervals), and their relationships to thyroid cancer. ORs are used to describe the association between risk factors and disease, while 95% CIs assess the precision of these estimates.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited scope of entities and their relationships provided.",
      "findings": [
        {
          "summary": "Role of ORs in assessing risk factors for thyroid cancer",
          "explanation": "ORs (Odds Ratios) are statistical measures used to assess the association between risk factors and thyroid cancer. They provide a quantitative measure of the strength of association between a particular risk factor and the occurrence of thyroid cancer."
        },
        {
          "summary": "Importance of 95% CIs in estimating precision",
          "explanation": "95% CIs (Confidence Intervals) are used to assess the precision of OR estimates. A 95% CI that does not include 1 indicates a statistically significant association between the risk factor and thyroid cancer."
        },
        {
          "summary": "Relationship between ORs and 95% CIs",
          "explanation": "The relationship between ORs and 95% CIs is crucial in epidemiological studies. ORs provide the estimated effect size, while 95% CIs provide a range of plausible values for the true effect size, thereby offering insight into the precision of the estimates."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 96",
    "edges": [
      [
        "\"ORS\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"95% CIS\"",
        "\"ORS\""
      ]
    ],
    "nodes": [
      "\"ORS\"",
      "\"95% CIS\""
    ],
    "chunk_ids": [
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-13eed85551aee8769bdd7d566a9388a3"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "88": {
    "report_string": "# Genetic Factors in Bipolar Disorder and Obesity\n\nThe community revolves around genetic factors associated with bipolar disorder and obesity. Key entities include the RPGRIP1L gene, FTO gene, and bipolar disorder. These entities are interconnected through their roles in genetic associations and chromosomal locations.\n\n## RPGRIP1L gene and its association with bipolar disorder\n\nThe RPGRIP1L gene is associated with bipolar disorder, a mental health condition characterized by extreme mood swings. This gene is located downstream of FTO on chromosome 16 and has SNPs at specific positions, highlighting its potential role in the disorder.\n\n## FTO gene and its relationship with RPGRIP1L and bipolar disorder\n\nThe FTO gene is associated with bipolar disorder, and RPGRIP1L is located downstream of FTO on chromosome 16. Variants in the FTO gene have been linked to bipolar disorder, suggesting a potential genetic link between these entities.\n\n## RPGRIP1L and FTO genes in the context of obesity\n\nRPGRIP1L, along with IRX3, IRX5, IRX6, and FTO, is located in a 2 Mb region associated with obesity. This highlights the potential for these genes to contribute to obesity risk, which is often comorbid with bipolar disorder.\n\n## RPGRIP1L gene and its genetic variations\n\nThe RPGRIP1L gene has SNPs located at position 53710931, which may influence its function or association with bipolar disorder and obesity. Understanding these variations can provide insights into the genetic underpinnings of these conditions.\n\n## Bipolar disorder and genetic associations\n\nBipolar disorder is associated with variants in the RPGRIP1L and FTO genes. This underscores the complex genetic landscape of the disorder and the potential for targeted therapeutic approaches based on genetic profiles.",
    "report_json": {
      "title": "Genetic Factors in Bipolar Disorder and Obesity",
      "summary": "The community revolves around genetic factors associated with bipolar disorder and obesity. Key entities include the RPGRIP1L gene, FTO gene, and bipolar disorder. These entities are interconnected through their roles in genetic associations and chromosomal locations.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the association of genetic variants with bipolar disorder and obesity, indicating a potential influence on health and disease.",
      "findings": [
        {
          "summary": "RPGRIP1L gene and its association with bipolar disorder",
          "explanation": "The RPGRIP1L gene is associated with bipolar disorder, a mental health condition characterized by extreme mood swings. This gene is located downstream of FTO on chromosome 16 and has SNPs at specific positions, highlighting its potential role in the disorder."
        },
        {
          "summary": "FTO gene and its relationship with RPGRIP1L and bipolar disorder",
          "explanation": "The FTO gene is associated with bipolar disorder, and RPGRIP1L is located downstream of FTO on chromosome 16. Variants in the FTO gene have been linked to bipolar disorder, suggesting a potential genetic link between these entities."
        },
        {
          "summary": "RPGRIP1L and FTO genes in the context of obesity",
          "explanation": "RPGRIP1L, along with IRX3, IRX5, IRX6, and FTO, is located in a 2 Mb region associated with obesity. This highlights the potential for these genes to contribute to obesity risk, which is often comorbid with bipolar disorder."
        },
        {
          "summary": "RPGRIP1L gene and its genetic variations",
          "explanation": "The RPGRIP1L gene has SNPs located at position 53710931, which may influence its function or association with bipolar disorder and obesity. Understanding these variations can provide insights into the genetic underpinnings of these conditions."
        },
        {
          "summary": "Bipolar disorder and genetic associations",
          "explanation": "Bipolar disorder is associated with variants in the RPGRIP1L and FTO genes. This underscores the complex genetic landscape of the disorder and the potential for targeted therapeutic approaches based on genetic profiles."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 88",
    "edges": [
      [
        "\"BIPOLAR DISORDER\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"IRX3\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ]
    ],
    "nodes": [
      "\"BIPOLAR DISORDER\"",
      "\"RPGRIP1L\""
    ],
    "chunk_ids": [
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-8743fb6113d9382f66ada1dbf201090b"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "104": {
    "report_string": "# TCF7L2 and Type2 Diabetes: Genetic Associations\n\nThe community centers around TCF7L2, a gene associated with type2 diabetes (T2D) and glucose homeostasis. TCF7L2 is located on chromosome10 and has variants significantly linked to T2DM, particularly among Ghanaians, Cameroonians, and Nigerians. The WTCCC GWAS dataset provides genetic association data for T2D, including TCF7L2.\n\n## TCF7L2 gene and type2 diabetes association\n\nTCF7L2 is a gene located on chromosome10 and is significantly associated with an increased risk of type2 diabetes. Variants of TCF7L2 have been linked to T2DM among various populations, including Ghanaians, Cameroonians, and Nigerians. This gene plays a critical role in glucose homeostasis, which is a key factor in type2 diabetes risk.\n\n## TCF7L2 involvement in glucose homeostasis\n\nTCF7L2 is involved in glucose homeostasis, which is crucial for maintaining normal blood glucose levels. The gene's association with type2 diabetes underscores the importance of genetic factors in metabolic health. Variants of TCF7L2 can disrupt normal glucose regulation, leading to increased disease risk.\n\n## WTCCC GWAS dataset and genetic associations\n\nThe WTCCC GWAS dataset provides valuable genetic association data for type2 diabetes, including TCF7L2. This dataset has reported associations between TCF7L2 and T2D, highlighting the gene's significance in disease pathology. The dataset is a critical resource for understanding genetic contributions to type2 diabetes.\n\n## Chromosome10 and TCF7L2 location\n\nTCF7L2 is located on chromosome10, which is a key piece of information for understanding the gene's role in type2 diabetes. The location of TCF7L2 on chromosome10 has been consistently reported and is fundamental to its genetic association studies.",
    "report_json": {
      "title": "TCF7L2 and Type2 Diabetes: Genetic Associations",
      "summary": "The community centers around TCF7L2, a gene associated with type2 diabetes (T2D) and glucose homeostasis. TCF7L2 is located on chromosome10 and has variants significantly linked to T2DM, particularly among Ghanaians, Cameroonians, and Nigerians. The WTCCC GWAS dataset provides genetic association data for T2D, including TCF7L2.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to TCF7L2's significant association with type2 diabetes risk and its role in glucose homeostasis.",
      "findings": [
        {
          "summary": "TCF7L2 gene and type2 diabetes association",
          "explanation": "TCF7L2 is a gene located on chromosome10 and is significantly associated with an increased risk of type2 diabetes. Variants of TCF7L2 have been linked to T2DM among various populations, including Ghanaians, Cameroonians, and Nigerians. This gene plays a critical role in glucose homeostasis, which is a key factor in type2 diabetes risk."
        },
        {
          "summary": "TCF7L2 involvement in glucose homeostasis",
          "explanation": "TCF7L2 is involved in glucose homeostasis, which is crucial for maintaining normal blood glucose levels. The gene's association with type2 diabetes underscores the importance of genetic factors in metabolic health. Variants of TCF7L2 can disrupt normal glucose regulation, leading to increased disease risk."
        },
        {
          "summary": "WTCCC GWAS dataset and genetic associations",
          "explanation": "The WTCCC GWAS dataset provides valuable genetic association data for type2 diabetes, including TCF7L2. This dataset has reported associations between TCF7L2 and T2D, highlighting the gene's significance in disease pathology. The dataset is a critical resource for understanding genetic contributions to type2 diabetes."
        },
        {
          "summary": "Chromosome10 and TCF7L2 location",
          "explanation": "TCF7L2 is located on chromosome10, which is a key piece of information for understanding the gene's role in type2 diabetes. The location of TCF7L2 on chromosome10 has been consistently reported and is fundamental to its genetic association studies."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 104",
    "edges": [
      [
        "\"TSPAN8\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"T2D\"",
        "\"TCF7L2\""
      ],
      [
        "\"TCF7L2\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CHROMOSOME 10\"",
        "\"TCF7L2\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CHROMOSOME10\"",
        "\"TCF7L2\""
      ]
    ],
    "nodes": [
      "\"TCF7L2\"",
      "\"WTCCC GWAS DATASET\"",
      "\"CHROMOSOME 10\"",
      "\"CHROMOSOME10\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce"
    ],
    "occurrence": 0.10294117647058823,
    "sub_communities": []
  },
  "103": {
    "report_string": "# Type2 Diabetes and Associated Genetic and Environmental Factors\n\nThe community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and impaired insulin secretion. Key entities include T2D, CAD (Coronary Artery Disease), genetic variants like RS7723, and biological processes such as pancreas development and apolipoprotein binding. These entities are interconnected through their roles in disease susceptibility, risk prediction, and metabolic regulation.\n\n## T2D and its association with genetic variants\n\nT2D is associated with various genetic variants, including RS7723, which is linked to metabolomics regulation. This highlights the importance of genetic factors in T2D susceptibility and the potential for targeted interventions based on genetic profiles.\n\n## The role of pancreas development in T2D\n\nPancreas development is a biological process that affects T2D susceptibility. Impaired pancreas development can lead to reduced insulin secretion, increasing the risk of T2D. This underscores the need for early intervention and prevention strategies that target pancreas health.\n\n## The relationship between T2D and CAD\n\nT2D and CAD are associated with increased risk of cardiovascular disease. This relationship highlights the importance of managing T2D to prevent CAD and the need for comprehensive treatment plans that address both conditions.\n\n## The impact of childhood obesity on T2D and CAD\n\nChildhood obesity is a risk factor for both T2D and CAD. This emphasizes the need for early intervention and prevention strategies that target obesity and related metabolic disorders.\n\n## The role of risk markers in T2D prediction\n\nRisk markers are used to predict the risk of T2D. The use of these markers can help identify individuals at high risk and enable targeted interventions to prevent or delay disease onset.",
    "report_json": {
      "title": "Type2 Diabetes and Associated Genetic and Environmental Factors",
      "summary": "The community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and impaired insulin secretion. Key entities include T2D, CAD (Coronary Artery Disease), genetic variants like RS7723, and biological processes such as pancreas development and apolipoprotein binding. These entities are interconnected through their roles in disease susceptibility, risk prediction, and metabolic regulation.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2D risk and management.",
      "findings": [
        {
          "summary": "T2D and its association with genetic variants",
          "explanation": "T2D is associated with various genetic variants, including RS7723, which is linked to metabolomics regulation. This highlights the importance of genetic factors in T2D susceptibility and the potential for targeted interventions based on genetic profiles."
        },
        {
          "summary": "The role of pancreas development in T2D",
          "explanation": "Pancreas development is a biological process that affects T2D susceptibility. Impaired pancreas development can lead to reduced insulin secretion, increasing the risk of T2D. This underscores the need for early intervention and prevention strategies that target pancreas health."
        },
        {
          "summary": "The relationship between T2D and CAD",
          "explanation": "T2D and CAD are associated with increased risk of cardiovascular disease. This relationship highlights the importance of managing T2D to prevent CAD and the need for comprehensive treatment plans that address both conditions."
        },
        {
          "summary": "The impact of childhood obesity on T2D and CAD",
          "explanation": "Childhood obesity is a risk factor for both T2D and CAD. This emphasizes the need for early intervention and prevention strategies that target obesity and related metabolic disorders."
        },
        {
          "summary": "The role of risk markers in T2D prediction",
          "explanation": "Risk markers are used to predict the risk of T2D. The use of these markers can help identify individuals at high risk and enable targeted interventions to prevent or delay disease onset."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 103",
    "edges": [
      [
        "\"CHILDHOOD OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"GWAS\"",
        "\"T2D\""
      ],
      [
        "\"T2D\"",
        "\"TSPAN8\""
      ],
      [
        "\"L3MBTL3\"",
        "\"T2D\""
      ],
      [
        "\"T2D\"",
        "\"TCF7L2\""
      ],
      [
        "\"RS7723\"",
        "\"T2D\""
      ],
      [
        "\"RISK MARKERS\"",
        "\"T2D\""
      ],
      [
        "\"CAD\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"CAD\"",
        "\"T2D\""
      ],
      [
        "\"CELF4\"",
        "\"T2D\""
      ],
      [
        "\"RUNX1\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"PANCREAS DEVELOPMENT\"",
        "\"T2D\""
      ],
      [
        "\"APOLIPOPROTEIN BINDING\"",
        "\"CAD\""
      ],
      [
        "\"NRI\"",
        "\"T2D\""
      ]
    ],
    "nodes": [
      "\"T2D\"",
      "\"RS7723\"",
      "\"APOLIPOPROTEIN BINDING\"",
      "\"CAD\"",
      "\"PANCREAS DEVELOPMENT\"",
      "\"RISK MARKERS\"",
      "\"NRI\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-6f4c442093f64b0adfa1c090d805321b",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-49cf6074543d5f5d4e9ea8750a88794c",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.14705882352941177,
    "sub_communities": []
  },
  "85": {
    "report_string": "# Obesity and BMI Related Physiological States\n\nThe community consists of two key entities: 'EXTREME OBESITY' as a disease and 'NON-OBESE' as a physiological state. These entities are related through their definitions based on BMI (Body Mass Index) values. The community highlights the distinction between extreme obesity and non-obese states, with BMI being a critical factor in their characterization.\n\n## Definition and Relationship of EXTREME OBESITY and NON-OBESE\n\nEXTREME OBESITY is defined as a condition characterized by a BMI 35, indicating a severe level of obesity with potential health risks. On the other hand, NON-OBESE refers to a BMI between 18.5 and 25 kg/m2, representing a healthy weight range. The relationship between these two entities underscores the importance of BMI in classifying physiological states and potential health risks. The distinction between these states is critical for understanding and addressing obesity-related health issues.\n\n## Role of BMI in Defining Physiological States\n\nBMI plays a crucial role in defining various physiological states, including EXTREME OBESITY and NON-OBESE. It serves as a simple index of weight-for-height that is commonly used to classify underweight, normal weight, overweight, and obesity in adults. The use of BMI in characterizing these states highlights its utility in public health and clinical settings for assessing and managing weight-related health risks.\n\n## Health Implications of EXTREME OBESITY\n\nEXTREME OBESITY, characterized by a high BMI, is associated with increased risks of various health conditions, including diabetes, cardiovascular disease, and certain types of cancer. Understanding the health implications of extreme obesity is essential for developing strategies to mitigate these risks and improve health outcomes.\n\n## Importance of Distinction Between EXTREME OBESITY and NON-OBESE\n\nThe distinction between EXTREME OBESITY and NON-OBESE is crucial for tailoring health interventions and recommendations. Individuals with extreme obesity may require intensive lifestyle and possibly medical interventions to manage their condition and reduce health risks. In contrast, those in the non-obese category are generally considered to have a lower risk of obesity-related health issues, although they still need to maintain a healthy lifestyle to prevent weight gain.",
    "report_json": {
      "title": "Obesity and BMI Related Physiological States",
      "summary": "The community consists of two key entities: 'EXTREME OBESITY' as a disease and 'NON-OBESE' as a physiological state. These entities are related through their definitions based on BMI (Body Mass Index) values. The community highlights the distinction between extreme obesity and non-obese states, with BMI being a critical factor in their characterization.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant health implications associated with extreme obesity and the importance of BMI in defining various physiological states.",
      "findings": [
        {
          "summary": "Definition and Relationship of EXTREME OBESITY and NON-OBESE",
          "explanation": "EXTREME OBESITY is defined as a condition characterized by a BMI 35, indicating a severe level of obesity with potential health risks. On the other hand, NON-OBESE refers to a BMI between 18.5 and 25 kg/m2, representing a healthy weight range. The relationship between these two entities underscores the importance of BMI in classifying physiological states and potential health risks. The distinction between these states is critical for understanding and addressing obesity-related health issues."
        },
        {
          "summary": "Role of BMI in Defining Physiological States",
          "explanation": "BMI plays a crucial role in defining various physiological states, including EXTREME OBESITY and NON-OBESE. It serves as a simple index of weight-for-height that is commonly used to classify underweight, normal weight, overweight, and obesity in adults. The use of BMI in characterizing these states highlights its utility in public health and clinical settings for assessing and managing weight-related health risks."
        },
        {
          "summary": "Health Implications of EXTREME OBESITY",
          "explanation": "EXTREME OBESITY, characterized by a high BMI, is associated with increased risks of various health conditions, including diabetes, cardiovascular disease, and certain types of cancer. Understanding the health implications of extreme obesity is essential for developing strategies to mitigate these risks and improve health outcomes."
        },
        {
          "summary": "Importance of Distinction Between EXTREME OBESITY and NON-OBESE",
          "explanation": "The distinction between EXTREME OBESITY and NON-OBESE is crucial for tailoring health interventions and recommendations. Individuals with extreme obesity may require intensive lifestyle and possibly medical interventions to manage their condition and reduce health risks. In contrast, those in the non-obese category are generally considered to have a lower risk of obesity-related health issues, although they still need to maintain a healthy lifestyle to prevent weight gain."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 85",
    "edges": [
      [
        "\"EXTREME OBESITY\"",
        "\"NON-OBESE\""
      ],
      [
        "\"BMI\"",
        "\"EXTREME OBESITY\""
      ]
    ],
    "nodes": [
      "\"NON-OBESE\"",
      "\"EXTREME OBESITY\""
    ],
    "chunk_ids": [
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-ca6b0a71d21533320d52baa951dafe5e"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "95": {
    "report_string": "# Diabetes and Associated Genetic Factors\n\nThe community revolves around DM2, a condition of diabetes, and its associations with other entities such as obesity, TDH, and the gene FAMA167-AS1. The relationships indicate that DM2 is linked to obesity and TDH, and FAMA167-AS1 is associated with DM2.\n\n## DM2 and its association with obesity\n\nDM2 is associated with obesity, which is a major risk factor for developing type 2 diabetes. This relationship highlights the importance of managing obesity to prevent or mitigate DM2.\n\n## DM2 and its association with TDH\n\nDM2 is also associated with TDH, suggesting a link between DM2 and other metabolic or health conditions. The exact nature of this association requires further investigation.\n\n## FAMA167-AS1 and its association with DM2\n\nThe gene FAMA167-AS1 is associated with DM2, indicating a potential genetic component to the condition. Further research is needed to understand the role of FAMA167-AS1 in DM2.",
    "report_json": {
      "title": "Diabetes and Associated Genetic Factors",
      "summary": "The community revolves around DM2, a condition of diabetes, and its associations with other entities such as obesity, TDH, and the gene FAMA167-AS1. The relationships indicate that DM2 is linked to obesity and TDH, and FAMA167-AS1 is associated with DM2.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations between DM2 and other health conditions like obesity.",
      "findings": [
        {
          "summary": "DM2 and its association with obesity",
          "explanation": "DM2 is associated with obesity, which is a major risk factor for developing type 2 diabetes. This relationship highlights the importance of managing obesity to prevent or mitigate DM2."
        },
        {
          "summary": "DM2 and its association with TDH",
          "explanation": "DM2 is also associated with TDH, suggesting a link between DM2 and other metabolic or health conditions. The exact nature of this association requires further investigation."
        },
        {
          "summary": "FAMA167-AS1 and its association with DM2",
          "explanation": "The gene FAMA167-AS1 is associated with DM2, indicating a potential genetic component to the condition. Further research is needed to understand the role of FAMA167-AS1 in DM2."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 95",
    "edges": [
      [
        "\"DM2\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"FAMA167-AS1\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ]
    ],
    "nodes": [
      "\"DM2\"",
      "\"FAMA167-AS1\""
    ],
    "chunk_ids": [
      "chunk-7d4f390e7ed8da1820efe209eab19293"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "91": {
    "report_string": "# Dietary Patterns and Genetic Factors in Obesity\n\nThe community revolves around the interplay between dietary patterns, genetic variants, and obesity-related diseases. Key entities include the MDS dietary pattern, GRS genetic risk score, abdominal obesity, and FTO SNPs. These entities are interconnected through their roles in modulating obesity risk and disease associations.\n\n## MDS dietary pattern and its association with obesity risk\n\nThe MDS dietary pattern is associated with lower risk of obesity, particularly in individuals with high GRS. This suggests that a tailored dietary approach may help mitigate genetic predispositions to obesity. The MDS pattern likely interacts with genetic variants like FTO SNPs to modulate obesity risk.\n\n## GRS and its role in obesity risk\n\nThe GRS is a genetic risk score that reflects the cumulative effect of multiple genetic variants on obesity risk. Its effects can be modulated by dietary patterns, such as MDS, indicating a complex interplay between genetic and environmental factors in obesity development.\n\n## Abdominal obesity and its association with FTO SNPs\n\nAbdominal obesity is a disease characterized by excess fat around the abdomen and is associated with FTO SNPs. The effects of FTO SNPs on abdominal obesity risk can be modulated by dietary patterns like MDS, highlighting the importance of considering both genetic and environmental factors in disease management.\n\n## Interaction between GRS, MDS, and obesity risk\n\nThe interaction between GRS and MDS influences obesity risk, suggesting that individuals with a high GRS may benefit from adhering to a beneficial dietary pattern like MDS to reduce their risk. This highlights the potential for personalized dietary recommendations based on genetic profiles.\n\n## Role of MDS in modulating FTO SNPs effects\n\nMDS modulates the association of FTO SNPs with obesity risk, including abdominal obesity and high waist-to-hip ratio (WHR). This indicates that a specific dietary pattern can significantly impact the expression of genetic predispositions related to obesity.",
    "report_json": {
      "title": "Dietary Patterns and Genetic Factors in Obesity",
      "summary": "The community revolves around the interplay between dietary patterns, genetic variants, and obesity-related diseases. Key entities include the MDS dietary pattern, GRS genetic risk score, abdominal obesity, and FTO SNPs. These entities are interconnected through their roles in modulating obesity risk and disease associations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of dietary patterns and genetic factors on obesity risk and disease management.",
      "findings": [
        {
          "summary": "MDS dietary pattern and its association with obesity risk",
          "explanation": "The MDS dietary pattern is associated with lower risk of obesity, particularly in individuals with high GRS. This suggests that a tailored dietary approach may help mitigate genetic predispositions to obesity. The MDS pattern likely interacts with genetic variants like FTO SNPs to modulate obesity risk."
        },
        {
          "summary": "GRS and its role in obesity risk",
          "explanation": "The GRS is a genetic risk score that reflects the cumulative effect of multiple genetic variants on obesity risk. Its effects can be modulated by dietary patterns, such as MDS, indicating a complex interplay between genetic and environmental factors in obesity development."
        },
        {
          "summary": "Abdominal obesity and its association with FTO SNPs",
          "explanation": "Abdominal obesity is a disease characterized by excess fat around the abdomen and is associated with FTO SNPs. The effects of FTO SNPs on abdominal obesity risk can be modulated by dietary patterns like MDS, highlighting the importance of considering both genetic and environmental factors in disease management."
        },
        {
          "summary": "Interaction between GRS, MDS, and obesity risk",
          "explanation": "The interaction between GRS and MDS influences obesity risk, suggesting that individuals with a high GRS may benefit from adhering to a beneficial dietary pattern like MDS to reduce their risk. This highlights the potential for personalized dietary recommendations based on genetic profiles."
        },
        {
          "summary": "Role of MDS in modulating FTO SNPs effects",
          "explanation": "MDS modulates the association of FTO SNPs with obesity risk, including abdominal obesity and high waist-to-hip ratio (WHR). This indicates that a specific dietary pattern can significantly impact the expression of genetic predispositions related to obesity."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 91",
    "edges": [
      [
        "\"GRS\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"MDS\""
      ],
      [
        "\"HIGH WHR\"",
        "\"MDS\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"FTO SNPS\""
      ],
      [
        "\"MDS\"",
        "\"OBESITY\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"MDS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MDS\""
      ]
    ],
    "nodes": [
      "\"ABDOMINAL OBESITY\"",
      "\"GRS\"",
      "\"MDS\""
    ],
    "chunk_ids": [
      "chunk-8962f590f087ca0056b21a8a98a9cfb5"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "94": {
    "report_string": "# Body Shape Score and Obesity Risk\n\nThe community centers around the Body Shape Score, a physiological process measure associated with obesity risk. The score varies across different types and is linked to obesity, with higher scores indicating increased risk.\n\n## Body Shape Score and Obesity Risk Association\n\nThe Body Shape Score is directly associated with the risk of obesity. Higher Body Shape Scores are monotonically increasing with the risk of obesity across different types. This relationship highlights the potential utility of Body Shape Score as a predictive tool for obesity risk.\n\n## Variation of Body Shape Score Across Types\n\nThe Body Shape Score varies across different types, suggesting that the relationship between body shape and obesity risk may be influenced by categorical classifications. Understanding these variations can help in developing targeted interventions for obesity prevention and management.",
    "report_json": {
      "title": "Body Shape Score and Obesity Risk",
      "summary": "The community centers around the Body Shape Score, a physiological process measure associated with obesity risk. The score varies across different types and is linked to obesity, with higher scores indicating increased risk.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the association of Body Shape Score with obesity risk, a significant public health concern.",
      "findings": [
        {
          "summary": "Body Shape Score and Obesity Risk Association",
          "explanation": "The Body Shape Score is directly associated with the risk of obesity. Higher Body Shape Scores are monotonically increasing with the risk of obesity across different types. This relationship highlights the potential utility of Body Shape Score as a predictive tool for obesity risk."
        },
        {
          "summary": "Variation of Body Shape Score Across Types",
          "explanation": "The Body Shape Score varies across different types, suggesting that the relationship between body shape and obesity risk may be influenced by categorical classifications. Understanding these variations can help in developing targeted interventions for obesity prevention and management."
        }
      ]
    },
    "level": 2,
    "title": "Cluster 94",
    "edges": [
      [
        "\"BODY SHAPE SCORE\"",
        "\"TYPE\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"TYPE\"",
      "\"BODY SHAPE SCORE\""
    ],
    "chunk_ids": [
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "48": {
    "report_string": "# Genetic Variants and Nutrient Interactions in Obesity and Type 2 Diabetes\n\nThe community revolves around genetic variants, nutrients, and their interactions with obesity and type 2 diabetes. Key entities include genomic variants in the FTO gene, nutrients like carbohydrate intake, and diseases such as obesity and type 2 diabetes. These entities are interconnected through their roles in metabolic health, insulin function, and disease risk.\n\n## FTO gene variants and obesity risk\n\nThe FTO gene contains genomic variants, such as rs56137030, associated with increased BMI and obesity risk. Variants in the FTO gene have been linked to obesity phenotypes, including BMI and waist circumference. This highlights the importance of considering genetic factors in obesity management.\n\n## Carbohydrate intake and genetic variants\n\nCarbohydrate intake is a nutrient associated with various genetic variants, including SNP rs9939609 in the FTO gene, which is linked to lower carbohydrate intake. Other variants, such as SNP rs2815752 and rs368794, are associated with higher carbohydrate intake. This suggests that genetic factors can influence dietary preferences and nutrient metabolism.\n\n## Genomic variants and type 2 diabetes risk\n\nA genomic variant in the TCF7L2 gene has been linked to an increased risk of type 2 diabetes. Genomic variants, such as SNPs, can affect type 2 diabetes susceptibility. This highlights the importance of genetic testing in identifying individuals at high risk of developing type 2 diabetes.\n\n## Relationship between BMI and walking pace\n\nBMI is associated with self-reported walking pace, suggesting a link between physical activity and metabolic health. Genomic variants can influence both BMI and walking pace, highlighting the complex interplay between genetic and environmental factors in determining health outcomes.\n\n## Hardy-Weinberg Equilibrium and genetic associations\n\nThe Hardy-Weinberg equilibrium is a principle used to assess the genetic equilibrium of a population and filter SNPs. It is used to test for deviations in the study group and ensure the accuracy of genetic associations. This highlights the importance of statistical methods in genetic analysis.",
    "report_json": {
      "title": "Genetic Variants and Nutrient Interactions in Obesity and Type 2 Diabetes",
      "summary": "The community revolves around genetic variants, nutrients, and their interactions with obesity and type 2 diabetes. Key entities include genomic variants in the FTO gene, nutrients like carbohydrate intake, and diseases such as obesity and type 2 diabetes. These entities are interconnected through their roles in metabolic health, insulin function, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants on obesity and type 2 diabetes risk and management.",
      "findings": [
        {
          "summary": "FTO gene variants and obesity risk",
          "explanation": "The FTO gene contains genomic variants, such as rs56137030, associated with increased BMI and obesity risk. Variants in the FTO gene have been linked to obesity phenotypes, including BMI and waist circumference. This highlights the importance of considering genetic factors in obesity management."
        },
        {
          "summary": "Carbohydrate intake and genetic variants",
          "explanation": "Carbohydrate intake is a nutrient associated with various genetic variants, including SNP rs9939609 in the FTO gene, which is linked to lower carbohydrate intake. Other variants, such as SNP rs2815752 and rs368794, are associated with higher carbohydrate intake. This suggests that genetic factors can influence dietary preferences and nutrient metabolism."
        },
        {
          "summary": "Genomic variants and type 2 diabetes risk",
          "explanation": "A genomic variant in the TCF7L2 gene has been linked to an increased risk of type 2 diabetes. Genomic variants, such as SNPs, can affect type 2 diabetes susceptibility. This highlights the importance of genetic testing in identifying individuals at high risk of developing type 2 diabetes."
        },
        {
          "summary": "Relationship between BMI and walking pace",
          "explanation": "BMI is associated with self-reported walking pace, suggesting a link between physical activity and metabolic health. Genomic variants can influence both BMI and walking pace, highlighting the complex interplay between genetic and environmental factors in determining health outcomes."
        },
        {
          "summary": "Hardy-Weinberg Equilibrium and genetic associations",
          "explanation": "The Hardy-Weinberg equilibrium is a principle used to assess the genetic equilibrium of a population and filter SNPs. It is used to test for deviations in the study group and ensure the accuracy of genetic associations. This highlights the importance of statistical methods in genetic analysis."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 48",
    "edges": [
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HWE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"HARDY-WEINBERG EQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OR\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HAPLOTYPE\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS2815752\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PARENTAL ORIGIN\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS368794\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"INTRON1 PROMOTER FLANKING\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"P-VALUE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID SEQUENCING TECHNOLOGY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY PHENOTYPE\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LD BLOCK\""
      ],
      [
        "\"DBSNP DATABASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HARDY-WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"DBSNP\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"TAQMAN ASSAY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MULTIPLE TESTING\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"FGF21\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE ANALYSIS\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GOLDENGATE ARRAY\""
      ],
      [
        "\"CI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"HWE\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"CI\"",
      "\"LMI\"",
      "\"CARBOHYDRATE INTAKE\"",
      "\"OBESITY PHENOTYPE\"",
      "\"INTRON1 PROMOTER FLANKING\"",
      "\"GENOMIC VARIANT\"",
      "\"HARDY-WEINBERG EQUILIBRIUM\"",
      "\"WALKING PACE\"",
      "\"LD BLOCK\"",
      "\"OR\"",
      "\"TAQMAN ASSAY\"",
      "\"SNP RS2815752\"",
      "\"SOLID\"",
      "\"SOLID SEQUENCING TECHNOLOGY\"",
      "\"HWE\"",
      "\"PARENTAL ORIGIN\"",
      "\"SNP RS368794\"",
      "\"GOLDENGATE ARRAY\"",
      "\"LINKAGE ANALYSIS\"",
      "\"MULTIPLE TESTING\"",
      "\"DBSNP DATABASE\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.5,
    "sub_communities": [
      "99",
      "98"
    ]
  },
  "77": {
    "report_string": "# Macronutrient Intake and Diabetes Risk\n\nThe community revolves around macronutrient intake and its influence on disease risk, particularly type 2 diabetes (T2DM). Key entities include macronutrients like carbohydrate, fat, protein, and sugar, as well as environmental factors such as diet. These entities are interconnected through their roles in regulating macronutrient intake, gene expression, and disease susceptibility.\n\n## Diet's influence on macronutrient intake and disease risk\n\nDiet is a critical environmental factor that influences macronutrient intake, which in turn affects the risk of developing type 2 diabetes (T2DM) and other metabolic disorders. The relationship between diet, macronutrient intake, and disease risk highlights the importance of personalized dietary recommendations for managing metabolic health.\n\n## Role of macronutrients in energy provision and growth\n\nMacronutrients such as carbohydrate, fat, protein, and sugar provide energy and support growth and maintenance of body tissues. The balance of these macronutrients in the diet is crucial for maintaining optimal health and preventing chronic diseases like T2DM.\n\n## Brain's regulation of macronutrient intake\n\nThe brain plays a central role in regulating macronutrient intake through the central nervous system. This regulatory mechanism is essential for maintaining energy homeostasis and preventing metabolic disorders.\n\n## Diet's impact on gene expression\n\nDiet can affect gene expression by providing the necessary nutrients for gene function. This highlights the complex interplay between environmental factors, genetics, and disease susceptibility.\n\n## Macronutrient intake and disease risk\n\nThe community highlights the importance of balanced macronutrient intake in managing disease risk, particularly for type 2 diabetes. A better understanding of the relationships between macronutrient intake, diet, and disease risk can inform personalized nutrition strategies for disease prevention and management.",
    "report_json": {
      "title": "Macronutrient Intake and Diabetes Risk",
      "summary": "The community revolves around macronutrient intake and its influence on disease risk, particularly type 2 diabetes (T2DM). Key entities include macronutrients like carbohydrate, fat, protein, and sugar, as well as environmental factors such as diet. These entities are interconnected through their roles in regulating macronutrient intake, gene expression, and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of macronutrient intake and diet on type 2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Diet's influence on macronutrient intake and disease risk",
          "explanation": "Diet is a critical environmental factor that influences macronutrient intake, which in turn affects the risk of developing type 2 diabetes (T2DM) and other metabolic disorders. The relationship between diet, macronutrient intake, and disease risk highlights the importance of personalized dietary recommendations for managing metabolic health."
        },
        {
          "summary": "Role of macronutrients in energy provision and growth",
          "explanation": "Macronutrients such as carbohydrate, fat, protein, and sugar provide energy and support growth and maintenance of body tissues. The balance of these macronutrients in the diet is crucial for maintaining optimal health and preventing chronic diseases like T2DM."
        },
        {
          "summary": "Brain's regulation of macronutrient intake",
          "explanation": "The brain plays a central role in regulating macronutrient intake through the central nervous system. This regulatory mechanism is essential for maintaining energy homeostasis and preventing metabolic disorders."
        },
        {
          "summary": "Diet's impact on gene expression",
          "explanation": "Diet can affect gene expression by providing the necessary nutrients for gene function. This highlights the complex interplay between environmental factors, genetics, and disease susceptibility."
        },
        {
          "summary": "Macronutrient intake and disease risk",
          "explanation": "The community highlights the importance of balanced macronutrient intake in managing disease risk, particularly for type 2 diabetes. A better understanding of the relationships between macronutrient intake, diet, and disease risk can inform personalized nutrition strategies for disease prevention and management."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 77",
    "edges": [
      [
        "\"CARBOHYDRATE\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"DIET\"",
        "\"MAFLD\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"SUGAR\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"GENE EXPRESSION\""
      ],
      [
        "\"CENTRAL NERVOUS SYSTEM\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"FAT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"PROTEIN\""
      ]
    ],
    "nodes": [
      "\"MACRONUTRIENT INTAKE\"",
      "\"PROTEIN\"",
      "\"CENTRAL NERVOUS SYSTEM\"",
      "\"FAT\"",
      "\"SUGAR\"",
      "\"CARBOHYDRATE\"",
      "\"DIET\"",
      "\"BRAIN\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.16176470588235295,
    "sub_communities": []
  },
  "78": {
    "report_string": "# Genetic and Physiological Interactions in Type2 Diabetes\n\nThe community revolves around type2 diabetes, gene expression, and genetic variants. Key entities include physiological processes like gene expression, bioinformatic tools such as GTEx, and genetic variants like LD SNPS. These entities are interconnected through their roles in gene regulation, disease risk, and potential dietary influences.\n\n## Gene expression and its regulation by genetic variants\n\nGene expression is a critical physiological process that can be regulated by transcription factors and histone modifications. Genetic variants, such as LD SNPS, can affect gene expression by altering transcription factor binding sites. This relationship highlights the importance of understanding genetic influences on gene expression in the context of type2 diabetes.\n\n## Role of LD SNPS in type2 diabetes risk\n\nLD SNPS are genetic variants associated with an increased risk of type2 diabetes. Their impact on gene expression and disease risk underscores the significance of genetic factors in type2 diabetes susceptibility. The relationship between LD SNPS and type2 diabetes emphasizes the need for personalized risk assessments based on genetic profiles.\n\n## GTEx as a tool for evaluating genetic variant effects\n\nGTEx is a bioinformatic tool used to evaluate the functional effects of genetic variants on gene expression. By utilizing GTEx, researchers can better understand how genetic variants like LD SNPS influence gene expression and disease risk. This highlights the utility of bioinformatic tools in uncovering the biological relevance of genetic variants.\n\n## Dietary influence on gene expression\n\nDiet can affect gene expression by providing necessary nutrients for gene function. This relationship suggests that dietary interventions could be tailored to mitigate the effects of genetic variants on type2 diabetes risk. Understanding the interplay between diet and gene expression can inform personalized nutrition strategies for disease management.\n\n## Link between gene expression and type2 diabetes\n\nThe connection between gene expression and type2 diabetes is complex, involving both genetic and environmental factors. Genetic variants like LD SNPS can affect gene expression, which in turn influences disease risk. This highlights the need for comprehensive approaches to understanding type2 diabetes etiology and developing effective interventions.",
    "report_json": {
      "title": "Genetic and Physiological Interactions in Type2 Diabetes",
      "summary": "The community revolves around type2 diabetes, gene expression, and genetic variants. Key entities include physiological processes like gene expression, bioinformatic tools such as GTEx, and genetic variants like LD SNPS. These entities are interconnected through their roles in gene regulation, disease risk, and potential dietary influences.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants and gene expression on type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Gene expression and its regulation by genetic variants",
          "explanation": "Gene expression is a critical physiological process that can be regulated by transcription factors and histone modifications. Genetic variants, such as LD SNPS, can affect gene expression by altering transcription factor binding sites. This relationship highlights the importance of understanding genetic influences on gene expression in the context of type2 diabetes."
        },
        {
          "summary": "Role of LD SNPS in type2 diabetes risk",
          "explanation": "LD SNPS are genetic variants associated with an increased risk of type2 diabetes. Their impact on gene expression and disease risk underscores the significance of genetic factors in type2 diabetes susceptibility. The relationship between LD SNPS and type2 diabetes emphasizes the need for personalized risk assessments based on genetic profiles."
        },
        {
          "summary": "GTEx as a tool for evaluating genetic variant effects",
          "explanation": "GTEx is a bioinformatic tool used to evaluate the functional effects of genetic variants on gene expression. By utilizing GTEx, researchers can better understand how genetic variants like LD SNPS influence gene expression and disease risk. This highlights the utility of bioinformatic tools in uncovering the biological relevance of genetic variants."
        },
        {
          "summary": "Dietary influence on gene expression",
          "explanation": "Diet can affect gene expression by providing necessary nutrients for gene function. This relationship suggests that dietary interventions could be tailored to mitigate the effects of genetic variants on type2 diabetes risk. Understanding the interplay between diet and gene expression can inform personalized nutrition strategies for disease management."
        },
        {
          "summary": "Link between gene expression and type2 diabetes",
          "explanation": "The connection between gene expression and type2 diabetes is complex, involving both genetic and environmental factors. Genetic variants like LD SNPS can affect gene expression, which in turn influences disease risk. This highlights the need for comprehensive approaches to understanding type2 diabetes etiology and developing effective interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 78",
    "edges": [
      [
        "\"GENE EXPRESSION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"LD SNPS\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"GTEX\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"DIET\"",
        "\"GENE EXPRESSION\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE2 DIABETES\""
      ]
    ],
    "nodes": [
      "\"GENE EXPRESSION\"",
      "\"GTEX\"",
      "\"LD SNPS\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "62": {
    "report_string": "# Physical Activity and Type 2 Diabetes Risk\n\nThe community revolves around physical activity and its impact on type 2 diabetes (T2DM) risk. Key entities include lifestyle factors (physical activity), environmental factors/interventions (COSTRIDE, HW), physiological measures (VO2 max), and genetic variants (RS9939609). These entities are interconnected through their roles in physical fitness, obesity risk, and disease susceptibility.\n\n## Physical activity influences T2DM risk\n\nPhysical activity is an environmental factor that influences the risk of T2DM. This relationship is supported by multiple connections in the network, highlighting the importance of physical activity in disease prevention and management.\n\n## Interaction between physical activity and genetic variants\n\nThe effect of the RS9939609 genetic variant on BMI is modified by physical activity. This interaction suggests that physical activity can mitigate or exacerbate the genetic risk of obesity and related metabolic disorders.\n\n## Role of physical activity in obesity risk\n\nPhysical activity level can impact obesity risk and overall health. As a lifestyle factor, physical activity influences BMI and obesity-related traits, which are critical factors in T2DM development.\n\n## Impact of interventions on physical activity and fitness\n\nInterventions like COSTRIDE and HW aim to promote physical activity, which can in turn affect VO2 max, a measure of aerobic fitness. These interventions may have a positive impact on physical fitness and overall health.\n\n## Assessment of physical activity levels\n\nThe PAR assessment is a tool used to evaluate physical activity levels. Accurate assessment of physical activity is crucial for understanding its impact on health outcomes and for developing effective interventions.",
    "report_json": {
      "title": "Physical Activity and Type 2 Diabetes Risk",
      "summary": "The community revolves around physical activity and its impact on type 2 diabetes (T2DM) risk. Key entities include lifestyle factors (physical activity), environmental factors/interventions (COSTRIDE, HW), physiological measures (VO2 max), and genetic variants (RS9939609). These entities are interconnected through their roles in physical fitness, obesity risk, and disease susceptibility.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of physical activity on T2DM risk and management, as well as its interaction with genetic variants.",
      "findings": [
        {
          "summary": "Physical activity influences T2DM risk",
          "explanation": "Physical activity is an environmental factor that influences the risk of T2DM. This relationship is supported by multiple connections in the network, highlighting the importance of physical activity in disease prevention and management."
        },
        {
          "summary": "Interaction between physical activity and genetic variants",
          "explanation": "The effect of the RS9939609 genetic variant on BMI is modified by physical activity. This interaction suggests that physical activity can mitigate or exacerbate the genetic risk of obesity and related metabolic disorders."
        },
        {
          "summary": "Role of physical activity in obesity risk",
          "explanation": "Physical activity level can impact obesity risk and overall health. As a lifestyle factor, physical activity influences BMI and obesity-related traits, which are critical factors in T2DM development."
        },
        {
          "summary": "Impact of interventions on physical activity and fitness",
          "explanation": "Interventions like COSTRIDE and HW aim to promote physical activity, which can in turn affect VO2 max, a measure of aerobic fitness. These interventions may have a positive impact on physical fitness and overall health."
        },
        {
          "summary": "Assessment of physical activity levels",
          "explanation": "The PAR assessment is a tool used to evaluate physical activity levels. Accurate assessment of physical activity is crucial for understanding its impact on health outcomes and for developing effective interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 62",
    "edges": [
      [
        "\"HW\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BODY SIZE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RS9939609\""
      ],
      [
        "\"COSTRIDE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"METS\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"T2DM\""
      ],
      [
        "\"HW\"",
        "\"VO2 MAX\""
      ],
      [
        "\"PAR ASSESSMENT\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"COSTRIDE\"",
        "\"VO2 MAX\""
      ]
    ],
    "nodes": [
      "\"PHYSICAL ACTIVITY\"",
      "\"COSTRIDE\"",
      "\"VO2 MAX\"",
      "\"METS\"",
      "\"HW\"",
      "\"PAR ASSESSMENT\"",
      "\"BODY SIZE\""
    ],
    "chunk_ids": [
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6c935916492da41e4048751fc4c84348"
    ],
    "occurrence": 0.19117647058823528,
    "sub_communities": []
  },
  "33": {
    "report_string": "# BMI and Obesity Risk Factors\n\nThe community revolves around Body Mass Index (BMI) and its associations with various physiological processes, diseases, and genetic factors. Key entities include BMI, FTO gene, genomic variants, obesity, and related physiological processes. These entities are interconnected through their roles in body composition, obesity risk, and metabolic health.\n\n## BMI and its association with obesity\n\nBMI is a measure used to assess obesity risk and is characterized by a high BMI in cases of extreme obesity. The relationship between BMI and obesity highlights the importance of monitoring BMI for disease risk assessment.\n\n## FTO gene and BMI variation\n\nThe FTO gene is associated with BMI and body composition. Variants in the FTO gene, such as rs9939609, rs3751812, and rs56137030, are linked to BMI variation and obesity risk. This underscores the genetic component of BMI regulation.\n\n## Genomic variants and BMI\n\nGenome-wide SNPs, including those in the FTO gene like rs17818902, rs17818920, and rs7185735, are associated with BMI. These genetic variants contribute to the understanding of BMI's genetic basis and its implications for health.\n\n## BMI and physiological processes\n\nBMI is related to various physiological processes, including body composition, waist-hip ratio, and plasma leptin levels. These relationships highlight the multifaceted nature of BMI as a measure of health.\n\n## Nutritional intervention and TBFat (kg)\n\nNutritional intervention affects TBFat (kg), a measure of total body fat. This indicates that dietary factors play a role in body composition and potentially in BMI regulation.\n\n## BMI and disease risk\n\nBMI is associated with various health outcomes, including cardiovascular disease, type2 diabetes, and thyroid cancer. This emphasizes the importance of BMI as a risk factor for disease.\n\n## Educational attainment and BMI\n\nEducational attainment is a complex trait that can be influenced by genetic and environmental factors, similar to BMI. The relationship between educational attainment and BMI suggests a potential interplay between socioeconomic and genetic factors in health outcomes.",
    "report_json": {
      "title": "BMI and Obesity Risk Factors",
      "summary": "The community revolves around Body Mass Index (BMI) and its associations with various physiological processes, diseases, and genetic factors. Key entities include BMI, FTO gene, genomic variants, obesity, and related physiological processes. These entities are interconnected through their roles in body composition, obesity risk, and metabolic health.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on BMI and obesity risk.",
      "findings": [
        {
          "summary": "BMI and its association with obesity",
          "explanation": "BMI is a measure used to assess obesity risk and is characterized by a high BMI in cases of extreme obesity. The relationship between BMI and obesity highlights the importance of monitoring BMI for disease risk assessment."
        },
        {
          "summary": "FTO gene and BMI variation",
          "explanation": "The FTO gene is associated with BMI and body composition. Variants in the FTO gene, such as rs9939609, rs3751812, and rs56137030, are linked to BMI variation and obesity risk. This underscores the genetic component of BMI regulation."
        },
        {
          "summary": "Genomic variants and BMI",
          "explanation": "Genome-wide SNPs, including those in the FTO gene like rs17818902, rs17818920, and rs7185735, are associated with BMI. These genetic variants contribute to the understanding of BMI's genetic basis and its implications for health."
        },
        {
          "summary": "BMI and physiological processes",
          "explanation": "BMI is related to various physiological processes, including body composition, waist-hip ratio, and plasma leptin levels. These relationships highlight the multifaceted nature of BMI as a measure of health."
        },
        {
          "summary": "Nutritional intervention and TBFat (kg)",
          "explanation": "Nutritional intervention affects TBFat (kg), a measure of total body fat. This indicates that dietary factors play a role in body composition and potentially in BMI regulation."
        },
        {
          "summary": "BMI and disease risk",
          "explanation": "BMI is associated with various health outcomes, including cardiovascular disease, type2 diabetes, and thyroid cancer. This emphasizes the importance of BMI as a risk factor for disease."
        },
        {
          "summary": "Educational attainment and BMI",
          "explanation": "Educational attainment is a complex trait that can be influenced by genetic and environmental factors, similar to BMI. The relationship between educational attainment and BMI suggests a potential interplay between socioeconomic and genetic factors in health outcomes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 33",
    "edges": [
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ],
      [
        "\"BMI\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"BMI\"",
        "\"DURBIN-HAUSMAN TEST\""
      ],
      [
        "\"BMI\"",
        "\"BODY COMPOSITION\""
      ],
      [
        "\"BMI\"",
        "\"RS56137030\""
      ],
      [
        "\"BMI\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"LEPTIN\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"BMI\"",
        "\"RS9939609\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE\""
      ],
      [
        "\"BMI\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"BMI\"",
        "\"EXTREME OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 3\""
      ],
      [
        "\"GENOME-WIDE SNPS\"",
        "\"PRINCIPAL COMPONENTS\""
      ],
      [
        "\"BMI\"",
        "\"MAFLD\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"BMI\"",
        "\"EDUCATIONAL ATTAINMENT\""
      ],
      [
        "\"BMI\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"MINOR ALLELES\""
      ],
      [
        "\"BMI\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"BMI\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BMI\"",
        "\"RS17818902\""
      ],
      [
        "\"AGE\"",
        "\"BMI\""
      ],
      [
        "\"NUTRITIONAL INTERVENTION\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"BMI\"",
        "\"CARDIOVASCULAR DISEASE\""
      ],
      [
        "\"BMI\"",
        "\"RS17818920\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"BODY FATNESS\""
      ],
      [
        "\"FTO GENE\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"EXTREME OBESITY\"",
        "\"NON-OBESE\""
      ],
      [
        "\"BMI\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"TDH\""
      ],
      [
        "\"BMI\"",
        "\"WAIST-HIP RATIO\""
      ],
      [
        "\"BMI\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"MC4R SNPS\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 2\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY RATE\""
      ],
      [
        "\"BMI\"",
        "\"GENOME-WIDE SNPS\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"RS7185735\""
      ],
      [
        "\"BMI\"",
        "\"GENOTYPE\""
      ]
    ],
    "nodes": [
      "\"RS17818902\"",
      "\"INTRON 1\"",
      "\"NON-OBESE\"",
      "\"TBFAT (KG)\"",
      "\"RS56137030\"",
      "\"EDUCATIONAL ATTAINMENT\"",
      "\"BODY COMPOSITION\"",
      "\"BMI\"",
      "\"PRINCIPAL COMPONENTS\"",
      "\"TDH\"",
      "\"OBESITY RATE\"",
      "\"EXTREME OBESITY\"",
      "\"GENOME-WIDE SNPS\"",
      "\"RS7185735\"",
      "\"WAIST-HIP RATIO\"",
      "\"RS17818920\"",
      "\"MC4R SNPS\"",
      "\"INTRON 3\"",
      "\"INTRON 2\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.7794117647058824,
    "sub_communities": [
      "85",
      "84",
      "86"
    ]
  },
  "36": {
    "report_string": "# Leptin and Cardiovascular Disease: Genetic and Environmental Interactions\n\nThe community revolves around the interactions between leptin, cardiovascular disease, and various genetic and environmental factors. Key entities include the LEP gene, plasma leptin levels, cardiovascular disease, and the Mediterranean diet. These entities are interconnected through their roles in energy balance, body weight regulation, and cardiovascular health.\n\n## LEP gene and plasma leptin levels\n\nThe LEP gene encodes the leptin protein, which plays a crucial role in energy balance and body weight regulation. Variants in the LEP gene, such as rs10487505, are associated with circulating leptin levels. This highlights the importance of genetic factors in determining plasma leptin levels and their potential impact on cardiovascular health.\n\n## Cardiovascular disease and plasma leptin levels\n\nCardiovascular disease is associated with altered plasma leptin levels, which are influenced by genetic and environmental factors. This relationship suggests that plasma leptin levels may serve as a biomarker for cardiovascular health and that interventions targeting leptin levels may help mitigate cardiovascular risk.\n\n## Mediterranean diet and plasma leptin levels\n\nThe Mediterranean diet influences plasma leptin levels, which are also affected by physical activity and other lifestyle factors. This highlights the importance of dietary patterns in managing cardiovascular health and the potential benefits of the Mediterranean diet in reducing cardiovascular risk.\n\n## Smoking status and cardiovascular disease\n\nSmoking status is a risk factor for cardiovascular disease, which is also influenced by genetic and lifestyle factors. This relationship emphasizes the need to consider environmental factors in assessing cardiovascular risk and the importance of smoking cessation in preventing cardiovascular disease.\n\n## LEP gene and cardiovascular disease\n\nThe LEP gene is associated with cardiovascular disease risk, which is influenced by genetic and environmental factors. This relationship suggests that genetic variants in the LEP gene may contribute to cardiovascular susceptibility and that targeting leptin-related pathways may help mitigate cardiovascular risk.",
    "report_json": {
      "title": "Leptin and Cardiovascular Disease: Genetic and Environmental Interactions",
      "summary": "The community revolves around the interactions between leptin, cardiovascular disease, and various genetic and environmental factors. Key entities include the LEP gene, plasma leptin levels, cardiovascular disease, and the Mediterranean diet. These entities are interconnected through their roles in energy balance, body weight regulation, and cardiovascular health.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on cardiovascular disease risk and management.",
      "findings": [
        {
          "summary": "LEP gene and plasma leptin levels",
          "explanation": "The LEP gene encodes the leptin protein, which plays a crucial role in energy balance and body weight regulation. Variants in the LEP gene, such as rs10487505, are associated with circulating leptin levels. This highlights the importance of genetic factors in determining plasma leptin levels and their potential impact on cardiovascular health."
        },
        {
          "summary": "Cardiovascular disease and plasma leptin levels",
          "explanation": "Cardiovascular disease is associated with altered plasma leptin levels, which are influenced by genetic and environmental factors. This relationship suggests that plasma leptin levels may serve as a biomarker for cardiovascular health and that interventions targeting leptin levels may help mitigate cardiovascular risk."
        },
        {
          "summary": "Mediterranean diet and plasma leptin levels",
          "explanation": "The Mediterranean diet influences plasma leptin levels, which are also affected by physical activity and other lifestyle factors. This highlights the importance of dietary patterns in managing cardiovascular health and the potential benefits of the Mediterranean diet in reducing cardiovascular risk."
        },
        {
          "summary": "Smoking status and cardiovascular disease",
          "explanation": "Smoking status is a risk factor for cardiovascular disease, which is also influenced by genetic and lifestyle factors. This relationship emphasizes the need to consider environmental factors in assessing cardiovascular risk and the importance of smoking cessation in preventing cardiovascular disease."
        },
        {
          "summary": "LEP gene and cardiovascular disease",
          "explanation": "The LEP gene is associated with cardiovascular disease risk, which is influenced by genetic and environmental factors. This relationship suggests that genetic variants in the LEP gene may contribute to cardiovascular susceptibility and that targeting leptin-related pathways may help mitigate cardiovascular risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 36",
    "edges": [
      [
        "\"BMI\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"KILPELIN ET AL.\"",
        "\"LEP\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"LEP\""
      ],
      [
        "\"LEP\"",
        "\"RS10487505\""
      ],
      [
        "\"BMI\"",
        "\"CARDIOVASCULAR DISEASE\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING STATUS\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"DIABETES\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"LEP\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"MEDITERRANEAN DIET\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"LEP\"",
        "\"LEPTIN\""
      ],
      [
        "\"LEP\"",
        "\"SNP\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"LIPID METABOLISM\""
      ]
    ],
    "nodes": [
      "\"LEP\"",
      "\"PLASMA LEPTIN LEVELS\"",
      "\"CARDIOVASCULAR DISEASE\"",
      "\"MEDITERRANEAN DIET\"",
      "\"SMOKING STATUS\"",
      "\"RS10487505\"",
      "\"KILPELIN ET AL.\"",
      "\"LIPID METABOLISM\""
    ],
    "chunk_ids": [
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.19117647058823528,
    "sub_communities": []
  },
  "80": {
    "report_string": "# Genetic and Metabolic Associations in Type 2 Diabetes\n\nThe community revolves around genetic and metabolic factors associated with Type 2 Diabetes (T2D), involving entities such as GWAS, genetic variants, and various studies and tools used in genetic analysis. These entities are interconnected through their roles in identifying genetic associations, analyzing genetic data, and understanding disease mechanisms.\n\n## GWAS and its role in identifying genetic variants associated with T2D\n\nGenome-Wide Association Studies (GWAS) play a crucial role in identifying genetic variants associated with Type 2 Diabetes (T2D). GWAS examines the entire genome to find genetic differences between people with and without T2D, providing insights into the genetic basis of the disease. This has led to the identification of numerous genetic variants that contribute to T2D susceptibility.\n\n## Role of BOLT-LMM in GWAS\n\nBOLT-LMM is a statistical tool used in GWAS to account for genetic variation and estimate heritability. It helps in understanding the genetic architecture of complex traits like T2D, enabling researchers to identify genetic associations while controlling for genetic variation.\n\n## Importance of UK Biobank in GWAS\n\nThe UK Biobank is a large-scale biomedical database that provides rich genetic and phenotypic data on a large cohort of individuals. It serves as a valuable resource for GWAS, allowing researchers to identify genetic variants associated with T2D and other diseases, and understand their relationships with environmental factors.\n\n## GWAS and anthropometric traits\n\nGWAS is used to identify genetic associations with anthropometric traits, which are relevant to T2D risk. By studying genetic variants associated with body mass index (BMI) and other anthropometric measures, researchers can better understand the relationship between genetic factors, metabolic health, and T2D susceptibility.\n\n## NHGRI-EBI Catalog as a resource for GWAS\n\nThe NHGRI-EBI Catalog is a comprehensive catalog of published GWAS. It provides a centralized resource for accessing information on genetic variants associated with diseases, including T2D, facilitating the integration of genetic data and phenotypic information.",
    "report_json": {
      "title": "Genetic and Metabolic Associations in Type 2 Diabetes",
      "summary": "The community revolves around genetic and metabolic factors associated with Type 2 Diabetes (T2D), involving entities such as GWAS, genetic variants, and various studies and tools used in genetic analysis. These entities are interconnected through their roles in identifying genetic associations, analyzing genetic data, and understanding disease mechanisms.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors and metabolic pathways on the risk and management of Type 2 Diabetes.",
      "findings": [
        {
          "summary": "GWAS and its role in identifying genetic variants associated with T2D",
          "explanation": "Genome-Wide Association Studies (GWAS) play a crucial role in identifying genetic variants associated with Type 2 Diabetes (T2D). GWAS examines the entire genome to find genetic differences between people with and without T2D, providing insights into the genetic basis of the disease. This has led to the identification of numerous genetic variants that contribute to T2D susceptibility."
        },
        {
          "summary": "Role of BOLT-LMM in GWAS",
          "explanation": "BOLT-LMM is a statistical tool used in GWAS to account for genetic variation and estimate heritability. It helps in understanding the genetic architecture of complex traits like T2D, enabling researchers to identify genetic associations while controlling for genetic variation."
        },
        {
          "summary": "Importance of UK Biobank in GWAS",
          "explanation": "The UK Biobank is a large-scale biomedical database that provides rich genetic and phenotypic data on a large cohort of individuals. It serves as a valuable resource for GWAS, allowing researchers to identify genetic variants associated with T2D and other diseases, and understand their relationships with environmental factors."
        },
        {
          "summary": "GWAS and anthropometric traits",
          "explanation": "GWAS is used to identify genetic associations with anthropometric traits, which are relevant to T2D risk. By studying genetic variants associated with body mass index (BMI) and other anthropometric measures, researchers can better understand the relationship between genetic factors, metabolic health, and T2D susceptibility."
        },
        {
          "summary": "NHGRI-EBI Catalog as a resource for GWAS",
          "explanation": "The NHGRI-EBI Catalog is a comprehensive catalog of published GWAS. It provides a centralized resource for accessing information on genetic variants associated with diseases, including T2D, facilitating the integration of genetic data and phenotypic information."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 80",
    "edges": [
      [
        "\"BOLT-LMM\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"GWAS\"",
        "\"WTCCC T2D PHENOTYPE\""
      ],
      [
        "\"GWAS\"",
        "\"T2D\""
      ],
      [
        "\"GWAS\"",
        "\"MO\""
      ],
      [
        "\"GWAS\"",
        "\"NHGRI-EBI CATALOG\""
      ],
      [
        "\"GWAS\"",
        "\"SORBS DATA SET\""
      ],
      [
        "\"GWAS\"",
        "\"PLINK\""
      ],
      [
        "\"GENOMIC VARIANT IDENTIFICATION\"",
        "\"GWAS\""
      ],
      [
        "\"CASE-CONTROL STUDY\"",
        "\"GWAS\""
      ],
      [
        "\"COHORT\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"PHEWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"PRINCIPAL COMPONENTS (PC1-PC4)\""
      ],
      [
        "\"GWAS\"",
        "\"OBESITY\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"UK BIOBANK\""
      ]
    ],
    "nodes": [
      "\"BOLT-LMM\"",
      "\"PRINCIPAL COMPONENTS (PC1-PC4)\"",
      "\"GWAS\"",
      "\"GENOMIC VARIANT IDENTIFICATION\"",
      "\"PLINK\"",
      "\"NHGRI-EBI CATALOG\"",
      "\"WTCCC T2D PHENOTYPE\"",
      "\"SORBS DATA SET\"",
      "\"CASE-CONTROL STUDY\"",
      "\"UK BIOBANK\""
    ],
    "chunk_ids": [
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.29411764705882354,
    "sub_communities": []
  },
  "29": {
    "report_string": "# APOE and Alzheimer's Disease: Fatty Acid Metabolism Connections\n\nThe community centers around the APOE gene, Alzheimer's disease, and fatty acid metabolism. APOE is linked to Alzheimer's disease and fatty acid metabolism, indicating a complex interplay between genetic factors, metabolic processes, and disease risk.\n\n## APOE gene and Alzheimer's disease risk\n\nThe APOE gene is directly associated with Alzheimer's disease, suggesting that genetic factors play a crucial role in disease susceptibility. This relationship highlights the importance of considering genetic risk factors in disease management and prevention strategies.\n\n## APOE involvement in fatty acid metabolism\n\nAPOE's involvement in fatty acid metabolism indicates a link between metabolic processes and neurological health. This connection suggests that dietary interventions targeting fatty acid metabolism might impact Alzheimer's disease risk or progression.\n\n## Fatty acid metabolism alterations in T2DM\n\nThe alteration of fatty acid metabolism in type 2 diabetes mellitus (T2DM) implies a shared metabolic pathway between T2DM and Alzheimer's disease. This overlap suggests that managing T2DM through dietary interventions could have implications for Alzheimer's disease risk.\n\n## APOE and Alzheimer's risk relationship\n\nThe direct association between APOE and Alzheimer's risk underscores the genetic component of the disease. This relationship supports the need for personalized risk assessments based on genetic profiles to guide early intervention and prevention strategies.",
    "report_json": {
      "title": "APOE and Alzheimer's Disease: Fatty Acid Metabolism Connections",
      "summary": "The community centers around the APOE gene, Alzheimer's disease, and fatty acid metabolism. APOE is linked to Alzheimer's disease and fatty acid metabolism, indicating a complex interplay between genetic factors, metabolic processes, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant association of APOE with Alzheimer's disease and its role in fatty acid metabolism, which are critical for neurological health and disease risk.",
      "findings": [
        {
          "summary": "APOE gene and Alzheimer's disease risk",
          "explanation": "The APOE gene is directly associated with Alzheimer's disease, suggesting that genetic factors play a crucial role in disease susceptibility. This relationship highlights the importance of considering genetic risk factors in disease management and prevention strategies."
        },
        {
          "summary": "APOE involvement in fatty acid metabolism",
          "explanation": "APOE's involvement in fatty acid metabolism indicates a link between metabolic processes and neurological health. This connection suggests that dietary interventions targeting fatty acid metabolism might impact Alzheimer's disease risk or progression."
        },
        {
          "summary": "Fatty acid metabolism alterations in T2DM",
          "explanation": "The alteration of fatty acid metabolism in type 2 diabetes mellitus (T2DM) implies a shared metabolic pathway between T2DM and Alzheimer's disease. This overlap suggests that managing T2DM through dietary interventions could have implications for Alzheimer's disease risk."
        },
        {
          "summary": "APOE and Alzheimer's risk relationship",
          "explanation": "The direct association between APOE and Alzheimer's risk underscores the genetic component of the disease. This relationship supports the need for personalized risk assessments based on genetic profiles to guide early intervention and prevention strategies."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 29",
    "edges": [
      [
        "\"ALZHEIMER'S RISK\"",
        "\"APOE\""
      ],
      [
        "\"APOE\"",
        "\"FATTY ACID METABOLISM\""
      ],
      [
        "\"ALZHEIMER'S DISEASE\"",
        "\"APOE\""
      ],
      [
        "\"FATTY ACID METABOLISM\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"ALZHEIMER'S DISEASE\"",
      "\"ALZHEIMER'S RISK\"",
      "\"APOE\"",
      "\"FATTY ACID METABOLISM\""
    ],
    "chunk_ids": [
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-2f2c90dea13e0dad5235137b025e03b7"
    ],
    "occurrence": 0.04411764705882353,
    "sub_communities": []
  },
  "56": {
    "report_string": "# Type2 Diabetes Genetic Network\n\nThe community revolves around type2 diabetes, influenced by genetic factors through genes such as ADAM30 and NOTCH2. These genes are associated with the pathogenesis and risk of type2 diabetes. The network highlights the complexity of type2 diabetes, involving multiple genetic contributors.\n\n## ADAM30 gene association with type2 diabetes\n\nThe ADAM30 gene is associated with type2 diabetes. This gene plays a role in the disease's pathology, as supported by its frequent discussion in type2 diabetes research and its linkage to risk SNPs.\n\n## NOTCH2 gene involvement in type2 diabetes pathogenesis\n\nThe NOTCH2 gene is involved in the pathogenesis of type2 diabetes. Its role in the disease highlights the genetic complexity of type2 diabetes and the need for personalized treatment approaches.\n\n## Adiposity as a risk factor for type2 diabetes\n\nAdiposity is a significant risk factor for type2 diabetes, with obesity GWAS genes contributing to this relationship. This underscores the importance of lifestyle factors in managing type2 diabetes risk.\n\n## FTO variants and type2 diabetes risk\n\nFTO variants are associated with an increased risk of type2 diabetes. This highlights the role of genetic factors in type2 diabetes susceptibility and the potential for targeted interventions.\n\n## LD SNPs association with type2 diabetes\n\nLD SNPs are associated with an increased risk of type2 diabetes. These genetic markers provide insights into the disease's genetic architecture and potential therapeutic targets.",
    "report_json": {
      "title": "Type2 Diabetes Genetic Network",
      "summary": "The community revolves around type2 diabetes, influenced by genetic factors through genes such as ADAM30 and NOTCH2. These genes are associated with the pathogenesis and risk of type2 diabetes. The network highlights the complexity of type2 diabetes, involving multiple genetic contributors.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic factors on type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "ADAM30 gene association with type2 diabetes",
          "explanation": "The ADAM30 gene is associated with type2 diabetes. This gene plays a role in the disease's pathology, as supported by its frequent discussion in type2 diabetes research and its linkage to risk SNPs."
        },
        {
          "summary": "NOTCH2 gene involvement in type2 diabetes pathogenesis",
          "explanation": "The NOTCH2 gene is involved in the pathogenesis of type2 diabetes. Its role in the disease highlights the genetic complexity of type2 diabetes and the need for personalized treatment approaches."
        },
        {
          "summary": "Adiposity as a risk factor for type2 diabetes",
          "explanation": "Adiposity is a significant risk factor for type2 diabetes, with obesity GWAS genes contributing to this relationship. This underscores the importance of lifestyle factors in managing type2 diabetes risk."
        },
        {
          "summary": "FTO variants and type2 diabetes risk",
          "explanation": "FTO variants are associated with an increased risk of type2 diabetes. This highlights the role of genetic factors in type2 diabetes susceptibility and the potential for targeted interventions."
        },
        {
          "summary": "LD SNPs association with type2 diabetes",
          "explanation": "LD SNPs are associated with an increased risk of type2 diabetes. These genetic markers provide insights into the disease's genetic architecture and potential therapeutic targets."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 56",
    "edges": [
      [
        "\"ADIPOSITY\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADAM30\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADAM30\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"NOTCH2\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"NOTCH2\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TYPE2 DIABETES\""
      ]
    ],
    "nodes": [
      "\"TYPE2 DIABETES\"",
      "\"NOTCH2\"",
      "\"TYPE 2 DIABETES\"",
      "\"ADAM30\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6c935916492da41e4048751fc4c84348"
    ],
    "occurrence": 0.1323529411764706,
    "sub_communities": []
  },
  "41": {
    "report_string": "# Obesity Genetic and Environmental Factors\n\nThe community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include genes such as FTO, LEPR, and ADIPOQ, nutrients like dietary fiber and energy intake, and diseases like type 2 diabetes and colorectal cancer. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk, with variants such as rs9939609 and rs3751812 linked to increased risk. The FTO gene's role in fat mass and obesity highlights the genetic component of obesity.\n\n## Dietary fiber and obesity risk\n\nDietary fiber intake is important for maintaining a healthy weight and reducing obesity risk. The relationship between dietary fiber and obesity underscores the significance of nutritional factors in obesity prevention.\n\n## LEPR gene and obesity\n\nThe LEPR gene, encoding the leptin receptor, is involved in energy balance and obesity. Variants in LEPR have been associated with obesity phenotypes, emphasizing the genetic contribution to obesity susceptibility.\n\n## Obesity and type 2 diabetes\n\nObesity is a significant risk factor for type 2 diabetes, and genetic variants like those in the FTO gene can contribute to both conditions. The interplay between obesity and type 2 diabetes highlights the complexity of metabolic health.\n\n## ADIPOQ gene and metabolic health\n\nThe ADIPOQ gene, associated with adiponectin production, is linked to insulin signaling and glucose homeostasis. Dysregulation of ADIPOQ in obesity underscores its role in metabolic health.",
    "report_json": {
      "title": "Obesity Genetic and Environmental Factors",
      "summary": "The community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include genes such as FTO, LEPR, and ADIPOQ, nutrients like dietary fiber and energy intake, and diseases like type 2 diabetes and colorectal cancer. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity risk and its association with various chronic diseases.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk, with variants such as rs9939609 and rs3751812 linked to increased risk. The FTO gene's role in fat mass and obesity highlights the genetic component of obesity."
        },
        {
          "summary": "Dietary fiber and obesity risk",
          "explanation": "Dietary fiber intake is important for maintaining a healthy weight and reducing obesity risk. The relationship between dietary fiber and obesity underscores the significance of nutritional factors in obesity prevention."
        },
        {
          "summary": "LEPR gene and obesity",
          "explanation": "The LEPR gene, encoding the leptin receptor, is involved in energy balance and obesity. Variants in LEPR have been associated with obesity phenotypes, emphasizing the genetic contribution to obesity susceptibility."
        },
        {
          "summary": "Obesity and type 2 diabetes",
          "explanation": "Obesity is a significant risk factor for type 2 diabetes, and genetic variants like those in the FTO gene can contribute to both conditions. The interplay between obesity and type 2 diabetes highlights the complexity of metabolic health."
        },
        {
          "summary": "ADIPOQ gene and metabolic health",
          "explanation": "The ADIPOQ gene, associated with adiponectin production, is linked to insulin signaling and glucose homeostasis. Dysregulation of ADIPOQ in obesity underscores its role in metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 41",
    "edges": [
      [
        "\"MEC\"",
        "\"OBESITY\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ],
      [
        "\"META-ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"NPY\"",
        "\"OBESITY\""
      ],
      [
        "\"MDS\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO UPSTREAM REGION\"",
        "\"OBESITY\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"MULTIVITAMINS\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI VALUE\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1558902\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PFKFB3\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"LEPTIN\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SEX\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"LDL CHOLESTEROL\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PPARG\""
      ],
      [
        "\"CABP5\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"T2DM\""
      ],
      [
        "\"FTO SNPS\"",
        "\"OBESITY\""
      ],
      [
        "\"FISHER'S EXACT TEST\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"OBESITY\"",
        "\"POLISH ADULT SUBJECTS\""
      ],
      [
        "\"IRX5 RS12444481\"",
        "\"OBESITY\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"OBESITY\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1421085\"",
        "\"OBESITY\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"IRX3 RS4270172\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"TRIGLYCERIDE\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9930506\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"RS9939609\""
      ],
      [
        "\"ENERGY AND MACRONUTRIENT INTAKES\"",
        "\"OBESITY\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"TYPE\""
      ],
      [
        "\"EDUCATIONAL LEVEL\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"OBESITY\""
      ],
      [
        "\"LOCI\"",
        "\"OBESITY\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"FAMA167-AS1\""
      ],
      [
        "\"IRX5 RS4435250\"",
        "\"OBESITY\""
      ],
      [
        "\"NEGR1\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"HUMAN FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"CREB1\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"AGE\"",
        "\"OBESITY\""
      ],
      [
        "\"GWAS\"",
        "\"OBESITY\""
      ],
      [
        "\"DIETARY FIBER\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"OBESITY\""
      ],
      [
        "\"CEBPB\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"ENERGY AND MACRONUTRIENT INTAKES\"",
      "\"CTNNBL1\"",
      "\"BMI VALUE\"",
      "\"BODY SHAPE SCORE\"",
      "\"IRX5 RS4435250\"",
      "\"FAMA167-AS1\"",
      "\"TYPE\"",
      "\"MEC\"",
      "\"IRX5 RS12444481\"",
      "\"FTO RS9930506\"",
      "\"DM2\"",
      "\"FTO UPSTREAM REGION\"",
      "\"POLISH ADULT SUBJECTS\"",
      "\"HUMAN FTO GENE\"",
      "\"LEPR\"",
      "\"MULTIVITAMINS\"",
      "\"DIETARY FIBER\"",
      "\"OBESITY\"",
      "\"PPARG\"",
      "\"LOCI\"",
      "\"PFKFB3\"",
      "\"TRIGLYCERIDE\"",
      "\"LDL CHOLESTEROL\"",
      "\"CEBPB\"",
      "\"IRX3 RS4270172\"",
      "\"NPY\"",
      "\"CAUCASIANS\"",
      "\"FISHER'S EXACT TEST\"",
      "\"EDUCATIONAL LEVEL\"",
      "\"ADIPOQ\"",
      "\"CABP5\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.6764705882352942,
    "sub_communities": [
      "95",
      "93",
      "94"
    ]
  },
  "43": {
    "report_string": "# Genetic and Dietary Influences on Energy Intake and Obesity\n\nThe community revolves around the interplay between genetic factors, dietary patterns, and physiological processes influencing energy intake and obesity risk. Key entities include genes such as NEGR1 and FTO, genomic variants like rs1620977 and rs2815752, and concepts like dietary patterns and energy intake. These entities are interconnected through their roles in regulating energy balance, nutrient metabolism, and disease susceptibility.\n\n## NEGR1 gene and its association with energy intake and obesity\n\nThe NEGR1 gene is associated with obesity risk and energy intake. Variants in NEGR1, such as rs2815752, are linked to lower total energy intake, highlighting the gene's role in regulating physiological processes related to energy balance. This relationship suggests that genetic factors influencing energy intake may contribute to obesity susceptibility.\n\n## Impact of dietary patterns on energy intake and obesity\n\nDietary patterns significantly influence energy intake, which is a risk factor for obesity. The interplay between dietary patterns, energy intake, and genetic factors like NEGR1 and FTO underscores the complexity of obesity etiology. Understanding these relationships can inform personalized dietary recommendations for obesity prevention and management.\n\n## Role of genomic variants in obesity susceptibility\n\nGenomic variants such as rs1620977 are associated with morbid obesity and interact with genes like NEGR1 to influence obesity risk. These genetic factors highlight the importance of considering individual genetic profiles in assessing obesity susceptibility and developing targeted interventions.\n\n## FTO gene and energy intake\n\nThe FTO gene is associated with energy intake, with specific alleles linked to lower or higher energy intake. This relationship between FTO, energy intake, and obesity risk emphasizes the role of genetic factors in regulating energy balance and metabolic health.\n\n## Energy intake as a risk factor for obesity\n\nEnergy intake is a significant risk factor for obesity, and its regulation is influenced by both genetic and environmental factors. The complex interplay between energy intake, genetic predisposition, and obesity highlights the need for comprehensive approaches to address obesity prevention and treatment.",
    "report_json": {
      "title": "Genetic and Dietary Influences on Energy Intake and Obesity",
      "summary": "The community revolves around the interplay between genetic factors, dietary patterns, and physiological processes influencing energy intake and obesity risk. Key entities include genes such as NEGR1 and FTO, genomic variants like rs1620977 and rs2815752, and concepts like dietary patterns and energy intake. These entities are interconnected through their roles in regulating energy balance, nutrient metabolism, and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and dietary factors on energy intake and obesity risk.",
      "findings": [
        {
          "summary": "NEGR1 gene and its association with energy intake and obesity",
          "explanation": "The NEGR1 gene is associated with obesity risk and energy intake. Variants in NEGR1, such as rs2815752, are linked to lower total energy intake, highlighting the gene's role in regulating physiological processes related to energy balance. This relationship suggests that genetic factors influencing energy intake may contribute to obesity susceptibility."
        },
        {
          "summary": "Impact of dietary patterns on energy intake and obesity",
          "explanation": "Dietary patterns significantly influence energy intake, which is a risk factor for obesity. The interplay between dietary patterns, energy intake, and genetic factors like NEGR1 and FTO underscores the complexity of obesity etiology. Understanding these relationships can inform personalized dietary recommendations for obesity prevention and management."
        },
        {
          "summary": "Role of genomic variants in obesity susceptibility",
          "explanation": "Genomic variants such as rs1620977 are associated with morbid obesity and interact with genes like NEGR1 to influence obesity risk. These genetic factors highlight the importance of considering individual genetic profiles in assessing obesity susceptibility and developing targeted interventions."
        },
        {
          "summary": "FTO gene and energy intake",
          "explanation": "The FTO gene is associated with energy intake, with specific alleles linked to lower or higher energy intake. This relationship between FTO, energy intake, and obesity risk emphasizes the role of genetic factors in regulating energy balance and metabolic health."
        },
        {
          "summary": "Energy intake as a risk factor for obesity",
          "explanation": "Energy intake is a significant risk factor for obesity, and its regulation is influenced by both genetic and environmental factors. The complex interplay between energy intake, genetic predisposition, and obesity highlights the need for comprehensive approaches to address obesity prevention and treatment."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 43",
    "edges": [
      [
        "\"ENERGY INTAKE\"",
        "\"NEGR1\""
      ],
      [
        "\"NEGR1\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"NEGR1 SNP RS2815752\""
      ],
      [
        "\"NEGR1\"",
        "\"RS1620977\""
      ],
      [
        "\"DIETARY PATTERN\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"FTO\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS8050136\""
      ]
    ],
    "nodes": [
      "\"ENERGY INTAKE\"",
      "\"NEGR1\"",
      "\"RS1620977\"",
      "\"NEGR1 SNP RS2815752\"",
      "\"DIETARY PATTERN\""
    ],
    "chunk_ids": [
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "57": {
    "report_string": "# Alcohol Consumption and Pregnancy\n\nThe community revolves around alcohol consumption and its impact on pregnancy, involving genes such as ADH1C, GRM8, and PDYN. These entities are interconnected through their roles in alcohol metabolism, pregnancy outcomes, and potential effects on obesity and disease risk.\n\n## Alcohol consumption and its genetic associations\n\nThe community highlights the role of genes such as ADH1C, GRM8, and PDYN in alcohol consumption during pregnancy. These genes are associated with alcohol metabolism and may influence an individual's susceptibility to the effects of alcohol consumption.\n\n## Impact of alcohol consumption on pregnancy\n\nAlcohol consumption is a significant environmental factor that affects pregnancy outcomes. It can impact obesity risk and disease susceptibility, emphasizing the need for careful management of alcohol intake during pregnancy.\n\n## Relationship between alcohol consumption and binge drinking\n\nBinge drinking is identified as a type of alcohol consumption, suggesting that patterns of alcohol intake have distinct implications for health outcomes.\n\n## Genetic factors influencing alcohol consumption\n\nThe involvement of genes like ADH1C, GRM8, and PDYN in alcohol consumption during pregnancy underscores the genetic component of alcohol metabolism and its effects on pregnancy.\n\n## Alcohol consumption and adiposity traits\n\nThe community also reveals a link between alcohol consumption and adiposity traits, suggesting that alcohol intake may influence obesity risk and related metabolic health issues.",
    "report_json": {
      "title": "Alcohol Consumption and Pregnancy",
      "summary": "The community revolves around alcohol consumption and its impact on pregnancy, involving genes such as ADH1C, GRM8, and PDYN. These entities are interconnected through their roles in alcohol metabolism, pregnancy outcomes, and potential effects on obesity and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of alcohol consumption on pregnancy outcomes and disease risk.",
      "findings": [
        {
          "summary": "Alcohol consumption and its genetic associations",
          "explanation": "The community highlights the role of genes such as ADH1C, GRM8, and PDYN in alcohol consumption during pregnancy. These genes are associated with alcohol metabolism and may influence an individual's susceptibility to the effects of alcohol consumption."
        },
        {
          "summary": "Impact of alcohol consumption on pregnancy",
          "explanation": "Alcohol consumption is a significant environmental factor that affects pregnancy outcomes. It can impact obesity risk and disease susceptibility, emphasizing the need for careful management of alcohol intake during pregnancy."
        },
        {
          "summary": "Relationship between alcohol consumption and binge drinking",
          "explanation": "Binge drinking is identified as a type of alcohol consumption, suggesting that patterns of alcohol intake have distinct implications for health outcomes."
        },
        {
          "summary": "Genetic factors influencing alcohol consumption",
          "explanation": "The involvement of genes like ADH1C, GRM8, and PDYN in alcohol consumption during pregnancy underscores the genetic component of alcohol metabolism and its effects on pregnancy."
        },
        {
          "summary": "Alcohol consumption and adiposity traits",
          "explanation": "The community also reveals a link between alcohol consumption and adiposity traits, suggesting that alcohol intake may influence obesity risk and related metabolic health issues."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 57",
    "edges": [
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PDYN\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"BINGE DRINKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PREGNANCY\""
      ],
      [
        "\"PREGNANCY\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"GRM8\""
      ],
      [
        "\"ADH1C\"",
        "\"ALCOHOL CONSUMPTION\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"ALCOHOL CONSUMPTION\""
      ]
    ],
    "nodes": [
      "\"ALCOHOL CONSUMPTION\"",
      "\"PDYN\"",
      "\"ADH1C\"",
      "\"PREGNANCY\"",
      "\"BINGE DRINKING\"",
      "\"GRM8\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.08823529411764706,
    "sub_communities": []
  },
  "59": {
    "report_string": "# Genetic and Physiological Factors in Obesity\n\nThe community revolves around obesity, which is influenced by genetic and physiological factors. Key entities include the genomic variant rs9939609, waist circumference, fasting glucose, and BMI. These entities are interconnected through their roles in obesity risk, metabolic health, and genetic associations.\n\n## The rs9939609 genomic variant and its association with obesity\n\nThe rs9939609 genomic variant is associated with an increased risk of obesity, particularly in populations of European ancestry. This variant is located in the FTO gene and has been linked to higher BMI values and obesity-related traits. The rs9939609 A allele is a risk variant for obesity, with a significant association reported in several studies.\n\n## Waist circumference as a measure of central obesity\n\nWaist circumference is a physiological process that measures central obesity, which is a key indicator of metabolic health. It is associated with increased risk of MAFLD and is influenced by genetic variants such as rs9939609. Waist circumference is a quantitative measure of obesity and is used to assess body shape.\n\n## The role of fasting glucose in metabolic health\n\nFasting glucose is a physiological process associated with type2 diabetes and metabolic health. While the rs9939609 A allele is not significantly associated with fasting glucose, childhood obesity is associated with increased fasting glucose levels. This highlights the importance of monitoring fasting glucose levels in individuals with obesity.\n\n## The relationship between rs9939609 and BMI\n\nThe rs9939609 genomic variant is associated with higher BMI values, and the rs9939609 A allele is associated with obesity defined as BMI 28 kg/m2. The beta value estimates the effect size of rs9939609 on BMI, indicating a significant genetic influence on body mass index.\n\n## The FTO gene and its variants\n\nThe FTO gene contains the rs9939609 A allele, which is a risk variant for obesity. Another SNP, rs76804286, is in complete dependence with rs9939609 in the FTO gene, highlighting the genetic complexity of obesity. These variants are associated with obesity risk and BMI values.",
    "report_json": {
      "title": "Genetic and Physiological Factors in Obesity",
      "summary": "The community revolves around obesity, which is influenced by genetic and physiological factors. Key entities include the genomic variant rs9939609, waist circumference, fasting glucose, and BMI. These entities are interconnected through their roles in obesity risk, metabolic health, and genetic associations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and physiological factors on obesity risk and management.",
      "findings": [
        {
          "summary": "The rs9939609 genomic variant and its association with obesity",
          "explanation": "The rs9939609 genomic variant is associated with an increased risk of obesity, particularly in populations of European ancestry. This variant is located in the FTO gene and has been linked to higher BMI values and obesity-related traits. The rs9939609 A allele is a risk variant for obesity, with a significant association reported in several studies."
        },
        {
          "summary": "Waist circumference as a measure of central obesity",
          "explanation": "Waist circumference is a physiological process that measures central obesity, which is a key indicator of metabolic health. It is associated with increased risk of MAFLD and is influenced by genetic variants such as rs9939609. Waist circumference is a quantitative measure of obesity and is used to assess body shape."
        },
        {
          "summary": "The role of fasting glucose in metabolic health",
          "explanation": "Fasting glucose is a physiological process associated with type2 diabetes and metabolic health. While the rs9939609 A allele is not significantly associated with fasting glucose, childhood obesity is associated with increased fasting glucose levels. This highlights the importance of monitoring fasting glucose levels in individuals with obesity."
        },
        {
          "summary": "The relationship between rs9939609 and BMI",
          "explanation": "The rs9939609 genomic variant is associated with higher BMI values, and the rs9939609 A allele is associated with obesity defined as BMI 28 kg/m2. The beta value estimates the effect size of rs9939609 on BMI, indicating a significant genetic influence on body mass index."
        },
        {
          "summary": "The FTO gene and its variants",
          "explanation": "The FTO gene contains the rs9939609 A allele, which is a risk variant for obesity. Another SNP, rs76804286, is in complete dependence with rs9939609 in the FTO gene, highlighting the genetic complexity of obesity. These variants are associated with obesity risk and BMI values."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 59",
    "edges": [
      [
        "\"OBESE GROUP\"",
        "\"RS9939609\""
      ],
      [
        "\"BMI 28 KG/M2\"",
        "\"RS9939609\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"FASTING GLUCOSE\""
      ],
      [
        "\"BMI\"",
        "\"RS9939609\""
      ],
      [
        "\"BETA\"",
        "\"RS9939609\""
      ],
      [
        "\"RS9939609\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"RS76804286\"",
        "\"RS9939609\""
      ],
      [
        "\"P-VALUE\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO GENE\"",
        "\"RS9939609\""
      ],
      [
        "\"AGE\"",
        "\"RS9939609\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"FASTING GLUCOSE\"",
        "\"RS9939609\""
      ],
      [
        "\"EUROPEAN ANCESTRY\"",
        "\"RS9939609\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RS9939609\""
      ],
      [
        "\"OBESITY\"",
        "\"RS9939609\""
      ],
      [
        "\"MAFLD\"",
        "\"RS9939609\""
      ],
      [
        "\"RS9939609\"",
        "\"SEX\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"MAFLD\"",
        "\"WAIST CIRCUMFERENCE\""
      ]
    ],
    "nodes": [
      "\"RS9939609\"",
      "\"BMI 28 KG/M2\"",
      "\"RS76804286\"",
      "\"FASTING GLUCOSE\"",
      "\"BETA\"",
      "\"WAIST CIRCUMFERENCE\""
    ],
    "chunk_ids": [
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.22058823529411764,
    "sub_communities": []
  },
  "49": {
    "report_string": "# Genetic Variants and Anthropometric Traits\n\nThe community revolves around genetic variants, particularly SNPs, and their associations with anthropometric traits and diseases. Key entities include SNPs, genes like FTO and ADCY3, and physiological processes such as body fatness and BMI. These entities are interconnected through their roles in genetic associations, disease risk, and metabolic health.\n\n## SNPs and their role in genetic associations\n\nSNPs are genetic variants associated with various diseases and traits, including obesity, body fatness, and thyroid cancer. They are used in GWAS to identify genetic associations with anthropometric traits and diseases. For example, SNPs in the FTO gene are associated with BMI and obesity.\n\n## FTO gene and its association with obesity\n\nThe FTO gene has multiple SNPs associated with BMI and obesity. These genetic variants can influence body fatness and metabolic health. The FTO gene is a key entity in the community, and its SNPs are used to study genetic associations with obesity.\n\n## Anthropometric traits and their relationship with genetic variants\n\nAnthropometric traits, such as BMI and body fatness, are influenced by genetic variants, including SNPs. These traits are used to assess an individual's health and physical characteristics. The relationship between genetic variants and anthropometric traits highlights the importance of considering genetic factors in metabolic health.\n\n## dbSNP and its role in genetic variant research\n\ndbSNP is a database of known genetic variants, including SNPs and indels. It is used to study genetic associations with diseases and traits. dbSNP provides a comprehensive resource for researchers to analyze genetic variants and their relationships with anthropometric traits.\n\n## Gender and its influence on anthropometric traits\n\nGender is an environmental factor that affects BMI and obesity. It can influence the risk of certain diseases, such as MAFLD. The relationship between gender and anthropometric traits highlights the importance of considering environmental factors in metabolic health.",
    "report_json": {
      "title": "Genetic Variants and Anthropometric Traits",
      "summary": "The community revolves around genetic variants, particularly SNPs, and their associations with anthropometric traits and diseases. Key entities include SNPs, genes like FTO and ADCY3, and physiological processes such as body fatness and BMI. These entities are interconnected through their roles in genetic associations, disease risk, and metabolic health.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants on anthropometric traits and disease risk.",
      "findings": [
        {
          "summary": "SNPs and their role in genetic associations",
          "explanation": "SNPs are genetic variants associated with various diseases and traits, including obesity, body fatness, and thyroid cancer. They are used in GWAS to identify genetic associations with anthropometric traits and diseases. For example, SNPs in the FTO gene are associated with BMI and obesity."
        },
        {
          "summary": "FTO gene and its association with obesity",
          "explanation": "The FTO gene has multiple SNPs associated with BMI and obesity. These genetic variants can influence body fatness and metabolic health. The FTO gene is a key entity in the community, and its SNPs are used to study genetic associations with obesity."
        },
        {
          "summary": "Anthropometric traits and their relationship with genetic variants",
          "explanation": "Anthropometric traits, such as BMI and body fatness, are influenced by genetic variants, including SNPs. These traits are used to assess an individual's health and physical characteristics. The relationship between genetic variants and anthropometric traits highlights the importance of considering genetic factors in metabolic health."
        },
        {
          "summary": "dbSNP and its role in genetic variant research",
          "explanation": "dbSNP is a database of known genetic variants, including SNPs and indels. It is used to study genetic associations with diseases and traits. dbSNP provides a comprehensive resource for researchers to analyze genetic variants and their relationships with anthropometric traits."
        },
        {
          "summary": "Gender and its influence on anthropometric traits",
          "explanation": "Gender is an environmental factor that affects BMI and obesity. It can influence the risk of certain diseases, such as MAFLD. The relationship between gender and anthropometric traits highlights the importance of considering environmental factors in metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 49",
    "edges": [
      [
        "\"MINOR ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"SNP\""
      ],
      [
        "\"HARDY-WEINBERG EQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"SNP\""
      ],
      [
        "\"GENE\"",
        "\"SNP\""
      ],
      [
        "\"GENETIC VARIATION\"",
        "\"SNP\""
      ],
      [
        "\"LINKAGE DISEQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GENDER\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"ADCY3\"",
        "\"SNP\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"AGE\"",
        "\"ANTHROPOMETRIC TRAITS\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"GENE\"",
        "\"MAGMA\""
      ],
      [
        "\"SNP\"",
        "\"TMEM18\""
      ],
      [
        "\"DBSNP\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"INDEL\"",
        "\"SNP\""
      ],
      [
        "\"GENE\"",
        "\"MIRNA\""
      ],
      [
        "\"GENOTYPE\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CTSS\"",
        "\"SNP\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"GENDER\"",
        "\"MAFLD\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"LD PLOT\"",
        "\"SNP\""
      ],
      [
        "\"HWE\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"SNP\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"MAF\"",
        "\"SNP\""
      ],
      [
        "\"LEP\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"GENOTYPING\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELE FREQUENCY\"",
      "\"GENOTYPING\"",
      "\"MIRNA\"",
      "\"GENETIC VARIATION\"",
      "\"UVAM\"",
      "\"MAF\"",
      "\"GENDER\"",
      "\"SNP\"",
      "\"DBSNP\"",
      "\"ANTHROPOMETRIC TRAITS\"",
      "\"GENE\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.45588235294117646,
    "sub_communities": [
      "100",
      "101",
      "102"
    ]
  },
  "34": {
    "report_string": "# FTO Gene and Obesity Risk\n\nThe community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and related metabolic disorders. The FTO gene interacts with various physiological processes, including glucose homeostasis, and is linked to diseases such as type2 diabetes, hypertension, and hypercholesterolemia.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants of the FTO gene, such as rs3751812 and rs8050136, have been linked to increased obesity risk. The gene's association with obesity phenotypes, including self-reported walking pace and physical activity, highlights its importance in understanding the genetic factors underlying obesity.\n\n## FTO gene and glucose homeostasis\n\nThe FTO gene is involved in glucose homeostasis and is associated with type2 diabetes risk. The gene's interaction with glucose homeostasis is critical in understanding the link between obesity and metabolic disorders. Variants of the FTO gene have been associated with impaired glucose regulation, increasing the risk of type2 diabetes.\n\n## FTO gene and hypertension\n\nThe FTO gene is associated with hypertension, a condition characterized by high blood pressure. The gene's variants have been linked to increased risk of hypertension, highlighting the importance of considering genetic factors in the management of blood pressure.\n\n## FTO gene and impulsivity traits\n\nThe FTO gene is associated with impulsivity traits, including delay discounting of rewards and negative urgency. The gene's interaction with impulsivity traits highlights the complex interplay between genetic factors and behavior, particularly in the context of obesity and metabolic disorders.\n\n## FTO gene and skeletal robustness\n\nThe FTO gene may be associated with skeletal robustness, including measures of height and knee, wrist, and elbow breadth. The gene's interaction with skeletal robustness highlights its potential role in understanding the genetic factors underlying physical characteristics.",
    "report_json": {
      "title": "FTO Gene and Obesity Risk",
      "summary": "The community revolves around the FTO gene, which is associated with obesity risk, body mass index (BMI), and related metabolic disorders. The FTO gene interacts with various physiological processes, including glucose homeostasis, and is linked to diseases such as type2 diabetes, hypertension, and hypercholesterolemia.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of the FTO gene on obesity risk and related metabolic disorders.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk, BMI, and fat mass. Variants of the FTO gene, such as rs3751812 and rs8050136, have been linked to increased obesity risk. The gene's association with obesity phenotypes, including self-reported walking pace and physical activity, highlights its importance in understanding the genetic factors underlying obesity."
        },
        {
          "summary": "FTO gene and glucose homeostasis",
          "explanation": "The FTO gene is involved in glucose homeostasis and is associated with type2 diabetes risk. The gene's interaction with glucose homeostasis is critical in understanding the link between obesity and metabolic disorders. Variants of the FTO gene have been associated with impaired glucose regulation, increasing the risk of type2 diabetes."
        },
        {
          "summary": "FTO gene and hypertension",
          "explanation": "The FTO gene is associated with hypertension, a condition characterized by high blood pressure. The gene's variants have been linked to increased risk of hypertension, highlighting the importance of considering genetic factors in the management of blood pressure."
        },
        {
          "summary": "FTO gene and impulsivity traits",
          "explanation": "The FTO gene is associated with impulsivity traits, including delay discounting of rewards and negative urgency. The gene's interaction with impulsivity traits highlights the complex interplay between genetic factors and behavior, particularly in the context of obesity and metabolic disorders."
        },
        {
          "summary": "FTO gene and skeletal robustness",
          "explanation": "The FTO gene may be associated with skeletal robustness, including measures of height and knee, wrist, and elbow breadth. The gene's interaction with skeletal robustness highlights its potential role in understanding the genetic factors underlying physical characteristics."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 34",
    "edges": [
      [
        "\"BODY SHAPE\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF6\""
      ],
      [
        "\"FTO\"",
        "\"MYOD1\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"FTO\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"FTO\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"RS17817964\""
      ],
      [
        "\"MAFLD\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"IMPULSIVITY TRAITS\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"IGF-1\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"FTO\"",
        "\"HYPERCHOLESTEROLEMIA\""
      ],
      [
        "\"FM\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYOG\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"GENETIC EPIDEMIOLOGY\""
      ],
      [
        "\"FTO\"",
        "\"META-ANALYSES\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"FTO\""
      ],
      [
        "\"CHROMOSOME16\"",
        "\"FTO\""
      ],
      [
        "\"OBESITY RISK\"",
        "\"RS3751812\""
      ],
      [
        "\"FTO\"",
        "\"RS12595985\""
      ],
      [
        "\"IRX3\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"FTO\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"FTO\"",
        "\"SKELETAL ROBUSTNESS\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"MAFLD\"",
        "\"RS3751812\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYF5\""
      ],
      [
        "\"FTO\"",
        "\"IRX3\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO\"",
        "\"SEX\""
      ],
      [
        "\"FTO\"",
        "\"PBF\""
      ],
      [
        "\"FTO\"",
        "\"GLUCOSE HOMEOSTASIS\""
      ],
      [
        "\"CHROMOSOME 16\"",
        "\"FTO\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"HYPERTENSION\""
      ],
      [
        "\"FTO\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"OBESITY GWAS GENES\""
      ]
    ],
    "nodes": [
      "\"FTO\"",
      "\"MYF5\"",
      "\"GENETIC EPIDEMIOLOGY\"",
      "\"RS17817964\"",
      "\"PBF\"",
      "\"RS3751812\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"MYOG\"",
      "\"IRX3\"",
      "\"RPGRIP1L\"",
      "\"HYPERTENSION\"",
      "\"IGF-1\"",
      "\"FM\"",
      "\"IMPULSIVITY TRAITS\"",
      "\"HYPERCHOLESTEROLEMIA\"",
      "\"MYF6\"",
      "\"RS8050136\"",
      "\"RS12595985\"",
      "\"META-ANALYSES\"",
      "\"GLUCOSE HOMEOSTASIS\"",
      "\"BIPOLAR DISORDER\"",
      "\"MYOD1\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.6029411764705882,
    "sub_communities": [
      "87",
      "88",
      "89"
    ]
  },
  "60": {
    "report_string": "# Genetic and Environmental Factors in Obesity and Type 2 Diabetes\n\nThe community revolves around the interplay of genetic, environmental, and physiological factors influencing obesity and type 2 diabetes (T2DM). Key entities include environmental factors like age and European ancestry, genetic variants such as FTO rs3751812, and physiological processes like BMI and risk estimates. These entities are interconnected through their roles in metabolic health, disease risk, and genetic associations.\n\n## Age as a risk factor for obesity and T2DM\n\nAge is a significant environmental factor that influences obesity risk and the development of T2DM. It affects anthropometric measures, BMI, and is associated with adiposity traits. The relationship between age and these conditions highlights the importance of considering age in risk assessments and interventions.\n\n## Role of FTO rs3751812 in obesity\n\nThe FTO rs3751812 variant is associated with an increased risk of obesity, and its effect is influenced by age and European ancestry. This genetic variant plays a crucial role in understanding obesity susceptibility and the development of targeted interventions.\n\n## Impact of European ancestry on genetic associations\n\nEuropean ancestry is a population characteristic that influences the association between FTO rs3751812 and BMI. This highlights the importance of considering population genetics in understanding disease risk and developing personalized interventions.\n\n## Relationship between BMI and risk estimates\n\nBMI does not notably change risk estimates, suggesting that while BMI is an important anthropometric measure, it may not directly impact risk assessments for obesity and T2DM.\n\n## Interaction between age and genetic variants\n\nAge did not interact with the rs9939609 genotype on the risk of obesity or BMI, indicating that the effect of certain genetic variants on obesity risk may not be modified by age.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity and Type 2 Diabetes",
      "summary": "The community revolves around the interplay of genetic, environmental, and physiological factors influencing obesity and type 2 diabetes (T2DM). Key entities include environmental factors like age and European ancestry, genetic variants such as FTO rs3751812, and physiological processes like BMI and risk estimates. These entities are interconnected through their roles in metabolic health, disease risk, and genetic associations.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on obesity and T2DM risk and management.",
      "findings": [
        {
          "summary": "Age as a risk factor for obesity and T2DM",
          "explanation": "Age is a significant environmental factor that influences obesity risk and the development of T2DM. It affects anthropometric measures, BMI, and is associated with adiposity traits. The relationship between age and these conditions highlights the importance of considering age in risk assessments and interventions."
        },
        {
          "summary": "Role of FTO rs3751812 in obesity",
          "explanation": "The FTO rs3751812 variant is associated with an increased risk of obesity, and its effect is influenced by age and European ancestry. This genetic variant plays a crucial role in understanding obesity susceptibility and the development of targeted interventions."
        },
        {
          "summary": "Impact of European ancestry on genetic associations",
          "explanation": "European ancestry is a population characteristic that influences the association between FTO rs3751812 and BMI. This highlights the importance of considering population genetics in understanding disease risk and developing personalized interventions."
        },
        {
          "summary": "Relationship between BMI and risk estimates",
          "explanation": "BMI does not notably change risk estimates, suggesting that while BMI is an important anthropometric measure, it may not directly impact risk assessments for obesity and T2DM."
        },
        {
          "summary": "Interaction between age and genetic variants",
          "explanation": "Age did not interact with the rs9939609 genotype on the risk of obesity or BMI, indicating that the effect of certain genetic variants on obesity risk may not be modified by age."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 60",
    "edges": [
      [
        "\"AGE\"",
        "\"BMI\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"BMI\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"AGE\"",
        "\"RS9939609\""
      ],
      [
        "\"EUROPEAN ANCESTRY\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"AGE\"",
        "\"OBESITY\""
      ],
      [
        "\"AGE\"",
        "\"T2DM\""
      ],
      [
        "\"AGE\"",
        "\"ANTHROPOMETRIC TRAITS\""
      ],
      [
        "\"AGE\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"AGE\""
      ],
      [
        "\"EUROPEAN ANCESTRY\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"OBESITY\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ]
    ],
    "nodes": [
      "\"AGE\"",
      "\"RISK ESTIMATES\"",
      "\"FTO RS3751812\"",
      "\"EUROPEAN ANCESTRY\""
    ],
    "chunk_ids": [
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.3235294117647059,
    "sub_communities": []
  },
  "52": {
    "report_string": "# Sex-Stratified Genetic Associations with Obesity and Type2 Diabetes\n\nThe community revolves around the interplay between sex, genetic associations, and obesity, with implications for type2 diabetes. Key entities include environmental factors like SEX, molecular interactions such as GENETIC ASSOCIATION, and study designs like AGE STRATIFICATION. These entities are interconnected through their roles in influencing obesity risk, BMI, and disease associations.\n\n## Sex influences genetic associations with obesity\n\nThe entity SEX has a degree of 10, indicating its significant role as an environmental factor influencing the association between genetic variants and obesity. For instance, the relationship between SEX and OBESITY (id 9) shows that sex affects the impact of genetic variants on obesity risk. Furthermore, the interaction between SEX and FTO rs3751812 (id 4) highlights that the association between this genetic variant and BMI varies between males and females.\n\n## Role of genetic association in obesity\n\nThe GENETIC ASSOCIATION entity has a rank of 70, indicating its strong interaction with OBESITY. Genetic association studies have identified multiple genetic variants associated with obesity, and the influence of SEX on these associations is critical. For example, the relationship between GENETIC ASSOCIATION and SEX (id 7) shows that sex influences the genetic association between genetic variants and obesity.\n\n## Impact of age stratification on genetic associations\n\nThe AGE STRATIFICATION entity has a rank of 69, indicating its importance in analyzing the effect of age on obesity. The relationship between AGE STRATIFICATION and GENETIC ASSOCIATION (id 1) shows that age stratification affects the genetic association between genetic variants and obesity. This highlights the need to consider age in the analysis of genetic associations with metabolic conditions.\n\n## Sex-specific differences in plasma leptin levels\n\nThe relationship between SEX and LEPTIN (id 8) indicates that sex interacts with genetic variants to affect plasma leptin levels. Additionally, the SLIT3 gene shows sex-specific differences in plasma leptin levels (id 11). These findings suggest that sex-specific considerations are essential in the analysis of leptin levels and metabolic health.\n\n## Association between sex and BMI\n\nThe relationship between BMI and SEX (id 3) shows that sex is associated with BMI, with men and women having different average BMIs. This association is critical in understanding the role of sex in metabolic health and disease risk.",
    "report_json": {
      "title": "Sex-Stratified Genetic Associations with Obesity and Type2 Diabetes",
      "summary": "The community revolves around the interplay between sex, genetic associations, and obesity, with implications for type2 diabetes. Key entities include environmental factors like SEX, molecular interactions such as GENETIC ASSOCIATION, and study designs like AGE STRATIFICATION. These entities are interconnected through their roles in influencing obesity risk, BMI, and disease associations.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of sex on genetic associations with obesity and related metabolic conditions.",
      "findings": [
        {
          "summary": "Sex influences genetic associations with obesity",
          "explanation": "The entity SEX has a degree of 10, indicating its significant role as an environmental factor influencing the association between genetic variants and obesity. For instance, the relationship between SEX and OBESITY (id 9) shows that sex affects the impact of genetic variants on obesity risk. Furthermore, the interaction between SEX and FTO rs3751812 (id 4) highlights that the association between this genetic variant and BMI varies between males and females."
        },
        {
          "summary": "Role of genetic association in obesity",
          "explanation": "The GENETIC ASSOCIATION entity has a rank of 70, indicating its strong interaction with OBESITY. Genetic association studies have identified multiple genetic variants associated with obesity, and the influence of SEX on these associations is critical. For example, the relationship between GENETIC ASSOCIATION and SEX (id 7) shows that sex influences the genetic association between genetic variants and obesity."
        },
        {
          "summary": "Impact of age stratification on genetic associations",
          "explanation": "The AGE STRATIFICATION entity has a rank of 69, indicating its importance in analyzing the effect of age on obesity. The relationship between AGE STRATIFICATION and GENETIC ASSOCIATION (id 1) shows that age stratification affects the genetic association between genetic variants and obesity. This highlights the need to consider age in the analysis of genetic associations with metabolic conditions."
        },
        {
          "summary": "Sex-specific differences in plasma leptin levels",
          "explanation": "The relationship between SEX and LEPTIN (id 8) indicates that sex interacts with genetic variants to affect plasma leptin levels. Additionally, the SLIT3 gene shows sex-specific differences in plasma leptin levels (id 11). These findings suggest that sex-specific considerations are essential in the analysis of leptin levels and metabolic health."
        },
        {
          "summary": "Association between sex and BMI",
          "explanation": "The relationship between BMI and SEX (id 3) shows that sex is associated with BMI, with men and women having different average BMIs. This association is critical in understanding the role of sex in metabolic health and disease risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 52",
    "edges": [
      [
        "\"ADIPOSITY\"",
        "\"SEX\""
      ],
      [
        "\"SEX\"",
        "\"SLIT3\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"SEX\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"GENETIC ASSOCIATION\""
      ],
      [
        "\"OBESITY\"",
        "\"SEX\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"SEX\""
      ],
      [
        "\"FTO\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"SEX\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPTIN\"",
        "\"SEX\""
      ],
      [
        "\"SEX\"",
        "\"T2DM\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"OBESITY\""
      ],
      [
        "\"RS9939609\"",
        "\"SEX\""
      ]
    ],
    "nodes": [
      "\"AGE STRATIFICATION\"",
      "\"SEX\"",
      "\"GENETIC ASSOCIATION\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-b87db3f3e401355543bca374e5b87c57"
    ],
    "occurrence": 0.25,
    "sub_communities": []
  },
  "68": {
    "report_string": "# Childhood Obesity and Cardiometabolic Traits\n\nThe community revolves around childhood obesity, a condition influenced by genetic and environmental factors. Key entities include childhood obesity, cardiometabolic traits, lipid traits, and physiological processes like waist circumference and waist-to-hip ratio. These entities are interconnected through their roles in body fat distribution, lipid metabolism, and disease risk.\n\n## Childhood Obesity and Genetic Variants\n\nChildhood obesity is associated with genetic variants, including SNPs in the FTO gene. These genetic factors contribute to the development of childhood obesity, highlighting the importance of genetic considerations in obesity prevention and treatment.\n\n## Relationship between Childhood Obesity and Cardiometabolic Traits\n\nChildhood obesity is related to cardiometabolic traits, including BMI, coronary artery disease, and HDL cholesterol. This relationship underscores the need for early intervention to prevent long-term cardiometabolic consequences.\n\n## Waist Circumference and Waist-to-Hip Ratio as Indicators of Body Fat Distribution\n\nWaist circumference and waist-to-hip ratio are measures of body fat distribution associated with childhood obesity. These physiological processes are critical in assessing obesity risk and metabolic health.\n\n## Impact of Childhood Obesity on Lipid Traits\n\nChildhood obesity is associated with altered lipid profiles, including increased triglycerides and reduced HDL cholesterol. This highlights the importance of managing childhood obesity to prevent long-term lipid-related health issues.\n\n## Role of Trios in Studying Genetic Factors Associated with Childhood Obesity\n\nTrios, consisting of a child and both biological parents, are used to study genetic factors associated with childhood obesity. This family structure is essential in understanding the genetic basis of obesity and developing targeted interventions.",
    "report_json": {
      "title": "Childhood Obesity and Cardiometabolic Traits",
      "summary": "The community revolves around childhood obesity, a condition influenced by genetic and environmental factors. Key entities include childhood obesity, cardiometabolic traits, lipid traits, and physiological processes like waist circumference and waist-to-hip ratio. These entities are interconnected through their roles in body fat distribution, lipid metabolism, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of childhood obesity on cardiometabolic health and disease risk.",
      "findings": [
        {
          "summary": "Childhood Obesity and Genetic Variants",
          "explanation": "Childhood obesity is associated with genetic variants, including SNPs in the FTO gene. These genetic factors contribute to the development of childhood obesity, highlighting the importance of genetic considerations in obesity prevention and treatment."
        },
        {
          "summary": "Relationship between Childhood Obesity and Cardiometabolic Traits",
          "explanation": "Childhood obesity is related to cardiometabolic traits, including BMI, coronary artery disease, and HDL cholesterol. This relationship underscores the need for early intervention to prevent long-term cardiometabolic consequences."
        },
        {
          "summary": "Waist Circumference and Waist-to-Hip Ratio as Indicators of Body Fat Distribution",
          "explanation": "Waist circumference and waist-to-hip ratio are measures of body fat distribution associated with childhood obesity. These physiological processes are critical in assessing obesity risk and metabolic health."
        },
        {
          "summary": "Impact of Childhood Obesity on Lipid Traits",
          "explanation": "Childhood obesity is associated with altered lipid profiles, including increased triglycerides and reduced HDL cholesterol. This highlights the importance of managing childhood obesity to prevent long-term lipid-related health issues."
        },
        {
          "summary": "Role of Trios in Studying Genetic Factors Associated with Childhood Obesity",
          "explanation": "Trios, consisting of a child and both biological parents, are used to study genetic factors associated with childhood obesity. This family structure is essential in understanding the genetic basis of obesity and developing targeted interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 68",
    "edges": [
      [
        "\"CHILDHOOD OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"TRIOS\""
      ],
      [
        "\"CARDIOMETABOLIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"WC\""
      ],
      [
        "\"WC\"",
        "\"WHR\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CAD\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"WHR\""
      ],
      [
        "\"BMI\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"FASTING GLUCOSE\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"LIPID TRAITS\""
      ],
      [
        "\"MAFLD\"",
        "\"TG\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"TG\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"WHR\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"HDL-C\""
      ]
    ],
    "nodes": [
      "\"TG\"",
      "\"TRIOS\"",
      "\"LIPID TRAITS\"",
      "\"CARDIOMETABOLIC TRAITS\"",
      "\"CHILDHOOD OBESITY\"",
      "\"WC\"",
      "\"WHR\""
    ],
    "chunk_ids": [
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "65": {
    "report_string": "# Body Fatness and Associated Genetic Markers\n\nThe community revolves around body fatness, a physiological process influenced by genetic markers and measured by various physiological processes such as UAW, PC1, and UAC. Key entities include body fatness, SNP markers like rs16952517, and physiological measurements like UAW and PC2. These entities are interconnected through their roles in measuring and influencing body fatness.\n\n## Relationship between body fatness and genetic markers\n\nBody fatness is associated with various genetic markers, including SNP markers like rs1421085 and rs16952517. These genetic markers are linked to body fatness, indicating a genetic component to body fatness.\n\n## UAW and its relationship with body fatness and PC2\n\nUAW (Upper Arm Width) is a measure of body fatness and is related to PC2, a principle component that explains the variance in UAW. The relationship between UAW and body fatness highlights the importance of considering multiple measures when assessing body fatness.\n\n## Role of PC1 and PC2 in body fatness\n\nPC1 explains the variance in body fatness measures, while PC2 explains the variance in UAW. These principle components are crucial for understanding the complex relationships between body fatness and its measurements.\n\n## Association between rs16952517 and UAW\n\nThe genomic variant rs16952517 is associated with UAW, indicating a genetic influence on this measure of body fatness. This association highlights the potential for genetic markers to inform personalized assessments of body fatness.\n\n## Relationship between body fatness and physiological measurements\n\nBody fatness is related to various physiological measurements, including UAW, UAC, and WHR. These measurements provide a comprehensive understanding of body fatness and its implications for health.",
    "report_json": {
      "title": "Body Fatness and Associated Genetic Markers",
      "summary": "The community revolves around body fatness, a physiological process influenced by genetic markers and measured by various physiological processes such as UAW, PC1, and UAC. Key entities include body fatness, SNP markers like rs16952517, and physiological measurements like UAW and PC2. These entities are interconnected through their roles in measuring and influencing body fatness.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic markers and physiological measurements on body fatness, which is a critical factor in health and disease.",
      "findings": [
        {
          "summary": "Relationship between body fatness and genetic markers",
          "explanation": "Body fatness is associated with various genetic markers, including SNP markers like rs1421085 and rs16952517. These genetic markers are linked to body fatness, indicating a genetic component to body fatness."
        },
        {
          "summary": "UAW and its relationship with body fatness and PC2",
          "explanation": "UAW (Upper Arm Width) is a measure of body fatness and is related to PC2, a principle component that explains the variance in UAW. The relationship between UAW and body fatness highlights the importance of considering multiple measures when assessing body fatness."
        },
        {
          "summary": "Role of PC1 and PC2 in body fatness",
          "explanation": "PC1 explains the variance in body fatness measures, while PC2 explains the variance in UAW. These principle components are crucial for understanding the complex relationships between body fatness and its measurements."
        },
        {
          "summary": "Association between rs16952517 and UAW",
          "explanation": "The genomic variant rs16952517 is associated with UAW, indicating a genetic influence on this measure of body fatness. This association highlights the potential for genetic markers to inform personalized assessments of body fatness."
        },
        {
          "summary": "Relationship between body fatness and physiological measurements",
          "explanation": "Body fatness is related to various physiological measurements, including UAW, UAC, and WHR. These measurements provide a comprehensive understanding of body fatness and its implications for health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 65",
    "edges": [
      [
        "\"PC2\"",
        "\"UAW\""
      ],
      [
        "\"RS16952517\"",
        "\"UAW\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"UAW\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"UAC\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"PC1\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"SNP\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"WHR\""
      ],
      [
        "\"BMI\"",
        "\"BODY FATNESS\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"RS1421085\""
      ]
    ],
    "nodes": [
      "\"RS16952517\"",
      "\"PC2\"",
      "\"UAC\"",
      "\"BODY FATNESS\"",
      "\"PC1\"",
      "\"UAW\""
    ],
    "chunk_ids": [
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-c11750e689f69b55e5ea3262ddcb4ba6"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "46": {
    "report_string": "# Thyroid Cancer Risk Factors and Genetic Associations\n\nThe community revolves around thyroid cancer, influenced by genetic variants, obesity, and statistical models. Key entities include disease (thyroid cancer, overweight), genetic variants (rs12149832, rs17817288, rs1861867, rs9937053), and physiological processes (codominant model, dominant model, recessive model). These entities are interconnected through their roles in assessing thyroid cancer risk and the precision of these risk estimates.\n\n## Association between genetic variants and thyroid cancer risk\n\nMultiple genetic variants (rs12149832, rs17817288, rs1861867, rs9937053) are associated with thyroid cancer risk. These SNPs have been identified as risk factors in various studies, highlighting the genetic component of thyroid cancer susceptibility.\n\n## Role of obesity and overweight in thyroid cancer risk\n\nObesity and being overweight are significant risk factors for thyroid cancer. The relationship between BMI and thyroid cancer risk is well-established, with higher BMI values increasing the risk. This connection underscores the importance of weight management in reducing thyroid cancer risk.\n\n## Statistical models for assessing genetic associations\n\nThe codominant, dominant, and recessive models are used to assess the association between genetic variants and thyroid cancer risk. These models help in understanding the genetic architecture of thyroid cancer and in identifying individuals at higher risk.\n\n## Precision of risk estimates using 95% CIs and ORs\n\n95% Confidence Intervals (CIs) and Odds Ratios (ORs) are crucial statistical measures used to assess the precision of estimates and the association between risk factors (such as genetic variants and BMI) and thyroid cancer. These measures provide insights into the reliability and significance of the associations found.\n\n## Interaction between genetic variants and obesity in thyroid cancer risk\n\nThere is evidence suggesting that certain genetic variants (e.g., rs12149832, rs17817288) have a more significant association with thyroid cancer risk in overweight and obese individuals. This interaction highlights the importance of considering both genetic and physiological factors in assessing thyroid cancer risk.",
    "report_json": {
      "title": "Thyroid Cancer Risk Factors and Genetic Associations",
      "summary": "The community revolves around thyroid cancer, influenced by genetic variants, obesity, and statistical models. Key entities include disease (thyroid cancer, overweight), genetic variants (rs12149832, rs17817288, rs1861867, rs9937053), and physiological processes (codominant model, dominant model, recessive model). These entities are interconnected through their roles in assessing thyroid cancer risk and the precision of these risk estimates.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant associations between genetic variants, obesity, and thyroid cancer risk.",
      "findings": [
        {
          "summary": "Association between genetic variants and thyroid cancer risk",
          "explanation": "Multiple genetic variants (rs12149832, rs17817288, rs1861867, rs9937053) are associated with thyroid cancer risk. These SNPs have been identified as risk factors in various studies, highlighting the genetic component of thyroid cancer susceptibility."
        },
        {
          "summary": "Role of obesity and overweight in thyroid cancer risk",
          "explanation": "Obesity and being overweight are significant risk factors for thyroid cancer. The relationship between BMI and thyroid cancer risk is well-established, with higher BMI values increasing the risk. This connection underscores the importance of weight management in reducing thyroid cancer risk."
        },
        {
          "summary": "Statistical models for assessing genetic associations",
          "explanation": "The codominant, dominant, and recessive models are used to assess the association between genetic variants and thyroid cancer risk. These models help in understanding the genetic architecture of thyroid cancer and in identifying individuals at higher risk."
        },
        {
          "summary": "Precision of risk estimates using 95% CIs and ORs",
          "explanation": "95% Confidence Intervals (CIs) and Odds Ratios (ORs) are crucial statistical measures used to assess the precision of estimates and the association between risk factors (such as genetic variants and BMI) and thyroid cancer. These measures provide insights into the reliability and significance of the associations found."
        },
        {
          "summary": "Interaction between genetic variants and obesity in thyroid cancer risk",
          "explanation": "There is evidence suggesting that certain genetic variants (e.g., rs12149832, rs17817288) have a more significant association with thyroid cancer risk in overweight and obese individuals. This interaction highlights the importance of considering both genetic and physiological factors in assessing thyroid cancer risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 46",
    "edges": [
      [
        "\"OVERWEIGHT\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"DOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"95% CIS\"",
        "\"ORS\""
      ],
      [
        "\"ORS\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS17817288\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS1861867\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS12149832\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"CODOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"SNP\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RECESSIVE MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS9937053\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ]
    ],
    "nodes": [
      "\"RS17817288\"",
      "\"RS1861867\"",
      "\"DOMINANT MODEL\"",
      "\"ORS\"",
      "\"RS9937053\"",
      "\"RECESSIVE MODEL\"",
      "\"THYROID CANCER\"",
      "\"RS12149832\"",
      "\"CODOMINANT MODEL\"",
      "\"OVERWEIGHT\"",
      "\"95% CIS\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9"
    ],
    "occurrence": 0.1323529411764706,
    "sub_communities": [
      "97",
      "96"
    ]
  },
  "63": {
    "report_string": "# Genetic and Physiological Factors in Metabolic Associated Fatty Liver Disease (MAFLD)\n\nThe community revolves around MAFLD, a condition characterized by excessive fat accumulation in the liver associated with metabolic disorders. Key entities include genetic variants like rs1421085, physiological measures such as ALT, GGT, and FPG, and risk factors like body fatness and diet. These entities are interconnected through their roles in liver health, metabolic regulation, and disease risk.\n\n## The role of rs1421085 in body fatness and MAFLD\n\nThe rs1421085 SNP marker is associated with body fatness and increased risk of MAFLD. This genetic variant has allele-specific binding affinity for CUX1 and is located in the FTO gene, which is linked to obesity traits. The association between rs1421085 and MAFLD highlights the importance of genetic factors in metabolic health.\n\n## Physiological measures and MAFLD risk\n\nPhysiological measures such as ALT, GGT, FPG, diastolic blood pressure, and systolic blood pressure are associated with increased risk of MAFLD. These measures are indicative of liver health, glucose regulation, and cardiovascular health, which are all relevant to MAFLD pathology.\n\n## The impact of diet on MAFLD\n\nDiet is an environmental factor that modulates the risk of MAFLD. While specific dietary components are not mentioned, the relationship between diet and MAFLD suggests that nutritional interventions could play a role in managing the condition.\n\n## The relationship between MAFLD and comorbidities\n\nMAFLD is associated with comorbidities such as diabetes, which suggests that managing MAFLD may require consideration of these related conditions. The presence of MAFLD can increase the risk of complications and vice versa.\n\n## Haplotype associations with MAFLD risk\n\nThe haplotype of TCGT is associated with lower risk of MAFLD, while the CATA haplotype is associated with increased risk. This suggests that genetic profiling could help identify individuals at higher risk of developing MAFLD.",
    "report_json": {
      "title": "Genetic and Physiological Factors in Metabolic Associated Fatty Liver Disease (MAFLD)",
      "summary": "The community revolves around MAFLD, a condition characterized by excessive fat accumulation in the liver associated with metabolic disorders. Key entities include genetic variants like rs1421085, physiological measures such as ALT, GGT, and FPG, and risk factors like body fatness and diet. These entities are interconnected through their roles in liver health, metabolic regulation, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and physiological factors on MAFLD risk and progression.",
      "findings": [
        {
          "summary": "The role of rs1421085 in body fatness and MAFLD",
          "explanation": "The rs1421085 SNP marker is associated with body fatness and increased risk of MAFLD. This genetic variant has allele-specific binding affinity for CUX1 and is located in the FTO gene, which is linked to obesity traits. The association between rs1421085 and MAFLD highlights the importance of genetic factors in metabolic health."
        },
        {
          "summary": "Physiological measures and MAFLD risk",
          "explanation": "Physiological measures such as ALT, GGT, FPG, diastolic blood pressure, and systolic blood pressure are associated with increased risk of MAFLD. These measures are indicative of liver health, glucose regulation, and cardiovascular health, which are all relevant to MAFLD pathology."
        },
        {
          "summary": "The impact of diet on MAFLD",
          "explanation": "Diet is an environmental factor that modulates the risk of MAFLD. While specific dietary components are not mentioned, the relationship between diet and MAFLD suggests that nutritional interventions could play a role in managing the condition."
        },
        {
          "summary": "The relationship between MAFLD and comorbidities",
          "explanation": "MAFLD is associated with comorbidities such as diabetes, which suggests that managing MAFLD may require consideration of these related conditions. The presence of MAFLD can increase the risk of complications and vice versa."
        },
        {
          "summary": "Haplotype associations with MAFLD risk",
          "explanation": "The haplotype of TCGT is associated with lower risk of MAFLD, while the CATA haplotype is associated with increased risk. This suggests that genetic profiling could help identify individuals at higher risk of developing MAFLD."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 63",
    "edges": [
      [
        "\"FTO GENE\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"RS1421085\""
      ],
      [
        "\"DIASTOLIC BLOOD PRESSURE\"",
        "\"MAFLD\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"RS1421085\""
      ],
      [
        "\"DIET\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"RS8050136\""
      ],
      [
        "\"MAFLD\"",
        "\"SYSTOLIC BLOOD PRESSURE\""
      ],
      [
        "\"HDL-C\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"TG\""
      ],
      [
        "\"MAFLD\"",
        "\"RS9939609\""
      ],
      [
        "\"MAFLD\"",
        "\"RS1421085-RS8050136-RS3751812-RS9939609\""
      ],
      [
        "\"ALT\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"RS3751812\""
      ],
      [
        "\"GENDER\"",
        "\"MAFLD\""
      ],
      [
        "\"FPG\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"DIABETES\"",
        "\"MAFLD\""
      ],
      [
        "\"GGT\"",
        "\"MAFLD\""
      ],
      [
        "\"BMI\"",
        "\"MAFLD\""
      ]
    ],
    "nodes": [
      "\"ALT\"",
      "\"SYSTOLIC BLOOD PRESSURE\"",
      "\"RS1421085-RS8050136-RS3751812-RS9939609\"",
      "\"DIASTOLIC BLOOD PRESSURE\"",
      "\"FPG\"",
      "\"RS1421085\"",
      "\"MAFLD\"",
      "\"GGT\""
    ],
    "chunk_ids": [
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "61": {
    "report_string": "# Statistical Analysis of Genetic Associations\n\nThe community consists of statistical concepts and physiological processes related to genetic associations, including P-value, Bonferroni correction, GO functional categories, and SNK test. These entities are interconnected through their roles in assessing significance and evaluating genetic associations.\n\n## Role of P-value in genetic associations\n\nThe P-value is a statistical measure used to assess the significance of genetic associations. It determines the probability of obtaining a result at least as extreme as the one observed. In the context of genetic variants like rs9939609, the P-value is crucial in evaluating the association with BMI.\n\n## Bonferroni correction for multiple testing\n\nBonferroni correction is a statistical method used to adjust for multiple testing and avoid false positives. It is applied to P-values to ensure the accuracy of genetic associations. This method is essential in genetic studies to prevent incorrect conclusions due to multiple testing.\n\n## GO functional categories and genetic associations\n\nGO functional categories are biological processes significantly enriched with obesity GWAS genes, with a P-value <0.05. This indicates that these categories are relevant to understanding the genetic basis of obesity and related metabolic processes.\n\n## SNK test for evaluating significance\n\nThe SNK test is a statistical method used to compare groups and evaluate the significance of results, as indicated by P-values. This test is important in genetic studies to determine the significance of genetic associations and their implications for physiological processes.\n\n## Interconnection of statistical concepts\n\nThe community highlights the interconnection of statistical concepts like P-value, Bonferroni correction, and SNK test in evaluating genetic associations. These concepts work together to ensure the accuracy and significance of genetic studies, ultimately informing our understanding of physiological processes and disease mechanisms.",
    "report_json": {
      "title": "Statistical Analysis of Genetic Associations",
      "summary": "The community consists of statistical concepts and physiological processes related to genetic associations, including P-value, Bonferroni correction, GO functional categories, and SNK test. These entities are interconnected through their roles in assessing significance and evaluating genetic associations.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the importance of statistical analysis in evaluating genetic associations and determining significance.",
      "findings": [
        {
          "summary": "Role of P-value in genetic associations",
          "explanation": "The P-value is a statistical measure used to assess the significance of genetic associations. It determines the probability of obtaining a result at least as extreme as the one observed. In the context of genetic variants like rs9939609, the P-value is crucial in evaluating the association with BMI."
        },
        {
          "summary": "Bonferroni correction for multiple testing",
          "explanation": "Bonferroni correction is a statistical method used to adjust for multiple testing and avoid false positives. It is applied to P-values to ensure the accuracy of genetic associations. This method is essential in genetic studies to prevent incorrect conclusions due to multiple testing."
        },
        {
          "summary": "GO functional categories and genetic associations",
          "explanation": "GO functional categories are biological processes significantly enriched with obesity GWAS genes, with a P-value <0.05. This indicates that these categories are relevant to understanding the genetic basis of obesity and related metabolic processes."
        },
        {
          "summary": "SNK test for evaluating significance",
          "explanation": "The SNK test is a statistical method used to compare groups and evaluate the significance of results, as indicated by P-values. This test is important in genetic studies to determine the significance of genetic associations and their implications for physiological processes."
        },
        {
          "summary": "Interconnection of statistical concepts",
          "explanation": "The community highlights the interconnection of statistical concepts like P-value, Bonferroni correction, and SNK test in evaluating genetic associations. These concepts work together to ensure the accuracy and significance of genetic studies, ultimately informing our understanding of physiological processes and disease mechanisms."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 61",
    "edges": [
      [
        "\"P-VALUE\"",
        "\"RS9939609\""
      ],
      [
        "\"GO FUNCTIONAL CATEGORIES\"",
        "\"P-VALUE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"P-VALUE\""
      ],
      [
        "\"BONFERRONI CORRECTION\"",
        "\"P-VALUE\""
      ],
      [
        "\"P-VALUE\"",
        "\"SNK TEST\""
      ]
    ],
    "nodes": [
      "\"BONFERRONI CORRECTION\"",
      "\"SNK TEST\"",
      "\"P-VALUE\"",
      "\"GO FUNCTIONAL CATEGORIES\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-c11750e689f69b55e5ea3262ddcb4ba6",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.14705882352941177,
    "sub_communities": []
  },
  "45": {
    "report_string": "# Meta-Analysis in Genetic Studies\n\nThe community revolves around the use of meta-analysis in studying genetic associations, particularly with obesity. Key entities include 'META-ANALYSIS' as a statistical method and 'REPLICATION SAMPLES' which are used in conjunction with meta-analysis.\n\n## Role of Meta-Analysis in Genetic Studies\n\nMeta-analysis is a statistical method used to combine results from multiple studies. In the context of genetics, it is utilized to synthesize findings from various research efforts, enhancing the statistical power to detect associations between genetic variants and conditions like obesity. The provided relationships indicate that meta-analysis is used to study the association between genetic variants and obesity, as well as to combine results from multiple replication samples, which is crucial for validating genetic associations.\n\n## Importance of Replication Samples\n\nReplication samples are essential in genetic studies as they provide independent datasets to validate the findings of genetic associations. The relationship between 'META-ANALYSIS' and 'REPLICATION SAMPLES' highlights the critical role of replication in ensuring the reliability of meta-analysis results. By combining data from multiple replication samples, researchers can increase the confidence in their findings regarding genetic influences on diseases.\n\n## Limitations and Future Directions\n\nThe current community of entities is limited by the scarcity of information on specific genetic variants, diseases, and nutrients. Future studies should aim to integrate a broader range of genetic and environmental factors to better understand their interactions and impacts on health. This would involve expanding the entity network to include specific genes, diseases, and dietary components, and elucidating their relationships through meta-analysis of diverse studies.",
    "report_json": {
      "title": "Meta-Analysis in Genetic Studies",
      "summary": "The community revolves around the use of meta-analysis in studying genetic associations, particularly with obesity. Key entities include 'META-ANALYSIS' as a statistical method and 'REPLICATION SAMPLES' which are used in conjunction with meta-analysis.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited information provided about the direct impact of these entities on health, disease, or personalized nutrition.",
      "findings": [
        {
          "summary": "Role of Meta-Analysis in Genetic Studies",
          "explanation": "Meta-analysis is a statistical method used to combine results from multiple studies. In the context of genetics, it is utilized to synthesize findings from various research efforts, enhancing the statistical power to detect associations between genetic variants and conditions like obesity. The provided relationships indicate that meta-analysis is used to study the association between genetic variants and obesity, as well as to combine results from multiple replication samples, which is crucial for validating genetic associations."
        },
        {
          "summary": "Importance of Replication Samples",
          "explanation": "Replication samples are essential in genetic studies as they provide independent datasets to validate the findings of genetic associations. The relationship between 'META-ANALYSIS' and 'REPLICATION SAMPLES' highlights the critical role of replication in ensuring the reliability of meta-analysis results. By combining data from multiple replication samples, researchers can increase the confidence in their findings regarding genetic influences on diseases."
        },
        {
          "summary": "Limitations and Future Directions",
          "explanation": "The current community of entities is limited by the scarcity of information on specific genetic variants, diseases, and nutrients. Future studies should aim to integrate a broader range of genetic and environmental factors to better understand their interactions and impacts on health. This would involve expanding the entity network to include specific genes, diseases, and dietary components, and elucidating their relationships through meta-analysis of diverse studies."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 45",
    "edges": [
      [
        "\"META-ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"META-ANALYSIS\"",
        "\"REPLICATION SAMPLES\""
      ]
    ],
    "nodes": [
      "\"META-ANALYSIS\"",
      "\"REPLICATION SAMPLES\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "58": {
    "report_string": "# Genetic and Ethnic Factors in Type2 Diabetes Risk\n\nThe community revolves around the genetic and ethnic factors influencing type2 diabetes risk, with key entities including FTO variants, ethnic groups, and statistical measures like Pearson's correlation coefficient. These entities are interconnected through their roles in allele frequency, obesity, and disease risk.\n\n## FTO variants and their association with obesity and type2 diabetes\n\nFTO variants are associated with an increased risk of obesity and type2 diabetes. This relationship highlights the importance of genetic factors in disease risk. The FTO gene has variants associated with obesity and related traits, and these variants have different frequencies in different ethnic groups.\n\n## Allele frequency and its role in evaluating genetic variants\n\nAllele frequency is a measure of the proportion of a particular allele in a population. It is used to evaluate the frequency of alleles in a population and varies among different ethnic groups. This variability is crucial in understanding the genetic risk of diseases like type2 diabetes across different populations.\n\n## Ethnic group and FTO variant frequency\n\nFTO variants have different frequencies in different ethnic groups. This variation is significant because it implies that the genetic risk of type2 diabetes may differ among ethnic groups. Understanding these differences can help in developing targeted interventions for high-risk populations.\n\n## Pearson's correlation coefficient and allele frequency analysis\n\nPearson's correlation coefficient is used to evaluate the correlation between allele frequencies. This statistical measure is essential in analyzing the relationship between genetic variants and disease risk, allowing researchers to quantify the strength and direction of these relationships.\n\n## FTO variants and type2 diabetes risk across ethnic groups\n\nFTO variants are associated with an increased risk of type2 diabetes, and their frequency varies among ethnic groups. This association underscores the importance of considering both genetic and ethnic factors in assessing disease risk and developing personalized interventions.",
    "report_json": {
      "title": "Genetic and Ethnic Factors in Type2 Diabetes Risk",
      "summary": "The community revolves around the genetic and ethnic factors influencing type2 diabetes risk, with key entities including FTO variants, ethnic groups, and statistical measures like Pearson's correlation coefficient. These entities are interconnected through their roles in allele frequency, obesity, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and ethnic factors on type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "FTO variants and their association with obesity and type2 diabetes",
          "explanation": "FTO variants are associated with an increased risk of obesity and type2 diabetes. This relationship highlights the importance of genetic factors in disease risk. The FTO gene has variants associated with obesity and related traits, and these variants have different frequencies in different ethnic groups."
        },
        {
          "summary": "Allele frequency and its role in evaluating genetic variants",
          "explanation": "Allele frequency is a measure of the proportion of a particular allele in a population. It is used to evaluate the frequency of alleles in a population and varies among different ethnic groups. This variability is crucial in understanding the genetic risk of diseases like type2 diabetes across different populations."
        },
        {
          "summary": "Ethnic group and FTO variant frequency",
          "explanation": "FTO variants have different frequencies in different ethnic groups. This variation is significant because it implies that the genetic risk of type2 diabetes may differ among ethnic groups. Understanding these differences can help in developing targeted interventions for high-risk populations."
        },
        {
          "summary": "Pearson's correlation coefficient and allele frequency analysis",
          "explanation": "Pearson's correlation coefficient is used to evaluate the correlation between allele frequencies. This statistical measure is essential in analyzing the relationship between genetic variants and disease risk, allowing researchers to quantify the strength and direction of these relationships."
        },
        {
          "summary": "FTO variants and type2 diabetes risk across ethnic groups",
          "explanation": "FTO variants are associated with an increased risk of type2 diabetes, and their frequency varies among ethnic groups. This association underscores the importance of considering both genetic and ethnic factors in assessing disease risk and developing personalized interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 58",
    "edges": [
      [
        "\"ALLELE FREQUENCY\"",
        "\"PEARSON'S CORRELATION COEFFICIENT\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"OBESITY\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ETHNIC GROUP\"",
        "\"FTO VARIANTS\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"ETHNIC GROUP\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"FTO VARIANTS\""
      ]
    ],
    "nodes": [
      "\"PEARSON'S CORRELATION COEFFICIENT\"",
      "\"FTO VARIANTS\"",
      "\"ALLELE FREQUENCY\"",
      "\"ETHNIC GROUP\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.08823529411764706,
    "sub_communities": []
  },
  "40": {
    "report_string": "# FTO SNPs and Obesity Risk\n\nThe community revolves around FTO SNPs, which are genetic variants associated with obesity risk. These SNPs interact with dietary patterns, such as MDS, and influence obesity traits in various ethnic groups, including Hispanic-Americans, African-Americans, and Chinese. The community also involves diseases like abdominal obesity and high WHR, highlighting the complex interplay between genetics, diet, and obesity.\n\n## FTO SNPs and Obesity Risk\n\nFTO SNPs are strongly associated with obesity risk, including abdominal obesity and high WHR. These genetic variants have been linked to BMI and obesity traits in various populations, with significant associations in Caucasians and marginal associations in non-Caucasian populations.\n\n## Interaction between FTO SNPs and Dietary Patterns\n\nThe Mediterranean diet (MDS) modulates the association of FTO SNPs with obesity risk. MDS is associated with lower risk of obesity, particularly in individuals with high genetic risk score (GRS). This interaction highlights the importance of personalized dietary recommendations for managing obesity risk.\n\n## FTO SNPs in Different Ethnic Groups\n\nFTO SNPs show varying levels of association with obesity traits across different ethnic groups. For example, rs7201444 is a FTO SNP specific to Hispanic-Americans, showing marginally significant associations with obesity traits. Similarly, FTO SNPs have marginal associations with obesity traits in African-Americans and Chinese.\n\n## Genetic Differentiation and FTO SNPs\n\nFTO SNPs exhibit genetic differentiation among populations, influencing obesity traits. This genetic variation affects the frequency of alleles and their associations with obesity risk.\n\n## FTO SNPs and Minor Allele Frequencies\n\nThe FTO SNPs have minor allele frequencies ranging from 0.41 to 0.45. This information is crucial for understanding the genetic architecture of obesity risk in different populations.",
    "report_json": {
      "title": "FTO SNPs and Obesity Risk",
      "summary": "The community revolves around FTO SNPs, which are genetic variants associated with obesity risk. These SNPs interact with dietary patterns, such as MDS, and influence obesity traits in various ethnic groups, including Hispanic-Americans, African-Americans, and Chinese. The community also involves diseases like abdominal obesity and high WHR, highlighting the complex interplay between genetics, diet, and obesity.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of FTO SNPs with obesity risk and their interaction with dietary patterns.",
      "findings": [
        {
          "summary": "FTO SNPs and Obesity Risk",
          "explanation": "FTO SNPs are strongly associated with obesity risk, including abdominal obesity and high WHR. These genetic variants have been linked to BMI and obesity traits in various populations, with significant associations in Caucasians and marginal associations in non-Caucasian populations."
        },
        {
          "summary": "Interaction between FTO SNPs and Dietary Patterns",
          "explanation": "The Mediterranean diet (MDS) modulates the association of FTO SNPs with obesity risk. MDS is associated with lower risk of obesity, particularly in individuals with high genetic risk score (GRS). This interaction highlights the importance of personalized dietary recommendations for managing obesity risk."
        },
        {
          "summary": "FTO SNPs in Different Ethnic Groups",
          "explanation": "FTO SNPs show varying levels of association with obesity traits across different ethnic groups. For example, rs7201444 is a FTO SNP specific to Hispanic-Americans, showing marginally significant associations with obesity traits. Similarly, FTO SNPs have marginal associations with obesity traits in African-Americans and Chinese."
        },
        {
          "summary": "Genetic Differentiation and FTO SNPs",
          "explanation": "FTO SNPs exhibit genetic differentiation among populations, influencing obesity traits. This genetic variation affects the frequency of alleles and their associations with obesity risk."
        },
        {
          "summary": "FTO SNPs and Minor Allele Frequencies",
          "explanation": "The FTO SNPs have minor allele frequencies ranging from 0.41 to 0.45. This information is crucial for understanding the genetic architecture of obesity risk in different populations."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 40",
    "edges": [
      [
        "\"FTO SNPS\"",
        "\"HARDY WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"MDS\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HIGH WHR\""
      ],
      [
        "\"HIGH WHR\"",
        "\"MDS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"AFRICAN-AMERICANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"MDS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"OBESITY\""
      ],
      [
        "\"CHINESE\"",
        "\"FTO SNPS\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MINOR ALLELE FREQUENCIES\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MDS\""
      ],
      [
        "\"EATING DISORDER\"",
        "\"FTO SNPS\""
      ],
      [
        "\"HISPANIC-AMERICANS\"",
        "\"RS7201444\""
      ],
      [
        "\"GRS\"",
        "\"MDS\""
      ],
      [
        "\"FTO SNPS\"",
        "\"GENETIC DIFFERENTIATION\""
      ],
      [
        "\"FTO SNPS\"",
        "\"TRAIT ANXIETY\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELE FREQUENCIES\"",
      "\"HARDY WEINBERG EQUILIBRIUM\"",
      "\"FTO SNPS\"",
      "\"TRAIT ANXIETY\"",
      "\"MDS\"",
      "\"GRS\"",
      "\"GENETIC DIFFERENTIATION\"",
      "\"CHINESE\"",
      "\"ABDOMINAL OBESITY\"",
      "\"AFRICAN-AMERICANS\"",
      "\"HISPANIC-AMERICANS\"",
      "\"RS7201444\"",
      "\"HIGH WHR\""
    ],
    "chunk_ids": [
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-6c935916492da41e4048751fc4c84348"
    ],
    "occurrence": 0.08823529411764706,
    "sub_communities": [
      "90",
      "92",
      "91"
    ]
  },
  "67": {
    "report_string": "# Genetic Factors Influencing Body Shape\n\nThe community revolves around body shape as a physiological process, influenced by various genetic factors including genes such as ETV5 and FAIM2, and genomic variants like rs1121980, rs7204609, rs925646, and rs9939881. These entities are interconnected through their roles in energy intake regulation, body shape, and obesity.\n\n## ETV5 gene's role in energy intake regulation and body shape\n\nThe ETV5 gene is involved in energy intake regulation and is associated with body shape. This suggests that genetic variations in ETV5 could influence an individual's body shape by affecting their energy intake and metabolism.\n\n## Association between genomic variants and body shape\n\nGenomic variants such as rs1121980, rs7204609, rs925646, and rs9939881 are associated with body shape. These variants may contribute to individual differences in body shape and obesity risk by influencing genes involved in energy balance and metabolism.\n\n## Role of FAIM2 in body shape\n\nThe FAIM2 gene is associated with body shape, indicating that it may play a role in the regulation of body shape and obesity susceptibility. Variations in FAIM2 could potentially impact an individual's body shape.\n\n## Relationship between body shape and obesity\n\nBody shape is closely linked to obesity, a disease influenced by both genetic and environmental factors. Understanding the genetic factors influencing body shape can provide insights into obesity risk and potential interventions.\n\n## Importance of hip circumference and waist circumference in measuring body shape\n\nHip circumference and waist circumference are measures used to assess body shape. These measurements are important in evaluating the risk of obesity-related health issues and can be influenced by genetic factors.",
    "report_json": {
      "title": "Genetic Factors Influencing Body Shape",
      "summary": "The community revolves around body shape as a physiological process, influenced by various genetic factors including genes such as ETV5 and FAIM2, and genomic variants like rs1121980, rs7204609, rs925646, and rs9939881. These entities are interconnected through their roles in energy intake regulation, body shape, and obesity.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors on body shape and associated health implications.",
      "findings": [
        {
          "summary": "ETV5 gene's role in energy intake regulation and body shape",
          "explanation": "The ETV5 gene is involved in energy intake regulation and is associated with body shape. This suggests that genetic variations in ETV5 could influence an individual's body shape by affecting their energy intake and metabolism."
        },
        {
          "summary": "Association between genomic variants and body shape",
          "explanation": "Genomic variants such as rs1121980, rs7204609, rs925646, and rs9939881 are associated with body shape. These variants may contribute to individual differences in body shape and obesity risk by influencing genes involved in energy balance and metabolism."
        },
        {
          "summary": "Role of FAIM2 in body shape",
          "explanation": "The FAIM2 gene is associated with body shape, indicating that it may play a role in the regulation of body shape and obesity susceptibility. Variations in FAIM2 could potentially impact an individual's body shape."
        },
        {
          "summary": "Relationship between body shape and obesity",
          "explanation": "Body shape is closely linked to obesity, a disease influenced by both genetic and environmental factors. Understanding the genetic factors influencing body shape can provide insights into obesity risk and potential interventions."
        },
        {
          "summary": "Importance of hip circumference and waist circumference in measuring body shape",
          "explanation": "Hip circumference and waist circumference are measures used to assess body shape. These measurements are important in evaluating the risk of obesity-related health issues and can be influenced by genetic factors."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 67",
    "edges": [
      [
        "\"BODY SHAPE\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"FTO\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS925646\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS1121980\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS9939881\""
      ],
      [
        "\"BDNF\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"HIP CIRCUMFERENCE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"MC4R\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"ETV5\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS7204609\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"PRS\""
      ],
      [
        "\"BMI\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"TMEM18\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"FAIM2\""
      ]
    ],
    "nodes": [
      "\"RS9939881\"",
      "\"FAIM2\"",
      "\"RS925646\"",
      "\"ETV5\"",
      "\"RS1121980\"",
      "\"HIP CIRCUMFERENCE\"",
      "\"RS7204609\"",
      "\"BODY SHAPE\"",
      "\"PRS\""
    ],
    "chunk_ids": [
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-606e3745887d305085abbdeeda7ea958"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "47": {
    "report_string": "# Genetic Factors in Obesity and Weight Gain\n\nThe community revolves around genetic factors influencing obesity and weight gain. Key entities include genes such as TMEM18 and PPAR, genomic variants like rs2293084 and rs1801282, and physiological processes like weight gain. These entities are interconnected through their roles in adiposity traits, body shape, and metabolic health.\n\n## TMEM18 gene and its association with obesity traits\n\nThe TMEM18 gene is associated with adiposity traits, body shape, and weight gain during pregnancy. Variants in this gene, such as rs2293084, have been linked to increased risk of obesity and weight gain. This highlights the importance of considering genetic factors in obesity risk assessment and management.\n\n## PPAR gene and its role in metabolic health\n\nThe PPAR gene is involved in peroxisome proliferator-activated receptor gamma, which plays a crucial role in glucose and lipid metabolism. Variants in this gene, such as rs1801282, have been associated with decreased waist circumference and improved metabolic health. This underscores the significance of PPAR in obesity and metabolic disorder management.\n\n## Genomic variants and their impact on obesity risk\n\nGenomic variants like rs2293084 in TMEM18 and rs1801282 in PPAR have been linked to obesity traits and metabolic health. These variants can influence an individual's susceptibility to weight gain and obesity, emphasizing the need for personalized approaches to obesity prevention and treatment.\n\n## Relationship between TMEM18 and weight gain during pregnancy\n\nThe TMEM18 gene has been associated with weight gain during pregnancy, suggesting that genetic factors may play a role in pregnancy-related weight changes. This highlights the importance of considering genetic influences on weight gain in pregnant individuals.\n\n## Adiposity traits and their connection to TMEM18\n\nThe TMEM18 gene is associated with adiposity traits, which are a key component of obesity. This relationship underscores the potential for TMEM18 to serve as a biomarker for obesity risk and for informing targeted interventions.",
    "report_json": {
      "title": "Genetic Factors in Obesity and Weight Gain",
      "summary": "The community revolves around genetic factors influencing obesity and weight gain. Key entities include genes such as TMEM18 and PPAR, genomic variants like rs2293084 and rs1801282, and physiological processes like weight gain. These entities are interconnected through their roles in adiposity traits, body shape, and metabolic health.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors on obesity and weight gain.",
      "findings": [
        {
          "summary": "TMEM18 gene and its association with obesity traits",
          "explanation": "The TMEM18 gene is associated with adiposity traits, body shape, and weight gain during pregnancy. Variants in this gene, such as rs2293084, have been linked to increased risk of obesity and weight gain. This highlights the importance of considering genetic factors in obesity risk assessment and management."
        },
        {
          "summary": "PPAR gene and its role in metabolic health",
          "explanation": "The PPAR gene is involved in peroxisome proliferator-activated receptor gamma, which plays a crucial role in glucose and lipid metabolism. Variants in this gene, such as rs1801282, have been associated with decreased waist circumference and improved metabolic health. This underscores the significance of PPAR in obesity and metabolic disorder management."
        },
        {
          "summary": "Genomic variants and their impact on obesity risk",
          "explanation": "Genomic variants like rs2293084 in TMEM18 and rs1801282 in PPAR have been linked to obesity traits and metabolic health. These variants can influence an individual's susceptibility to weight gain and obesity, emphasizing the need for personalized approaches to obesity prevention and treatment."
        },
        {
          "summary": "Relationship between TMEM18 and weight gain during pregnancy",
          "explanation": "The TMEM18 gene has been associated with weight gain during pregnancy, suggesting that genetic factors may play a role in pregnancy-related weight changes. This highlights the importance of considering genetic influences on weight gain in pregnant individuals."
        },
        {
          "summary": "Adiposity traits and their connection to TMEM18",
          "explanation": "The TMEM18 gene is associated with adiposity traits, which are a key component of obesity. This relationship underscores the potential for TMEM18 to serve as a biomarker for obesity risk and for informing targeted interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 47",
    "edges": [
      [
        "\"TMEM18\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TMEM18\""
      ],
      [
        "\"CENTRAL OBESITY\"",
        "\"PPAR\""
      ],
      [
        "\"RS2293084\"",
        "\"TMEM18\""
      ],
      [
        "\"SNP\"",
        "\"TMEM18\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"PPAR\"",
        "\"RS1801282\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"TMEM18\""
      ],
      [
        "\"CENTRAL OBESITY\"",
        "\"TMEM18\""
      ]
    ],
    "nodes": [
      "\"WEIGHT GAIN\"",
      "\"RS1801282\"",
      "\"PPAR\"",
      "\"RS2293084\"",
      "\"TMEM18\"",
      "\"CENTRAL OBESITY\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.1323529411764706,
    "sub_communities": []
  },
  "64": {
    "report_string": "# FTO Gene and Obesity-Related Traits\n\nThe community revolves around the FTO gene and its associations with obesity, body mass index (BMI), and related metabolic traits. Key entities include the FTO gene, genetic variants such as SNPs rs1421085 and rs8050136, and physiological processes like linkage disequilibrium (LD). These entities are interconnected through their roles in obesity risk, energy intake, and metabolic disorders.\n\n## FTO gene and obesity risk\n\nThe FTO gene is strongly associated with obesity risk and BMI. Variants in the FTO gene, such as SNPs rs1421085 and rs8050136, have been linked to increased obesity risk and fat intake. The gene's role in obesity is further supported by its association with obesity-related metabolic traits.\n\n## FTO gene and energy intake\n\nSNPs in the FTO gene, including rs1421085 and rs8050136, are associated with energy intake. This suggests that genetic variations in the FTO gene may influence dietary behaviors and contribute to obesity risk.\n\n## Linkage disequilibrium (LD) and FTO gene\n\nThe FTO gene exhibits high similarity in LD structures across different populations. LD is a physiological process used to analyze genetic variants of the FTO gene, which can help identify genetic associations with obesity and related traits.\n\n## Haplotype block and FTO gene\n\nThe haplotype block is a region of the FTO gene associated with obesity. This region contains multiple genetic variants that are inherited together and influence disease risk, including obesity and related metabolic traits.\n\n## FTO gene and metabolic disorders\n\nThe FTO gene is associated with obesity-related metabolic traits and has been linked to increased risk of metabolic disorders, including MAFLD (Metabolic Associated Fatty Liver Disease). Variants in the FTO gene may contribute to the development of these conditions.",
    "report_json": {
      "title": "FTO Gene and Obesity-Related Traits",
      "summary": "The community revolves around the FTO gene and its associations with obesity, body mass index (BMI), and related metabolic traits. Key entities include the FTO gene, genetic variants such as SNPs rs1421085 and rs8050136, and physiological processes like linkage disequilibrium (LD). These entities are interconnected through their roles in obesity risk, energy intake, and metabolic disorders.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of the FTO gene and its variants on obesity risk and related metabolic traits.",
      "findings": [
        {
          "summary": "FTO gene and obesity risk",
          "explanation": "The FTO gene is strongly associated with obesity risk and BMI. Variants in the FTO gene, such as SNPs rs1421085 and rs8050136, have been linked to increased obesity risk and fat intake. The gene's role in obesity is further supported by its association with obesity-related metabolic traits."
        },
        {
          "summary": "FTO gene and energy intake",
          "explanation": "SNPs in the FTO gene, including rs1421085 and rs8050136, are associated with energy intake. This suggests that genetic variations in the FTO gene may influence dietary behaviors and contribute to obesity risk."
        },
        {
          "summary": "Linkage disequilibrium (LD) and FTO gene",
          "explanation": "The FTO gene exhibits high similarity in LD structures across different populations. LD is a physiological process used to analyze genetic variants of the FTO gene, which can help identify genetic associations with obesity and related traits."
        },
        {
          "summary": "Haplotype block and FTO gene",
          "explanation": "The haplotype block is a region of the FTO gene associated with obesity. This region contains multiple genetic variants that are inherited together and influence disease risk, including obesity and related metabolic traits."
        },
        {
          "summary": "FTO gene and metabolic disorders",
          "explanation": "The FTO gene is associated with obesity-related metabolic traits and has been linked to increased risk of metabolic disorders, including MAFLD (Metabolic Associated Fatty Liver Disease). Variants in the FTO gene may contribute to the development of these conditions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 64",
    "edges": [
      [
        "\"FTO GENE\"",
        "\"MAFLD\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO GENE\"",
        "\"RS9939609\""
      ],
      [
        "\"INDEL\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY-RELATED METABOLIC TRAITS\""
      ],
      [
        "\"FTO GENE\"",
        "\"INDEL\""
      ],
      [
        "\"FTO GENE\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"HAPLOTYPE BLOCK\""
      ],
      [
        "\"FTO GENE\"",
        "\"LD\""
      ],
      [
        "\"INDEL\"",
        "\"SNP\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"FTO GENE\"",
        "\"FTO VARIANTS\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"FTO GENE\"",
        "\"INTRON 1\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"FTO GENE\"",
      "\"SNP RS1421085\"",
      "\"INDEL\"",
      "\"HAPLOTYPE BLOCK\"",
      "\"OBESITY-RELATED METABOLIC TRAITS\"",
      "\"LD\"",
      "\"SNP RS8050136\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-6c935916492da41e4048751fc4c84348"
    ],
    "occurrence": 0.23529411764705882,
    "sub_communities": []
  },
  "76": {
    "report_string": "# NRXN3 Gene and Colorectal Cancer Risk\n\nThe community centers around the NRXN3 gene and its association with colorectal cancer risk. Key entities include the NRXN3 gene, the rs10146997 variant, ethnicity, and colorectal cancer. These entities are interconnected through their roles in cancer risk and genetic associations.\n\n## NRXN3 gene and colorectal cancer risk\n\nThe NRXN3 gene is linked to colorectal cancer risk, with the rs10146997 variant being inversely associated with this risk in whites. This suggests a genetic component to colorectal cancer susceptibility that may vary across different ethnic groups.\n\n## Influence of ethnicity on genetic associations\n\nEthnicity influences the association between the rs10146997 variant of the NRXN3 gene and colorectal cancer risk. This highlights the importance of considering ethnic background in genetic studies and personalized medicine approaches.\n\n## Rs10146997 variant and NRXN3 gene\n\nThe rs10146997 variant is a genomic variant of the NRXN3 gene, and it has been specifically associated with reduced colorectal cancer risk. This variant's impact underscores the role of genetic variations in cancer susceptibility.\n\n## SNP-cancer associations and ethnicity\n\nSNP-cancer associations, such as those involving the NRXN3 gene and colorectal cancer, can vary across different ethnicities. This variability is crucial for understanding and managing cancer risk in diverse populations.\n\n## NRXN3 gene and its broader implications\n\nThe NRXN3 gene is not only linked to colorectal cancer risk but also associated with obesity and waist-to-hip ratio. This suggests that NRXN3 may have broader implications for metabolic and oncological health.",
    "report_json": {
      "title": "NRXN3 Gene and Colorectal Cancer Risk",
      "summary": "The community centers around the NRXN3 gene and its association with colorectal cancer risk. Key entities include the NRXN3 gene, the rs10146997 variant, ethnicity, and colorectal cancer. These entities are interconnected through their roles in cancer risk and genetic associations.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of the NRXN3 gene variant with colorectal cancer risk and the influence of ethnicity on this association.",
      "findings": [
        {
          "summary": "NRXN3 gene and colorectal cancer risk",
          "explanation": "The NRXN3 gene is linked to colorectal cancer risk, with the rs10146997 variant being inversely associated with this risk in whites. This suggests a genetic component to colorectal cancer susceptibility that may vary across different ethnic groups."
        },
        {
          "summary": "Influence of ethnicity on genetic associations",
          "explanation": "Ethnicity influences the association between the rs10146997 variant of the NRXN3 gene and colorectal cancer risk. This highlights the importance of considering ethnic background in genetic studies and personalized medicine approaches."
        },
        {
          "summary": "Rs10146997 variant and NRXN3 gene",
          "explanation": "The rs10146997 variant is a genomic variant of the NRXN3 gene, and it has been specifically associated with reduced colorectal cancer risk. This variant's impact underscores the role of genetic variations in cancer susceptibility."
        },
        {
          "summary": "SNP-cancer associations and ethnicity",
          "explanation": "SNP-cancer associations, such as those involving the NRXN3 gene and colorectal cancer, can vary across different ethnicities. This variability is crucial for understanding and managing cancer risk in diverse populations."
        },
        {
          "summary": "NRXN3 gene and its broader implications",
          "explanation": "The NRXN3 gene is not only linked to colorectal cancer risk but also associated with obesity and waist-to-hip ratio. This suggests that NRXN3 may have broader implications for metabolic and oncological health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 76",
    "edges": [
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ],
      [
        "\"ETHNICITY\"",
        "\"SNP-CANCER ASSOCIATIONS\""
      ],
      [
        "\"NRXN3\"",
        "\"RS10146997\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"ETHNICITY\"",
        "\"RS10146997\""
      ]
    ],
    "nodes": [
      "\"SNP-CANCER ASSOCIATIONS\"",
      "\"RS10146997\"",
      "\"ETHNICITY\"",
      "\"NRXN3\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "81": {
    "report_string": "# Genetic and Nutrient Interactions in Fat Intake Regulation\n\nThe community revolves around fat intake regulation, involving genes such as CD36, SH2B1, and PPARG, and their interactions with fat intake and genetic variants. These entities are interconnected through their roles in energy intake regulation, obesity risk, and response to dietary fat.\n\n## CD36 gene and its role in fat intake regulation\n\nThe CD36 gene is involved in fat intake regulation, and its variant, CD36 SNP rs1761667, is associated with higher fat intake. This suggests that genetic variations in CD36 may influence an individual's susceptibility to increased fat intake and potentially obesity.\n\n## SH2B1 gene and energy intake regulation\n\nThe SH2B1 gene is involved in energy intake regulation and is associated with obesity risk. The variant SH2B1 SNP rs7498665 is linked to higher fat intake, indicating that SH2B1 plays a role in modulating dietary fat consumption.\n\n## PPARG gene and fat intake\n\nThe PPARG gene variant rs1801282 is associated with higher fat intake. PPARG plays a significant role in glucose and lipid metabolism, and its variation can influence an individual's response to dietary fat.\n\n## FGF21 SNP RS838133 and lower fat intake\n\nThe FGF21 SNP rs838133 is associated with lower fat intake. This suggests that genetic variations in FGF21 may influence dietary preferences or metabolism, potentially impacting obesity risk and metabolic health.\n\n## Interactions between genetic variants and fat intake\n\nThe community highlights several interactions between genetic variants and fat intake, including CD36 SNP rs1761667, SH2B1 SNP rs7498665, and PPARG SNP rs1801282, all of which are associated with higher fat intake. These interactions underscore the complex interplay between genetics and dietary behavior.",
    "report_json": {
      "title": "Genetic and Nutrient Interactions in Fat Intake Regulation",
      "summary": "The community revolves around fat intake regulation, involving genes such as CD36, SH2B1, and PPARG, and their interactions with fat intake and genetic variants. These entities are interconnected through their roles in energy intake regulation, obesity risk, and response to dietary fat.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and dietary factors on fat intake regulation and obesity risk.",
      "findings": [
        {
          "summary": "CD36 gene and its role in fat intake regulation",
          "explanation": "The CD36 gene is involved in fat intake regulation, and its variant, CD36 SNP rs1761667, is associated with higher fat intake. This suggests that genetic variations in CD36 may influence an individual's susceptibility to increased fat intake and potentially obesity."
        },
        {
          "summary": "SH2B1 gene and energy intake regulation",
          "explanation": "The SH2B1 gene is involved in energy intake regulation and is associated with obesity risk. The variant SH2B1 SNP rs7498665 is linked to higher fat intake, indicating that SH2B1 plays a role in modulating dietary fat consumption."
        },
        {
          "summary": "PPARG gene and fat intake",
          "explanation": "The PPARG gene variant rs1801282 is associated with higher fat intake. PPARG plays a significant role in glucose and lipid metabolism, and its variation can influence an individual's response to dietary fat."
        },
        {
          "summary": "FGF21 SNP RS838133 and lower fat intake",
          "explanation": "The FGF21 SNP rs838133 is associated with lower fat intake. This suggests that genetic variations in FGF21 may influence dietary preferences or metabolism, potentially impacting obesity risk and metabolic health."
        },
        {
          "summary": "Interactions between genetic variants and fat intake",
          "explanation": "The community highlights several interactions between genetic variants and fat intake, including CD36 SNP rs1761667, SH2B1 SNP rs7498665, and PPARG SNP rs1801282, all of which are associated with higher fat intake. These interactions underscore the complex interplay between genetics and dietary behavior."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 81",
    "edges": [
      [
        "\"FAT INTAKE\"",
        "\"SH2B1 SNP RS7498665\""
      ],
      [
        "\"CD36 SNP RS1761667\"",
        "\"FAT INTAKE\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SH2B1\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG SNP RS1801282\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"FGF21 SNP RS838133\""
      ],
      [
        "\"CD36\"",
        "\"FAT INTAKE\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SNP RS9939609\""
      ]
    ],
    "nodes": [
      "\"SH2B1\"",
      "\"CD36\"",
      "\"FAT INTAKE\"",
      "\"SH2B1 SNP RS7498665\"",
      "\"PPARG SNP RS1801282\"",
      "\"FGF21 SNP RS838133\"",
      "\"CD36 SNP RS1761667\""
    ],
    "chunk_ids": [
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "75": {
    "report_string": "# Genetic and Environmental Factors in Colorectal Cancer\n\nThe community revolves around colorectal cancer, a disease influenced by genetic and environmental factors. Key entities include genes such as MC4R, KCTD15, and NRXN3, environmental factors like physical activity level, and genomic variants like rs4784329 and rs8046502. These entities are interconnected through their roles in obesity, adiposity, and disease risk.\n\n## MC4R gene and its role in obesity and colorectal cancer\n\nThe MC4R gene plays a crucial role in energy balance and obesity. Variants of the MC4R gene have been associated with increased risk of colorectal cancer. This highlights the importance of considering genetic factors in assessing colorectal cancer risk, particularly in individuals with obesity.\n\n## KCTD15 gene and its link to obesity and colorectal cancer\n\nThe KCTD15 gene is linked to obesity risk and has been associated with colorectal cancer. This suggests that genetic factors contributing to obesity may also influence colorectal cancer risk.\n\n## Physical activity level and its impact on colorectal cancer risk\n\nPhysical activity level is an environmental factor that affects colorectal cancer risk. Increased physical activity has been shown to reduce the risk of colorectal cancer, highlighting the importance of lifestyle interventions in disease prevention.\n\n## Genomic variants rs4784329 and rs8046502 in colorectal cancer\n\nThe genomic variants rs4784329 and rs8046502 have been associated with an increased risk of colorectal cancer. These findings underscore the role of genetic factors in disease susceptibility and the potential for targeted screening and prevention strategies.\n\n## NRXN3 gene variant and its association with colorectal cancer\n\nThe NRXN3 gene variant has been linked to colorectal cancer risk. This highlights the importance of considering genetic factors in assessing disease risk and developing personalized prevention and treatment plans.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Colorectal Cancer",
      "summary": "The community revolves around colorectal cancer, a disease influenced by genetic and environmental factors. Key entities include genes such as MC4R, KCTD15, and NRXN3, environmental factors like physical activity level, and genomic variants like rs4784329 and rs8046502. These entities are interconnected through their roles in obesity, adiposity, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on colorectal cancer risk and management.",
      "findings": [
        {
          "summary": "MC4R gene and its role in obesity and colorectal cancer",
          "explanation": "The MC4R gene plays a crucial role in energy balance and obesity. Variants of the MC4R gene have been associated with increased risk of colorectal cancer. This highlights the importance of considering genetic factors in assessing colorectal cancer risk, particularly in individuals with obesity."
        },
        {
          "summary": "KCTD15 gene and its link to obesity and colorectal cancer",
          "explanation": "The KCTD15 gene is linked to obesity risk and has been associated with colorectal cancer. This suggests that genetic factors contributing to obesity may also influence colorectal cancer risk."
        },
        {
          "summary": "Physical activity level and its impact on colorectal cancer risk",
          "explanation": "Physical activity level is an environmental factor that affects colorectal cancer risk. Increased physical activity has been shown to reduce the risk of colorectal cancer, highlighting the importance of lifestyle interventions in disease prevention."
        },
        {
          "summary": "Genomic variants rs4784329 and rs8046502 in colorectal cancer",
          "explanation": "The genomic variants rs4784329 and rs8046502 have been associated with an increased risk of colorectal cancer. These findings underscore the role of genetic factors in disease susceptibility and the potential for targeted screening and prevention strategies."
        },
        {
          "summary": "NRXN3 gene variant and its association with colorectal cancer",
          "explanation": "The NRXN3 gene variant has been linked to colorectal cancer risk. This highlights the importance of considering genetic factors in assessing disease risk and developing personalized prevention and treatment plans."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 75",
    "edges": [
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS8046502\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"KCTD15\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"PHYSICAL ACTIVITY LEVEL\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS4784329\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"MC4R\""
      ]
    ],
    "nodes": [
      "\"MC4R\"",
      "\"RS8046502\"",
      "\"COLORECTAL CANCER\"",
      "\"PHYSICAL ACTIVITY LEVEL\"",
      "\"RS4784329\"",
      "\"KCTD15\""
    ],
    "chunk_ids": [
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "54": {
    "report_string": "# Smoking and Pregnancy: Genetic and Environmental Factors\n\nThe community revolves around the impact of smoking on pregnancy, involving genes such as ACTN1, CHRNA3, CHRND, DBH, and FAAH, and environmental factors like smoking and cigarettes. These entities are interconnected through their roles in smoking during pregnancy, adiposity traits, and disease risk.\n\n## Smoking's impact on pregnancy\n\nSmoking is an environmental factor that affects pregnancy. It is associated with various genes including ACTN1, CHRNA3, CHRND, DBH, and FAAH, which are linked to smoking during pregnancy. This highlights the complex interplay between genetic and environmental factors in pregnancy outcomes.\n\n## Relationship between smoking and adiposity traits\n\nSmoking is associated with adiposity traits, suggesting that it may influence obesity risk. This relationship underscores the potential long-term health implications of smoking beyond pregnancy.\n\n## Smoking's influence on cardiovascular health\n\nSmoking affects cardiovascular health, which is also influenced by genetic and lifestyle factors. This highlights the broader health implications of smoking beyond pregnancy and adiposity traits.\n\n## Role of FAAH in quitting smoking during pregnancy\n\nThe FAAH gene is associated with quitting smoking during pregnancy. This suggests that genetic factors may play a role in smoking cessation strategies during pregnancy.\n\n## Genetic factors associated with smoking during pregnancy\n\nGenes such as ACTN1, CHRNA3, CHRND, and DBH are associated with smoking during pregnancy. These genetic factors may contribute to the variability in smoking behavior and its effects on pregnancy outcomes.",
    "report_json": {
      "title": "Smoking and Pregnancy: Genetic and Environmental Factors",
      "summary": "The community revolves around the impact of smoking on pregnancy, involving genes such as ACTN1, CHRNA3, CHRND, DBH, and FAAH, and environmental factors like smoking and cigarettes. These entities are interconnected through their roles in smoking during pregnancy, adiposity traits, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of smoking on pregnancy and disease risk.",
      "findings": [
        {
          "summary": "Smoking's impact on pregnancy",
          "explanation": "Smoking is an environmental factor that affects pregnancy. It is associated with various genes including ACTN1, CHRNA3, CHRND, DBH, and FAAH, which are linked to smoking during pregnancy. This highlights the complex interplay between genetic and environmental factors in pregnancy outcomes."
        },
        {
          "summary": "Relationship between smoking and adiposity traits",
          "explanation": "Smoking is associated with adiposity traits, suggesting that it may influence obesity risk. This relationship underscores the potential long-term health implications of smoking beyond pregnancy."
        },
        {
          "summary": "Smoking's influence on cardiovascular health",
          "explanation": "Smoking affects cardiovascular health, which is also influenced by genetic and lifestyle factors. This highlights the broader health implications of smoking beyond pregnancy and adiposity traits."
        },
        {
          "summary": "Role of FAAH in quitting smoking during pregnancy",
          "explanation": "The FAAH gene is associated with quitting smoking during pregnancy. This suggests that genetic factors may play a role in smoking cessation strategies during pregnancy."
        },
        {
          "summary": "Genetic factors associated with smoking during pregnancy",
          "explanation": "Genes such as ACTN1, CHRNA3, CHRND, and DBH are associated with smoking during pregnancy. These genetic factors may contribute to the variability in smoking behavior and its effects on pregnancy outcomes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 54",
    "edges": [
      [
        "\"ADIPOSITY\"",
        "\"SMOKING\""
      ],
      [
        "\"ACTN1\"",
        "\"SMOKING\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"PREGNANCY\"",
        "\"SMOKING\""
      ],
      [
        "\"CHRNA3\"",
        "\"SMOKING\""
      ],
      [
        "\"DBH\"",
        "\"SMOKING\""
      ],
      [
        "\"FAAH\"",
        "\"SMOKING\""
      ],
      [
        "\"CHRND\"",
        "\"SMOKING\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING\""
      ],
      [
        "\"CIGARETTES\"",
        "\"SMOKING\""
      ]
    ],
    "nodes": [
      "\"ACTN1\"",
      "\"DBH\"",
      "\"SMOKING\"",
      "\"CHRND\"",
      "\"CIGARETTES\"",
      "\"FAAH\"",
      "\"CHRNA3\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "73": {
    "report_string": "# Genetic and Physiological Interactions in T2DM\n\nThe community revolves around Type 2 Diabetes Mellitus (T2DM), involving key entities such as genes (PACAP, PPARGC1), proteins (FTO PROTEIN), physiological processes (PHYSIOLOGICAL PROCESS), and hormones (EPINEPHRINE). These entities are interconnected through their roles in glucose regulation, metabolic pathways, and physiological responses.\n\n## FTO PROTEIN and its role in obesity and metabolic pathways\n\nThe FTO protein is involved in BMI regulation and physiological processes related to obesity. It interacts with metabolic pathways associated with MAFLD (Metabolic Associated Fatty Liver Disease), highlighting its role in metabolic health and potential impact on T2DM risk.\n\n## PACAP and its association with T2DM\n\nThe PACAP gene is associated with T2DM and is involved in pituitary adenylate cyclase-activating polypeptide production, influencing glucose regulation. This suggests that PACAP may play a role in the development or management of T2DM.\n\n## PPARGC1 and its role in T2DM and glucose metabolism\n\nThe PPARGC1 gene is associated with T2DM and is involved in peroxisome proliferator-activated receptor-gamma coactivation, influencing glucose metabolism. This highlights the importance of PPARGC1 in regulating metabolic processes relevant to T2DM.\n\n## PHYSIOLOGICAL PROCESS and its relation to various entities\n\nPhysiological processes are interconnected with various entities, including FTO PROTEIN, PACAP, and EPINEPHRINE. These connections suggest that physiological processes play a crucial role in integrating genetic and molecular factors to influence T2DM risk and progression.\n\n## EPINEPHRINE and its role in physiological processes\n\nEpinephrine is a hormone and neurotransmitter that plays a role in various physiological processes, including the body's 'fight or flight' response. Its involvement in physiological processes relevant to T2DM underscores the importance of hormonal regulation in metabolic health.",
    "report_json": {
      "title": "Genetic and Physiological Interactions in T2DM",
      "summary": "The community revolves around Type 2 Diabetes Mellitus (T2DM), involving key entities such as genes (PACAP, PPARGC1), proteins (FTO PROTEIN), physiological processes (PHYSIOLOGICAL PROCESS), and hormones (EPINEPHRINE). These entities are interconnected through their roles in glucose regulation, metabolic pathways, and physiological responses.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and physiological factors on T2DM risk and management.",
      "findings": [
        {
          "summary": "FTO PROTEIN and its role in obesity and metabolic pathways",
          "explanation": "The FTO protein is involved in BMI regulation and physiological processes related to obesity. It interacts with metabolic pathways associated with MAFLD (Metabolic Associated Fatty Liver Disease), highlighting its role in metabolic health and potential impact on T2DM risk."
        },
        {
          "summary": "PACAP and its association with T2DM",
          "explanation": "The PACAP gene is associated with T2DM and is involved in pituitary adenylate cyclase-activating polypeptide production, influencing glucose regulation. This suggests that PACAP may play a role in the development or management of T2DM."
        },
        {
          "summary": "PPARGC1 and its role in T2DM and glucose metabolism",
          "explanation": "The PPARGC1 gene is associated with T2DM and is involved in peroxisome proliferator-activated receptor-gamma coactivation, influencing glucose metabolism. This highlights the importance of PPARGC1 in regulating metabolic processes relevant to T2DM."
        },
        {
          "summary": "PHYSIOLOGICAL PROCESS and its relation to various entities",
          "explanation": "Physiological processes are interconnected with various entities, including FTO PROTEIN, PACAP, and EPINEPHRINE. These connections suggest that physiological processes play a crucial role in integrating genetic and molecular factors to influence T2DM risk and progression."
        },
        {
          "summary": "EPINEPHRINE and its role in physiological processes",
          "explanation": "Epinephrine is a hormone and neurotransmitter that plays a role in various physiological processes, including the body's 'fight or flight' response. Its involvement in physiological processes relevant to T2DM underscores the importance of hormonal regulation in metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 73",
    "edges": [
      [
        "\"FTO PROTEIN\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"BASOPHILS\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"FTO PROTEIN\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"EPINEPHRINE\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"PHYSIOLOGICAL PROCESS\"",
        "\"PPARGC1\""
      ],
      [
        "\"PACAP\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ]
    ],
    "nodes": [
      "\"BASOPHILS\"",
      "\"FTO PROTEIN\"",
      "\"PPARGC1\"",
      "\"PACAP\"",
      "\"EPINEPHRINE\"",
      "\"PHYSIOLOGICAL PROCESS\""
    ],
    "chunk_ids": [
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.19117647058823528,
    "sub_communities": []
  },
  "50": {
    "report_string": "# SOLiD Sequencing Community\n\nThe community revolves around SOLiD sequencing, a high-throughput sequencing technology. Key entities include SOLID SEQUENCING, SOLID SYSTEM, PCR, SNP, and INDEL. These entities are interconnected through their roles in DNA sequencing, amplification, and variation detection.\n\n## SOLiD Sequencing and Its Applications\n\nSOLiD sequencing is a high-throughput sequencing technology used for detecting genetic variations such as SNPs and indels. It is part of the SOLID SYSTEM. This technology is crucial for understanding genetic variations and their implications in various diseases.\n\n## Role of PCR in SOLiD Sequencing\n\nPCR (Polymerase Chain Reaction) is used to amplify specific DNA sequences, which are then analyzed using SOLiD sequencing. This step is essential for preparing DNA samples for high-throughput sequencing, ensuring that there is sufficient material for accurate analysis.\n\n## Relationship Between SOLiD Sequencing and Genetic Variations\n\nSOLiD sequencing is utilized to detect SNPs (Single Nucleotide Polymorphisms) and indels (insertions or deletions). These genetic variations are critical for understanding genetic diversity and their associations with diseases or traits.\n\n## SOLiD System and Sequencing\n\nThe SOLiD system is a platform used for SOLiD sequencing. It provides a technological foundation for high-throughput sequencing, enabling the rapid analysis of large genomes or specific regions of interest.",
    "report_json": {
      "title": "SOLiD Sequencing Community",
      "summary": "The community revolves around SOLiD sequencing, a high-throughput sequencing technology. Key entities include SOLID SEQUENCING, SOLID SYSTEM, PCR, SNP, and INDEL. These entities are interconnected through their roles in DNA sequencing, amplification, and variation detection.",
      "rating": 3.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific and technical nature of the entities and their relationships, primarily focused on sequencing and molecular interactions.",
      "findings": [
        {
          "summary": "SOLiD Sequencing and Its Applications",
          "explanation": "SOLiD sequencing is a high-throughput sequencing technology used for detecting genetic variations such as SNPs and indels. It is part of the SOLID SYSTEM. This technology is crucial for understanding genetic variations and their implications in various diseases."
        },
        {
          "summary": "Role of PCR in SOLiD Sequencing",
          "explanation": "PCR (Polymerase Chain Reaction) is used to amplify specific DNA sequences, which are then analyzed using SOLiD sequencing. This step is essential for preparing DNA samples for high-throughput sequencing, ensuring that there is sufficient material for accurate analysis."
        },
        {
          "summary": "Relationship Between SOLiD Sequencing and Genetic Variations",
          "explanation": "SOLiD sequencing is utilized to detect SNPs (Single Nucleotide Polymorphisms) and indels (insertions or deletions). These genetic variations are critical for understanding genetic diversity and their associations with diseases or traits."
        },
        {
          "summary": "SOLiD System and Sequencing",
          "explanation": "The SOLiD system is a platform used for SOLiD sequencing. It provides a technological foundation for high-throughput sequencing, enabling the rapid analysis of large genomes or specific regions of interest."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 50",
    "edges": [
      [
        "\"INDEL\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"SOLID SEQUENCING\"",
        "\"SOLID SYSTEM\""
      ],
      [
        "\"PCR\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SEQUENCING\""
      ]
    ],
    "nodes": [
      "\"PCR\"",
      "\"SOLID SEQUENCING\"",
      "\"SOLID SYSTEM\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "35": {
    "report_string": "# Genetic Association Analysis Community\n\nThe community revolves around the analysis of genetic associations with LMI, involving key entities such as SNP-based association results, quantile-quantile plots, and the FTO gene. These entities are interconnected through their roles in identifying and evaluating genetic variants associated with LMI.\n\n## SNP-based association results and their role in identifying genetic variants\n\nSNP-based association results are a crucial physiological process used to identify genetic variants associated with LMI. This method helps in understanding the genetic underpinnings of LMI by highlighting specific genetic variants that may contribute to its development. The FTO gene, for instance, is associated with LMI based on SNP-based association results, indicating its potential role in LMI pathology.\n\n## Quantile-quantile plots in evaluating SNP-based association results\n\nQuantile-quantile plots are a graphical method used to evaluate the distribution of SNP-based association results. This technique is essential for assessing the validity of the association results by comparing the observed distribution of test statistics to an expected distribution under a null hypothesis. This helps researchers to identify potential inflation of test statistics due to population structure or other biases.\n\n## The FTO gene and its association with LMI\n\nThe FTO gene is notably associated with LMI, as indicated by SNP-based association results. Variants in the FTO gene have been linked to body mass index (BMI) and obesity, which are risk factors for LMI. Understanding the genetic variants in the FTO gene can provide insights into the biological mechanisms underlying LMI and potentially inform personalized interventions.",
    "report_json": {
      "title": "Genetic Association Analysis Community",
      "summary": "The community revolves around the analysis of genetic associations with LMI, involving key entities such as SNP-based association results, quantile-quantile plots, and the FTO gene. These entities are interconnected through their roles in identifying and evaluating genetic variants associated with LMI.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the relevance of genetic association analysis in understanding LMI, but the provided information is limited.",
      "findings": [
        {
          "summary": "SNP-based association results and their role in identifying genetic variants",
          "explanation": "SNP-based association results are a crucial physiological process used to identify genetic variants associated with LMI. This method helps in understanding the genetic underpinnings of LMI by highlighting specific genetic variants that may contribute to its development. The FTO gene, for instance, is associated with LMI based on SNP-based association results, indicating its potential role in LMI pathology."
        },
        {
          "summary": "Quantile-quantile plots in evaluating SNP-based association results",
          "explanation": "Quantile-quantile plots are a graphical method used to evaluate the distribution of SNP-based association results. This technique is essential for assessing the validity of the association results by comparing the observed distribution of test statistics to an expected distribution under a null hypothesis. This helps researchers to identify potential inflation of test statistics due to population structure or other biases."
        },
        {
          "summary": "The FTO gene and its association with LMI",
          "explanation": "The FTO gene is notably associated with LMI, as indicated by SNP-based association results. Variants in the FTO gene have been linked to body mass index (BMI) and obesity, which are risk factors for LMI. Understanding the genetic variants in the FTO gene can provide insights into the biological mechanisms underlying LMI and potentially inform personalized interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 35",
    "edges": [
      [
        "\"FTO\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ],
      [
        "\"QUANTILE-QUANTILE PLOT\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ]
    ],
    "nodes": [
      "\"SNP-BASED ASSOCIATION RESULTS\"",
      "\"QUANTILE-QUANTILE PLOT\""
    ],
    "chunk_ids": [
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "39": {
    "report_string": "# Obesity Risk Associated Genomic Variants\n\nThe community revolves around obesity risk, a disease influenced by genetic factors. Key entities include the disease 'OBESITY RISK' and genomic variants 'RS7193144' and 'RS3751812', which are associated with increased obesity risk. These entities are interconnected through their roles in obesity risk.\n\n## Obesity Risk and Genetic Variants\n\nThe community centers around 'OBESITY RISK', a complex disease influenced by genetic and environmental factors. Two genomic variants, 'RS7193144' and 'RS3751812', are directly associated with increased obesity risk. The presence of these genetic variants can significantly impact an individual's likelihood of developing obesity.\n\n## RS7193144 and Obesity Risk\n\nThe 'RS7193144' genomic variant is specifically noted for its association with BMI and obesity risk. This variant's impact on obesity risk highlights the importance of genetic testing in understanding an individual's predisposition to obesity.\n\n## RS3751812 and Obesity Risk\n\nSimilarly, 'RS3751812' is another genomic variant linked to increased obesity risk. The relationship between this variant and obesity risk underscores the complex genetic landscape of obesity and the need for personalized risk assessments.\n\n## Genetic Factors in Obesity\n\nThe connections between 'OBESITY RISK' and the genomic variants 'RS7193144' and 'RS3751812' emphasize the critical role of genetic factors in obesity. Understanding these genetic associations can help in developing targeted interventions for obesity prevention and management.\n\n## Implications for Personalized Medicine\n\nThe findings from this community highlight the potential for personalized medicine approaches in obesity management. By identifying specific genetic variants associated with obesity risk, healthcare providers can offer tailored advice and interventions to mitigate this risk.",
    "report_json": {
      "title": "Obesity Risk Associated Genomic Variants",
      "summary": "The community revolves around obesity risk, a disease influenced by genetic factors. Key entities include the disease 'OBESITY RISK' and genomic variants 'RS7193144' and 'RS3751812', which are associated with increased obesity risk. These entities are interconnected through their roles in obesity risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic factors on obesity risk.",
      "findings": [
        {
          "summary": "Obesity Risk and Genetic Variants",
          "explanation": "The community centers around 'OBESITY RISK', a complex disease influenced by genetic and environmental factors. Two genomic variants, 'RS7193144' and 'RS3751812', are directly associated with increased obesity risk. The presence of these genetic variants can significantly impact an individual's likelihood of developing obesity."
        },
        {
          "summary": "RS7193144 and Obesity Risk",
          "explanation": "The 'RS7193144' genomic variant is specifically noted for its association with BMI and obesity risk. This variant's impact on obesity risk highlights the importance of genetic testing in understanding an individual's predisposition to obesity."
        },
        {
          "summary": "RS3751812 and Obesity Risk",
          "explanation": "Similarly, 'RS3751812' is another genomic variant linked to increased obesity risk. The relationship between this variant and obesity risk underscores the complex genetic landscape of obesity and the need for personalized risk assessments."
        },
        {
          "summary": "Genetic Factors in Obesity",
          "explanation": "The connections between 'OBESITY RISK' and the genomic variants 'RS7193144' and 'RS3751812' emphasize the critical role of genetic factors in obesity. Understanding these genetic associations can help in developing targeted interventions for obesity prevention and management."
        },
        {
          "summary": "Implications for Personalized Medicine",
          "explanation": "The findings from this community highlight the potential for personalized medicine approaches in obesity management. By identifying specific genetic variants associated with obesity risk, healthcare providers can offer tailored advice and interventions to mitigate this risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 39",
    "edges": [
      [
        "\"OBESITY RISK\"",
        "\"RS3751812\""
      ],
      [
        "\"OBESITY RISK\"",
        "\"RS7193144\""
      ]
    ],
    "nodes": [
      "\"OBESITY RISK\"",
      "\"RS7193144\""
    ],
    "chunk_ids": [
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-3f4f8136f50b2affe4eba97015885ad2"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "38": {
    "report_string": "# Genetic Factors on Chromosome 16 and Type 2 Diabetes\n\nThe community revolves around the genetic factors on chromosome 16 and their potential association with Type 2 Diabetes (T2D). Key entities include the CELF4 gene, chromosome 16, and the TAD genomic region. These entities are interconnected through their roles in genetic susceptibility to T2D.\n\n## CELF4 gene and its potential association with T2D\n\nThe CELF4 gene, located on chromosome 16, may be a new susceptibility gene for T2D. This suggests that genetic variations in CELF4 could contribute to the risk of developing T2D.\n\n## Chromosome 16 and its role in housing relevant genes\n\nChromosome 16 is the location of the CELF4 gene, which is potentially associated with T2D. Additionally, chromosome 16 is associated with the FTO gene, which is also relevant to metabolic health.\n\n## TAD genomic region and its relevance to the study\n\nA TAD (topologically associating domain) defined in embryonic stem cells was used to select the genomic region for the study. The TAD region on chromosome 16 was specifically selected, indicating its relevance to the genetic factors being studied.\n\n## CELF4 and chromosome 16 connection\n\nThe CELF4 gene is located on chromosome 16. This connection highlights the importance of considering the genetic context of CELF4 in understanding its potential role in T2D susceptibility.\n\n## Implications for T2D susceptibility and management\n\nThe potential association of CELF4 with T2D and the role of chromosome 16 in housing relevant genes suggest that genetic factors on chromosome 16 could play a significant role in T2D susceptibility and management.",
    "report_json": {
      "title": "Genetic Factors on Chromosome 16 and Type 2 Diabetes",
      "summary": "The community revolves around the genetic factors on chromosome 16 and their potential association with Type 2 Diabetes (T2D). Key entities include the CELF4 gene, chromosome 16, and the TAD genomic region. These entities are interconnected through their roles in genetic susceptibility to T2D.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the potential association of CELF4 with T2D and the role of chromosome 16 in housing relevant genes.",
      "findings": [
        {
          "summary": "CELF4 gene and its potential association with T2D",
          "explanation": "The CELF4 gene, located on chromosome 16, may be a new susceptibility gene for T2D. This suggests that genetic variations in CELF4 could contribute to the risk of developing T2D."
        },
        {
          "summary": "Chromosome 16 and its role in housing relevant genes",
          "explanation": "Chromosome 16 is the location of the CELF4 gene, which is potentially associated with T2D. Additionally, chromosome 16 is associated with the FTO gene, which is also relevant to metabolic health."
        },
        {
          "summary": "TAD genomic region and its relevance to the study",
          "explanation": "A TAD (topologically associating domain) defined in embryonic stem cells was used to select the genomic region for the study. The TAD region on chromosome 16 was specifically selected, indicating its relevance to the genetic factors being studied."
        },
        {
          "summary": "CELF4 and chromosome 16 connection",
          "explanation": "The CELF4 gene is located on chromosome 16. This connection highlights the importance of considering the genetic context of CELF4 in understanding its potential role in T2D susceptibility."
        },
        {
          "summary": "Implications for T2D susceptibility and management",
          "explanation": "The potential association of CELF4 with T2D and the role of chromosome 16 in housing relevant genes suggest that genetic factors on chromosome 16 could play a significant role in T2D susceptibility and management."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 38",
    "edges": [
      [
        "\"CHROMOSOME 16\"",
        "\"TAD\""
      ],
      [
        "\"CELF4\"",
        "\"CHROMOSOME 16\""
      ],
      [
        "\"CELF4\"",
        "\"T2D\""
      ],
      [
        "\"CHROMOSOME16\"",
        "\"FTO\""
      ],
      [
        "\"CHROMOSOME 16\"",
        "\"FTO\""
      ],
      [
        "\"CELF4\"",
        "\"CHROMOSOME16\""
      ]
    ],
    "nodes": [
      "\"CHROMOSOME16\"",
      "\"CHROMOSOME 16\"",
      "\"TAD\"",
      "\"CELF4\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "66": {
    "report_string": "# BDNF Gene and Obesity Risk\n\nThe community centers around the BDNF gene, which is associated with obesity risk, body shape, and brain function. The BDNF gene is affected by SNP rs6265, and its variants may influence obesity and body shape.\n\n## BDNF gene and its role in obesity risk\n\nThe BDNF gene is associated with obesity risk. This association suggests that genetic variations in BDNF, such as SNP rs6265, may play a role in obesity susceptibility.\n\n## BDNF gene and body shape\n\nThe BDNF gene is also associated with body shape, indicating that variations in this gene may influence not only obesity risk but also body composition.\n\n## BDNF gene and SNP rs6265\n\nThe BDNF gene is affected by SNP rs6265. This genetic variant may have implications for BDNF function and, consequently, for obesity risk and body shape.",
    "report_json": {
      "title": "BDNF Gene and Obesity Risk",
      "summary": "The community centers around the BDNF gene, which is associated with obesity risk, body shape, and brain function. The BDNF gene is affected by SNP rs6265, and its variants may influence obesity and body shape.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of BDNF with obesity risk and body shape.",
      "findings": [
        {
          "summary": "BDNF gene and its role in obesity risk",
          "explanation": "The BDNF gene is associated with obesity risk. This association suggests that genetic variations in BDNF, such as SNP rs6265, may play a role in obesity susceptibility."
        },
        {
          "summary": "BDNF gene and body shape",
          "explanation": "The BDNF gene is also associated with body shape, indicating that variations in this gene may influence not only obesity risk but also body composition."
        },
        {
          "summary": "BDNF gene and SNP rs6265",
          "explanation": "The BDNF gene is affected by SNP rs6265. This genetic variant may have implications for BDNF function and, consequently, for obesity risk and body shape."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 66",
    "edges": [
      [
        "\"BDNF\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"BDNF\"",
        "\"SNP RS6265\""
      ]
    ],
    "nodes": [
      "\"SNP RS6265\"",
      "\"BDNF\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "51": {
    "report_string": "# Leptin and Diabetes Interactions\n\nThe community revolves around the interactions between leptin, diabetes, and related genetic and physiological factors. Key entities include the leptin protein, diabetes, energy balance, insulin resistance, and genes such as NTRK2 and SORCS1. These entities are interconnected through their roles in energy balance, obesity, and plasma leptin levels.\n\n## Leptin's role in energy balance and diabetes\n\nLeptin is a protein hormone that regulates energy balance and body weight. It is associated with plasma leptin levels, which are influenced by genetic variants and environmental factors. Diabetes is linked to altered plasma leptin levels, and leptin plays a crucial role in energy balance and obesity, which are risk factors for diabetes.\n\n## Genetic variants affecting plasma leptin levels\n\nThe rs4074110 genomic variant is associated with plasma leptin levels in men. This highlights the genetic component of leptin regulation and its potential impact on metabolic health, including diabetes risk.\n\n## NTRK2 and SORCS1 genes in energy balance and obesity\n\nThe NTRK2 and SORCS1 genes are involved in energy balance and obesity, and are associated with plasma leptin levels. These genes play a role in the regulation of energy balance and body weight, which are critical factors in diabetes risk and management.\n\n## Insulin resistance and leptin\n\nInsulin resistance is associated with plasma leptin levels and genetic variants. Leptin plays a role in insulin signaling and glucose metabolism, and alterations in leptin levels or function can contribute to insulin resistance, a key feature of type 2 diabetes.\n\n## Sex-specific interactions with leptin\n\nSex interacts with genetic variants to affect plasma leptin levels. This suggests that there may be sex-specific differences in the regulation of leptin and its impact on metabolic health, including diabetes risk.",
    "report_json": {
      "title": "Leptin and Diabetes Interactions",
      "summary": "The community revolves around the interactions between leptin, diabetes, and related genetic and physiological factors. Key entities include the leptin protein, diabetes, energy balance, insulin resistance, and genes such as NTRK2 and SORCS1. These entities are interconnected through their roles in energy balance, obesity, and plasma leptin levels.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of leptin and genetic variants on diabetes risk and metabolic health.",
      "findings": [
        {
          "summary": "Leptin's role in energy balance and diabetes",
          "explanation": "Leptin is a protein hormone that regulates energy balance and body weight. It is associated with plasma leptin levels, which are influenced by genetic variants and environmental factors. Diabetes is linked to altered plasma leptin levels, and leptin plays a crucial role in energy balance and obesity, which are risk factors for diabetes."
        },
        {
          "summary": "Genetic variants affecting plasma leptin levels",
          "explanation": "The rs4074110 genomic variant is associated with plasma leptin levels in men. This highlights the genetic component of leptin regulation and its potential impact on metabolic health, including diabetes risk."
        },
        {
          "summary": "NTRK2 and SORCS1 genes in energy balance and obesity",
          "explanation": "The NTRK2 and SORCS1 genes are involved in energy balance and obesity, and are associated with plasma leptin levels. These genes play a role in the regulation of energy balance and body weight, which are critical factors in diabetes risk and management."
        },
        {
          "summary": "Insulin resistance and leptin",
          "explanation": "Insulin resistance is associated with plasma leptin levels and genetic variants. Leptin plays a role in insulin signaling and glucose metabolism, and alterations in leptin levels or function can contribute to insulin resistance, a key feature of type 2 diabetes."
        },
        {
          "summary": "Sex-specific interactions with leptin",
          "explanation": "Sex interacts with genetic variants to affect plasma leptin levels. This suggests that there may be sex-specific differences in the regulation of leptin and its impact on metabolic health, including diabetes risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 51",
    "edges": [
      [
        "\"LEPR\"",
        "\"LEPTIN\""
      ],
      [
        "\"LEPTIN\"",
        "\"RS4074110\""
      ],
      [
        "\"LEPTIN\"",
        "\"NTRK2\""
      ],
      [
        "\"ENERGY BALANCE\"",
        "\"LEPTIN\""
      ],
      [
        "\"DIABETES\"",
        "\"LEPTIN\""
      ],
      [
        "\"BMI\"",
        "\"LEPTIN\""
      ],
      [
        "\"LEPTIN\"",
        "\"SEX\""
      ],
      [
        "\"LEPTIN\"",
        "\"SLIT3\""
      ],
      [
        "\"LEPTIN\"",
        "\"SORCS1\""
      ],
      [
        "\"DIABETES\"",
        "\"MAFLD\""
      ],
      [
        "\"INSULIN RESISTANCE\"",
        "\"LEPTIN\""
      ],
      [
        "\"LEP\"",
        "\"LEPTIN\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"DIABETES\"",
        "\"PLASMA LEPTIN LEVELS\""
      ]
    ],
    "nodes": [
      "\"SORCS1\"",
      "\"NTRK2\"",
      "\"ENERGY BALANCE\"",
      "\"RS4074110\"",
      "\"DIABETES\"",
      "\"INSULIN RESISTANCE\"",
      "\"LEPTIN\""
    ],
    "chunk_ids": [
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.11764705882352941,
    "sub_communities": []
  },
  "79": {
    "report_string": "# Genetic Factors in Obesity\n\nThe community revolves around obesity (MO), a disease influenced by genetic variants and dietary factors. Key entities include genes such as CBLN4, RBFOX1, RP11-638L3.1, and TMTC1, genomic variants like SNP rs9939609 and SNP rs116917414, and dietary factors such as fat and carbohydrate intake. These entities are interconnected through their roles in obesity risk, energy intake, and metabolic traits.\n\n## SNP rs9939609 and its association with obesity risk\n\nThe SNP rs9939609 in the FTO gene is associated with obesity risk and fat intake. This genomic variant has a p-value of 1.32109 in joint analyses, indicating strong evidence for its association with obesity-related traits. Individuals with this variant may have higher fat intake, which can contribute to obesity risk.\n\n## Role of CBLN4, RBFOX1, RP11-638L3.1, and TMTC1 in obesity\n\nThe genes CBLN4, RBFOX1, RP11-638L3.1, and TMTC1 are associated with obesity-related traits. These genes may play a role in the biological pathways underlying obesity, although the exact mechanisms are not specified. Their association with obesity highlights the complex genetic architecture of the disease.\n\n## SNP rs116917414 and obesity risk\n\nThe SNP rs116917414 is associated with an increased risk of obesity, with a p-value of 1.151012 in the first stage GWAS. This strong association suggests that this genomic variant may be a significant contributor to obesity susceptibility.\n\n## Dietary factors and obesity\n\nThe community highlights the importance of dietary factors, such as fat and carbohydrate intake, in obesity risk. The SNP rs9939609 is associated with both higher fat intake and lower carbohydrate intake, suggesting that genetic variants can influence dietary preferences and obesity risk.\n\n## GWAS and obesity genetics\n\nGenome-wide association studies (GWAS) have identified genetic variants associated with obesity. The GWAS has been used to identify genomic variants like SNP rs9939609 and SNP rs116917414, which are linked to obesity risk and related traits.",
    "report_json": {
      "title": "Genetic Factors in Obesity",
      "summary": "The community revolves around obesity (MO), a disease influenced by genetic variants and dietary factors. Key entities include genes such as CBLN4, RBFOX1, RP11-638L3.1, and TMTC1, genomic variants like SNP rs9939609 and SNP rs116917414, and dietary factors such as fat and carbohydrate intake. These entities are interconnected through their roles in obesity risk, energy intake, and metabolic traits.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants on obesity risk and metabolic health.",
      "findings": [
        {
          "summary": "SNP rs9939609 and its association with obesity risk",
          "explanation": "The SNP rs9939609 in the FTO gene is associated with obesity risk and fat intake. This genomic variant has a p-value of 1.32109 in joint analyses, indicating strong evidence for its association with obesity-related traits. Individuals with this variant may have higher fat intake, which can contribute to obesity risk."
        },
        {
          "summary": "Role of CBLN4, RBFOX1, RP11-638L3.1, and TMTC1 in obesity",
          "explanation": "The genes CBLN4, RBFOX1, RP11-638L3.1, and TMTC1 are associated with obesity-related traits. These genes may play a role in the biological pathways underlying obesity, although the exact mechanisms are not specified. Their association with obesity highlights the complex genetic architecture of the disease."
        },
        {
          "summary": "SNP rs116917414 and obesity risk",
          "explanation": "The SNP rs116917414 is associated with an increased risk of obesity, with a p-value of 1.151012 in the first stage GWAS. This strong association suggests that this genomic variant may be a significant contributor to obesity susceptibility."
        },
        {
          "summary": "Dietary factors and obesity",
          "explanation": "The community highlights the importance of dietary factors, such as fat and carbohydrate intake, in obesity risk. The SNP rs9939609 is associated with both higher fat intake and lower carbohydrate intake, suggesting that genetic variants can influence dietary preferences and obesity risk."
        },
        {
          "summary": "GWAS and obesity genetics",
          "explanation": "Genome-wide association studies (GWAS) have identified genetic variants associated with obesity. The GWAS has been used to identify genomic variants like SNP rs9939609 and SNP rs116917414, which are linked to obesity risk and related traits."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 79",
    "edges": [
      [
        "\"MO\"",
        "\"SNP RS116917414\""
      ],
      [
        "\"MO\"",
        "\"RBFOX1\""
      ],
      [
        "\"GWAS\"",
        "\"MO\""
      ],
      [
        "\"CBLN4\"",
        "\"MO\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"MO\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"MO\"",
        "\"TMTC1\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"MO\"",
        "\"RP11-638L3.1\""
      ]
    ],
    "nodes": [
      "\"CBLN4\"",
      "\"SNP RS9939609\"",
      "\"MO\"",
      "\"RBFOX1\"",
      "\"RP11-638L3.1\"",
      "\"SNP RS116917414\"",
      "\"TMTC1\""
    ],
    "chunk_ids": [
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed"
    ],
    "occurrence": 0.04411764705882353,
    "sub_communities": []
  },
  "27": {
    "report_string": "# Family History and Type 2 Diabetes Risk\n\nThe community centers around the influence of family history on the risk of developing Type 2 Diabetes (T2DM). Key entities include 'FAMILY HISTORY' as an environmental factor, 'PFH' (Positive Family History) as a physiological process, and their relationships to T2DM. Family history, particularly a positive family history, is recognized as a significant risk factor for T2DM.\n\n## Role of Family History in T2DM Risk\n\nFamily history is a well-established environmental factor that increases the risk of developing T2DM. This is supported by the relationship between 'FAMILY HISTORY' and T2DM, indicating that family history plays a crucial role in the risk assessment of T2DM.\n\n## PFH as a Risk Factor for T2DM\n\nPFH (Positive Family History) is specifically identified as a physiological process influencing T2DM risk. The association between PFH and T2DM highlights the importance of considering family history in the risk assessment and management of T2DM.\n\n## Relationship Between Family History and PFH\n\nPFH is categorized as a type of family history, emphasizing that not all family histories are equal in terms of risk assessment. This distinction is crucial for personalized risk evaluation and intervention strategies.\n\n## Implications for T2DM Management\n\nUnderstanding the role of family history, particularly PFH, in T2DM risk can inform preventive measures and management strategies. Individuals with a positive family history may benefit from early screening and lifestyle interventions to mitigate their risk.",
    "report_json": {
      "title": "Family History and Type 2 Diabetes Risk",
      "summary": "The community centers around the influence of family history on the risk of developing Type 2 Diabetes (T2DM). Key entities include 'FAMILY HISTORY' as an environmental factor, 'PFH' (Positive Family History) as a physiological process, and their relationships to T2DM. Family history, particularly a positive family history, is recognized as a significant risk factor for T2DM.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of family history on the risk of developing T2DM.",
      "findings": [
        {
          "summary": "Role of Family History in T2DM Risk",
          "explanation": "Family history is a well-established environmental factor that increases the risk of developing T2DM. This is supported by the relationship between 'FAMILY HISTORY' and T2DM, indicating that family history plays a crucial role in the risk assessment of T2DM."
        },
        {
          "summary": "PFH as a Risk Factor for T2DM",
          "explanation": "PFH (Positive Family History) is specifically identified as a physiological process influencing T2DM risk. The association between PFH and T2DM highlights the importance of considering family history in the risk assessment and management of T2DM."
        },
        {
          "summary": "Relationship Between Family History and PFH",
          "explanation": "PFH is categorized as a type of family history, emphasizing that not all family histories are equal in terms of risk assessment. This distinction is crucial for personalized risk evaluation and intervention strategies."
        },
        {
          "summary": "Implications for T2DM Management",
          "explanation": "Understanding the role of family history, particularly PFH, in T2DM risk can inform preventive measures and management strategies. Individuals with a positive family history may benefit from early screening and lifestyle interventions to mitigate their risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 27",
    "edges": [
      [
        "\"PFH\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"PFH\""
      ]
    ],
    "nodes": [
      "\"FAMILY HISTORY\"",
      "\"PFH\""
    ],
    "chunk_ids": [
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "28": {
    "report_string": "# Type 2 Diabetes Mellitus (T2DM) Genetic and Environmental Factors\n\nThe community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic variants, environmental factors, and physiological processes. Key entities include genes (e.g., TCF7L2, CDKAL1, ENPP1), genomic variants (e.g., rs7903146, rs997509), populations (e.g., SSA, Ghanaian, Nigerian), and physiological processes (e.g., body mass index, glucose homeostasis). These entities interact through complex relationships, including genetic associations, environmental influences, and statistical measures.\n\n## TCF7L2 gene variants and T2DM risk\n\nThe TCF7L2 gene is significantly associated with T2DM risk. Variants such as rs7903146 have been linked to increased risk of T2DM among various populations, including Ghanaians, Cameroonians, and Nigerians. This highlights the importance of genetic screening for T2DM risk assessment.\n\n## CDKAL1 gene and T2DM susceptibility\n\nThe CDKAL1 gene is associated with T2DM susceptibility. Polymorphisms in CDKAL1 have been linked to increased risk of T2DM, emphasizing the role of genetic factors in disease etiology.\n\n## ENPP1 gene and T2DM risk\n\nThe ENPP1 gene is involved in T2DM risk, with variants like rs997509 showing significant association with T2DM among South-African Mixed ancestry. This underscores the importance of genetic studies in diverse populations.\n\n## Body Mass Index (BMI) and T2DM risk\n\nBody Mass Index (BMI) is a physiological process associated with T2DM risk. BMI is a measure of body fat based on height and weight, and it influences the risk of developing T2DM.\n\n## Genomic variants and T2DM risk\n\nVarious genomic variants, such as rs11745088-C, rs1799817-A, rs2059806-T, and rs2241766-G, have been associated with protective or increased risk of T2DM. These findings highlight the complex genetic architecture of T2DM.",
    "report_json": {
      "title": "Type 2 Diabetes Mellitus (T2DM) Genetic and Environmental Factors",
      "summary": "The community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic variants, environmental factors, and physiological processes. Key entities include genes (e.g., TCF7L2, CDKAL1, ENPP1), genomic variants (e.g., rs7903146, rs997509), populations (e.g., SSA, Ghanaian, Nigerian), and physiological processes (e.g., body mass index, glucose homeostasis). These entities interact through complex relationships, including genetic associations, environmental influences, and statistical measures.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2DM risk and management in various populations.",
      "findings": [
        {
          "summary": "TCF7L2 gene variants and T2DM risk",
          "explanation": "The TCF7L2 gene is significantly associated with T2DM risk. Variants such as rs7903146 have been linked to increased risk of T2DM among various populations, including Ghanaians, Cameroonians, and Nigerians. This highlights the importance of genetic screening for T2DM risk assessment."
        },
        {
          "summary": "CDKAL1 gene and T2DM susceptibility",
          "explanation": "The CDKAL1 gene is associated with T2DM susceptibility. Polymorphisms in CDKAL1 have been linked to increased risk of T2DM, emphasizing the role of genetic factors in disease etiology."
        },
        {
          "summary": "ENPP1 gene and T2DM risk",
          "explanation": "The ENPP1 gene is involved in T2DM risk, with variants like rs997509 showing significant association with T2DM among South-African Mixed ancestry. This underscores the importance of genetic studies in diverse populations."
        },
        {
          "summary": "Body Mass Index (BMI) and T2DM risk",
          "explanation": "Body Mass Index (BMI) is a physiological process associated with T2DM risk. BMI is a measure of body fat based on height and weight, and it influences the risk of developing T2DM."
        },
        {
          "summary": "Genomic variants and T2DM risk",
          "explanation": "Various genomic variants, such as rs11745088-C, rs1799817-A, rs2059806-T, and rs2241766-G, have been associated with protective or increased risk of T2DM. These findings highlight the complex genetic architecture of T2DM."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 28",
    "edges": [
      [
        "\"PTEN\"",
        "\"T2DM\""
      ],
      [
        "\"ROC CURVE\"",
        "\"T2DM\""
      ],
      [
        "\"IRS-1\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"IDE\"",
        "\"T2DM\""
      ],
      [
        "\"INSR\"",
        "\"T2DM\""
      ],
      [
        "\"PFH\"",
        "\"T2DM\""
      ],
      [
        "\"AMOAH\"",
        "\"T2DM\""
      ],
      [
        "\"FATTY ACID METABOLISM\"",
        "\"T2DM\""
      ],
      [
        "\"C2D4B\"",
        "\"T2DM\""
      ],
      [
        "\"SLC30A8\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"RS6494730-T\"",
        "\"T2DM\""
      ],
      [
        "\"GENOME-WIDE ASSOCIATION STUDIES\"",
        "\"T2DM\""
      ],
      [
        "\"KCNJ11\"",
        "\"T2DM\""
      ],
      [
        "\"ODDS RATIO\"",
        "\"T2DM\""
      ],
      [
        "\"GHANAIAN\"",
        "\"T2DM\""
      ],
      [
        "\"SSA\"",
        "\"T2DM\""
      ],
      [
        "\"HAPTOGLOBIN\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1 RS997509\"",
        "\"T2DM\""
      ],
      [
        "\"ESR2\"",
        "\"T2DM\""
      ],
      [
        "\"SCL40A1\"",
        "\"T2DM\""
      ],
      [
        "\"HYPERANDROGENISM\"",
        "\"T2DM\""
      ],
      [
        "\"AGE\"",
        "\"T2DM\""
      ],
      [
        "\"ADIPOQ\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1\"",
        "\"T2DM\""
      ],
      [
        "\"BODY MASS INDEX\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC\"",
        "\"T2DM\""
      ],
      [
        "\"AGMO\"",
        "\"T2DM\""
      ],
      [
        "\"RS2241766-G\"",
        "\"T2DM\""
      ],
      [
        "\"FOLLICULOGENESIS\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TNF- 308G/A\""
      ],
      [
        "\"T2DM\"",
        "\"WAIST HIP RATIO\""
      ],
      [
        "\"MAURITANIAN\"",
        "\"T2DM\""
      ],
      [
        "\"RS2059806-T\"",
        "\"T2DM\""
      ],
      [
        "\"GENETIC RISK SCORE\"",
        "\"T2DM\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"FBN3\"",
        "\"T2DM\""
      ],
      [
        "\"ADEYEMO\"",
        "\"T2DM\""
      ],
      [
        "\"HYPOGONADISM\"",
        "\"T2DM\""
      ],
      [
        "\"FEM1B\"",
        "\"T2DM\""
      ],
      [
        "\"PCOS\"",
        "\"T2DM\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"T2DM\""
      ],
      [
        "\"CAMEROONIAN\"",
        "\"T2DM\""
      ],
      [
        "\"PPP1R5\"",
        "\"T2DM\""
      ],
      [
        "\"CDKAL1\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC G-11391-A\"",
        "\"T2DM\""
      ],
      [
        "\"RS11745088-C\"",
        "\"T2DM\""
      ],
      [
        "\"PRKAG3\"",
        "\"T2DM\""
      ],
      [
        "\"PSMD6\"",
        "\"T2DM\""
      ],
      [
        "\"AGRP\"",
        "\"T2DM\""
      ],
      [
        "\"SEX HORMONES\"",
        "\"T2DM\""
      ],
      [
        "\"MEILOUD\"",
        "\"T2DM\""
      ],
      [
        "\"RS1799817-A\"",
        "\"T2DM\""
      ],
      [
        "\"SEX\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2 RS7903146\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"T2DM\""
      ],
      [
        "\"ABCC8\"",
        "\"T2DM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"ERASMUS\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"PRKAG3\"",
      "\"ERASMUS\"",
      "\"RS2059806-T\"",
      "\"FOLLICULOGENESIS\"",
      "\"GHANAIAN\"",
      "\"RS6494730-T\"",
      "\"ODDS RATIO\"",
      "\"WAIST HIP RATIO\"",
      "\"HYPOGONADISM\"",
      "\"SLC30A8\"",
      "\"ABCC8\"",
      "\"RS11745088-C\"",
      "\"HAPTOGLOBIN\"",
      "\"PSMD6\"",
      "\"T2DM\"",
      "\"RS1799817-A\"",
      "\"TNF- 308G/A\"",
      "\"ADEYEMO\"",
      "\"ENPP1\"",
      "\"MAURITANIAN\"",
      "\"SEX HORMONES\"",
      "\"PPAR-\"",
      "\"ACDC\"",
      "\"ESR2\"",
      "\"GENOME-WIDE ASSOCIATION STUDIES\"",
      "\"BODY MASS INDEX\"",
      "\"RS2241766-G\"",
      "\"SCL40A1\"",
      "\"AGMO\"",
      "\"AGRP\"",
      "\"ROC CURVE\"",
      "\"GENETIC RISK SCORE\"",
      "\"AMOAH\"",
      "\"PPP1R5\"",
      "\"C2D4B\"",
      "\"CDKAL1\"",
      "\"HYPERANDROGENISM\"",
      "\"PCOS\"",
      "\"FBN3\"",
      "\"CAMEROONIAN\"",
      "\"KCNJ11\"",
      "\"ENPP1 RS997509\"",
      "\"ACDC G-11391-A\"",
      "\"SSA\"",
      "\"MEILOUD\"",
      "\"IDE\"",
      "\"IRS-1\""
    ],
    "chunk_ids": [
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.1323529411764706,
    "sub_communities": []
  },
  "30": {
    "report_string": "# PTEN and T2DM Interaction\n\nThe community consists of PTEN, a gene involved in cellular processes including tumor suppression and glucose regulation, and its association with T2DM. The PTEN gene plays a role in T2DM, and it is also involved in cellular processes.\n\n## PTEN gene and its role in T2DM\n\nThe PTEN gene is associated with T2DM, as indicated by its involvement in glucose regulation. This relationship highlights the potential genetic component of T2DM and the role of PTEN in disease pathology.\n\n## PTEN involvement in cellular processes\n\nPTEN is involved in cellular processes, including tumor suppression and glucose regulation. This suggests that PTEN's role extends beyond T2DM to other cellular functions, potentially impacting overall health and disease susceptibility.",
    "report_json": {
      "title": "PTEN and T2DM Interaction",
      "summary": "The community consists of PTEN, a gene involved in cellular processes including tumor suppression and glucose regulation, and its association with T2DM. The PTEN gene plays a role in T2DM, and it is also involved in cellular processes.",
      "rating": 5.0,
      "rating_explanation": "The impact severity rating is moderate due to the involvement of PTEN in both tumor suppression and glucose regulation, which are relevant to T2DM.",
      "findings": [
        {
          "summary": "PTEN gene and its role in T2DM",
          "explanation": "The PTEN gene is associated with T2DM, as indicated by its involvement in glucose regulation. This relationship highlights the potential genetic component of T2DM and the role of PTEN in disease pathology."
        },
        {
          "summary": "PTEN involvement in cellular processes",
          "explanation": "PTEN is involved in cellular processes, including tumor suppression and glucose regulation. This suggests that PTEN's role extends beyond T2DM to other cellular functions, potentially impacting overall health and disease susceptibility."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 30",
    "edges": [
      [
        "\"PTEN\"",
        "\"T2DM\""
      ],
      [
        "\"CELLULAR PROCESS\"",
        "\"PTEN\""
      ]
    ],
    "nodes": [
      "\"PTEN\"",
      "\"CELLULAR PROCESS\""
    ],
    "chunk_ids": [
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-70430b09782e1fdb643124aa15a06aae"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "69": {
    "report_string": "# Type2 Diabetes Genetic and Environmental Interactions\n\nThe community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and impaired insulin secretion. Key entities include the TCF7L2 gene, Coronary Artery Disease (CAD), and various risk markers. These entities are interconnected through their roles in glucose homeostasis, insulin secretion, and disease risk.\n\n## TCF7L2 gene and its association with T2D\n\nThe TCF7L2 gene is significantly associated with an increased risk of T2D. Variants of this gene have been linked to impaired glucose homeostasis and insulin secretion. Studies have reported that TCF7L2 is involved in glucose homeostasis and is associated with type2 diabetes risk. The gene's location on chromosome 10 has been confirmed, and its association with T2D has been reported in various datasets, including the WTCCC GWAS dataset.\n\n## Relationship between T2D and CAD\n\nT2D and CAD are related diseases with shared genetic factors. T2D is a risk factor for CAD, and both diseases are associated with increased risk of cardiovascular disease. The relationship between T2D and CAD highlights the importance of managing T2D to prevent cardiovascular complications.\n\n## Role of genomic variants in T2D susceptibility\n\nGenomic variants, such as SNPs, can affect T2D susceptibility. The CpG-SNP rs7723 is associated with T2D through metabolomics regulation. Additionally, variants of the TCF7L2 gene have been linked to increased risk of T2D. These findings emphasize the importance of genetic considerations in T2D risk assessment and management.\n\n## Importance of risk markers in T2D prediction\n\nRisk markers are used to predict the risk of T2D. The Net Reclassification Index (NRI) is a statistical measure used to evaluate the improvement in risk prediction for T2D. The use of risk markers, such as genomic variants and clinical factors, can help identify individuals at high risk of developing T2D and enable early intervention.\n\n## Pancreas development and T2D susceptibility\n\nPancreas development is a biological process that affects T2D susceptibility. The development of pancreatic beta-cells is crucial for glucose regulation, and abnormalities in this process can contribute to T2D. Understanding the relationship between pancreas development and T2D can provide insights into the pathogenesis of the disease.",
    "report_json": {
      "title": "Type2 Diabetes Genetic and Environmental Interactions",
      "summary": "The community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and impaired insulin secretion. Key entities include the TCF7L2 gene, Coronary Artery Disease (CAD), and various risk markers. These entities are interconnected through their roles in glucose homeostasis, insulin secretion, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2D risk and management.",
      "findings": [
        {
          "summary": "TCF7L2 gene and its association with T2D",
          "explanation": "The TCF7L2 gene is significantly associated with an increased risk of T2D. Variants of this gene have been linked to impaired glucose homeostasis and insulin secretion. Studies have reported that TCF7L2 is involved in glucose homeostasis and is associated with type2 diabetes risk. The gene's location on chromosome 10 has been confirmed, and its association with T2D has been reported in various datasets, including the WTCCC GWAS dataset."
        },
        {
          "summary": "Relationship between T2D and CAD",
          "explanation": "T2D and CAD are related diseases with shared genetic factors. T2D is a risk factor for CAD, and both diseases are associated with increased risk of cardiovascular disease. The relationship between T2D and CAD highlights the importance of managing T2D to prevent cardiovascular complications."
        },
        {
          "summary": "Role of genomic variants in T2D susceptibility",
          "explanation": "Genomic variants, such as SNPs, can affect T2D susceptibility. The CpG-SNP rs7723 is associated with T2D through metabolomics regulation. Additionally, variants of the TCF7L2 gene have been linked to increased risk of T2D. These findings emphasize the importance of genetic considerations in T2D risk assessment and management."
        },
        {
          "summary": "Importance of risk markers in T2D prediction",
          "explanation": "Risk markers are used to predict the risk of T2D. The Net Reclassification Index (NRI) is a statistical measure used to evaluate the improvement in risk prediction for T2D. The use of risk markers, such as genomic variants and clinical factors, can help identify individuals at high risk of developing T2D and enable early intervention."
        },
        {
          "summary": "Pancreas development and T2D susceptibility",
          "explanation": "Pancreas development is a biological process that affects T2D susceptibility. The development of pancreatic beta-cells is crucial for glucose regulation, and abnormalities in this process can contribute to T2D. Understanding the relationship between pancreas development and T2D can provide insights into the pathogenesis of the disease."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 69",
    "edges": [
      [
        "\"CHILDHOOD OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"T2D\"",
        "\"TSPAN8\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"RUNX1\"",
        "\"T2D\""
      ],
      [
        "\"PANCREAS DEVELOPMENT\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CHROMOSOME10\"",
        "\"TCF7L2\""
      ],
      [
        "\"TCF7L2\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"CAD\"",
        "\"T2D\""
      ],
      [
        "\"APOLIPOPROTEIN BINDING\"",
        "\"CAD\""
      ],
      [
        "\"CHROMOSOME 10\"",
        "\"TCF7L2\""
      ],
      [
        "\"RS7723\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"NRI\"",
        "\"T2D\""
      ],
      [
        "\"TSPAN8\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"GWAS\"",
        "\"T2D\""
      ],
      [
        "\"L3MBTL3\"",
        "\"T2D\""
      ],
      [
        "\"RISK MARKERS\"",
        "\"T2D\""
      ],
      [
        "\"T2D\"",
        "\"TCF7L2\""
      ],
      [
        "\"CAD\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CELF4\"",
        "\"T2D\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ]
    ],
    "nodes": [
      "\"T2D\"",
      "\"NRI\"",
      "\"RS7723\"",
      "\"APOLIPOPROTEIN BINDING\"",
      "\"CAD\"",
      "\"TCF7L2\"",
      "\"PANCREAS DEVELOPMENT\"",
      "\"RISK MARKERS\"",
      "\"CHROMOSOME10\"",
      "\"WTCCC GWAS DATASET\"",
      "\"CHROMOSOME 10\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-6f4c442093f64b0adfa1c090d805321b",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-49cf6074543d5f5d4e9ea8750a88794c",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.22058823529411764,
    "sub_communities": [
      "104",
      "103"
    ]
  },
  "32": {
    "report_string": "# TCF7L2 Variant and T2DM Risk in SSA Population\n\nThe community centers around the TCF7L2 rs7903146 variant, which is associated with an increased risk of Type 2 Diabetes (T2DM) in the South Sub-Saharan African (SSA) population. The variant's impact on T2DM risk is the primary connection between these entities.\n\n## TCF7L2 rs7903146 variant and T2DM risk\n\nThe TCF7L2 rs7903146 variant has a moderately strong effect on T2DM risk among the SSA population. This association indicates that genetic screening for this variant could help identify individuals at higher risk of developing T2DM.\n\n## Role of SSA population specificity\n\nThe impact of the TCF7L2 rs7903146 variant is specifically noted in the SSA population, suggesting that ethnic-specific genetic risk factors for T2DM exist. This highlights the importance of considering population genetics in assessing disease risk and management.",
    "report_json": {
      "title": "TCF7L2 Variant and T2DM Risk in SSA Population",
      "summary": "The community centers around the TCF7L2 rs7903146 variant, which is associated with an increased risk of Type 2 Diabetes (T2DM) in the South Sub-Saharan African (SSA) population. The variant's impact on T2DM risk is the primary connection between these entities.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but significant effect of the TCF7L2 rs7903146 variant on T2DM risk among the SSA population.",
      "findings": [
        {
          "summary": "TCF7L2 rs7903146 variant and T2DM risk",
          "explanation": "The TCF7L2 rs7903146 variant has a moderately strong effect on T2DM risk among the SSA population. This association indicates that genetic screening for this variant could help identify individuals at higher risk of developing T2DM."
        },
        {
          "summary": "Role of SSA population specificity",
          "explanation": "The impact of the TCF7L2 rs7903146 variant is specifically noted in the SSA population, suggesting that ethnic-specific genetic risk factors for T2DM exist. This highlights the importance of considering population genetics in assessing disease risk and management."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 32",
    "edges": [
      [
        "\"T2DM\"",
        "\"TCF7L2 RS7903146\""
      ],
      [
        "\"SSA POPULATION\"",
        "\"TCF7L2 RS7903146\""
      ]
    ],
    "nodes": [
      "\"TCF7L2 RS7903146\"",
      "\"SSA POPULATION\""
    ],
    "chunk_ids": [
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "42": {
    "report_string": "# Genetic Factors in Obesity and Body Composition\n\nThe community revolves around the FTO rs9939609 genomic variant, which is associated with body mass index, body composition, and obesity risk. The variant affects not only genotype and total body water but also the response to nutritional interventions. This highlights the interplay between genetic factors and physiological processes in determining obesity susceptibility and potential treatment strategies.\n\n## FTO rs9939609 and obesity risk\n\nThe FTO rs9939609 genomic variant is directly associated with an increased risk of obesity. This variant affects body mass index and body composition, indicating its role in physiological processes related to weight management. The relationship between FTO rs9939609 and obesity underscores the genetic component in obesity susceptibility.\n\n## Impact of FTO rs9939609 on nutritional interventions\n\nThe FTO rs9939609 variant affects the response to nutritional interventions, suggesting that individuals with this variant may require personalized dietary approaches to manage weight effectively. This highlights the importance of genetic information in tailoring nutritional advice for obesity management.\n\n## FTO rs9939609 and total body water\n\nThe FTO rs9939609 variant also affects total body water, a critical physiological process in maintaining proper bodily functions. Changes in body composition, as influenced by this variant, can have implications for overall health and disease risk.\n\n## Role of genotype in obesity and related traits\n\nThe genotype of an individual, including specific SNPs like FTO rs9939609, plays a significant role in determining obesity susceptibility and related traits. Understanding the genotype can provide insights into an individual's risk profile and potential for targeted interventions.",
    "report_json": {
      "title": "Genetic Factors in Obesity and Body Composition",
      "summary": "The community revolves around the FTO rs9939609 genomic variant, which is associated with body mass index, body composition, and obesity risk. The variant affects not only genotype and total body water but also the response to nutritional interventions. This highlights the interplay between genetic factors and physiological processes in determining obesity susceptibility and potential treatment strategies.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of the FTO rs9939609 variant with obesity risk and its implications for personalized nutritional interventions.",
      "findings": [
        {
          "summary": "FTO rs9939609 and obesity risk",
          "explanation": "The FTO rs9939609 genomic variant is directly associated with an increased risk of obesity. This variant affects body mass index and body composition, indicating its role in physiological processes related to weight management. The relationship between FTO rs9939609 and obesity underscores the genetic component in obesity susceptibility."
        },
        {
          "summary": "Impact of FTO rs9939609 on nutritional interventions",
          "explanation": "The FTO rs9939609 variant affects the response to nutritional interventions, suggesting that individuals with this variant may require personalized dietary approaches to manage weight effectively. This highlights the importance of genetic information in tailoring nutritional advice for obesity management."
        },
        {
          "summary": "FTO rs9939609 and total body water",
          "explanation": "The FTO rs9939609 variant also affects total body water, a critical physiological process in maintaining proper bodily functions. Changes in body composition, as influenced by this variant, can have implications for overall health and disease risk."
        },
        {
          "summary": "Role of genotype in obesity and related traits",
          "explanation": "The genotype of an individual, including specific SNPs like FTO rs9939609, plays a significant role in determining obesity susceptibility and related traits. Understanding the genotype can provide insights into an individual's risk profile and potential for targeted interventions."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 42",
    "edges": [
      [
        "\"FTO RS9939609\"",
        "\"NUTRITIONAL INTERVENTION\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"TBW\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"GENOTYPE\""
      ],
      [
        "\"GENOTYPE\"",
        "\"SNP\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"GENOTYPE\""
      ]
    ],
    "nodes": [
      "\"TBW\"",
      "\"GENOTYPE\"",
      "\"FTO RS9939609\""
    ],
    "chunk_ids": [
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-b87db3f3e401355543bca374e5b87c57"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "72": {
    "report_string": "# L3MBTL3 and Chromosome 6 in T2D Susceptibility\n\nThe community centers around L3MBTL3, a gene located on chromosome 6, and its potential association with type 2 diabetes (T2D). The L3MBTL3 gene and chromosome 6 are interconnected through the gene's location on the chromosome. Significant information includes L3MBTL3's potential role as a susceptibility gene for T2D.\n\n## L3MBTL3 gene and its location on chromosome 6\n\nThe L3MBTL3 gene is located on chromosome 6. This gene has been identified as potentially associated with type 2 diabetes (T2D). The relationship between L3MBTL3 and chromosome 6 is established through its physical location.\n\n## L3MBTL3 and its potential association with T2D\n\nL3MBTL3 may be a new susceptibility gene for T2D. This association suggests that genetic variations in L3MBTL3 could contribute to the risk of developing T2D. Further research is needed to confirm this relationship and understand the underlying mechanisms.",
    "report_json": {
      "title": "L3MBTL3 and Chromosome 6 in T2D Susceptibility",
      "summary": "The community centers around L3MBTL3, a gene located on chromosome 6, and its potential association with type 2 diabetes (T2D). The L3MBTL3 gene and chromosome 6 are interconnected through the gene's location on the chromosome. Significant information includes L3MBTL3's potential role as a susceptibility gene for T2D.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the preliminary evidence suggesting L3MBTL3's association with T2D susceptibility.",
      "findings": [
        {
          "summary": "L3MBTL3 gene and its location on chromosome 6",
          "explanation": "The L3MBTL3 gene is located on chromosome 6. This gene has been identified as potentially associated with type 2 diabetes (T2D). The relationship between L3MBTL3 and chromosome 6 is established through its physical location."
        },
        {
          "summary": "L3MBTL3 and its potential association with T2D",
          "explanation": "L3MBTL3 may be a new susceptibility gene for T2D. This association suggests that genetic variations in L3MBTL3 could contribute to the risk of developing T2D. Further research is needed to confirm this relationship and understand the underlying mechanisms."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 72",
    "edges": [
      [
        "\"L3MBTL3\"",
        "\"T2D\""
      ],
      [
        "\"CHROMOSOME 6\"",
        "\"L3MBTL3\""
      ],
      [
        "\"CHROMOSOME6\"",
        "\"L3MBTL3\""
      ]
    ],
    "nodes": [
      "\"L3MBTL3\"",
      "\"CHROMOSOME 6\"",
      "\"CHROMOSOME6\""
    ],
    "chunk_ids": [
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "70": {
    "report_string": "# Genetic Factors in Type 2 Diabetes: TSPAN8 and Chromosome 12\n\nThe community centers around the TSPAN8 gene, located on chromosome 12, and its association with type 2 diabetes (T2D). The TSPAN8 gene is linked to an increased risk of T2D, and this association has been reported in the WTCCC GWAS dataset. Chromosome 12 is the location of the TSPAN8 gene, highlighting the genetic basis of T2D susceptibility.\n\n## TSPAN8 gene and its association with T2D\n\nThe TSPAN8 gene, located on chromosome 12, is associated with an increased risk of type 2 diabetes. This association was reported in the WTCCC GWAS dataset, providing evidence for the genetic link between TSPAN8 and T2D.\n\n## Chromosome 12 and TSPAN8 location\n\nChromosome 12 serves as the location for the TSPAN8 gene. This gene's position on chromosome 12 is crucial for understanding its role in T2D susceptibility. The relationship between chromosome 12 and TSPAN8 highlights the genetic basis of T2D.\n\n## TSPAN8 and GWAS dataset\n\nThe association of TSPAN8 with T2D was reported in the WTCCC GWAS dataset. This finding underscores the importance of genetic studies in identifying susceptibility genes for T2D.",
    "report_json": {
      "title": "Genetic Factors in Type 2 Diabetes: TSPAN8 and Chromosome 12",
      "summary": "The community centers around the TSPAN8 gene, located on chromosome 12, and its association with type 2 diabetes (T2D). The TSPAN8 gene is linked to an increased risk of T2D, and this association has been reported in the WTCCC GWAS dataset. Chromosome 12 is the location of the TSPAN8 gene, highlighting the genetic basis of T2D susceptibility.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but significant association of TSPAN8 with T2D risk.",
      "findings": [
        {
          "summary": "TSPAN8 gene and its association with T2D",
          "explanation": "The TSPAN8 gene, located on chromosome 12, is associated with an increased risk of type 2 diabetes. This association was reported in the WTCCC GWAS dataset, providing evidence for the genetic link between TSPAN8 and T2D."
        },
        {
          "summary": "Chromosome 12 and TSPAN8 location",
          "explanation": "Chromosome 12 serves as the location for the TSPAN8 gene. This gene's position on chromosome 12 is crucial for understanding its role in T2D susceptibility. The relationship between chromosome 12 and TSPAN8 highlights the genetic basis of T2D."
        },
        {
          "summary": "TSPAN8 and GWAS dataset",
          "explanation": "The association of TSPAN8 with T2D was reported in the WTCCC GWAS dataset. This finding underscores the importance of genetic studies in identifying susceptibility genes for T2D."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 70",
    "edges": [
      [
        "\"TSPAN8\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CHROMOSOME12\"",
        "\"TSPAN8\""
      ],
      [
        "\"CHROMOSOME 12\"",
        "\"TSPAN8\""
      ],
      [
        "\"T2D\"",
        "\"TSPAN8\""
      ]
    ],
    "nodes": [
      "\"CHROMOSOME 12\"",
      "\"TSPAN8\"",
      "\"CHROMOSOME12\""
    ],
    "chunk_ids": [
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "71": {
    "report_string": "# RUNX1 and Chromosome 21 in Type 2 Diabetes\n\nThe community revolves around the RUNX1 gene located on chromosome 21 and its potential association with type 2 diabetes (T2D). The key entities include the RUNX1 gene, chromosome 21, and T2D. The relationships between these entities suggest that RUNX1 may be a new susceptibility gene for T2D, and it is physically located on chromosome 21.\n\n## RUNX1 gene and its location on chromosome 21\n\nThe RUNX1 gene is located on chromosome 21. This is a well-established fact based on the provided information. The gene's location on chromosome 21 is crucial for understanding its potential role in diseases associated with this chromosome.\n\n## Potential association of RUNX1 with type 2 diabetes\n\nRUNX1 may be a new susceptibility gene for type 2 diabetes (T2D). This potential association suggests that genetic variations in RUNX1 could contribute to the risk of developing T2D. Further studies are needed to confirm this association and understand the underlying mechanisms.\n\n## Role of chromosome 21 in RUNX1 function\n\nChromosome 21 is the location of the RUNX1 gene. The relationship between chromosome 21 and RUNX1 is fundamental to understanding the gene's expression and function. Any abnormalities or variations in chromosome 21 could potentially affect RUNX1's role in T2D susceptibility.",
    "report_json": {
      "title": "RUNX1 and Chromosome 21 in Type 2 Diabetes",
      "summary": "The community revolves around the RUNX1 gene located on chromosome 21 and its potential association with type 2 diabetes (T2D). The key entities include the RUNX1 gene, chromosome 21, and T2D. The relationships between these entities suggest that RUNX1 may be a new susceptibility gene for T2D, and it is physically located on chromosome 21.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the potential association of RUNX1 with T2D, which warrants further investigation.",
      "findings": [
        {
          "summary": "RUNX1 gene and its location on chromosome 21",
          "explanation": "The RUNX1 gene is located on chromosome 21. This is a well-established fact based on the provided information. The gene's location on chromosome 21 is crucial for understanding its potential role in diseases associated with this chromosome."
        },
        {
          "summary": "Potential association of RUNX1 with type 2 diabetes",
          "explanation": "RUNX1 may be a new susceptibility gene for type 2 diabetes (T2D). This potential association suggests that genetic variations in RUNX1 could contribute to the risk of developing T2D. Further studies are needed to confirm this association and understand the underlying mechanisms."
        },
        {
          "summary": "Role of chromosome 21 in RUNX1 function",
          "explanation": "Chromosome 21 is the location of the RUNX1 gene. The relationship between chromosome 21 and RUNX1 is fundamental to understanding the gene's expression and function. Any abnormalities or variations in chromosome 21 could potentially affect RUNX1's role in T2D susceptibility."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 71",
    "edges": [
      [
        "\"CHROMOSOME21\"",
        "\"RUNX1\""
      ],
      [
        "\"RUNX1\"",
        "\"T2D\""
      ],
      [
        "\"CHROMOSOME 21\"",
        "\"RUNX1\""
      ]
    ],
    "nodes": [
      "\"RUNX1\"",
      "\"CHROMOSOME 21\"",
      "\"CHROMOSOME21\""
    ],
    "chunk_ids": [
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "82": {
    "report_string": "# Cohort and Study Methodology Community\n\nThe community consists of a cohort of participants and methodological processes such as exclusion criteria. These entities are interconnected through their roles in study design and participant selection. The cohort is central to GWAS studies and is shaped by exclusion criteria.\n\n## Cohort and its role in GWAS\n\nThe cohort is a group of participants used in a study, specifically in Genome-Wide Association Studies (GWAS) to identify genetic associations. This highlights the importance of well-defined cohorts in genetic research.\n\n## Exclusion criteria in cohort selection\n\nExclusion criteria are used to select participants for a cohort by determining who should be excluded from the study. This process is crucial for ensuring the validity and relevance of the study findings.\n\n## Relationship between cohort and exclusion criteria\n\nThe relationship between the cohort and exclusion criteria is fundamental to study design. Exclusion criteria help in refining the cohort to better match the study objectives, thereby enhancing the reliability of the research outcomes.",
    "report_json": {
      "title": "Cohort and Study Methodology Community",
      "summary": "The community consists of a cohort of participants and methodological processes such as exclusion criteria. These entities are interconnected through their roles in study design and participant selection. The cohort is central to GWAS studies and is shaped by exclusion criteria.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited scope and general nature of the entities and their relationships provided.",
      "findings": [
        {
          "summary": "Cohort and its role in GWAS",
          "explanation": "The cohort is a group of participants used in a study, specifically in Genome-Wide Association Studies (GWAS) to identify genetic associations. This highlights the importance of well-defined cohorts in genetic research."
        },
        {
          "summary": "Exclusion criteria in cohort selection",
          "explanation": "Exclusion criteria are used to select participants for a cohort by determining who should be excluded from the study. This process is crucial for ensuring the validity and relevance of the study findings."
        },
        {
          "summary": "Relationship between cohort and exclusion criteria",
          "explanation": "The relationship between the cohort and exclusion criteria is fundamental to study design. Exclusion criteria help in refining the cohort to better match the study objectives, thereby enhancing the reliability of the research outcomes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 82",
    "edges": [
      [
        "\"COHORT\"",
        "\"EXCLUSION CRITERIA\""
      ],
      [
        "\"COHORT\"",
        "\"GWAS\""
      ]
    ],
    "nodes": [
      "\"COHORT\"",
      "\"EXCLUSION CRITERIA\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "83": {
    "report_string": "# PHEWAS and EHR Phenotype Groups in Genetic Associations\n\nThe community centers around PHEWAS, a metabolic pathway used to identify associations between genetic variants and diseases, and EHR phenotype groups, classifications of phenotypes based on electronic health records. These entities are connected through their roles in analyzing genetic associations and phenotypic classifications.\n\n## PHEWAS as a metabolic pathway\n\nPHEWAS is described as a metabolic pathway used to identify associations between genetic variants and diseases. It is a type of study that examines the associations between genetic variants and multiple phenotypes. This indicates PHEWAS's role in understanding the genetic underpinnings of various conditions.\n\n## EHR phenotype groups and their classification\n\nEHR phenotype groups are classifications of phenotypes based on electronic health records. These groups are utilized in PheWAS studies, suggesting their importance in categorizing and understanding phenotypic expressions in the context of genetic research.\n\n## Relationship between GWAS, PHEWAS, and EHR phenotype groups\n\nGWAS and PheWAS are related study types used to analyze genetic associations. EHR phenotype groups are used in PheWAS studies. This interconnection highlights the integrated approach researchers take to understand genetic associations with diseases and phenotypes.",
    "report_json": {
      "title": "PHEWAS and EHR Phenotype Groups in Genetic Associations",
      "summary": "The community centers around PHEWAS, a metabolic pathway used to identify associations between genetic variants and diseases, and EHR phenotype groups, classifications of phenotypes based on electronic health records. These entities are connected through their roles in analyzing genetic associations and phenotypic classifications.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited information provided about the direct impact of these entities on health, disease, and personalized nutrition.",
      "findings": [
        {
          "summary": "PHEWAS as a metabolic pathway",
          "explanation": "PHEWAS is described as a metabolic pathway used to identify associations between genetic variants and diseases. It is a type of study that examines the associations between genetic variants and multiple phenotypes. This indicates PHEWAS's role in understanding the genetic underpinnings of various conditions."
        },
        {
          "summary": "EHR phenotype groups and their classification",
          "explanation": "EHR phenotype groups are classifications of phenotypes based on electronic health records. These groups are utilized in PheWAS studies, suggesting their importance in categorizing and understanding phenotypic expressions in the context of genetic research."
        },
        {
          "summary": "Relationship between GWAS, PHEWAS, and EHR phenotype groups",
          "explanation": "GWAS and PheWAS are related study types used to analyze genetic associations. EHR phenotype groups are used in PheWAS studies. This interconnection highlights the integrated approach researchers take to understand genetic associations with diseases and phenotypes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 83",
    "edges": [
      [
        "\"GWAS\"",
        "\"PHEWAS\""
      ],
      [
        "\"EHR PHENOTYPE GROUPS\"",
        "\"PHEWAS\""
      ]
    ],
    "nodes": [
      "\"PHEWAS\"",
      "\"EHR PHENOTYPE GROUPS\""
    ],
    "chunk_ids": [
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "55": {
    "report_string": "# Adiposity and Glucose Homeostasis Network\n\nThe community revolves around adiposity and its relationships with various physiological processes, genes, and genomic variants. Key entities include adiposity, obesity GWAS genes, SLC2A9, SUA, and response to glucose. These entities are interconnected through their roles in glucose homeostasis, body fat accumulation, and disease risk.\n\n## Adiposity's role in metabolic health\n\nAdiposity is a physiological process related to body mass and composition. It is associated with obesity risk and has connections to various factors including age, sex, smoking, and alcohol consumption. Adiposity is also a risk factor for type2 diabetes, and obesity GWAS genes contribute to this relationship.\n\n## Genetic factors influencing adiposity\n\nObesity GWAS genes are a set of genes associated with obesity, identified through genome-wide association studies. These genes confer risk of adiposity, which in turn increases the risk of type2 diabetes. The SLC2A9 gene is also associated with adiposity traits and SUA levels.\n\n## Relationship between adiposity and SUA\n\nSUA (Serum Uric Acid) is positively correlated with adiposity traits. The SLC2A9 gene, which is associated with adiposity traits, is also linked to SUA levels. Furthermore, the rs6855911 variant is associated with SUA levels.\n\n## Role of glucose homeostasis in adiposity\n\nResponse to glucose is a biological process that regulates the cellular response to glucose, and is significantly enriched with obesity GWAS genes. This suggests a link between obesity and glucose regulation, which is critical for metabolic health.\n\n## Impact of genetic variants on adiposity\n\nThe rs6855911 variant is associated with SUA levels, and the SLC2A9 gene is linked to adiposity traits and SUA levels. These genetic factors highlight the importance of considering genetic information in understanding adiposity and metabolic health.",
    "report_json": {
      "title": "Adiposity and Glucose Homeostasis Network",
      "summary": "The community revolves around adiposity and its relationships with various physiological processes, genes, and genomic variants. Key entities include adiposity, obesity GWAS genes, SLC2A9, SUA, and response to glucose. These entities are interconnected through their roles in glucose homeostasis, body fat accumulation, and disease risk.",
      "rating": 6.5,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of adiposity and related genetic factors on metabolic health and disease risk.",
      "findings": [
        {
          "summary": "Adiposity's role in metabolic health",
          "explanation": "Adiposity is a physiological process related to body mass and composition. It is associated with obesity risk and has connections to various factors including age, sex, smoking, and alcohol consumption. Adiposity is also a risk factor for type2 diabetes, and obesity GWAS genes contribute to this relationship."
        },
        {
          "summary": "Genetic factors influencing adiposity",
          "explanation": "Obesity GWAS genes are a set of genes associated with obesity, identified through genome-wide association studies. These genes confer risk of adiposity, which in turn increases the risk of type2 diabetes. The SLC2A9 gene is also associated with adiposity traits and SUA levels."
        },
        {
          "summary": "Relationship between adiposity and SUA",
          "explanation": "SUA (Serum Uric Acid) is positively correlated with adiposity traits. The SLC2A9 gene, which is associated with adiposity traits, is also linked to SUA levels. Furthermore, the rs6855911 variant is associated with SUA levels."
        },
        {
          "summary": "Role of glucose homeostasis in adiposity",
          "explanation": "Response to glucose is a biological process that regulates the cellular response to glucose, and is significantly enriched with obesity GWAS genes. This suggests a link between obesity and glucose regulation, which is critical for metabolic health."
        },
        {
          "summary": "Impact of genetic variants on adiposity",
          "explanation": "The rs6855911 variant is associated with SUA levels, and the SLC2A9 gene is linked to adiposity traits and SUA levels. These genetic factors highlight the importance of considering genetic information in understanding adiposity and metabolic health."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 55",
    "edges": [
      [
        "\"ADIPOSITY\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SMOKING\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"INSTRUMENTAL VARIABLES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TMEM18\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"AGE\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SUA\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SEX\""
      ],
      [
        "\"RS6855911\"",
        "\"SUA\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENETIC SCORES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"FTO\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"MC4R\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"ALCOHOL CONSUMPTION\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"OBESITY GWAS GENES\"",
        "\"RESPONSE TO GLUCOSE\""
      ],
      [
        "\"SLC2A9\"",
        "\"SUA\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SLC2A9\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"OBESITY GWAS GENES\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"OBESITY GWAS GENES\""
      ]
    ],
    "nodes": [
      "\"SLC2A9\"",
      "\"RS6855911\"",
      "\"GENETIC SCORES\"",
      "\"OBESITY GWAS GENES\"",
      "\"SUA\"",
      "\"ADIPOSITY\"",
      "\"RESPONSE TO GLUCOSE\"",
      "\"INSTRUMENTAL VARIABLES\""
    ],
    "chunk_ids": [
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-e868b6533e734748b2f371dbeb6df838"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "37": {
    "report_string": "# Genetic Variants and Obesity Risk\n\nThe community revolves around the relationship between genetic variants, specifically minor alleles of rs9939609, and obesity risk. Key entities include the MINOR ALLELES, OBESE GROUP, and the genomic variant rs9939609. These entities are interconnected through their roles in obesity risk and BMI values.\n\n## Association between MINOR ALLELES and OBESE GROUP\n\nThe minor alleles of rs9939609 are more frequent in the obese group, indicating a potential genetic link to obesity. This relationship suggests that genetic factors may play a role in obesity risk.\n\n## Relationship between MINOR ALLELES and BMI\n\nThe presence of minor alleles of rs9939609 is correlated with higher BMI values. This correlation highlights the potential impact of genetic variants on body mass index.\n\n## Role of rs9939609 in obesity risk\n\nThe genomic variant rs9939609 is more frequent in the obese group and carriers of the minor alleles have a higher risk of obesity. This suggests that rs9939609 may be a risk factor for obesity.\n\n## Connection between OBESE GROUP and MINOR ALLELES\n\nThe obese group consists of individuals with a BMI 30 kg/m2, and the minor alleles of rs9939609 are more frequent in this group. This connection underscores the potential relationship between genetic variants and obesity.",
    "report_json": {
      "title": "Genetic Variants and Obesity Risk",
      "summary": "The community revolves around the relationship between genetic variants, specifically minor alleles of rs9939609, and obesity risk. Key entities include the MINOR ALLELES, OBESE GROUP, and the genomic variant rs9939609. These entities are interconnected through their roles in obesity risk and BMI values.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association between minor alleles of rs9939609 and obesity risk.",
      "findings": [
        {
          "summary": "Association between MINOR ALLELES and OBESE GROUP",
          "explanation": "The minor alleles of rs9939609 are more frequent in the obese group, indicating a potential genetic link to obesity. This relationship suggests that genetic factors may play a role in obesity risk."
        },
        {
          "summary": "Relationship between MINOR ALLELES and BMI",
          "explanation": "The presence of minor alleles of rs9939609 is correlated with higher BMI values. This correlation highlights the potential impact of genetic variants on body mass index."
        },
        {
          "summary": "Role of rs9939609 in obesity risk",
          "explanation": "The genomic variant rs9939609 is more frequent in the obese group and carriers of the minor alleles have a higher risk of obesity. This suggests that rs9939609 may be a risk factor for obesity."
        },
        {
          "summary": "Connection between OBESE GROUP and MINOR ALLELES",
          "explanation": "The obese group consists of individuals with a BMI 30 kg/m2, and the minor alleles of rs9939609 are more frequent in this group. This connection underscores the potential relationship between genetic variants and obesity."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 37",
    "edges": [
      [
        "\"MINOR ALLELES\"",
        "\"OBESE GROUP\""
      ],
      [
        "\"OBESE GROUP\"",
        "\"RS9939609\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"MINOR ALLELES\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELES\"",
      "\"OBESE GROUP\""
    ],
    "chunk_ids": [
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-27b6a78dbd979d1827c235ae16860183"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "44": {
    "report_string": "# FTO Genomic Variants and Obesity Risk\n\nThe community centers around FTO genomic variants and their association with obesity risk. Key entities include FTO rs1558902, FTO rs1421085, and FTO rs12149832, which are interconnected through their relationships with obesity.\n\n## FTO rs1558902 and obesity risk\n\nThe FTO rs1558902 variant is associated with an increased risk of obesity, with a relationship rank of 70. This suggests a strong link between this genomic variant and obesity susceptibility.\n\n## FTO rs1421085 and obesity risk\n\nThe FTO rs1421085 variant is also associated with an increased risk of obesity, with a relationship rank of 69. This variant is connected to FTO rs1558902, indicating a potential cumulative effect on obesity risk.\n\n## Relationship between FTO rs1421085 and FTO rs1558902\n\nThe FTO rs1421085 and rs1558902 variants are both associated with obesity, with a relationship rank of 5. This connection suggests that individuals with both variants may be at higher risk of obesity.\n\n## FTO rs12149832 and FTO rs1558902 relationship\n\nThe FTO rs12149832 and rs1558902 variants are also connected, with a relationship rank of 4. This link indicates that these variants may collectively contribute to obesity susceptibility.\n\n## FTO genomic variants and obesity\n\nThe FTO genomic variants, including rs1558902, rs1421085, and rs12149832, are all associated with increased risk of obesity. Their connections highlight the complex genetic landscape of obesity and the importance of considering multiple genetic factors in risk assessment.",
    "report_json": {
      "title": "FTO Genomic Variants and Obesity Risk",
      "summary": "The community centers around FTO genomic variants and their association with obesity risk. Key entities include FTO rs1558902, FTO rs1421085, and FTO rs12149832, which are interconnected through their relationships with obesity.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant association of FTO genomic variants with increased risk of obesity.",
      "findings": [
        {
          "summary": "FTO rs1558902 and obesity risk",
          "explanation": "The FTO rs1558902 variant is associated with an increased risk of obesity, with a relationship rank of 70. This suggests a strong link between this genomic variant and obesity susceptibility."
        },
        {
          "summary": "FTO rs1421085 and obesity risk",
          "explanation": "The FTO rs1421085 variant is also associated with an increased risk of obesity, with a relationship rank of 69. This variant is connected to FTO rs1558902, indicating a potential cumulative effect on obesity risk."
        },
        {
          "summary": "Relationship between FTO rs1421085 and FTO rs1558902",
          "explanation": "The FTO rs1421085 and rs1558902 variants are both associated with obesity, with a relationship rank of 5. This connection suggests that individuals with both variants may be at higher risk of obesity."
        },
        {
          "summary": "FTO rs12149832 and FTO rs1558902 relationship",
          "explanation": "The FTO rs12149832 and rs1558902 variants are also connected, with a relationship rank of 4. This link indicates that these variants may collectively contribute to obesity susceptibility."
        },
        {
          "summary": "FTO genomic variants and obesity",
          "explanation": "The FTO genomic variants, including rs1558902, rs1421085, and rs12149832, are all associated with increased risk of obesity. Their connections highlight the complex genetic landscape of obesity and the importance of considering multiple genetic factors in risk assessment."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 44",
    "edges": [
      [
        "\"FTO RS1421085\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1421085\"",
        "\"FTO RS1558902\""
      ],
      [
        "\"FTO RS12149832\"",
        "\"FTO RS1558902\""
      ],
      [
        "\"FTO RS1558902\"",
        "\"OBESITY\""
      ]
    ],
    "nodes": [
      "\"FTO RS12149832\"",
      "\"FTO RS1558902\"",
      "\"FTO RS1421085\""
    ],
    "chunk_ids": [
      "chunk-2107b32e444ab30c1d84364536b3ecf9"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "74": {
    "report_string": "# Genetic and Metabolic Insights into Type2 Diabetes\n\nThe community revolves around the metabolic pathway associated with MAFLD, involving key entities such as GCKR, CCNL1, and their associated genetic variants. These entities are interconnected through their roles in glucose metabolism, leptin regulation, and disease risk.\n\n## GCKR gene and its role in glucose metabolism\n\nThe GCKR gene is associated with type2 diabetes and is involved in glucose metabolism. The genetic variant rs780093 in GCKR is linked to circulating leptin levels, highlighting the importance of GCKR in metabolic health.\n\n## CCNL1 gene and its association with leptin levels\n\nThe CCNL1 gene is associated with circulating leptin levels in women, and the genetic variant rs17451107 affects leptin levels. This suggests a potential link between CCNL1 and metabolic health.\n\n## METABOLIC PATHWAY and its interactions\n\nThe metabolic pathway associated with MAFLD involves lipid metabolism and glucose regulation. The interactions between CCNL1, GCKR, and this pathway highlight the complex relationships between genetic and metabolic factors in disease susceptibility.\n\n## Genetic variants and their impact on metabolic health\n\nThe genetic variants rs17451107 and rs780093 are associated with circulating leptin levels and are linked to metabolic health. These variants highlight the importance of genetic considerations in understanding disease susceptibility and metabolic regulation.\n\n## Leptin regulation and its significance\n\nLeptin regulation is a critical aspect of metabolic health, and the associations between CCNL1, GCKR, and leptin levels underscore the complex interplay between genetic and metabolic factors in disease risk.",
    "report_json": {
      "title": "Genetic and Metabolic Insights into Type2 Diabetes",
      "summary": "The community revolves around the metabolic pathway associated with MAFLD, involving key entities such as GCKR, CCNL1, and their associated genetic variants. These entities are interconnected through their roles in glucose metabolism, leptin regulation, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors on glucose metabolism and disease susceptibility.",
      "findings": [
        {
          "summary": "GCKR gene and its role in glucose metabolism",
          "explanation": "The GCKR gene is associated with type2 diabetes and is involved in glucose metabolism. The genetic variant rs780093 in GCKR is linked to circulating leptin levels, highlighting the importance of GCKR in metabolic health."
        },
        {
          "summary": "CCNL1 gene and its association with leptin levels",
          "explanation": "The CCNL1 gene is associated with circulating leptin levels in women, and the genetic variant rs17451107 affects leptin levels. This suggests a potential link between CCNL1 and metabolic health."
        },
        {
          "summary": "METABOLIC PATHWAY and its interactions",
          "explanation": "The metabolic pathway associated with MAFLD involves lipid metabolism and glucose regulation. The interactions between CCNL1, GCKR, and this pathway highlight the complex relationships between genetic and metabolic factors in disease susceptibility."
        },
        {
          "summary": "Genetic variants and their impact on metabolic health",
          "explanation": "The genetic variants rs17451107 and rs780093 are associated with circulating leptin levels and are linked to metabolic health. These variants highlight the importance of genetic considerations in understanding disease susceptibility and metabolic regulation."
        },
        {
          "summary": "Leptin regulation and its significance",
          "explanation": "Leptin regulation is a critical aspect of metabolic health, and the associations between CCNL1, GCKR, and leptin levels underscore the complex interplay between genetic and metabolic factors in disease risk."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 74",
    "edges": [
      [
        "\"FTO PROTEIN\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"GCKR\"",
        "\"RS780093\""
      ],
      [
        "\"GCKR\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"CCNL1\"",
        "\"RS17451107\""
      ],
      [
        "\"CCNL1\"",
        "\"METABOLIC PATHWAY\""
      ]
    ],
    "nodes": [
      "\"METABOLIC PATHWAY\"",
      "\"CCNL1\"",
      "\"RS17451107\"",
      "\"GCKR\"",
      "\"RS780093\""
    ],
    "chunk_ids": [
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "31": {
    "report_string": "# INSR and FEM1B Genes in Type 2 Diabetes\n\nThe community revolves around the INSR and FEM1B genes, which are associated with type 2 diabetes mellitus (T2DM) through insulin signaling and glucose homeostasis. Genomic variants such as rs1799817, rs2059806, and rs6494730 in these genes may influence T2DM risk.\n\n## INSR gene and its association with T2DM\n\nThe INSR gene, encoding the insulin receptor, plays a crucial role in insulin signaling. Variants such as rs1799817 and rs2059806 in the INSR gene have been identified, which may affect insulin signaling and contribute to T2DM risk.\n\n## FEM1B gene and its role in glucose homeostasis\n\nThe FEM1B gene is involved in glucose homeostasis and insulin signaling. It interacts with the INSR gene in these processes, and the rs6494730 variant in FEM1B may influence T2DM susceptibility.\n\n## Interaction between INSR and FEM1B genes\n\nThe INSR and FEM1B genes interact in insulin signaling and glucose homeostasis, highlighting the complexity of T2DM genetics. This interaction suggests that multiple genetic factors should be considered in assessing T2DM risk.\n\n## Genomic variants and T2DM risk\n\nGenomic variants such as rs1799817, rs2059806, and rs6494730 in the INSR and FEM1B genes have been associated with T2DM risk. These variants may affect gene function and contribute to disease susceptibility.\n\n## Implications for personalized medicine\n\nUnderstanding the genetic factors contributing to T2DM, such as the roles of INSR and FEM1B genes and their variants, can inform personalized dietary and therapeutic interventions. This may help in managing T2DM risk and improving patient outcomes.",
    "report_json": {
      "title": "INSR and FEM1B Genes in Type 2 Diabetes",
      "summary": "The community revolves around the INSR and FEM1B genes, which are associated with type 2 diabetes mellitus (T2DM) through insulin signaling and glucose homeostasis. Genomic variants such as rs1799817, rs2059806, and rs6494730 in these genes may influence T2DM risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of INSR and FEM1B genes with insulin signaling and T2DM risk.",
      "findings": [
        {
          "summary": "INSR gene and its association with T2DM",
          "explanation": "The INSR gene, encoding the insulin receptor, plays a crucial role in insulin signaling. Variants such as rs1799817 and rs2059806 in the INSR gene have been identified, which may affect insulin signaling and contribute to T2DM risk."
        },
        {
          "summary": "FEM1B gene and its role in glucose homeostasis",
          "explanation": "The FEM1B gene is involved in glucose homeostasis and insulin signaling. It interacts with the INSR gene in these processes, and the rs6494730 variant in FEM1B may influence T2DM susceptibility."
        },
        {
          "summary": "Interaction between INSR and FEM1B genes",
          "explanation": "The INSR and FEM1B genes interact in insulin signaling and glucose homeostasis, highlighting the complexity of T2DM genetics. This interaction suggests that multiple genetic factors should be considered in assessing T2DM risk."
        },
        {
          "summary": "Genomic variants and T2DM risk",
          "explanation": "Genomic variants such as rs1799817, rs2059806, and rs6494730 in the INSR and FEM1B genes have been associated with T2DM risk. These variants may affect gene function and contribute to disease susceptibility."
        },
        {
          "summary": "Implications for personalized medicine",
          "explanation": "Understanding the genetic factors contributing to T2DM, such as the roles of INSR and FEM1B genes and their variants, can inform personalized dietary and therapeutic interventions. This may help in managing T2DM risk and improving patient outcomes."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 31",
    "edges": [
      [
        "\"INSR\"",
        "\"RS2059806\""
      ],
      [
        "\"FEM1B\"",
        "\"RS6494730\""
      ],
      [
        "\"FEM1B\"",
        "\"T2DM\""
      ],
      [
        "\"INSR\"",
        "\"T2DM\""
      ],
      [
        "\"INSR\"",
        "\"RS1799817\""
      ],
      [
        "\"FEM1B\"",
        "\"INSR\""
      ]
    ],
    "nodes": [
      "\"RS2059806\"",
      "\"RS6494730\"",
      "\"INSR\"",
      "\"RS1799817\"",
      "\"FEM1B\""
    ],
    "chunk_ids": [
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "53": {
    "report_string": "# SLIT3 and Estrogen Interactions in Leptin Regulation\n\nThe community centers around the SLIT3 gene, which interacts with leptin levels in a sex-specific manner, influenced by estrogens and a genomic variant rs11954861. These entities are connected through their roles in regulating plasma leptin levels and gene expression.\n\n## SLIT3 gene and its interaction with leptin levels\n\nThe SLIT3 gene is involved in sex-specific differences in plasma leptin levels. This suggests that SLIT3 plays a role in regulating leptin, which is crucial for energy balance and metabolism. The interaction between SLIT3 and leptin levels highlights the potential for SLIT3 to influence metabolic health in a sex-specific manner.\n\n## Estrogens and SLIT3 gene expression\n\nEstrogens regulate the expression of the SLIT3 gene, indicating a direct link between hormonal influences and genetic regulation. This relationship suggests that estrogen levels could impact SLIT3's role in leptin regulation, potentially affecting metabolic processes.\n\n## rs11954861 genomic variant and plasma leptin levels\n\nThe rs11954861 genomic variant in the SLIT3 gene is associated with plasma leptin levels. This implies that genetic variations in SLIT3 could influence leptin regulation, potentially impacting metabolic health. The presence of this variant may necessitate personalized approaches to managing leptin-related metabolic risks.\n\n## Sex-specific differences in SLIT3 and leptin regulation\n\nThe SLIT3 gene shows sex-specific differences in plasma leptin levels, suggesting that sex hormones like estrogens play a role in modulating SLIT3's effects on leptin. This sex-specific interaction highlights the complexity of genetic and hormonal influences on metabolism.",
    "report_json": {
      "title": "SLIT3 and Estrogen Interactions in Leptin Regulation",
      "summary": "The community centers around the SLIT3 gene, which interacts with leptin levels in a sex-specific manner, influenced by estrogens and a genomic variant rs11954861. These entities are connected through their roles in regulating plasma leptin levels and gene expression.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but significant influence of SLIT3, estrogens, and the rs11954861 variant on leptin levels and gene expression.",
      "findings": [
        {
          "summary": "SLIT3 gene and its interaction with leptin levels",
          "explanation": "The SLIT3 gene is involved in sex-specific differences in plasma leptin levels. This suggests that SLIT3 plays a role in regulating leptin, which is crucial for energy balance and metabolism. The interaction between SLIT3 and leptin levels highlights the potential for SLIT3 to influence metabolic health in a sex-specific manner."
        },
        {
          "summary": "Estrogens and SLIT3 gene expression",
          "explanation": "Estrogens regulate the expression of the SLIT3 gene, indicating a direct link between hormonal influences and genetic regulation. This relationship suggests that estrogen levels could impact SLIT3's role in leptin regulation, potentially affecting metabolic processes."
        },
        {
          "summary": "rs11954861 genomic variant and plasma leptin levels",
          "explanation": "The rs11954861 genomic variant in the SLIT3 gene is associated with plasma leptin levels. This implies that genetic variations in SLIT3 could influence leptin regulation, potentially impacting metabolic health. The presence of this variant may necessitate personalized approaches to managing leptin-related metabolic risks."
        },
        {
          "summary": "Sex-specific differences in SLIT3 and leptin regulation",
          "explanation": "The SLIT3 gene shows sex-specific differences in plasma leptin levels, suggesting that sex hormones like estrogens play a role in modulating SLIT3's effects on leptin. This sex-specific interaction highlights the complexity of genetic and hormonal influences on metabolism."
        }
      ]
    },
    "level": 1,
    "title": "Cluster 53",
    "edges": [
      [
        "\"ESTROGENS\"",
        "\"SLIT3\""
      ],
      [
        "\"SEX\"",
        "\"SLIT3\""
      ],
      [
        "\"LEPTIN\"",
        "\"SLIT3\""
      ],
      [
        "\"RS11954861\"",
        "\"SLIT3\""
      ]
    ],
    "nodes": [
      "\"RS11954861\"",
      "\"SLIT3\"",
      "\"ESTROGENS\""
    ],
    "chunk_ids": [
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "20": {
    "report_string": "# Dietary Intake and Genetic Variants Community\n\nThe community revolves around the relationship between dietary intake, genetic variants, and phenotypic variance. Key entities include DRAM1 gene, LEAD SNPS, DIETGEN study, FFQS nutrient assessment tool, and SELF-REPORT QUESTIONNAIRES. These entities are interconnected through their roles in assessing and influencing dietary intake and phenotypic traits.\n\n## Role of DRAM1 in dietary intake\n\nThe DRAM1 gene is associated with dietary intake, although the exact nature of this relationship is not clearly specified. This association suggests that genetic factors may play a role in shaping an individual's dietary habits or responses to nutrients.\n\n## LEAD SNPS and phenotypic variance\n\nLead SNPs are genetic variants associated with dietary intake and contribute to phenotypic variance. This relationship highlights the potential for genetic factors to influence both dietary habits and phenotypic traits.\n\n## DIETGEN study and genetic variants\n\nThe DIETGEN study examines the relationship between genetic variants and dietary intake. This research aims to understand how genetic factors influence dietary habits and responses to nutrients, which can have implications for personalized nutrition and disease prevention.\n\n## FFQS and dietary intake assessment\n\nFFQs (Food Frequency Questionnaires) are a tool used to assess dietary intake. This method is crucial for understanding the relationship between dietary habits and genetic factors, as well as for identifying potential nutritional interventions.\n\n## SELF-REPORT QUESTIONNAIRES in dietary assessment\n\nSelf-report questionnaires are used to collect data on dietary intake and other environmental factors. These tools provide valuable insights into the complex interplay between genetic predispositions, dietary habits, and phenotypic outcomes.\n\n## Coefficient of determination (R2) and phenotypic variance\n\nThe coefficient of determination (R2) measures the proportion of phenotypic variance explained by a particular genetic variant. This metric helps researchers understand the impact of genetic factors on phenotypic traits and can inform the development of targeted interventions.",
    "report_json": {
      "title": "Dietary Intake and Genetic Variants Community",
      "summary": "The community revolves around the relationship between dietary intake, genetic variants, and phenotypic variance. Key entities include DRAM1 gene, LEAD SNPS, DIETGEN study, FFQS nutrient assessment tool, and SELF-REPORT QUESTIONNAIRES. These entities are interconnected through their roles in assessing and influencing dietary intake and phenotypic traits.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the exploratory nature of the relationships between genetic variants, dietary intake, and phenotypic variance.",
      "findings": [
        {
          "summary": "Role of DRAM1 in dietary intake",
          "explanation": "The DRAM1 gene is associated with dietary intake, although the exact nature of this relationship is not clearly specified. This association suggests that genetic factors may play a role in shaping an individual's dietary habits or responses to nutrients."
        },
        {
          "summary": "LEAD SNPS and phenotypic variance",
          "explanation": "Lead SNPs are genetic variants associated with dietary intake and contribute to phenotypic variance. This relationship highlights the potential for genetic factors to influence both dietary habits and phenotypic traits."
        },
        {
          "summary": "DIETGEN study and genetic variants",
          "explanation": "The DIETGEN study examines the relationship between genetic variants and dietary intake. This research aims to understand how genetic factors influence dietary habits and responses to nutrients, which can have implications for personalized nutrition and disease prevention."
        },
        {
          "summary": "FFQS and dietary intake assessment",
          "explanation": "FFQs (Food Frequency Questionnaires) are a tool used to assess dietary intake. This method is crucial for understanding the relationship between dietary habits and genetic factors, as well as for identifying potential nutritional interventions."
        },
        {
          "summary": "SELF-REPORT QUESTIONNAIRES in dietary assessment",
          "explanation": "Self-report questionnaires are used to collect data on dietary intake and other environmental factors. These tools provide valuable insights into the complex interplay between genetic predispositions, dietary habits, and phenotypic outcomes."
        },
        {
          "summary": "Coefficient of determination (R2) and phenotypic variance",
          "explanation": "The coefficient of determination (R2) measures the proportion of phenotypic variance explained by a particular genetic variant. This metric helps researchers understand the impact of genetic factors on phenotypic traits and can inform the development of targeted interventions."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 20",
    "edges": [
      [
        "\"DIETARY INTAKE\"",
        "\"LEAD SNPS\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"SELF-REPORT QUESTIONNAIRES\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"DIETGEN\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"FFQS\""
      ],
      [
        "\"COEFFICIENT OF DETERMINATION (R2)\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"LEAD SNPS\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"DIETARY INTAKE\"",
        "\"DRAM1\""
      ]
    ],
    "nodes": [
      "\"DIETGEN\"",
      "\"COEFFICIENT OF DETERMINATION (R2)\"",
      "\"FFQS\"",
      "\"DRAM1\"",
      "\"PHENOTYPIC VARIANCE\"",
      "\"LEAD SNPS\"",
      "\"SELF-REPORT QUESTIONNAIRES\"",
      "\"DIETARY INTAKE\""
    ],
    "chunk_ids": [
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-7c36aa6b71801f70e3b21a56383ca249"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "4": {
    "report_string": "# Genetic and Environmental Factors in Obesity and Thyroid Cancer\n\nThe community involves genetic variants, environmental factors, and diseases such as obesity and thyroid cancer. Key entities include genes like FTO and TMEM18, genomic variants such as SNPs, and environmental factors like carbohydrate intake. These entities interact to influence disease risk.\n\n## Role of FTO gene in obesity\n\nThe FTO gene contains genomic variants associated with obesity risk. Variants in the FTO gene, such as rs56137030, are linked to increased BMI and obesity. This suggests that genetic factors play a crucial role in obesity risk.\n\n## Impact of carbohydrate intake on disease risk\n\nGenomic variants are associated with carbohydrate intake. For example, SNP rs2815752 is linked to higher carbohydrate intake, which can influence obesity and thyroid cancer risk. This highlights the importance of dietary factors in disease risk.\n\n## Genetic associations with thyroid cancer\n\nSeveral SNPs, including rs17817288, rs9937053, and rs12149832, are associated with thyroid cancer risk, particularly in overweight and obese individuals. This suggests that genetic factors contribute to thyroid cancer risk, potentially interacting with environmental factors like obesity.\n\n## TMEM18 gene and adiposity traits\n\nThe TMEM18 gene is associated with adiposity traits and weight gain. Variants in the TMEM18 gene, such as rs2293084, are linked to weight gain during pregnancy. This highlights the role of genetic factors in body weight regulation.\n\n## Interaction between genetic variants and environmental factors\n\nThe community highlights interactions between genetic variants, environmental factors like carbohydrate intake, and diseases like obesity and thyroid cancer. Understanding these interactions can inform personalized interventions for disease prevention.\n\n## Importance of Hardy-Weinberg Equilibrium in genetic studies\n\nThe Hardy-Weinberg Equilibrium is used to assess the genetic equilibrium of a population and filter SNPs. This principle is crucial in genetic association studies to ensure the reliability of genetic data.\n\n## Role of SOLiD sequencing technology in genetic analysis\n\nSOLiD sequencing technology is used to detect genomic variants, including SNPs and indels. This technology has contributed significantly to the understanding of genetic variations associated with diseases.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity and Thyroid Cancer",
      "summary": "The community involves genetic variants, environmental factors, and diseases such as obesity and thyroid cancer. Key entities include genes like FTO and TMEM18, genomic variants such as SNPs, and environmental factors like carbohydrate intake. These entities interact to influence disease risk.",
      "rating": 6.2,
      "rating_explanation": "The impact severity rating is high due to significant associations between genetic variants and obesity, thyroid cancer risk, and environmental factors.",
      "findings": [
        {
          "summary": "Role of FTO gene in obesity",
          "explanation": "The FTO gene contains genomic variants associated with obesity risk. Variants in the FTO gene, such as rs56137030, are linked to increased BMI and obesity. This suggests that genetic factors play a crucial role in obesity risk."
        },
        {
          "summary": "Impact of carbohydrate intake on disease risk",
          "explanation": "Genomic variants are associated with carbohydrate intake. For example, SNP rs2815752 is linked to higher carbohydrate intake, which can influence obesity and thyroid cancer risk. This highlights the importance of dietary factors in disease risk."
        },
        {
          "summary": "Genetic associations with thyroid cancer",
          "explanation": "Several SNPs, including rs17817288, rs9937053, and rs12149832, are associated with thyroid cancer risk, particularly in overweight and obese individuals. This suggests that genetic factors contribute to thyroid cancer risk, potentially interacting with environmental factors like obesity."
        },
        {
          "summary": "TMEM18 gene and adiposity traits",
          "explanation": "The TMEM18 gene is associated with adiposity traits and weight gain. Variants in the TMEM18 gene, such as rs2293084, are linked to weight gain during pregnancy. This highlights the role of genetic factors in body weight regulation."
        },
        {
          "summary": "Interaction between genetic variants and environmental factors",
          "explanation": "The community highlights interactions between genetic variants, environmental factors like carbohydrate intake, and diseases like obesity and thyroid cancer. Understanding these interactions can inform personalized interventions for disease prevention."
        },
        {
          "summary": "Importance of Hardy-Weinberg Equilibrium in genetic studies",
          "explanation": "The Hardy-Weinberg Equilibrium is used to assess the genetic equilibrium of a population and filter SNPs. This principle is crucial in genetic association studies to ensure the reliability of genetic data."
        },
        {
          "summary": "Role of SOLiD sequencing technology in genetic analysis",
          "explanation": "SOLiD sequencing technology is used to detect genomic variants, including SNPs and indels. This technology has contributed significantly to the understanding of genetic variations associated with diseases."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 4",
    "edges": [
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENETIC VARIATION\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LMI\""
      ],
      [
        "\"95% CIS\"",
        "\"ORS\""
      ],
      [
        "\"INDEL\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"AGE\"",
        "\"ANTHROPOMETRIC TRAITS\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY PHENOTYPE\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LD BLOCK\""
      ],
      [
        "\"DBSNP DATABASE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HARDY-WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"RS17817288\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENE\"",
        "\"MAGMA\""
      ],
      [
        "\"SNP\"",
        "\"TMEM18\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"TMEM18\""
      ],
      [
        "\"DBSNP\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GOLDENGATE ARRAY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"WALKING PACE\""
      ],
      [
        "\"SNP\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"CENTRAL OBESITY\"",
        "\"TMEM18\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OR\""
      ],
      [
        "\"RS1861867\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HAPLOTYPE\""
      ],
      [
        "\"PPAR\"",
        "\"RS1801282\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PARENTAL ORIGIN\""
      ],
      [
        "\"TMEM18\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"INTRON1 PROMOTER FLANKING\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID SEQUENCING TECHNOLOGY\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GWAS\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"ORS\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RS2293084\"",
        "\"TMEM18\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"MULTIPLE TESTING\""
      ],
      [
        "\"GENE\"",
        "\"MIRNA\""
      ],
      [
        "\"GENOTYPE\"",
        "\"SNP\""
      ],
      [
        "\"PCR\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"CTSS\"",
        "\"SNP\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"HWE\"",
        "\"SNP\""
      ],
      [
        "\"SNP\"",
        "\"UVAM\""
      ],
      [
        "\"SNP\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"MAF\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"SNP\""
      ],
      [
        "\"GENOTYPING\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HWE\""
      ],
      [
        "\"MINOR ALLELE FREQUENCY\"",
        "\"SNP\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"RS12149832\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENE\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS368794\""
      ],
      [
        "\"DOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"P-VALUE\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DBSNP\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"CODOMINANT MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"FGF21\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE ANALYSIS\""
      ],
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"PHENOTYPIC VARIANCE\""
      ],
      [
        "\"LD PLOT\"",
        "\"SNP\""
      ],
      [
        "\"LEP\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"OVERWEIGHT\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SOLID\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNP\""
      ],
      [
        "\"HARDY-WEINBERG EQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS2815752\""
      ],
      [
        "\"RS9937053\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"RECESSIVE MODEL\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"LINKAGE DISEQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TMEM18\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GENDER\""
      ],
      [
        "\"ADCY3\"",
        "\"SNP\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"TAQMAN ASSAY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"INDEL\"",
        "\"SNP\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"GENDER\"",
        "\"MAFLD\""
      ],
      [
        "\"CENTRAL OBESITY\"",
        "\"PPAR\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"SOLID SEQUENCING\"",
        "\"SOLID SYSTEM\""
      ]
    ],
    "nodes": [
      "\"PCR\"",
      "\"MINOR ALLELE FREQUENCY\"",
      "\"MIRNA\"",
      "\"CI\"",
      "\"RS9937053\"",
      "\"UVAM\"",
      "\"SOLID SEQUENCING\"",
      "\"LMI\"",
      "\"GENDER\"",
      "\"CARBOHYDRATE INTAKE\"",
      "\"SNP\"",
      "\"TMEM18\"",
      "\"RECESSIVE MODEL\"",
      "\"OVERWEIGHT\"",
      "\"OBESITY PHENOTYPE\"",
      "\"RS1801282\"",
      "\"RS1861867\"",
      "\"INTRON1 PROMOTER FLANKING\"",
      "\"GENOMIC VARIANT\"",
      "\"HARDY-WEINBERG EQUILIBRIUM\"",
      "\"ORS\"",
      "\"DOMINANT MODEL\"",
      "\"MAF\"",
      "\"WALKING PACE\"",
      "\"RS12149832\"",
      "\"LD BLOCK\"",
      "\"95% CIS\"",
      "\"GENE\"",
      "\"OR\"",
      "\"SOLID SYSTEM\"",
      "\"GENOTYPING\"",
      "\"GENETIC VARIATION\"",
      "\"ANTHROPOMETRIC TRAITS\"",
      "\"THYROID CANCER\"",
      "\"TAQMAN ASSAY\"",
      "\"CODOMINANT MODEL\"",
      "\"SNP RS2815752\"",
      "\"SOLID SEQUENCING TECHNOLOGY\"",
      "\"WEIGHT GAIN\"",
      "\"SOLID\"",
      "\"RS17817288\"",
      "\"PPAR\"",
      "\"HWE\"",
      "\"PARENTAL ORIGIN\"",
      "\"SNP RS368794\"",
      "\"DBSNP\"",
      "\"RS2293084\"",
      "\"GOLDENGATE ARRAY\"",
      "\"LINKAGE ANALYSIS\"",
      "\"CENTRAL OBESITY\"",
      "\"MULTIPLE TESTING\"",
      "\"DBSNP DATABASE\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.8235294117647058,
    "sub_communities": [
      "46",
      "50",
      "48",
      "49",
      "47"
    ]
  },
  "23": {
    "report_string": "# Diet, Genetics, and Type2 Diabetes\n\nThe community revolves around the interplay between diet, genetic factors, and type2 diabetes. Key entities include nutrients like carbohydrate, fat, protein, and sugar, physiological processes such as gene expression and macronutrient intake, and genetic elements like LD SNPs. These entities are interconnected through their roles in metabolic health, disease risk, and response to dietary factors.\n\n## Diet's Influence on Type2 Diabetes Risk\n\nDiet is a critical environmental factor that influences the risk of developing type2 diabetes. It affects macronutrient intake, which in turn impacts metabolic health. The relationship between diet and type2 diabetes is well-established, with dietary patterns playing a crucial role in disease prevention and management.\n\n## Role of Gene Expression in Metabolic Health\n\nGene expression is a vital process that can be regulated by dietary factors. It is influenced by genetic variants, including LD SNPs, which can affect gene function and, consequently, metabolic health. Understanding gene expression is essential for elucidating how diet and genetics interact to influence type2 diabetes risk.\n\n## Macronutrient Intake and Metabolic Health\n\nMacronutrient intake is a physiological process influenced by diet and regulated by the brain and central nervous system. The types of macronutrients (carbohydrates, fats, proteins, and sugars) and their balance are crucial for metabolic health and disease risk. For instance, carbohydrate intake is directly linked to energy supply and metabolic health.\n\n## Impact of LD SNPs on Type2 Diabetes Risk\n\nLD SNPs (Linkage Disequilibrium Single Nucleotide Polymorphisms) are genetic variants associated with an increased risk of type2 diabetes. These variants can affect gene expression, influencing metabolic pathways and disease susceptibility. The presence of LD SNPs underscores the genetic component of type2 diabetes and the need for personalized risk assessment.\n\n## Nutrient-Gene Interaction in Type2 Diabetes\n\nThe interaction between nutrients and genes is critical in the context of type2 diabetes. For example, diet can affect the expression of genes involved in metabolic pathways, and genetic variants can influence how nutrients are metabolized. This interplay is fundamental to understanding disease risk and developing targeted interventions.",
    "report_json": {
      "title": "Diet, Genetics, and Type2 Diabetes",
      "summary": "The community revolves around the interplay between diet, genetic factors, and type2 diabetes. Key entities include nutrients like carbohydrate, fat, protein, and sugar, physiological processes such as gene expression and macronutrient intake, and genetic elements like LD SNPs. These entities are interconnected through their roles in metabolic health, disease risk, and response to dietary factors.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of diet and genetic factors on type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Diet's Influence on Type2 Diabetes Risk",
          "explanation": "Diet is a critical environmental factor that influences the risk of developing type2 diabetes. It affects macronutrient intake, which in turn impacts metabolic health. The relationship between diet and type2 diabetes is well-established, with dietary patterns playing a crucial role in disease prevention and management."
        },
        {
          "summary": "Role of Gene Expression in Metabolic Health",
          "explanation": "Gene expression is a vital process that can be regulated by dietary factors. It is influenced by genetic variants, including LD SNPs, which can affect gene function and, consequently, metabolic health. Understanding gene expression is essential for elucidating how diet and genetics interact to influence type2 diabetes risk."
        },
        {
          "summary": "Macronutrient Intake and Metabolic Health",
          "explanation": "Macronutrient intake is a physiological process influenced by diet and regulated by the brain and central nervous system. The types of macronutrients (carbohydrates, fats, proteins, and sugars) and their balance are crucial for metabolic health and disease risk. For instance, carbohydrate intake is directly linked to energy supply and metabolic health."
        },
        {
          "summary": "Impact of LD SNPs on Type2 Diabetes Risk",
          "explanation": "LD SNPs (Linkage Disequilibrium Single Nucleotide Polymorphisms) are genetic variants associated with an increased risk of type2 diabetes. These variants can affect gene expression, influencing metabolic pathways and disease susceptibility. The presence of LD SNPs underscores the genetic component of type2 diabetes and the need for personalized risk assessment."
        },
        {
          "summary": "Nutrient-Gene Interaction in Type2 Diabetes",
          "explanation": "The interaction between nutrients and genes is critical in the context of type2 diabetes. For example, diet can affect the expression of genes involved in metabolic pathways, and genetic variants can influence how nutrients are metabolized. This interplay is fundamental to understanding disease risk and developing targeted interventions."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 23",
    "edges": [
      [
        "\"GENE EXPRESSION\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"CARBOHYDRATE\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"LD SNPS\""
      ],
      [
        "\"DIET\"",
        "\"MAFLD\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"SUGAR\""
      ],
      [
        "\"GENE EXPRESSION\"",
        "\"GTEX\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"GENE EXPRESSION\""
      ],
      [
        "\"CENTRAL NERVOUS SYSTEM\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"DIET\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"FAT\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"BRAIN\"",
        "\"MACRONUTRIENT INTAKE\""
      ],
      [
        "\"MACRONUTRIENT INTAKE\"",
        "\"PROTEIN\""
      ]
    ],
    "nodes": [
      "\"LD SNPS\"",
      "\"MACRONUTRIENT INTAKE\"",
      "\"PROTEIN\"",
      "\"GTEX\"",
      "\"CENTRAL NERVOUS SYSTEM\"",
      "\"FAT\"",
      "\"SUGAR\"",
      "\"CARBOHYDRATE\"",
      "\"BRAIN\"",
      "\"DIET\"",
      "\"GENE EXPRESSION\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.25,
    "sub_communities": [
      "78",
      "77"
    ]
  },
  "13": {
    "report_string": "# Genetic and Environmental Factors in Obesity\n\nThe community revolves around obesity, which is influenced by genetic, environmental, and lifestyle factors. Key entities include the genomic variant rs9939609, physical activity, age, and waist circumference. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.\n\n## The rs9939609 genomic variant and its association with obesity\n\nThe rs9939609 A allele is a risk variant for obesity in populations of European ancestry. This variant is associated with increased BMI and obesity-related traits. The effect of rs9939609 on BMI is modified by physical activity, suggesting that lifestyle interventions can mitigate genetic risk.\n\n## The role of physical activity in obesity and metabolic health\n\nPhysical activity is an environmental factor that influences obesity risk and overall health. It can impact BMI and waist circumference, which are measures of central obesity. Physical activity also influences plasma leptin levels, which are affected by dietary patterns and environmental factors.\n\n## The impact of age on obesity and metabolic health\n\nAge is an environmental factor that affects anthropometric measures, including BMI and waist circumference. Age influences the association between genetic variants and obesity, and it is a risk factor for metabolic disorders such as type 2 diabetes.\n\n## The relationship between waist circumference and metabolic health\n\nWaist circumference is a measure of central obesity that is associated with increased risk of metabolic disorders, including MAFLD. It is also a physiological process that measures body shape and is influenced by genetic and environmental factors.\n\n## The FTO gene and its variants in obesity\n\nThe FTO gene contains variants such as rs9939609 and rs3751812, which are associated with increased risk of obesity. The FTO gene is involved in body size and adiposity traits, and its variants can influence BMI and obesity-related traits.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity",
      "summary": "The community revolves around obesity, which is influenced by genetic, environmental, and lifestyle factors. Key entities include the genomic variant rs9939609, physical activity, age, and waist circumference. These entities are interconnected through their roles in obesity risk, metabolic health, and disease susceptibility.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity risk and related metabolic disorders.",
      "findings": [
        {
          "summary": "The rs9939609 genomic variant and its association with obesity",
          "explanation": "The rs9939609 A allele is a risk variant for obesity in populations of European ancestry. This variant is associated with increased BMI and obesity-related traits. The effect of rs9939609 on BMI is modified by physical activity, suggesting that lifestyle interventions can mitigate genetic risk."
        },
        {
          "summary": "The role of physical activity in obesity and metabolic health",
          "explanation": "Physical activity is an environmental factor that influences obesity risk and overall health. It can impact BMI and waist circumference, which are measures of central obesity. Physical activity also influences plasma leptin levels, which are affected by dietary patterns and environmental factors."
        },
        {
          "summary": "The impact of age on obesity and metabolic health",
          "explanation": "Age is an environmental factor that affects anthropometric measures, including BMI and waist circumference. Age influences the association between genetic variants and obesity, and it is a risk factor for metabolic disorders such as type 2 diabetes."
        },
        {
          "summary": "The relationship between waist circumference and metabolic health",
          "explanation": "Waist circumference is a measure of central obesity that is associated with increased risk of metabolic disorders, including MAFLD. It is also a physiological process that measures body shape and is influenced by genetic and environmental factors."
        },
        {
          "summary": "The FTO gene and its variants in obesity",
          "explanation": "The FTO gene contains variants such as rs9939609 and rs3751812, which are associated with increased risk of obesity. The FTO gene is involved in body size and adiposity traits, and its variants can influence BMI and obesity-related traits."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 13",
    "edges": [
      [
        "\"EUROPEAN ANCESTRY\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"OBESE GROUP\"",
        "\"RS9939609\""
      ],
      [
        "\"BMI 28 KG/M2\"",
        "\"RS9939609\""
      ],
      [
        "\"HW\"",
        "\"VO2 MAX\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"FASTING GLUCOSE\""
      ],
      [
        "\"PAR ASSESSMENT\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BMI\"",
        "\"RS9939609\""
      ],
      [
        "\"BETA\"",
        "\"RS9939609\""
      ],
      [
        "\"RS9939609\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"P-VALUE\"",
        "\"SNK TEST\""
      ],
      [
        "\"RS76804286\"",
        "\"RS9939609\""
      ],
      [
        "\"P-VALUE\"",
        "\"RS9939609\""
      ],
      [
        "\"HW\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"RS9939609\""
      ],
      [
        "\"AGE\"",
        "\"RS9939609\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"P-VALUE\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"METS\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"AGE\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"ANTHROPOMETRIC TRAITS\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"AGE\""
      ],
      [
        "\"BONFERRONI CORRECTION\"",
        "\"P-VALUE\""
      ],
      [
        "\"EUROPEAN ANCESTRY\"",
        "\"RS9939609\""
      ],
      [
        "\"FASTING GLUCOSE\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"OBESITY\""
      ],
      [
        "\"AGE\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"AGE\"",
        "\"BMI\""
      ],
      [
        "\"BODY SIZE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"SEX\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"T2DM\""
      ],
      [
        "\"OBESITY\"",
        "\"RS9939609\""
      ],
      [
        "\"MAFLD\"",
        "\"RS9939609\""
      ],
      [
        "\"RS9939609\"",
        "\"SEX\""
      ],
      [
        "\"COSTRIDE\"",
        "\"VO2 MAX\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"BMI\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"COSTRIDE\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"MAFLD\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"AGE\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"AGE\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"GO FUNCTIONAL CATEGORIES\"",
        "\"P-VALUE\""
      ]
    ],
    "nodes": [
      "\"AGE\"",
      "\"RS9939609\"",
      "\"HW\"",
      "\"WAIST CIRCUMFERENCE\"",
      "\"PHYSICAL ACTIVITY\"",
      "\"METS\"",
      "\"BODY SIZE\"",
      "\"P-VALUE\"",
      "\"RS76804286\"",
      "\"COSTRIDE\"",
      "\"RISK ESTIMATES\"",
      "\"SNK TEST\"",
      "\"VO2 MAX\"",
      "\"PAR ASSESSMENT\"",
      "\"FTO RS3751812\"",
      "\"BONFERRONI CORRECTION\"",
      "\"BETA\"",
      "\"GO FUNCTIONAL CATEGORIES\"",
      "\"BMI 28 KG/M2\"",
      "\"FASTING GLUCOSE\"",
      "\"EUROPEAN ANCESTRY\""
    ],
    "chunk_ids": [
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-c11750e689f69b55e5ea3262ddcb4ba6",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.6323529411764706,
    "sub_communities": [
      "59",
      "60",
      "61",
      "62"
    ]
  },
  "2": {
    "report_string": "# Genetic and Physiological Factors Influencing Obesity and Related Diseases\n\nThe community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include the FTO gene, BMI, plasma leptin levels, and related diseases such as type2 diabetes and cardiovascular disease. These entities are interconnected through their roles in body weight regulation, metabolic health, and disease susceptibility.\n\n## The FTO gene and its role in obesity\n\nThe FTO gene is associated with fat mass and obesity risk. Variants of the FTO gene, such as rs3751812 and rs8050136, have been linked to increased BMI and obesity susceptibility. The FTO gene influences body composition and is involved in glucose homeostasis and type2 diabetes risk. For example, the FTO gene variant rs9939609 is associated with higher BMI values, and carriers of the minor alleles of rs9939609 have a higher risk of obesity.\n\n## BMI as a measure of body fatness\n\nBMI is a widely used measure of body fatness and is influenced by genetic and environmental factors. BMI is associated with body composition, and its variation is linked to genetic variants in the FTO gene. BMI is also related to plasma leptin levels, which are influenced by body fat. For instance, BMI is used to categorize individuals into various weight status categories, including underweight, normal weight, overweight, and obesity.\n\n## The relationship between FTO gene and type2 diabetes\n\nThe FTO gene is associated with an increased risk of type2 diabetes through its effects on obesity and metabolic disorders. Variants of the FTO gene have been linked to type2 diabetes risk in various populations. For example, the FTO gene variant rs9941349 is near significance, associated with T2DM in Black South African mixed ancestry population.\n\n## The role of plasma leptin levels in energy balance\n\nPlasma leptin levels are influenced by genetic and environmental factors and play a crucial role in energy balance and body weight regulation. The LEP gene encodes the leptin protein, which is associated with plasma leptin levels. For instance, SNPs in the LEP gene, such as rs10487505, are associated with circulating leptin levels.\n\n## The impact of genetic variants on obesity risk\n\nGenetic variants in the FTO gene, such as rs3751812 and rs8050136, are associated with increased obesity risk. The presence of minor alleles of rs9939609 is correlated with higher BMI values and increased obesity risk. These genetic variants can influence body composition and metabolic health. For example, the T allele of rs3751812 is associated with increased risk of MAFLD.",
    "report_json": {
      "title": "Genetic and Physiological Factors Influencing Obesity and Related Diseases",
      "summary": "The community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include the FTO gene, BMI, plasma leptin levels, and related diseases such as type2 diabetes and cardiovascular disease. These entities are interconnected through their roles in body weight regulation, metabolic health, and disease susceptibility.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity and related diseases.",
      "findings": [
        {
          "summary": "The FTO gene and its role in obesity",
          "explanation": "The FTO gene is associated with fat mass and obesity risk. Variants of the FTO gene, such as rs3751812 and rs8050136, have been linked to increased BMI and obesity susceptibility. The FTO gene influences body composition and is involved in glucose homeostasis and type2 diabetes risk. For example, the FTO gene variant rs9939609 is associated with higher BMI values, and carriers of the minor alleles of rs9939609 have a higher risk of obesity."
        },
        {
          "summary": "BMI as a measure of body fatness",
          "explanation": "BMI is a widely used measure of body fatness and is influenced by genetic and environmental factors. BMI is associated with body composition, and its variation is linked to genetic variants in the FTO gene. BMI is also related to plasma leptin levels, which are influenced by body fat. For instance, BMI is used to categorize individuals into various weight status categories, including underweight, normal weight, overweight, and obesity."
        },
        {
          "summary": "The relationship between FTO gene and type2 diabetes",
          "explanation": "The FTO gene is associated with an increased risk of type2 diabetes through its effects on obesity and metabolic disorders. Variants of the FTO gene have been linked to type2 diabetes risk in various populations. For example, the FTO gene variant rs9941349 is near significance, associated with T2DM in Black South African mixed ancestry population."
        },
        {
          "summary": "The role of plasma leptin levels in energy balance",
          "explanation": "Plasma leptin levels are influenced by genetic and environmental factors and play a crucial role in energy balance and body weight regulation. The LEP gene encodes the leptin protein, which is associated with plasma leptin levels. For instance, SNPs in the LEP gene, such as rs10487505, are associated with circulating leptin levels."
        },
        {
          "summary": "The impact of genetic variants on obesity risk",
          "explanation": "Genetic variants in the FTO gene, such as rs3751812 and rs8050136, are associated with increased obesity risk. The presence of minor alleles of rs9939609 is correlated with higher BMI values and increased obesity risk. These genetic variants can influence body composition and metabolic health. For example, the T allele of rs3751812 is associated with increased risk of MAFLD."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 2",
    "edges": [
      [
        "\"BMI\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"FTO\""
      ],
      [
        "\"FTO\"",
        "\"MYOD1\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"DURBIN-HAUSMAN TEST\""
      ],
      [
        "\"BMI\"",
        "\"RS56137030\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"BMI\"",
        "\"EDUCATIONAL ATTAINMENT\""
      ],
      [
        "\"FTO\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"SKELETAL ROBUSTNESS\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"MINOR ALLELES\""
      ],
      [
        "\"BMI\"",
        "\"RS17818902\""
      ],
      [
        "\"FTO\"",
        "\"MYOG\""
      ],
      [
        "\"FTO\"",
        "\"GENETIC EPIDEMIOLOGY\""
      ],
      [
        "\"NUTRITIONAL INTERVENTION\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"LEP\"",
        "\"RS10487505\""
      ],
      [
        "\"BMI\"",
        "\"CARDIOVASCULAR DISEASE\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"FTO\"",
        "\"RS12595985\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"LEP\"",
        "\"LEPTIN\""
      ],
      [
        "\"FTO\"",
        "\"SKELETAL ROBUSTNESS\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"MAFLD\"",
        "\"RS3751812\""
      ],
      [
        "\"EXTREME OBESITY\"",
        "\"NON-OBESE\""
      ],
      [
        "\"KILPELIN ET AL.\"",
        "\"LEP\""
      ],
      [
        "\"BMI\"",
        "\"WAIST-HIP RATIO\""
      ],
      [
        "\"FTO\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"FTO\"",
        "\"RS8050136\""
      ],
      [
        "\"CELF4\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"PBF\""
      ],
      [
        "\"FTO\"",
        "\"GLUCOSE HOMEOSTASIS\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"HYPERTENSION\""
      ],
      [
        "\"BMI\"",
        "\"MAFLD\""
      ],
      [
        "\"BMI\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"RS7185735\""
      ],
      [
        "\"CELF4\"",
        "\"CHROMOSOME16\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING STATUS\""
      ],
      [
        "\"BMI\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"LIPID METABOLISM\""
      ],
      [
        "\"GENOME-WIDE SNPS\"",
        "\"PRINCIPAL COMPONENTS\""
      ],
      [
        "\"FTO\"",
        "\"IGF-1\""
      ],
      [
        "\"CHROMOSOME 16\"",
        "\"TAD\""
      ],
      [
        "\"FTO\"",
        "\"LMI\""
      ],
      [
        "\"IRX3\"",
        "\"RPGRIP1L\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"OBESITY GWAS GENES\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"FTO GENE\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"MYF5\""
      ],
      [
        "\"BMI\"",
        "\"MC4R SNPS\""
      ],
      [
        "\"BIPOLAR DISORDER\"",
        "\"FTO\""
      ],
      [
        "\"CHROMOSOME 16\"",
        "\"FTO\""
      ],
      [
        "\"QUANTILE-QUANTILE PLOT\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY RATE\""
      ],
      [
        "\"LEP\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"MEDITERRANEAN DIET\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ],
      [
        "\"FTO\"",
        "\"MYF6\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ],
      [
        "\"BMI\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"FTO\"",
        "\"IMPULSIVITY TRAITS\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"FTO\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"DIABETES\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"OBESITY RISK\"",
        "\"RS7193144\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ],
      [
        "\"BMI\"",
        "\"RISK ESTIMATES\""
      ],
      [
        "\"IMPULSIVITY TRAITS\"",
        "\"RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"FTO\"",
        "\"HYPERCHOLESTEROLEMIA\""
      ],
      [
        "\"FM\"",
        "\"FTO\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 1\""
      ],
      [
        "\"BMI\"",
        "\"GENDER\""
      ],
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"BMI\"",
        "\"FTO RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"TDH\""
      ],
      [
        "\"FTO\"",
        "\"IRX3\""
      ],
      [
        "\"FTO\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"GENOME-WIDE SNPS\""
      ],
      [
        "\"LEP\"",
        "\"SNP\""
      ],
      [
        "\"BMI\"",
        "\"BODY COMPOSITION\""
      ],
      [
        "\"OBESE GROUP\"",
        "\"RS9939609\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"LEPTIN\""
      ],
      [
        "\"BMI\"",
        "\"WALKING PACE\""
      ],
      [
        "\"BMI\"",
        "\"WEIGHT GAIN\""
      ],
      [
        "\"FTO\"",
        "\"SNP-BASED ASSOCIATION RESULTS\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE\""
      ],
      [
        "\"BMI\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"BMI\"",
        "\"EXTREME OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 3\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"LEP\""
      ],
      [
        "\"FTO\"",
        "\"RS17817964\""
      ],
      [
        "\"MAFLD\"",
        "\"RS8050136\""
      ],
      [
        "\"BMI\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"AGE\"",
        "\"BMI\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESE GROUP\""
      ],
      [
        "\"FTO\"",
        "\"META-ANALYSES\""
      ],
      [
        "\"CELF4\"",
        "\"CHROMOSOME 16\""
      ],
      [
        "\"CHROMOSOME16\"",
        "\"FTO\""
      ],
      [
        "\"OBESITY RISK\"",
        "\"RS3751812\""
      ],
      [
        "\"BMI\"",
        "\"RS17818920\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"BODY FATNESS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"BMI\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"INTRON 2\""
      ],
      [
        "\"FTO\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"BMI\"",
        "\"GENOTYPE\""
      ]
    ],
    "nodes": [
      "\"RS17818902\"",
      "\"FTO\"",
      "\"MYF5\"",
      "\"GENETIC EPIDEMIOLOGY\"",
      "\"RS17817964\"",
      "\"MEDITERRANEAN DIET\"",
      "\"QUANTILE-QUANTILE PLOT\"",
      "\"INTRON 1\"",
      "\"NON-OBESE\"",
      "\"RS7193144\"",
      "\"TBFAT (KG)\"",
      "\"CHROMOSOME 16\"",
      "\"INTRON 2\"",
      "\"CELF4\"",
      "\"CARDIOVASCULAR DISEASE\"",
      "\"PBF\"",
      "\"EDUCATIONAL ATTAINMENT\"",
      "\"SKELETAL ROBUSTNESS\"",
      "\"RS3751812\"",
      "\"RS56137030\"",
      "\"BODY COMPOSITION\"",
      "\"MYOG\"",
      "\"IRX3\"",
      "\"RPGRIP1L\"",
      "\"IGF-1\"",
      "\"HYPERTENSION\"",
      "\"OBESE GROUP\"",
      "\"LIPID METABOLISM\"",
      "\"BMI\"",
      "\"KILPELIN ET AL.\"",
      "\"PRINCIPAL COMPONENTS\"",
      "\"FM\"",
      "\"IMPULSIVITY TRAITS\"",
      "\"OBESITY RATE\"",
      "\"TDH\"",
      "\"HYPERCHOLESTEROLEMIA\"",
      "\"MYF6\"",
      "\"EXTREME OBESITY\"",
      "\"GENOME-WIDE SNPS\"",
      "\"RS8050136\"",
      "\"RS7185735\"",
      "\"RS12595985\"",
      "\"CHROMOSOME16\"",
      "\"META-ANALYSES\"",
      "\"SNP-BASED ASSOCIATION RESULTS\"",
      "\"TAD\"",
      "\"RS17818920\"",
      "\"MINOR ALLELES\"",
      "\"LEP\"",
      "\"PLASMA LEPTIN LEVELS\"",
      "\"OBESITY RISK\"",
      "\"MC4R SNPS\"",
      "\"SMOKING STATUS\"",
      "\"GLUCOSE HOMEOSTASIS\"",
      "\"BIPOLAR DISORDER\"",
      "\"RS10487505\"",
      "\"MYOD1\"",
      "\"INTRON 3\"",
      "\"WAIST-HIP RATIO\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-7d1efebc0446ed593d4a537624038948",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 1.0,
    "sub_communities": [
      "34",
      "33",
      "37",
      "36",
      "35",
      "39",
      "38"
    ]
  },
  "25": {
    "report_string": "# Genetic and Nutrient Interactions in Obesity\n\nThe community revolves around obesity (MO), which is influenced by genetic and dietary factors. Key entities include genes such as CD36, SH2B1, and FTO, nutrients like fat intake, and genetic variants like SNP rs9939609 and SNP rs1761667. These entities are interconnected through their roles in nutrient metabolism, energy intake regulation, and disease risk.\n\n## Role of SNP rs9939609 in fat intake and obesity\n\nThe SNP rs9939609 in the FTO gene is associated with higher fat intake and obesity risk. This genetic variant has been identified through Genome-Wide Association Studies (GWAS) as a significant factor in obesity-related traits. The relationship between SNP rs9939609 and fat intake highlights the importance of genetic considerations in dietary recommendations for obesity management.\n\n## CD36 gene and fat intake regulation\n\nThe CD36 gene is involved in fat intake regulation, and its variant, SNP rs1761667, is associated with higher fat intake. This underscores the role of CD36 in modulating fat intake and potentially influencing obesity susceptibility.\n\n## SH2B1 gene and energy intake regulation\n\nThe SH2B1 gene is involved in energy intake regulation, and its variant, SNP rs7498665, is associated with higher fat intake. This highlights the importance of SH2B1 in modulating energy balance and potentially impacting obesity risk.\n\n## GWAS and its role in identifying genetic variants\n\nGenome-Wide Association Studies (GWAS) is a study design used to identify genetic variants associated with diseases or traits, including obesity. GWAS has identified numerous genetic variants, such as SNP rs9939609, associated with obesity-related traits.\n\n## Importance of fat intake in obesity\n\nFat intake is a critical nutrient associated with obesity risk and energy intake. Variations in genes involved in fat intake regulation, such as CD36 and SH2B1, can influence obesity susceptibility. This highlights the importance of considering both genetic and dietary factors in obesity management.",
    "report_json": {
      "title": "Genetic and Nutrient Interactions in Obesity",
      "summary": "The community revolves around obesity (MO), which is influenced by genetic and dietary factors. Key entities include genes such as CD36, SH2B1, and FTO, nutrients like fat intake, and genetic variants like SNP rs9939609 and SNP rs1761667. These entities are interconnected through their roles in nutrient metabolism, energy intake regulation, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and dietary factors on obesity risk and management.",
      "findings": [
        {
          "summary": "Role of SNP rs9939609 in fat intake and obesity",
          "explanation": "The SNP rs9939609 in the FTO gene is associated with higher fat intake and obesity risk. This genetic variant has been identified through Genome-Wide Association Studies (GWAS) as a significant factor in obesity-related traits. The relationship between SNP rs9939609 and fat intake highlights the importance of genetic considerations in dietary recommendations for obesity management."
        },
        {
          "summary": "CD36 gene and fat intake regulation",
          "explanation": "The CD36 gene is involved in fat intake regulation, and its variant, SNP rs1761667, is associated with higher fat intake. This underscores the role of CD36 in modulating fat intake and potentially influencing obesity susceptibility."
        },
        {
          "summary": "SH2B1 gene and energy intake regulation",
          "explanation": "The SH2B1 gene is involved in energy intake regulation, and its variant, SNP rs7498665, is associated with higher fat intake. This highlights the importance of SH2B1 in modulating energy balance and potentially impacting obesity risk."
        },
        {
          "summary": "GWAS and its role in identifying genetic variants",
          "explanation": "Genome-Wide Association Studies (GWAS) is a study design used to identify genetic variants associated with diseases or traits, including obesity. GWAS has identified numerous genetic variants, such as SNP rs9939609, associated with obesity-related traits."
        },
        {
          "summary": "Importance of fat intake in obesity",
          "explanation": "Fat intake is a critical nutrient associated with obesity risk and energy intake. Variations in genes involved in fat intake regulation, such as CD36 and SH2B1, can influence obesity susceptibility. This highlights the importance of considering both genetic and dietary factors in obesity management."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 25",
    "edges": [
      [
        "\"BOLT-LMM\"",
        "\"GWAS\""
      ],
      [
        "\"MO\"",
        "\"SNP RS116917414\""
      ],
      [
        "\"GWAS\"",
        "\"WTCCC T2D PHENOTYPE\""
      ],
      [
        "\"MO\"",
        "\"RBFOX1\""
      ],
      [
        "\"CD36 SNP RS1761667\"",
        "\"FAT INTAKE\""
      ],
      [
        "\"GWAS\"",
        "\"SORBS DATA SET\""
      ],
      [
        "\"GWAS\"",
        "\"PLINK\""
      ],
      [
        "\"COHORT\"",
        "\"EXCLUSION CRITERIA\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG\""
      ],
      [
        "\"CD36\"",
        "\"FAT INTAKE\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"EHR PHENOTYPE GROUPS\"",
        "\"PHEWAS\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SH2B1 SNP RS7498665\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"SH2B1\""
      ],
      [
        "\"GENOMIC VARIANT IDENTIFICATION\"",
        "\"GWAS\""
      ],
      [
        "\"CASE-CONTROL STUDY\"",
        "\"GWAS\""
      ],
      [
        "\"GWAS\"",
        "\"PRINCIPAL COMPONENTS (PC1-PC4)\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"GWAS\""
      ],
      [
        "\"MO\"",
        "\"RP11-638L3.1\""
      ],
      [
        "\"GWAS\"",
        "\"SNP\""
      ],
      [
        "\"GWAS\"",
        "\"MO\""
      ],
      [
        "\"CBLN4\"",
        "\"MO\""
      ],
      [
        "\"COHORT\"",
        "\"GWAS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"GWAS\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"FGF21 SNP RS838133\""
      ],
      [
        "\"MO\"",
        "\"TMTC1\""
      ],
      [
        "\"GWAS\"",
        "\"T2D\""
      ],
      [
        "\"GWAS\"",
        "\"NHGRI-EBI CATALOG\""
      ],
      [
        "\"GWAS\"",
        "\"PHEWAS\""
      ],
      [
        "\"GWAS\"",
        "\"OBESITY\""
      ],
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG SNP RS1801282\""
      ],
      [
        "\"MO\"",
        "\"SNP RS9939609\""
      ],
      [
        "\"GWAS\"",
        "\"UK BIOBANK\""
      ]
    ],
    "nodes": [
      "\"PRINCIPAL COMPONENTS (PC1-PC4)\"",
      "\"GWAS\"",
      "\"PLINK\"",
      "\"NHGRI-EBI CATALOG\"",
      "\"WTCCC T2D PHENOTYPE\"",
      "\"CBLN4\"",
      "\"SH2B1\"",
      "\"RP11-638L3.1\"",
      "\"SH2B1 SNP RS7498665\"",
      "\"CD36 SNP RS1761667\"",
      "\"BOLT-LMM\"",
      "\"GENOMIC VARIANT IDENTIFICATION\"",
      "\"EHR PHENOTYPE GROUPS\"",
      "\"SORBS DATA SET\"",
      "\"COHORT\"",
      "\"SNP RS116917414\"",
      "\"PPARG SNP RS1801282\"",
      "\"FGF21 SNP RS838133\"",
      "\"PHEWAS\"",
      "\"MO\"",
      "\"RBFOX1\"",
      "\"TMTC1\"",
      "\"CASE-CONTROL STUDY\"",
      "\"EXCLUSION CRITERIA\"",
      "\"CD36\"",
      "\"SNP RS9939609\"",
      "\"FAT INTAKE\"",
      "\"UK BIOBANK\""
    ],
    "chunk_ids": [
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.35294117647058826,
    "sub_communities": [
      "81",
      "83",
      "80",
      "82",
      "79"
    ]
  },
  "24": {
    "report_string": "# MAGMA Gene Identification Community\n\nThe community revolves around MAGMA, a bioinformatic analysis tool used to identify genes associated with complex traits and dietary intake. The entities in this community are related through their involvement in gene identification and analysis. MAGMA is the central entity, connected to gene identification and GENE, highlighting its role in analyzing genetic data.\n\n## MAGMA's role in gene identification\n\nMAGMA is a statistical method used to identify genes associated with complex traits. It is utilized in gene identification processes, making it a crucial tool in understanding genetic associations with dietary intake and other complex traits.\n\n## Relationship between GENE IDENTIFICATION and MAGMA\n\nGENE IDENTIFICATION is related to MAGMA as MAGMA is used for identifying genes associated with dietary intake. This relationship highlights the application of MAGMA in practical genetic analysis.\n\n## MAGMA's involvement in complex trait analysis\n\nMAGMA is involved in the analysis of complex traits, which can include various health conditions influenced by genetics and diet. This involvement underscores the potential of MAGMA in personalized nutrition and disease prevention.",
    "report_json": {
      "title": "MAGMA Gene Identification Community",
      "summary": "The community revolves around MAGMA, a bioinformatic analysis tool used to identify genes associated with complex traits and dietary intake. The entities in this community are related through their involvement in gene identification and analysis. MAGMA is the central entity, connected to gene identification and GENE, highlighting its role in analyzing genetic data.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited information provided about the entities and their relationships.",
      "findings": [
        {
          "summary": "MAGMA's role in gene identification",
          "explanation": "MAGMA is a statistical method used to identify genes associated with complex traits. It is utilized in gene identification processes, making it a crucial tool in understanding genetic associations with dietary intake and other complex traits."
        },
        {
          "summary": "Relationship between GENE IDENTIFICATION and MAGMA",
          "explanation": "GENE IDENTIFICATION is related to MAGMA as MAGMA is used for identifying genes associated with dietary intake. This relationship highlights the application of MAGMA in practical genetic analysis."
        },
        {
          "summary": "MAGMA's involvement in complex trait analysis",
          "explanation": "MAGMA is involved in the analysis of complex traits, which can include various health conditions influenced by genetics and diet. This involvement underscores the potential of MAGMA in personalized nutrition and disease prevention."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 24",
    "edges": [
      [
        "\"GENE IDENTIFICATION\"",
        "\"MAGMA\""
      ],
      [
        "\"GENE\"",
        "\"MAGMA\""
      ]
    ],
    "nodes": [
      "\"MAGMA\"",
      "\"GENE IDENTIFICATION\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-521bed5210a0e902e5e59f17fccc1452"
    ],
    "occurrence": 0.04411764705882353,
    "sub_communities": []
  },
  "10": {
    "report_string": "# Genetic Variants and Obesity Risk\n\nThe community revolves around genetic variants, particularly SNPs, and their associations with obesity risk and related traits. Key entities include SNPs, linkage disequilibrium, and pleiotropy, which are interconnected through their roles in genetic correlation, disease risk, and trait influence.\n\n## SNPs and their role in obesity risk\n\nSNPs (Single Nucleotide Polymorphisms) are genomic variants that can contribute to disease risk or traits, including obesity. They are used to investigate genetic associations with obesity risk and related traits. For instance, SNPs in the FTO gene are associated with obesity.\n\n## Linkage disequilibrium and genetic correlation\n\nLinkage disequilibrium (LD) is a measure of the correlation between genetic variants, such as SNPs. LD analysis is used to evaluate the relationships between SNPs and their impact on disease risk or traits. For example, FTO gene variants are in linkage disequilibrium with each other.\n\n## Pleiotropy and its effects on multiple traits\n\nPleiotropy is a phenomenon where a single gene influences multiple traits. SNPs can have pleiotropic effects on multiple traits, including obesity and related metabolic traits. This highlights the complexity of genetic influences on disease risk and traits.\n\n## Polygenic effects and disease risk\n\nPolygenic effects refer to the combined influence of multiple genes on a particular trait or disease. SNPs can contribute to polygenic effects, influencing disease risk or traits such as obesity. This underscores the importance of considering multiple genetic variants in assessing disease risk.\n\n## Glycemic traits and genetic associations\n\nGlycemic traits are physiological processes related to blood sugar levels. SNPs are associated with glycemic traits through causal relationships, highlighting the potential for genetic factors to influence metabolic health.",
    "report_json": {
      "title": "Genetic Variants and Obesity Risk",
      "summary": "The community revolves around genetic variants, particularly SNPs, and their associations with obesity risk and related traits. Key entities include SNPs, linkage disequilibrium, and pleiotropy, which are interconnected through their roles in genetic correlation, disease risk, and trait influence.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic variants on obesity risk and related traits.",
      "findings": [
        {
          "summary": "SNPs and their role in obesity risk",
          "explanation": "SNPs (Single Nucleotide Polymorphisms) are genomic variants that can contribute to disease risk or traits, including obesity. They are used to investigate genetic associations with obesity risk and related traits. For instance, SNPs in the FTO gene are associated with obesity."
        },
        {
          "summary": "Linkage disequilibrium and genetic correlation",
          "explanation": "Linkage disequilibrium (LD) is a measure of the correlation between genetic variants, such as SNPs. LD analysis is used to evaluate the relationships between SNPs and their impact on disease risk or traits. For example, FTO gene variants are in linkage disequilibrium with each other."
        },
        {
          "summary": "Pleiotropy and its effects on multiple traits",
          "explanation": "Pleiotropy is a phenomenon where a single gene influences multiple traits. SNPs can have pleiotropic effects on multiple traits, including obesity and related metabolic traits. This highlights the complexity of genetic influences on disease risk and traits."
        },
        {
          "summary": "Polygenic effects and disease risk",
          "explanation": "Polygenic effects refer to the combined influence of multiple genes on a particular trait or disease. SNPs can contribute to polygenic effects, influencing disease risk or traits such as obesity. This underscores the importance of considering multiple genetic variants in assessing disease risk."
        },
        {
          "summary": "Glycemic traits and genetic associations",
          "explanation": "Glycemic traits are physiological processes related to blood sugar levels. SNPs are associated with glycemic traits through causal relationships, highlighting the potential for genetic factors to influence metabolic health."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 10",
    "edges": [
      [
        "\"CHILDHOOD OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"LD ANALYSIS\"",
        "\"SNPS\""
      ],
      [
        "\"LINKAGE DISEQUILIBRIUM\"",
        "\"SNP\""
      ],
      [
        "\"LINKAGE DISEQUILIBRIUM\"",
        "\"SNPS\""
      ],
      [
        "\"OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"SNPS\""
      ],
      [
        "\"FIGURE S1\"",
        "\"SNPS\""
      ],
      [
        "\"FOREST PLOT\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"FTO SNPS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"PLEIOTROPY\"",
        "\"SNPS\""
      ],
      [
        "\"GENOMIC INFLATION COEFFICIENT (LAMBDA)\"",
        "\"SNPS\""
      ],
      [
        "\"GLYCEMIC TRAITS\"",
        "\"SNPS\""
      ],
      [
        "\"FTO\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"POLYGENIC EFFECTS\"",
        "\"SNPS\""
      ]
    ],
    "nodes": [
      "\"PLEIOTROPY\"",
      "\"FIGURE S1\"",
      "\"FOREST PLOT\"",
      "\"POLYGENIC EFFECTS\"",
      "\"GLYCEMIC TRAITS\"",
      "\"GENOMIC INFLATION COEFFICIENT (LAMBDA)\"",
      "\"LINKAGE DISEQUILIBRIUM\"",
      "\"SNPS\"",
      "\"LD ANALYSIS\""
    ],
    "chunk_ids": [
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-728d6e8910b1d80980b6bb3f4b124595",
      "chunk-49cf6074543d5f5d4e9ea8750a88794c",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-521bed5210a0e902e5e59f17fccc1452",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.35294117647058826,
    "sub_communities": []
  },
  "0": {
    "report_string": "# Type 2 Diabetes Mellitus (T2DM) Genetic and Environmental Interactions\n\nThe community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic variants, environmental factors, and physiological processes. Key entities include genes such as INSR, FEM1B, and TCF7L2, environmental factors like family history and diet, and physiological processes such as glucose homeostasis and fatty acid metabolism. These entities interact to affect T2DM risk and management.\n\n## TCF7L2 gene and its role in T2DM\n\nThe TCF7L2 gene, particularly the rs7903146 variant, is significantly associated with an increased risk of T2DM among various populations, including Sub-Saharan Africans. This variant affects insulin secretion and glucose homeostasis, highlighting the importance of genetic considerations in T2DM management.\n\n## INSR gene and insulin signaling\n\nThe INSR gene, encoding the insulin receptor, plays a crucial role in insulin signaling and glucose metabolism. Variants in INSR, such as rs1799817 and rs2059806, are associated with T2DM risk, emphasizing the impact of genetic factors on insulin function and T2DM susceptibility.\n\n## Family history and T2DM risk\n\nFamily history is a significant environmental factor that influences T2DM risk. A positive family history (PFH) is associated with increased susceptibility to T2DM, highlighting the importance of considering familial factors in disease prevention and management strategies.\n\n## Diet and T2DM risk\n\nDiet is a critical environmental factor influencing T2DM risk. Nutritional interventions, including those focused on fatty acid metabolism and glucose homeostasis, can play a significant role in managing T2DM and preventing its onset.\n\n## Fatty acid metabolism and T2DM\n\nFatty acid metabolism is altered in T2DM, and genes involved in this process, such as APOE, contribute to disease risk. Understanding the relationship between fatty acid metabolism and T2DM can inform targeted therapeutic approaches and dietary recommendations.",
    "report_json": {
      "title": "Type 2 Diabetes Mellitus (T2DM) Genetic and Environmental Interactions",
      "summary": "The community revolves around Type 2 Diabetes Mellitus (T2DM), a metabolic disorder influenced by genetic variants, environmental factors, and physiological processes. Key entities include genes such as INSR, FEM1B, and TCF7L2, environmental factors like family history and diet, and physiological processes such as glucose homeostasis and fatty acid metabolism. These entities interact to affect T2DM risk and management.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2DM risk and management.",
      "findings": [
        {
          "summary": "TCF7L2 gene and its role in T2DM",
          "explanation": "The TCF7L2 gene, particularly the rs7903146 variant, is significantly associated with an increased risk of T2DM among various populations, including Sub-Saharan Africans. This variant affects insulin secretion and glucose homeostasis, highlighting the importance of genetic considerations in T2DM management."
        },
        {
          "summary": "INSR gene and insulin signaling",
          "explanation": "The INSR gene, encoding the insulin receptor, plays a crucial role in insulin signaling and glucose metabolism. Variants in INSR, such as rs1799817 and rs2059806, are associated with T2DM risk, emphasizing the impact of genetic factors on insulin function and T2DM susceptibility."
        },
        {
          "summary": "Family history and T2DM risk",
          "explanation": "Family history is a significant environmental factor that influences T2DM risk. A positive family history (PFH) is associated with increased susceptibility to T2DM, highlighting the importance of considering familial factors in disease prevention and management strategies."
        },
        {
          "summary": "Diet and T2DM risk",
          "explanation": "Diet is a critical environmental factor influencing T2DM risk. Nutritional interventions, including those focused on fatty acid metabolism and glucose homeostasis, can play a significant role in managing T2DM and preventing its onset."
        },
        {
          "summary": "Fatty acid metabolism and T2DM",
          "explanation": "Fatty acid metabolism is altered in T2DM, and genes involved in this process, such as APOE, contribute to disease risk. Understanding the relationship between fatty acid metabolism and T2DM can inform targeted therapeutic approaches and dietary recommendations."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 0",
    "edges": [
      [
        "\"PTEN\"",
        "\"T2DM\""
      ],
      [
        "\"INSR\"",
        "\"RS2059806\""
      ],
      [
        "\"ROC CURVE\"",
        "\"T2DM\""
      ],
      [
        "\"IRS-1\"",
        "\"T2DM\""
      ],
      [
        "\"PPAR-\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"ALZHEIMER'S RISK\"",
        "\"APOE\""
      ],
      [
        "\"ALZHEIMER'S DISEASE\"",
        "\"APOE\""
      ],
      [
        "\"IDE\"",
        "\"T2DM\""
      ],
      [
        "\"INSR\"",
        "\"T2DM\""
      ],
      [
        "\"PFH\"",
        "\"T2DM\""
      ],
      [
        "\"AMOAH\"",
        "\"T2DM\""
      ],
      [
        "\"FATTY ACID METABOLISM\"",
        "\"T2DM\""
      ],
      [
        "\"C2D4B\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"PFH\""
      ],
      [
        "\"SLC30A8\"",
        "\"T2DM\""
      ],
      [
        "\"FTO\"",
        "\"T2DM\""
      ],
      [
        "\"RS6494730-T\"",
        "\"T2DM\""
      ],
      [
        "\"GENOME-WIDE ASSOCIATION STUDIES\"",
        "\"T2DM\""
      ],
      [
        "\"KCNJ11\"",
        "\"T2DM\""
      ],
      [
        "\"ODDS RATIO\"",
        "\"T2DM\""
      ],
      [
        "\"FEM1B\"",
        "\"RS6494730\""
      ],
      [
        "\"GHANAIAN\"",
        "\"T2DM\""
      ],
      [
        "\"SSA\"",
        "\"T2DM\""
      ],
      [
        "\"HAPTOGLOBIN\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1 RS997509\"",
        "\"T2DM\""
      ],
      [
        "\"ESR2\"",
        "\"T2DM\""
      ],
      [
        "\"SCL40A1\"",
        "\"T2DM\""
      ],
      [
        "\"HYPERANDROGENISM\"",
        "\"T2DM\""
      ],
      [
        "\"AGE\"",
        "\"T2DM\""
      ],
      [
        "\"FAMILY HISTORY\"",
        "\"T2DM\""
      ],
      [
        "\"ADIPOQ\"",
        "\"T2DM\""
      ],
      [
        "\"ENPP1\"",
        "\"T2DM\""
      ],
      [
        "\"BODY MASS INDEX\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC\"",
        "\"T2DM\""
      ],
      [
        "\"AGMO\"",
        "\"T2DM\""
      ],
      [
        "\"RS2241766-G\"",
        "\"T2DM\""
      ],
      [
        "\"FOLLICULOGENESIS\"",
        "\"T2DM\""
      ],
      [
        "\"FEM1B\"",
        "\"INSR\""
      ],
      [
        "\"T2DM\"",
        "\"TNF- 308G/A\""
      ],
      [
        "\"T2DM\"",
        "\"WAIST HIP RATIO\""
      ],
      [
        "\"MAURITANIAN\"",
        "\"T2DM\""
      ],
      [
        "\"RS2059806-T\"",
        "\"T2DM\""
      ],
      [
        "\"GENETIC RISK SCORE\"",
        "\"T2DM\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"FBN3\"",
        "\"T2DM\""
      ],
      [
        "\"ADEYEMO\"",
        "\"T2DM\""
      ],
      [
        "\"HYPOGONADISM\"",
        "\"T2DM\""
      ],
      [
        "\"FEM1B\"",
        "\"T2DM\""
      ],
      [
        "\"PCOS\"",
        "\"T2DM\""
      ],
      [
        "\"CELLULAR PROCESS\"",
        "\"PTEN\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"DIET\"",
        "\"T2DM\""
      ],
      [
        "\"PHYSICAL ACTIVITY\"",
        "\"T2DM\""
      ],
      [
        "\"APOE\"",
        "\"FATTY ACID METABOLISM\""
      ],
      [
        "\"INSR\"",
        "\"RS1799817\""
      ],
      [
        "\"CAMEROONIAN\"",
        "\"T2DM\""
      ],
      [
        "\"PPP1R5\"",
        "\"T2DM\""
      ],
      [
        "\"CDKAL1\"",
        "\"T2DM\""
      ],
      [
        "\"ACDC G-11391-A\"",
        "\"T2DM\""
      ],
      [
        "\"RS11745088-C\"",
        "\"T2DM\""
      ],
      [
        "\"PRKAG3\"",
        "\"T2DM\""
      ],
      [
        "\"SSA POPULATION\"",
        "\"TCF7L2 RS7903146\""
      ],
      [
        "\"PSMD6\"",
        "\"T2DM\""
      ],
      [
        "\"AGRP\"",
        "\"T2DM\""
      ],
      [
        "\"SEX HORMONES\"",
        "\"T2DM\""
      ],
      [
        "\"MEILOUD\"",
        "\"T2DM\""
      ],
      [
        "\"RS1799817-A\"",
        "\"T2DM\""
      ],
      [
        "\"SEX\"",
        "\"T2DM\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2 RS7903146\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"T2DM\""
      ],
      [
        "\"ABCC8\"",
        "\"T2DM\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2DM\""
      ],
      [
        "\"ERASMUS\"",
        "\"T2DM\""
      ]
    ],
    "nodes": [
      "\"PRKAG3\"",
      "\"RS6494730\"",
      "\"ERASMUS\"",
      "\"CELLULAR PROCESS\"",
      "\"RS2059806-T\"",
      "\"FOLLICULOGENESIS\"",
      "\"FATTY ACID METABOLISM\"",
      "\"RS1799817\"",
      "\"GHANAIAN\"",
      "\"FEM1B\"",
      "\"ODDS RATIO\"",
      "\"RS6494730-T\"",
      "\"WAIST HIP RATIO\"",
      "\"PTEN\"",
      "\"HYPOGONADISM\"",
      "\"SLC30A8\"",
      "\"ABCC8\"",
      "\"SSA POPULATION\"",
      "\"RS11745088-C\"",
      "\"FAMILY HISTORY\"",
      "\"HAPTOGLOBIN\"",
      "\"PSMD6\"",
      "\"TCF7L2 RS7903146\"",
      "\"T2DM\"",
      "\"RS1799817-A\"",
      "\"TNF- 308G/A\"",
      "\"ADEYEMO\"",
      "\"ENPP1\"",
      "\"MAURITANIAN\"",
      "\"SEX HORMONES\"",
      "\"PPAR-\"",
      "\"ACDC\"",
      "\"ESR2\"",
      "\"GENOME-WIDE ASSOCIATION STUDIES\"",
      "\"APOE\"",
      "\"BODY MASS INDEX\"",
      "\"RS2241766-G\"",
      "\"SCL40A1\"",
      "\"AGMO\"",
      "\"AGRP\"",
      "\"ROC CURVE\"",
      "\"GENETIC RISK SCORE\"",
      "\"AMOAH\"",
      "\"PPP1R5\"",
      "\"C2D4B\"",
      "\"CDKAL1\"",
      "\"PFH\"",
      "\"HYPERANDROGENISM\"",
      "\"RS2059806\"",
      "\"ALZHEIMER'S RISK\"",
      "\"PCOS\"",
      "\"FBN3\"",
      "\"ALZHEIMER'S DISEASE\"",
      "\"CAMEROONIAN\"",
      "\"KCNJ11\"",
      "\"ENPP1 RS997509\"",
      "\"INSR\"",
      "\"ACDC G-11391-A\"",
      "\"SSA\"",
      "\"MEILOUD\"",
      "\"IDE\"",
      "\"IRS-1\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-6430a7be0477010057d515b73febb682"
    ],
    "occurrence": 0.19117647058823528,
    "sub_communities": [
      "27",
      "30",
      "32",
      "28",
      "31",
      "29"
    ]
  },
  "22": {
    "report_string": "# FGF21 and Taste Preference Community\n\nThe community centers around the FGF21 gene, which influences sweet and alcohol taste preference and is involved in carbohydrate intake regulation. It interacts with genes like KLB and MLXIPL, which code for essential cofactors and transcription factors, respectively. The community highlights the genetic underpinnings of taste preference and dietary intake.\n\n## FGF21 gene and carbohydrate intake regulation\n\nThe FGF21 gene is involved in carbohydrate intake regulation. A variant of FGF21, rs838133, is associated with higher carbohydrate intake. This suggests that genetic factors can influence dietary preferences and potentially impact metabolic health.\n\n## FGF21 and KLB interaction\n\nThe KLB gene codes for an essential cofactor to FGF21. This interaction is crucial for FGF21's function in regulating taste preference and carbohydrate intake. The dependency of FGF21 on KLB underscores the complexity of genetic influences on dietary behaviors.\n\n## FGF21 and MLXIPL interaction\n\nThe MLXIPL gene codes a transcription factor for FGF21. This relationship highlights the transcriptional regulation of FGF21 and its implications for carbohydrate metabolism and taste preference. The interplay between these genes suggests a tightly regulated biological pathway.\n\n## FGF21 influence on sweet and alcohol taste preference\n\nFGF21 influences sweet and alcohol taste preference. This connection between a genetic factor and taste preference has implications for understanding individual differences in dietary choices and potential impacts on health.",
    "report_json": {
      "title": "FGF21 and Taste Preference Community",
      "summary": "The community centers around the FGF21 gene, which influences sweet and alcohol taste preference and is involved in carbohydrate intake regulation. It interacts with genes like KLB and MLXIPL, which code for essential cofactors and transcription factors, respectively. The community highlights the genetic underpinnings of taste preference and dietary intake.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but significant influence of FGF21 on taste preference and carbohydrate intake regulation.",
      "findings": [
        {
          "summary": "FGF21 gene and carbohydrate intake regulation",
          "explanation": "The FGF21 gene is involved in carbohydrate intake regulation. A variant of FGF21, rs838133, is associated with higher carbohydrate intake. This suggests that genetic factors can influence dietary preferences and potentially impact metabolic health."
        },
        {
          "summary": "FGF21 and KLB interaction",
          "explanation": "The KLB gene codes for an essential cofactor to FGF21. This interaction is crucial for FGF21's function in regulating taste preference and carbohydrate intake. The dependency of FGF21 on KLB underscores the complexity of genetic influences on dietary behaviors."
        },
        {
          "summary": "FGF21 and MLXIPL interaction",
          "explanation": "The MLXIPL gene codes a transcription factor for FGF21. This relationship highlights the transcriptional regulation of FGF21 and its implications for carbohydrate metabolism and taste preference. The interplay between these genes suggests a tightly regulated biological pathway."
        },
        {
          "summary": "FGF21 influence on sweet and alcohol taste preference",
          "explanation": "FGF21 influences sweet and alcohol taste preference. This connection between a genetic factor and taste preference has implications for understanding individual differences in dietary choices and potential impacts on health."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 22",
    "edges": [
      [
        "\"CARBOHYDRATE INTAKE\"",
        "\"FGF21\""
      ],
      [
        "\"FGF21\"",
        "\"SWEET AND ALCOHOL TASTE PREFERENCE\""
      ],
      [
        "\"FGF21\"",
        "\"MLXIPL\""
      ],
      [
        "\"FGF21\"",
        "\"KLB\""
      ]
    ],
    "nodes": [
      "\"FGF21\"",
      "\"KLB\"",
      "\"SWEET AND ALCOHOL TASTE PREFERENCE\"",
      "\"MLXIPL\""
    ],
    "chunk_ids": [
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf"
    ],
    "occurrence": 0.029411764705882353,
    "sub_communities": []
  },
  "7": {
    "report_string": "# Genetic and Environmental Factors in Adiposity and Type2 Diabetes\n\nThe community revolves around adiposity and type2 diabetes, influenced by genetic and environmental factors such as smoking, alcohol consumption, and various genes including FTO, ADAM30, and NOTCH2. These entities interact through their roles in metabolic processes, disease risk, and physiological responses.\n\n## Role of FTO variants in obesity and type2 diabetes\n\nFTO variants are associated with an increased risk of obesity and type2 diabetes. The FTO gene is linked to adiposity traits, and its variants have been correlated with obesity risk. This relationship highlights the importance of genetic factors in metabolic health.\n\n## Impact of smoking on adiposity and type2 diabetes\n\nSmoking is an environmental factor that affects adiposity traits and increases the risk of type2 diabetes. Smoking exposure is associated with obesity risk, and several genes such as ACTN1, CHRNA3, and CHRND are linked to smoking during pregnancy, suggesting a complex interplay between genetic and environmental factors.\n\n## Relationship between adiposity and type2 diabetes\n\nAdiposity is a risk factor for type2 diabetes, and obesity GWAS genes contribute to this relationship. The FTO gene and other obesity-related genes are significantly enriched in glucose homeostasis and response to glucose, indicating a link between obesity and glucose regulation.\n\n## Influence of alcohol consumption on adiposity and type2 diabetes\n\nAlcohol consumption is an environmental factor that impacts obesity risk and adiposity traits. It is also associated with type2 diabetes risk, potentially through its effects on glucose metabolism and insulin sensitivity.\n\n## Role of genetic scores and allele frequency in adiposity\n\nGenetic scores and allele frequency are used to evaluate the frequency of alleles in a population and their association with adiposity traits. These genetic measures provide insights into the genetic architecture of metabolic traits and disease risk.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Adiposity and Type2 Diabetes",
      "summary": "The community revolves around adiposity and type2 diabetes, influenced by genetic and environmental factors such as smoking, alcohol consumption, and various genes including FTO, ADAM30, and NOTCH2. These entities interact through their roles in metabolic processes, disease risk, and physiological responses.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors on adiposity and type2 diabetes risk and management.",
      "findings": [
        {
          "summary": "Role of FTO variants in obesity and type2 diabetes",
          "explanation": "FTO variants are associated with an increased risk of obesity and type2 diabetes. The FTO gene is linked to adiposity traits, and its variants have been correlated with obesity risk. This relationship highlights the importance of genetic factors in metabolic health."
        },
        {
          "summary": "Impact of smoking on adiposity and type2 diabetes",
          "explanation": "Smoking is an environmental factor that affects adiposity traits and increases the risk of type2 diabetes. Smoking exposure is associated with obesity risk, and several genes such as ACTN1, CHRNA3, and CHRND are linked to smoking during pregnancy, suggesting a complex interplay between genetic and environmental factors."
        },
        {
          "summary": "Relationship between adiposity and type2 diabetes",
          "explanation": "Adiposity is a risk factor for type2 diabetes, and obesity GWAS genes contribute to this relationship. The FTO gene and other obesity-related genes are significantly enriched in glucose homeostasis and response to glucose, indicating a link between obesity and glucose regulation."
        },
        {
          "summary": "Influence of alcohol consumption on adiposity and type2 diabetes",
          "explanation": "Alcohol consumption is an environmental factor that impacts obesity risk and adiposity traits. It is also associated with type2 diabetes risk, potentially through its effects on glucose metabolism and insulin sensitivity."
        },
        {
          "summary": "Role of genetic scores and allele frequency in adiposity",
          "explanation": "Genetic scores and allele frequency are used to evaluate the frequency of alleles in a population and their association with adiposity traits. These genetic measures provide insights into the genetic architecture of metabolic traits and disease risk."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 7",
    "edges": [
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PDYN\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"PEARSON'S CORRELATION COEFFICIENT\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"GRM8\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"DBH\"",
        "\"SMOKING\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"INSTRUMENTAL VARIABLES\""
      ],
      [
        "\"NOTCH2\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"CARDIOVASCULAR DISEASE\"",
        "\"SMOKING\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"BINGE DRINKING\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TMEM18\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"AGE\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"ADAM30\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SUA\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SEX\""
      ],
      [
        "\"RS6855911\"",
        "\"SUA\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENETIC SCORES\""
      ],
      [
        "\"ETHNIC GROUP\"",
        "\"FTO VARIANTS\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"FTO\""
      ],
      [
        "\"LD SNPS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"ETHNIC GROUP\""
      ],
      [
        "\"ADH1C\"",
        "\"ALCOHOL CONSUMPTION\""
      ],
      [
        "\"FAAH\"",
        "\"SMOKING\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"ALCOHOL CONSUMPTION\""
      ],
      [
        "\"NOTCH2\"",
        "\"TYPE2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"FTO VARIANTS\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"MC4R\""
      ],
      [
        "\"ACTN1\"",
        "\"SMOKING\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"OBESITY GWAS GENES\"",
        "\"RESPONSE TO GLUCOSE\""
      ],
      [
        "\"ALLELE FREQUENCY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"PREGNANCY\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"PREGNANCY\"",
        "\"SMOKING\""
      ],
      [
        "\"CHRNA3\"",
        "\"SMOKING\""
      ],
      [
        "\"SLC2A9\"",
        "\"SUA\""
      ],
      [
        "\"CHRND\"",
        "\"SMOKING\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADAM30\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SLC2A9\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"OBESITY GWAS GENES\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"OBESITY GWAS GENES\""
      ],
      [
        "\"CIGARETTES\"",
        "\"SMOKING\""
      ]
    ],
    "nodes": [
      "\"SLC2A9\"",
      "\"DBH\"",
      "\"ALCOHOL CONSUMPTION\"",
      "\"PDYN\"",
      "\"TYPE 2 DIABETES\"",
      "\"BINGE DRINKING\"",
      "\"PEARSON'S CORRELATION COEFFICIENT\"",
      "\"CIGARETTES\"",
      "\"RESPONSE TO GLUCOSE\"",
      "\"FAAH\"",
      "\"CHRNA3\"",
      "\"INSTRUMENTAL VARIABLES\"",
      "\"FTO VARIANTS\"",
      "\"TYPE2 DIABETES\"",
      "\"ACTN1\"",
      "\"NOTCH2\"",
      "\"GENETIC SCORES\"",
      "\"SMOKING\"",
      "\"OBESITY GWAS GENES\"",
      "\"CHRND\"",
      "\"ADH1C\"",
      "\"GRM8\"",
      "\"ADIPOSITY\"",
      "\"ETHNIC GROUP\"",
      "\"RS6855911\"",
      "\"SUA\"",
      "\"PREGNANCY\"",
      "\"ADAM30\"",
      "\"ALLELE FREQUENCY\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-5e46b569d89cb6b5c4f3be19055aa4a0",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.3088235294117647,
    "sub_communities": [
      "54",
      "55",
      "58",
      "56",
      "57"
    ]
  },
  "3": {
    "report_string": "# Genetic and Environmental Factors in Obesity\n\nThe community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include the FTO gene, its variants such as rs9939609 and rs1421085, and other genes like ADIPOQ, LEPR, and NEGR1. These genetic factors interact with environmental factors like energy intake, dietary patterns, and physical activity to affect obesity risk. The community also involves various diseases and conditions, including type 2 diabetes, colorectal cancer, and thyroid cancer, which are associated with obesity.\n\n## The FTO gene and its variants are associated with obesity risk\n\nThe FTO gene is a key genetic factor associated with obesity risk. Variants such as rs9939609, rs1421085, and rs1558902 have been linked to increased obesity risk. These variants can affect energy intake and expenditure, leading to changes in body mass index (BMI) and body fat percentage. The FTO gene's association with obesity has been replicated across various ethnic groups, including Caucasians, African-Americans, and Hispanic-Americans.\n\n## Dietary patterns modulate the association of FTO SNPs with obesity risk\n\nMDS (Mediterranean Diet Score) modulates the association of FTO SNPs with obesity risk. A study found that individuals with high GRS (Genetic Risk Score) and high MDS had lower obesity risk. This suggests that a Mediterranean-style diet may mitigate the genetic risk of obesity associated with FTO SNPs.\n\n## The NEGR1 gene is associated with obesity and energy intake\n\nThe NEGR1 gene is associated with obesity risk and energy intake. A variant in the NEGR1 gene, rs2815752, is linked to lower total energy intake. This suggests that NEGR1 may play a role in regulating energy balance and obesity risk.\n\n## Obesity is a risk factor for various chronic diseases\n\nObesity is a risk factor for various chronic diseases, including type 2 diabetes, colorectal cancer, and thyroid cancer. The relationship between obesity and these diseases is complex and influenced by multiple genetic and environmental factors.\n\n## Genetic association studies have identified multiple genetic variants associated with obesity\n\nGenetic association studies have identified multiple genetic variants associated with obesity, including variants in the FTO, ADIPOQ, LEPR, and NEGR1 genes. These variants can contribute to obesity risk through various mechanisms, including effects on energy intake, expenditure, and fat storage.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Obesity",
      "summary": "The community revolves around obesity, a complex disease influenced by genetic and environmental factors. Key entities include the FTO gene, its variants such as rs9939609 and rs1421085, and other genes like ADIPOQ, LEPR, and NEGR1. These genetic factors interact with environmental factors like energy intake, dietary patterns, and physical activity to affect obesity risk. The community also involves various diseases and conditions, including type 2 diabetes, colorectal cancer, and thyroid cancer, which are associated with obesity.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on obesity risk and its association with various chronic diseases.",
      "findings": [
        {
          "summary": "The FTO gene and its variants are associated with obesity risk",
          "explanation": "The FTO gene is a key genetic factor associated with obesity risk. Variants such as rs9939609, rs1421085, and rs1558902 have been linked to increased obesity risk. These variants can affect energy intake and expenditure, leading to changes in body mass index (BMI) and body fat percentage. The FTO gene's association with obesity has been replicated across various ethnic groups, including Caucasians, African-Americans, and Hispanic-Americans."
        },
        {
          "summary": "Dietary patterns modulate the association of FTO SNPs with obesity risk",
          "explanation": "MDS (Mediterranean Diet Score) modulates the association of FTO SNPs with obesity risk. A study found that individuals with high GRS (Genetic Risk Score) and high MDS had lower obesity risk. This suggests that a Mediterranean-style diet may mitigate the genetic risk of obesity associated with FTO SNPs."
        },
        {
          "summary": "The NEGR1 gene is associated with obesity and energy intake",
          "explanation": "The NEGR1 gene is associated with obesity risk and energy intake. A variant in the NEGR1 gene, rs2815752, is linked to lower total energy intake. This suggests that NEGR1 may play a role in regulating energy balance and obesity risk."
        },
        {
          "summary": "Obesity is a risk factor for various chronic diseases",
          "explanation": "Obesity is a risk factor for various chronic diseases, including type 2 diabetes, colorectal cancer, and thyroid cancer. The relationship between obesity and these diseases is complex and influenced by multiple genetic and environmental factors."
        },
        {
          "summary": "Genetic association studies have identified multiple genetic variants associated with obesity",
          "explanation": "Genetic association studies have identified multiple genetic variants associated with obesity, including variants in the FTO, ADIPOQ, LEPR, and NEGR1 genes. These variants can contribute to obesity risk through various mechanisms, including effects on energy intake, expenditure, and fat storage."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 3",
    "edges": [
      [
        "\"MEC\"",
        "\"OBESITY\""
      ],
      [
        "\"ALCOHOL CONSUMPTION\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"FTO\""
      ],
      [
        "\"MDS\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO UPSTREAM REGION\"",
        "\"OBESITY\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BMI VALUE\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPR\"",
        "\"LEPTIN\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HIGH WHR\""
      ],
      [
        "\"DIETARY PATTERN\"",
        "\"ENERGY INTAKE\""
      ],
      [
        "\"LDL CHOLESTEROL\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PPARG\""
      ],
      [
        "\"CABP5\"",
        "\"OBESITY\""
      ],
      [
        "\"ADIPOQ\"",
        "\"T2DM\""
      ],
      [
        "\"FTO RS1421085\"",
        "\"FTO RS1558902\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"FTO SNPS\""
      ],
      [
        "\"OBESITY\"",
        "\"RS9939609\""
      ],
      [
        "\"FTO RS9930506\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO SNPS\"",
        "\"LINKAGE DISEQUILIBRIUM\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO\"",
        "\"LEPR\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"OBESITY\""
      ],
      [
        "\"HISPANIC-AMERICANS\"",
        "\"RS7201444\""
      ],
      [
        "\"FTO\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"NEGR1\""
      ],
      [
        "\"IRX5 RS4435250\"",
        "\"OBESITY\""
      ],
      [
        "\"NEGR1\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNP\""
      ],
      [
        "\"OBESITY\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"ADIPOQ\"",
        "\"OBESITY\""
      ],
      [
        "\"DIETARY FIBER\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PHYSICAL ACTIVITY\""
      ],
      [
        "\"NPY\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HARDY WEINBERG EQUILIBRIUM\""
      ],
      [
        "\"FTO RS1558902\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"NEGR1 SNP RS2815752\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"AFRICAN-AMERICANS\"",
        "\"FTO SNPS\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"TBW\""
      ],
      [
        "\"FTO SNPS\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS1421085\"",
        "\"OBESITY\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"OBESITY\""
      ],
      [
        "\"ENERGY AND MACRONUTRIENT INTAKES\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOTYPE\"",
        "\"SNP\""
      ],
      [
        "\"LOCI\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"MDS\""
      ],
      [
        "\"OBESITY\"",
        "\"SMOKING\""
      ],
      [
        "\"CREB1\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO SNPS\"",
        "\"GENETIC DIFFERENTIATION\""
      ],
      [
        "\"META-ANALYSIS\"",
        "\"REPLICATION SAMPLES\""
      ],
      [
        "\"FTO SNPS\"",
        "\"TRAIT ANXIETY\""
      ],
      [
        "\"DM2\"",
        "\"TDH\""
      ],
      [
        "\"META-ANALYSIS\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"BMI\"",
        "\"FTO SNPS\""
      ],
      [
        "\"MULTIVITAMINS\"",
        "\"OBESITY\""
      ],
      [
        "\"CTNNBL1\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"PFKFB3\""
      ],
      [
        "\"HIGH WHR\"",
        "\"MDS\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"NUTRITIONAL INTERVENTION\""
      ],
      [
        "\"FISHER'S EXACT TEST\"",
        "\"OBESITY\""
      ],
      [
        "\"ABDOMINAL OBESITY\"",
        "\"MDS\""
      ],
      [
        "\"OBESITY\"",
        "\"POLISH ADULT SUBJECTS\""
      ],
      [
        "\"HYPERTENSION\"",
        "\"OBESITY\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"OBESITY\""
      ],
      [
        "\"IRX3 RS4270172\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"TRIGLYCERIDE\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MINOR ALLELE FREQUENCIES\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"TYPE\""
      ],
      [
        "\"EDUCATIONAL LEVEL\"",
        "\"OBESITY\""
      ],
      [
        "\"CAUCASIANS\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"FAMA167-AS1\""
      ],
      [
        "\"FTO RS12149832\"",
        "\"FTO RS1558902\""
      ],
      [
        "\"LEPR\"",
        "\"OBESITY\""
      ],
      [
        "\"AGE\"",
        "\"OBESITY\""
      ],
      [
        "\"GWAS\"",
        "\"OBESITY\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"GENOTYPE\""
      ],
      [
        "\"MINOR ALLELES\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"FAT INTAKE\"",
        "\"PPARG\""
      ],
      [
        "\"BODY SHAPE SCORE\"",
        "\"OBESITY\""
      ],
      [
        "\"FTO VARIANTS\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"SEX\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"FTO SNPS\"",
        "\"HISPANIC-AMERICANS\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"OBESITY\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"OBESITY\""
      ],
      [
        "\"OBESITY\"",
        "\"THYROID CANCER\""
      ],
      [
        "\"IRX5 RS12444481\"",
        "\"OBESITY\""
      ],
      [
        "\"GRS\"",
        "\"OBESITY\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"NEGR1\"",
        "\"RS1620977\""
      ],
      [
        "\"CHINESE\"",
        "\"FTO SNPS\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"FTO\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"FTO SNPS\"",
        "\"MDS\""
      ],
      [
        "\"EATING DISORDER\"",
        "\"FTO SNPS\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"OBESITY\""
      ],
      [
        "\"HUMAN FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"DM2\"",
        "\"OBESITY\""
      ],
      [
        "\"CEBPB\"",
        "\"OBESITY\""
      ],
      [
        "\"BMI\"",
        "\"GENOTYPE\""
      ]
    ],
    "nodes": [
      "\"MINOR ALLELE FREQUENCIES\"",
      "\"ENERGY AND MACRONUTRIENT INTAKES\"",
      "\"CTNNBL1\"",
      "\"NEGR1\"",
      "\"RS1620977\"",
      "\"BMI VALUE\"",
      "\"GENOTYPE\"",
      "\"FTO RS1421085\"",
      "\"AFRICAN-AMERICANS\"",
      "\"HISPANIC-AMERICANS\"",
      "\"DIETARY PATTERN\"",
      "\"RS7201444\"",
      "\"IRX5 RS4435250\"",
      "\"BODY SHAPE SCORE\"",
      "\"FAMA167-AS1\"",
      "\"TYPE\"",
      "\"ENERGY INTAKE\"",
      "\"FTO SNPS\"",
      "\"MEC\"",
      "\"IRX5 RS12444481\"",
      "\"FTO RS9930506\"",
      "\"DM2\"",
      "\"FTO RS9939609\"",
      "\"FTO UPSTREAM REGION\"",
      "\"POLISH ADULT SUBJECTS\"",
      "\"HARDY WEINBERG EQUILIBRIUM\"",
      "\"REPLICATION SAMPLES\"",
      "\"HUMAN FTO GENE\"",
      "\"LEPR\"",
      "\"MULTIVITAMINS\"",
      "\"DIETARY FIBER\"",
      "\"OBESITY\"",
      "\"PPARG\"",
      "\"LOCI\"",
      "\"PFKFB3\"",
      "\"MDS\"",
      "\"TRIGLYCERIDE\"",
      "\"LDL CHOLESTEROL\"",
      "\"CEBPB\"",
      "\"CHINESE\"",
      "\"GRS\"",
      "\"IRX3 RS4270172\"",
      "\"ABDOMINAL OBESITY\"",
      "\"GENETIC DIFFERENTIATION\"",
      "\"NPY\"",
      "\"CAUCASIANS\"",
      "\"FISHER'S EXACT TEST\"",
      "\"EDUCATIONAL LEVEL\"",
      "\"FTO RS12149832\"",
      "\"NEGR1 SNP RS2815752\"",
      "\"META-ANALYSIS\"",
      "\"TRAIT ANXIETY\"",
      "\"ADIPOQ\"",
      "\"FTO RS1558902\"",
      "\"HIGH WHR\"",
      "\"TBW\"",
      "\"CABP5\""
    ],
    "chunk_ids": [
      "chunk-6597969605ab7ec27974930fa63633c2",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-9bafd0463858b9e67fde1eaa89761c40",
      "chunk-3f4f8136f50b2affe4eba97015885ad2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-4ce2aa0b1c542f53dbfd73accbc2c44a",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-01e63ea37667afa8a8ab7cecb122a8da",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-8d427a22e5679655268214490de43a1c",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-fc1bc70120da21ba22d5a49c167ee4b4",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-dc80fc41865c0a736dae4c714560ecf9",
      "chunk-27b6a78dbd979d1827c235ae16860183",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-2f2c90dea13e0dad5235137b025e03b7",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-fa2f1e59fd749f4c7a4fa3d912fa5c4d",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-43c3419720ce07459c9fbe4cee716054",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.7352941176470589,
    "sub_communities": [
      "42",
      "40",
      "41",
      "45",
      "44",
      "43"
    ]
  },
  "6": {
    "report_string": "# Leptin and Genetic Interactions in Obesity and Diabetes\n\nThe community revolves around the interactions between leptin, genetic variants, and environmental factors in the context of obesity and diabetes. Key entities include the LEPTIN protein, genes such as SLIT3, NTRK2, and SORCS1, and environmental factors like SEX. These entities are interconnected through their roles in energy balance, body weight regulation, and disease susceptibility.\n\n## LEPTIN's role in energy balance and obesity\n\nLeptin is a protein hormone that plays a crucial role in energy balance and body weight regulation. It is involved in the physiological process of energy balance and is associated with plasma leptin levels, which are influenced by genetic and environmental factors. The LEP gene encodes the leptin protein, and variations in this gene can affect leptin levels and obesity risk.\n\n## Sex-specific differences in plasma leptin levels\n\nSex is an environmental factor that influences plasma leptin levels in a sex-specific manner. The SLIT3 gene shows sex-specific differences in plasma leptin levels, and the rs11954861 genomic variant is associated with plasma leptin levels in the SLIT3 gene. Additionally, the rs4074110 genomic variant is associated with plasma leptin levels in men, highlighting the importance of considering sex in the analysis of leptin levels and obesity risk.\n\n## Genetic associations with obesity and diabetes\n\nGenetic association studies have identified multiple genetic variants associated with obesity, including the FTO gene. The association between genetic variants and obesity can vary between males and females, and sex influences the effect of genetic variants on obesity. The NTRK2 gene is involved in energy balance and obesity, and the SORCS1 gene is associated with plasma leptin levels, further highlighting the complex interplay between genetics and obesity.\n\n## LEPTIN's interaction with other genes and environmental factors\n\nLeptin interacts with other genes, such as SLIT3, NTRK2, and SORCS1, which are involved in energy balance and obesity. Environmental factors, like sex, also interact with genetic variants to affect plasma leptin levels and obesity risk. The complex interplay between leptin, genetics, and environmental factors underscores the need for personalized approaches to managing obesity and diabetes.\n\n## Impact of diabetes on plasma leptin levels\n\nDiabetes is associated with altered plasma leptin levels, which are influenced by genetic and environmental factors. The relationship between diabetes and leptin levels highlights the importance of considering metabolic health in the context of obesity and genetic variants.",
    "report_json": {
      "title": "Leptin and Genetic Interactions in Obesity and Diabetes",
      "summary": "The community revolves around the interactions between leptin, genetic variants, and environmental factors in the context of obesity and diabetes. Key entities include the LEPTIN protein, genes such as SLIT3, NTRK2, and SORCS1, and environmental factors like SEX. These entities are interconnected through their roles in energy balance, body weight regulation, and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and environmental factors, including leptin and sex, on obesity and diabetes risk and management.",
      "findings": [
        {
          "summary": "LEPTIN's role in energy balance and obesity",
          "explanation": "Leptin is a protein hormone that plays a crucial role in energy balance and body weight regulation. It is involved in the physiological process of energy balance and is associated with plasma leptin levels, which are influenced by genetic and environmental factors. The LEP gene encodes the leptin protein, and variations in this gene can affect leptin levels and obesity risk."
        },
        {
          "summary": "Sex-specific differences in plasma leptin levels",
          "explanation": "Sex is an environmental factor that influences plasma leptin levels in a sex-specific manner. The SLIT3 gene shows sex-specific differences in plasma leptin levels, and the rs11954861 genomic variant is associated with plasma leptin levels in the SLIT3 gene. Additionally, the rs4074110 genomic variant is associated with plasma leptin levels in men, highlighting the importance of considering sex in the analysis of leptin levels and obesity risk."
        },
        {
          "summary": "Genetic associations with obesity and diabetes",
          "explanation": "Genetic association studies have identified multiple genetic variants associated with obesity, including the FTO gene. The association between genetic variants and obesity can vary between males and females, and sex influences the effect of genetic variants on obesity. The NTRK2 gene is involved in energy balance and obesity, and the SORCS1 gene is associated with plasma leptin levels, further highlighting the complex interplay between genetics and obesity."
        },
        {
          "summary": "LEPTIN's interaction with other genes and environmental factors",
          "explanation": "Leptin interacts with other genes, such as SLIT3, NTRK2, and SORCS1, which are involved in energy balance and obesity. Environmental factors, like sex, also interact with genetic variants to affect plasma leptin levels and obesity risk. The complex interplay between leptin, genetics, and environmental factors underscores the need for personalized approaches to managing obesity and diabetes."
        },
        {
          "summary": "Impact of diabetes on plasma leptin levels",
          "explanation": "Diabetes is associated with altered plasma leptin levels, which are influenced by genetic and environmental factors. The relationship between diabetes and leptin levels highlights the importance of considering metabolic health in the context of obesity and genetic variants."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 6",
    "edges": [
      [
        "\"SEX\"",
        "\"SLIT3\""
      ],
      [
        "\"DIABETES\"",
        "\"LEPTIN\""
      ],
      [
        "\"BMI\"",
        "\"LEPTIN\""
      ],
      [
        "\"LEPTIN\"",
        "\"SLIT3\""
      ],
      [
        "\"DIABETES\"",
        "\"PLASMA LEPTIN LEVELS\""
      ],
      [
        "\"LEPR\"",
        "\"LEPTIN\""
      ],
      [
        "\"ESTROGENS\"",
        "\"SLIT3\""
      ],
      [
        "\"OBESITY\"",
        "\"SEX\""
      ],
      [
        "\"INSULIN RESISTANCE\"",
        "\"LEPTIN\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"SEX\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"GENETIC ASSOCIATION\""
      ],
      [
        "\"ENERGY BALANCE\"",
        "\"LEPTIN\""
      ],
      [
        "\"FTO RS3751812\"",
        "\"SEX\""
      ],
      [
        "\"AGE STRATIFICATION\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPTIN\"",
        "\"SEX\""
      ],
      [
        "\"LEPTIN\"",
        "\"SORCS1\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"OBESITY\""
      ],
      [
        "\"RS9939609\"",
        "\"SEX\""
      ],
      [
        "\"LEP\"",
        "\"LEPTIN\""
      ],
      [
        "\"DIABETES\"",
        "\"OBESITY\""
      ],
      [
        "\"LEPTIN\"",
        "\"NTRK2\""
      ],
      [
        "\"RS11954861\"",
        "\"SLIT3\""
      ],
      [
        "\"LEPTIN\"",
        "\"RS4074110\""
      ],
      [
        "\"GENETIC ASSOCIATION\"",
        "\"SEX\""
      ],
      [
        "\"FTO\"",
        "\"SEX\""
      ],
      [
        "\"BMI\"",
        "\"SEX\""
      ],
      [
        "\"SEX\"",
        "\"T2DM\""
      ],
      [
        "\"DIABETES\"",
        "\"MAFLD\""
      ]
    ],
    "nodes": [
      "\"RS11954861\"",
      "\"SORCS1\"",
      "\"GENETIC ASSOCIATION\"",
      "\"NTRK2\"",
      "\"ENERGY BALANCE\"",
      "\"SEX\"",
      "\"DIABETES\"",
      "\"RS4074110\"",
      "\"AGE STRATIFICATION\"",
      "\"SLIT3\"",
      "\"ESTROGENS\"",
      "\"INSULIN RESISTANCE\"",
      "\"LEPTIN\""
    ],
    "chunk_ids": [
      "chunk-2107b32e444ab30c1d84364536b3ecf9",
      "chunk-b5e2a430b6b0959e6af1095376c9c3d6",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-2e9912c99d71f4f220e2c735e8e00f8b",
      "chunk-161d5ffe5369ff9e228fae70fe2d7c82",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-8743fb6113d9382f66ada1dbf201090b",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-84861a91f27adb095877d1a6ab6a6a69",
      "chunk-30b6c1e8c381d8ef61bc310608b42ebc",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-7d4f390e7ed8da1820efe209eab19293",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.3382352941176471,
    "sub_communities": [
      "53",
      "52",
      "51"
    ]
  },
  "17": {
    "report_string": "# Type2 Diabetes and Associated Genetic Factors\n\nThe community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and high blood sugar levels. Key entities include genes such as TCF7L2, TSPAN8, L3MBTL3, and RUNX1, which are associated with T2D. Other important entities are childhood obesity, CAD, and physiological processes like waist circumference and triglycerides. These entities are interconnected through their roles in glucose homeostasis, insulin secretion, and disease risk.\n\n## TCF7L2 gene and its association with T2D\n\nThe TCF7L2 gene is significantly associated with T2D, and its variants are linked to an increased risk of the disease. This gene is involved in glucose homeostasis, highlighting its importance in diabetes susceptibility.\n\n## Childhood obesity as a risk factor for T2D and CAD\n\nChildhood obesity is a risk factor for both T2D and CAD, and is associated with increased BMI, waist circumference, and altered lipid profiles. This highlights the importance of early intervention in obesity to prevent long-term metabolic consequences.\n\n## TSPAN8 gene and its association with T2D\n\nThe TSPAN8 gene is associated with T2D, and its location on chromosome 12 has been identified through genome-wide association studies. Variants of this gene may influence disease susceptibility.\n\n## The role of L3MBTL3 and RUNX1 in T2D\n\nL3MBTL3 and RUNX1 are genes potentially associated with T2D. Their locations on chromosomes 6 and 21, respectively, have been identified, and they may play roles in glucose regulation and insulin secretion.\n\n## Relationship between genetic variants and T2D susceptibility\n\nGenomic variants, such as SNPs, can affect T2D susceptibility. Specific variants in genes like TCF7L2, TSPAN8, L3MBTL3, and RUNX1 have been associated with increased risk of T2D, highlighting the importance of genetic factors in disease risk.",
    "report_json": {
      "title": "Type2 Diabetes and Associated Genetic Factors",
      "summary": "The community revolves around Type2 Diabetes (T2D), a metabolic disorder characterized by insulin resistance and high blood sugar levels. Key entities include genes such as TCF7L2, TSPAN8, L3MBTL3, and RUNX1, which are associated with T2D. Other important entities are childhood obesity, CAD, and physiological processes like waist circumference and triglycerides. These entities are interconnected through their roles in glucose homeostasis, insulin secretion, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and environmental factors on T2D risk and management.",
      "findings": [
        {
          "summary": "TCF7L2 gene and its association with T2D",
          "explanation": "The TCF7L2 gene is significantly associated with T2D, and its variants are linked to an increased risk of the disease. This gene is involved in glucose homeostasis, highlighting its importance in diabetes susceptibility."
        },
        {
          "summary": "Childhood obesity as a risk factor for T2D and CAD",
          "explanation": "Childhood obesity is a risk factor for both T2D and CAD, and is associated with increased BMI, waist circumference, and altered lipid profiles. This highlights the importance of early intervention in obesity to prevent long-term metabolic consequences."
        },
        {
          "summary": "TSPAN8 gene and its association with T2D",
          "explanation": "The TSPAN8 gene is associated with T2D, and its location on chromosome 12 has been identified through genome-wide association studies. Variants of this gene may influence disease susceptibility."
        },
        {
          "summary": "The role of L3MBTL3 and RUNX1 in T2D",
          "explanation": "L3MBTL3 and RUNX1 are genes potentially associated with T2D. Their locations on chromosomes 6 and 21, respectively, have been identified, and they may play roles in glucose regulation and insulin secretion."
        },
        {
          "summary": "Relationship between genetic variants and T2D susceptibility",
          "explanation": "Genomic variants, such as SNPs, can affect T2D susceptibility. Specific variants in genes like TCF7L2, TSPAN8, L3MBTL3, and RUNX1 have been associated with increased risk of T2D, highlighting the importance of genetic factors in disease risk."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 17",
    "edges": [
      [
        "\"CHILDHOOD OBESITY\"",
        "\"SNPS\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"WC\""
      ],
      [
        "\"WC\"",
        "\"WHR\""
      ],
      [
        "\"T2D\"",
        "\"TSPAN8\""
      ],
      [
        "\"T2DM\"",
        "\"TCF7L2\""
      ],
      [
        "\"OBESITY\"",
        "\"T2D\""
      ],
      [
        "\"BMI\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"FASTING GLUCOSE\""
      ],
      [
        "\"RUNX1\"",
        "\"T2D\""
      ],
      [
        "\"PANCREAS DEVELOPMENT\"",
        "\"T2D\""
      ],
      [
        "\"FTO\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"CHROMOSOME10\"",
        "\"TCF7L2\""
      ],
      [
        "\"CARDIOMETABOLIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHROMOSOME 21\"",
        "\"RUNX1\""
      ],
      [
        "\"TCF7L2\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"T2D\""
      ],
      [
        "\"CAD\"",
        "\"T2D\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"TG\""
      ],
      [
        "\"CHROMOSOME 10\"",
        "\"TCF7L2\""
      ],
      [
        "\"APOLIPOPROTEIN BINDING\"",
        "\"CAD\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"TRIOS\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"RS7723\"",
        "\"T2D\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"WHR\""
      ],
      [
        "\"CHROMOSOME 12\"",
        "\"TSPAN8\""
      ],
      [
        "\"FTO\"",
        "\"T2D\""
      ],
      [
        "\"MAFLD\"",
        "\"TG\""
      ],
      [
        "\"CHROMOSOME21\"",
        "\"RUNX1\""
      ],
      [
        "\"ANTHROPOMETRIC TRAITS\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHROMOSOME 6\"",
        "\"L3MBTL3\""
      ],
      [
        "\"NRI\"",
        "\"T2D\""
      ],
      [
        "\"CHROMOSOME6\"",
        "\"L3MBTL3\""
      ],
      [
        "\"TSPAN8\"",
        "\"WTCCC GWAS DATASET\""
      ],
      [
        "\"GWAS\"",
        "\"T2D\""
      ],
      [
        "\"L3MBTL3\"",
        "\"T2D\""
      ],
      [
        "\"RISK MARKERS\"",
        "\"T2D\""
      ],
      [
        "\"T2D\"",
        "\"TCF7L2\""
      ],
      [
        "\"CAD\"",
        "\"CHILDHOOD OBESITY\""
      ],
      [
        "\"CHROMOSOME12\"",
        "\"TSPAN8\""
      ],
      [
        "\"CELF4\"",
        "\"T2D\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"LIPID TRAITS\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"WHR\""
      ],
      [
        "\"GLUCOSE HOMEOSTASIS\"",
        "\"TCF7L2\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"HDL-C\""
      ]
    ],
    "nodes": [
      "\"RUNX1\"",
      "\"CAD\"",
      "\"TRIOS\"",
      "\"TCF7L2\"",
      "\"CHROMOSOME 6\"",
      "\"CARDIOMETABOLIC TRAITS\"",
      "\"CHROMOSOME 21\"",
      "\"CHROMOSOME10\"",
      "\"WHR\"",
      "\"T2D\"",
      "\"TG\"",
      "\"CHROMOSOME 12\"",
      "\"APOLIPOPROTEIN BINDING\"",
      "\"LIPID TRAITS\"",
      "\"CHROMOSOME6\"",
      "\"PANCREAS DEVELOPMENT\"",
      "\"WTCCC GWAS DATASET\"",
      "\"CHROMOSOME12\"",
      "\"L3MBTL3\"",
      "\"TSPAN8\"",
      "\"NRI\"",
      "\"CHROMOSOME 10\"",
      "\"RS7723\"",
      "\"RISK MARKERS\"",
      "\"CHROMOSOME21\"",
      "\"CHILDHOOD OBESITY\"",
      "\"WC\""
    ],
    "chunk_ids": [
      "chunk-e868b6533e734748b2f371dbeb6df838",
      "chunk-5d093b5dcf750ac32552aa2ef0fad16a",
      "chunk-49cf6074543d5f5d4e9ea8750a88794c",
      "chunk-b7e190953e4c769a8b651f251bf00588",
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-931179aa057fedb28afdeeca70b0e815",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-6466a802171867da3f6f77f5f97eccfa",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-6430a7be0477010057d515b73febb682",
      "chunk-0b7372167ef52070ae481e88cac9cc02",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-2a4b98c3d60b0d64c3bb52d28b9ce8da",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-6f4c442093f64b0adfa1c090d805321b",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-d400b0ce64149201aa5dd17abdaae0ce"
    ],
    "occurrence": 0.3088235294117647,
    "sub_communities": [
      "71",
      "69",
      "72",
      "70",
      "68"
    ]
  },
  "26": {
    "report_string": "# Haplotyping and LD Plots in Genetic Analysis\n\nThe community revolves around haplotyping and LD plots, which are crucial in genetic analysis. Key entities include Haploview, a software tool used for haplotyping and generating LD plots, and LD plot, a graphical representation of genetic relationships between SNPs. These entities are interconnected through their roles in visualizing linkage disequilibrium and performing haplotyping.\n\n## Haploview and its role in haplotyping\n\nHaploview is a software tool used to perform haplotyping, which is the process of determining the combination of alleles at different loci that are inherited together. This is crucial in genetic analysis for understanding genetic variation and its implications. Haploview's role in haplotyping is directly mentioned, highlighting its utility in genetic studies.\n\n## LD Plot and its significance in genetic analysis\n\nLD plot (Linkage Disequilibrium plot) is a graphical representation of the genetic relationships between SNPs (Single Nucleotide Polymorphisms). It is used to visualize linkage disequilibrium, which is a measure of the non-random association of alleles at different loci. LD plots are significant because they help researchers understand the genetic structure of populations and identify genetic variants associated with diseases.\n\n## Relationship between Haploview and LD Plot\n\nHaploview is used to generate LD plots to visualize linkage disequilibrium. This relationship highlights the utility of Haploview in creating graphical representations that are essential for understanding genetic relationships between SNPs. This connection underscores the integrated approach in genetic analysis, where software tools like Haploview facilitate the visualization and interpretation of genetic data.\n\n## Limitations and Scope\n\nThe community's focus on tools and methods for genetic analysis, rather than directly on genes, nutrients, or diseases, limits its direct impact on health, disease, and personalized nutrition. However, understanding genetic relationships and haplotyping are critical steps in identifying genetic factors that can influence disease susceptibility and response to dietary interventions.",
    "report_json": {
      "title": "Haplotyping and LD Plots in Genetic Analysis",
      "summary": "The community revolves around haplotyping and LD plots, which are crucial in genetic analysis. Key entities include Haploview, a software tool used for haplotyping and generating LD plots, and LD plot, a graphical representation of genetic relationships between SNPs. These entities are interconnected through their roles in visualizing linkage disequilibrium and performing haplotyping.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is relatively low due to the limited scope of the community, which primarily focuses on genetic analysis tools and representations rather than directly influencing health, disease, or personalized nutrition.",
      "findings": [
        {
          "summary": "Haploview and its role in haplotyping",
          "explanation": "Haploview is a software tool used to perform haplotyping, which is the process of determining the combination of alleles at different loci that are inherited together. This is crucial in genetic analysis for understanding genetic variation and its implications. Haploview's role in haplotyping is directly mentioned, highlighting its utility in genetic studies."
        },
        {
          "summary": "LD Plot and its significance in genetic analysis",
          "explanation": "LD plot (Linkage Disequilibrium plot) is a graphical representation of the genetic relationships between SNPs (Single Nucleotide Polymorphisms). It is used to visualize linkage disequilibrium, which is a measure of the non-random association of alleles at different loci. LD plots are significant because they help researchers understand the genetic structure of populations and identify genetic variants associated with diseases."
        },
        {
          "summary": "Relationship between Haploview and LD Plot",
          "explanation": "Haploview is used to generate LD plots to visualize linkage disequilibrium. This relationship highlights the utility of Haploview in creating graphical representations that are essential for understanding genetic relationships between SNPs. This connection underscores the integrated approach in genetic analysis, where software tools like Haploview facilitate the visualization and interpretation of genetic data."
        },
        {
          "summary": "Limitations and Scope",
          "explanation": "The community's focus on tools and methods for genetic analysis, rather than directly on genes, nutrients, or diseases, limits its direct impact on health, disease, and personalized nutrition. However, understanding genetic relationships and haplotyping are critical steps in identifying genetic factors that can influence disease susceptibility and response to dietary interventions."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 26",
    "edges": [
      [
        "\"HAPLOVIEW\"",
        "\"LD PLOT\""
      ],
      [
        "\"HAPLOTYPING\"",
        "\"HAPLOVIEW\""
      ],
      [
        "\"LD PLOT\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"HAPLOTYPING\"",
      "\"HAPLOVIEW\"",
      "\"LD PLOT\""
    ],
    "chunk_ids": [
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-406fcc8c4dea697047c9215396f4ca01",
      "chunk-23f99f090070aea487163f2778574849"
    ],
    "occurrence": 0.04411764705882353,
    "sub_communities": []
  },
  "15": {
    "report_string": "# Genetic and Physiological Factors in Metabolic Associated Fatty Liver Disease (MAFLD)\n\nThe community revolves around MAFLD, a condition characterized by excessive fat accumulation in the liver, associated with metabolic disorders. Key entities include the FTO gene, body fatness, genomic variants like rs1421085 and rs8050136, and physiological measures such as ALT, GGT, and blood pressure. These entities are interconnected through their roles in obesity, metabolic health, and disease risk.\n\n## The FTO gene and its association with obesity and MAFLD\n\nThe FTO gene is associated with obesity and has variants linked to increased risk of MAFLD. Variants such as rs1421085 and rs8050136 in the FTO gene are associated with obesity-related traits and MAFLD risk. The FTO gene's role in body mass index and obesity highlights its potential impact on MAFLD.\n\n## The role of genomic variants in MAFLD risk\n\nGenomic variants like rs1421085, rs8050136, and rs9939609 in the FTO gene are associated with increased risk of MAFLD. The haplotype of TCGT is associated with lower risk of MAFLD, while the CATA haplotype is associated with increased risk. These variants influence disease risk and highlight the importance of genetic considerations in MAFLD management.\n\n## Body fatness and its physiological measures\n\nBody fatness is a measure of the amount of body fat, and physiological measures like UAW, PC1, and PC2 explain the variance in body fatness measures. These measures are associated with MAFLD risk and highlight the importance of monitoring body fatness in metabolic health.\n\n## The relationship between MAFLD and physiological measures\n\nMAFLD is associated with various physiological measures, including ALT, GGT, diastolic blood pressure, and fasting plasma glucose. These measures are used to assess liver health, cardiovascular health, and glucose regulation, all of which are relevant to MAFLD risk and management.\n\n## Diet and environmental factors in MAFLD risk\n\nDiet is an environmental factor that modulates the risk of MAFLD. The FTO gene's variants are associated with energy intake, and genomic variants like rs1421085 and rs8050136 are linked to energy intake. This highlights the importance of considering dietary factors in MAFLD prevention and management.",
    "report_json": {
      "title": "Genetic and Physiological Factors in Metabolic Associated Fatty Liver Disease (MAFLD)",
      "summary": "The community revolves around MAFLD, a condition characterized by excessive fat accumulation in the liver, associated with metabolic disorders. Key entities include the FTO gene, body fatness, genomic variants like rs1421085 and rs8050136, and physiological measures such as ALT, GGT, and blood pressure. These entities are interconnected through their roles in obesity, metabolic health, and disease risk.",
      "rating": 8.0,
      "rating_explanation": "The impact severity rating is high due to the significant influence of genetic and physiological factors on MAFLD risk and management.",
      "findings": [
        {
          "summary": "The FTO gene and its association with obesity and MAFLD",
          "explanation": "The FTO gene is associated with obesity and has variants linked to increased risk of MAFLD. Variants such as rs1421085 and rs8050136 in the FTO gene are associated with obesity-related traits and MAFLD risk. The FTO gene's role in body mass index and obesity highlights its potential impact on MAFLD."
        },
        {
          "summary": "The role of genomic variants in MAFLD risk",
          "explanation": "Genomic variants like rs1421085, rs8050136, and rs9939609 in the FTO gene are associated with increased risk of MAFLD. The haplotype of TCGT is associated with lower risk of MAFLD, while the CATA haplotype is associated with increased risk. These variants influence disease risk and highlight the importance of genetic considerations in MAFLD management."
        },
        {
          "summary": "Body fatness and its physiological measures",
          "explanation": "Body fatness is a measure of the amount of body fat, and physiological measures like UAW, PC1, and PC2 explain the variance in body fatness measures. These measures are associated with MAFLD risk and highlight the importance of monitoring body fatness in metabolic health."
        },
        {
          "summary": "The relationship between MAFLD and physiological measures",
          "explanation": "MAFLD is associated with various physiological measures, including ALT, GGT, diastolic blood pressure, and fasting plasma glucose. These measures are used to assess liver health, cardiovascular health, and glucose regulation, all of which are relevant to MAFLD risk and management."
        },
        {
          "summary": "Diet and environmental factors in MAFLD risk",
          "explanation": "Diet is an environmental factor that modulates the risk of MAFLD. The FTO gene's variants are associated with energy intake, and genomic variants like rs1421085 and rs8050136 are linked to energy intake. This highlights the importance of considering dietary factors in MAFLD prevention and management."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 15",
    "edges": [
      [
        "\"FTO GENE\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"RS1421085\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"UAW\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"DIASTOLIC BLOOD PRESSURE\"",
        "\"MAFLD\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"RS1421085\""
      ],
      [
        "\"BMI\"",
        "\"FTO GENE\""
      ],
      [
        "\"FTO GENE\"",
        "\"RS9939609\""
      ],
      [
        "\"GGT\"",
        "\"MAFLD\""
      ],
      [
        "\"DIET\"",
        "\"MAFLD\""
      ],
      [
        "\"INDEL\"",
        "\"SOLID SEQUENCING\""
      ],
      [
        "\"FTO GENE\"",
        "\"GENOMIC VARIANT\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"UAC\""
      ],
      [
        "\"MAFLD\"",
        "\"RS8050136\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP\""
      ],
      [
        "\"FTO GENE\"",
        "\"INDEL\""
      ],
      [
        "\"FTO GENE\"",
        "\"TYPE 2 DIABETES\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY-RELATED METABOLIC TRAITS\""
      ],
      [
        "\"MAFLD\"",
        "\"SYSTOLIC BLOOD PRESSURE\""
      ],
      [
        "\"HDL-C\"",
        "\"MAFLD\""
      ],
      [
        "\"FTO GENE\"",
        "\"HAPLOTYPE BLOCK\""
      ],
      [
        "\"FTO GENE\"",
        "\"LD\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"PC1\""
      ],
      [
        "\"MAFLD\"",
        "\"TG\""
      ],
      [
        "\"INDEL\"",
        "\"SNP\""
      ],
      [
        "\"MAFLD\"",
        "\"RS9939609\""
      ],
      [
        "\"BMI\"",
        "\"BODY FATNESS\""
      ],
      [
        "\"ENERGY INTAKE\"",
        "\"SNP RS8050136\""
      ],
      [
        "\"MAFLD\"",
        "\"RS1421085-RS8050136-RS3751812-RS9939609\""
      ],
      [
        "\"ALT\"",
        "\"MAFLD\""
      ],
      [
        "\"FTO GENE\"",
        "\"SNP RS1421085\""
      ],
      [
        "\"FTO GENE\"",
        "\"INTRON 1\""
      ],
      [
        "\"FTO GENE\"",
        "\"FTO VARIANTS\""
      ],
      [
        "\"MAFLD\"",
        "\"RS3751812\""
      ],
      [
        "\"PC2\"",
        "\"UAW\""
      ],
      [
        "\"GENDER\"",
        "\"MAFLD\""
      ],
      [
        "\"RS16952517\"",
        "\"UAW\""
      ],
      [
        "\"FTO GENE\"",
        "\"OBESITY\""
      ],
      [
        "\"FPG\"",
        "\"MAFLD\""
      ],
      [
        "\"MAFLD\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"DIABETES\"",
        "\"MAFLD\""
      ],
      [
        "\"BODY FATNESS\"",
        "\"WHR\""
      ],
      [
        "\"BMI\"",
        "\"MAFLD\""
      ]
    ],
    "nodes": [
      "\"ALT\"",
      "\"DIASTOLIC BLOOD PRESSURE\"",
      "\"SNP RS1421085\"",
      "\"INDEL\"",
      "\"FPG\"",
      "\"BODY FATNESS\"",
      "\"UAC\"",
      "\"PC1\"",
      "\"UAW\"",
      "\"RS16952517\"",
      "\"HAPLOTYPE BLOCK\"",
      "\"SNP RS8050136\"",
      "\"GGT\"",
      "\"SYSTOLIC BLOOD PRESSURE\"",
      "\"MAFLD\"",
      "\"FTO GENE\"",
      "\"RS1421085-RS8050136-RS3751812-RS9939609\"",
      "\"PC2\"",
      "\"OBESITY-RELATED METABOLIC TRAITS\"",
      "\"LD\"",
      "\"RS1421085\""
    ],
    "chunk_ids": [
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-b9cec02d00ebba431b8274b41a6f5db2",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-c11750e689f69b55e5ea3262ddcb4ba6",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-1d9e76d2394252014486b12168953c81",
      "chunk-6c935916492da41e4048751fc4c84348",
      "chunk-ff13d4cf02d1e26d99c66c84745de3ed",
      "chunk-1b7d6d1d933749984f77a4c5991eabfc",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-b87db3f3e401355543bca374e5b87c57",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-a5cac8e9cbcd82f3805ddefa0da1af54",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3",
      "chunk-7d1efebc0446ed593d4a537624038948"
    ],
    "occurrence": 0.3088235294117647,
    "sub_communities": [
      "64",
      "63",
      "65"
    ]
  },
  "16": {
    "report_string": "# Genetic Factors Influencing Body Shape\n\nThe community revolves around body shape as a physiological process influenced by various genetic factors, including genes such as BDNF, ETV5, FAIM2, and genetic variants like rs1121980, rs7204609, rs925646, and rs9939881. These entities are interconnected through their roles in regulating body shape, energy intake, and obesity risk.\n\n## BDNF gene and its association with body shape\n\nThe BDNF gene plays a crucial role in brain function and development and is associated with body shape. It is affected by SNP rs6265, which may influence its function in regulating body shape.\n\n## ETV5 and FAIM2 genes in energy intake regulation and body shape\n\nThe ETV5 and FAIM2 genes are involved in energy intake regulation and are associated with body shape. Their roles suggest that genetic factors influencing energy balance can impact body shape.\n\n## Genomic variants associated with body shape\n\nSeveral genomic variants, including rs1121980, rs7204609, rs925646, and rs9939881, are associated with body shape. These variants may contribute to the genetic risk of obesity and body shape.\n\n## Relationship between body shape and obesity\n\nBody shape is a physiological process linked to obesity, a disease influenced by genetic and environmental factors. The FTO gene, associated with body shape and obesity, and its variants can affect body shape.\n\n## Importance of PRS in predicting body shape\n\nThe PRS (Polygenic Risk Score) is used to predict body shape, with a strong correlation. This highlights the potential of genetic information in assessing body shape and related health risks.",
    "report_json": {
      "title": "Genetic Factors Influencing Body Shape",
      "summary": "The community revolves around body shape as a physiological process influenced by various genetic factors, including genes such as BDNF, ETV5, FAIM2, and genetic variants like rs1121980, rs7204609, rs925646, and rs9939881. These entities are interconnected through their roles in regulating body shape, energy intake, and obesity risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic factors on body shape and obesity risk.",
      "findings": [
        {
          "summary": "BDNF gene and its association with body shape",
          "explanation": "The BDNF gene plays a crucial role in brain function and development and is associated with body shape. It is affected by SNP rs6265, which may influence its function in regulating body shape."
        },
        {
          "summary": "ETV5 and FAIM2 genes in energy intake regulation and body shape",
          "explanation": "The ETV5 and FAIM2 genes are involved in energy intake regulation and are associated with body shape. Their roles suggest that genetic factors influencing energy balance can impact body shape."
        },
        {
          "summary": "Genomic variants associated with body shape",
          "explanation": "Several genomic variants, including rs1121980, rs7204609, rs925646, and rs9939881, are associated with body shape. These variants may contribute to the genetic risk of obesity and body shape."
        },
        {
          "summary": "Relationship between body shape and obesity",
          "explanation": "Body shape is a physiological process linked to obesity, a disease influenced by genetic and environmental factors. The FTO gene, associated with body shape and obesity, and its variants can affect body shape."
        },
        {
          "summary": "Importance of PRS in predicting body shape",
          "explanation": "The PRS (Polygenic Risk Score) is used to predict body shape, with a strong correlation. This highlights the potential of genetic information in assessing body shape and related health risks."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 16",
    "edges": [
      [
        "\"BODY SHAPE\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"FTO\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS925646\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS1121980\""
      ],
      [
        "\"BDNF\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BDNF\"",
        "\"SNP RS6265\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS9939881\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"HIP CIRCUMFERENCE\""
      ],
      [
        "\"BDNF\"",
        "\"OBESITY\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"MC4R\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"WAIST CIRCUMFERENCE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"ETV5\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"RS7204609\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"PRS\""
      ],
      [
        "\"BMI\"",
        "\"BODY SHAPE\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"TMEM18\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"FAIM2\""
      ]
    ],
    "nodes": [
      "\"SNP RS6265\"",
      "\"RS9939881\"",
      "\"FAIM2\"",
      "\"RS925646\"",
      "\"BDNF\"",
      "\"ETV5\"",
      "\"RS1121980\"",
      "\"HIP CIRCUMFERENCE\"",
      "\"RS7204609\"",
      "\"BODY SHAPE\"",
      "\"PRS\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-5a9f1e57fa2d040ea7ea9d7dcc54da14",
      "chunk-925f77b6b7102d795bffeed55b127dbf",
      "chunk-ccc3c42cc1f6db0cf475f8a6f56e30bf",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.10294117647058823,
    "sub_communities": [
      "66",
      "67"
    ]
  },
  "21": {
    "report_string": "# Genetic and Environmental Factors in Colorectal Cancer\n\nThe community revolves around colorectal cancer, influenced by genetic factors such as MC4R, KCTD15, and NRXN3 genes, and environmental factors like ethnicity, physical activity level, and obesity. These entities interact through complex relationships affecting disease risk.\n\n## MC4R gene and its role in colorectal cancer\n\nThe MC4R gene plays a crucial role in energy balance and obesity, and its variants are associated with colorectal cancer risk. The relationship between MC4R and obesity highlights the importance of considering genetic factors in disease prevention.\n\n## NRXN3 gene and its variant rs10146997\n\nThe NRXN3 gene is linked to obesity risk, and its variant rs10146997 is inversely associated with colorectal cancer risk in whites. This suggests that genetic associations can vary across ethnic groups.\n\n## Impact of ethnicity on genetic associations\n\nEthnicity influences the association between genetic variants like rs10146997 and colorectal cancer risk. This highlights the need for personalized medicine approaches that consider genetic and environmental factors.\n\n## Role of physical activity in colorectal cancer risk\n\nPhysical activity level is an environmental factor that affects colorectal cancer risk. This underscores the importance of lifestyle interventions in disease prevention.\n\n## Obesity as a risk factor for colorectal cancer\n\nObesity is a risk factor for colorectal cancer, and genes like MC4R and KCTD15 are associated with obesity risk. This highlights the complex interplay between genetic and environmental factors in disease risk.",
    "report_json": {
      "title": "Genetic and Environmental Factors in Colorectal Cancer",
      "summary": "The community revolves around colorectal cancer, influenced by genetic factors such as MC4R, KCTD15, and NRXN3 genes, and environmental factors like ethnicity, physical activity level, and obesity. These entities interact through complex relationships affecting disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of both genetic and environmental factors on colorectal cancer risk.",
      "findings": [
        {
          "summary": "MC4R gene and its role in colorectal cancer",
          "explanation": "The MC4R gene plays a crucial role in energy balance and obesity, and its variants are associated with colorectal cancer risk. The relationship between MC4R and obesity highlights the importance of considering genetic factors in disease prevention."
        },
        {
          "summary": "NRXN3 gene and its variant rs10146997",
          "explanation": "The NRXN3 gene is linked to obesity risk, and its variant rs10146997 is inversely associated with colorectal cancer risk in whites. This suggests that genetic associations can vary across ethnic groups."
        },
        {
          "summary": "Impact of ethnicity on genetic associations",
          "explanation": "Ethnicity influences the association between genetic variants like rs10146997 and colorectal cancer risk. This highlights the need for personalized medicine approaches that consider genetic and environmental factors."
        },
        {
          "summary": "Role of physical activity in colorectal cancer risk",
          "explanation": "Physical activity level is an environmental factor that affects colorectal cancer risk. This underscores the importance of lifestyle interventions in disease prevention."
        },
        {
          "summary": "Obesity as a risk factor for colorectal cancer",
          "explanation": "Obesity is a risk factor for colorectal cancer, and genes like MC4R and KCTD15 are associated with obesity risk. This highlights the complex interplay between genetic and environmental factors in disease risk."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 21",
    "edges": [
      [
        "\"COLORECTAL CANCER\"",
        "\"NRXN3\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"FTO\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS8046502\""
      ],
      [
        "\"AGE\"",
        "\"COLORECTAL CANCER\""
      ],
      [
        "\"ETHNICITY\"",
        "\"SNP-CANCER ASSOCIATIONS\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"OBESITY\""
      ],
      [
        "\"MC4R\"",
        "\"OBESITY\""
      ],
      [
        "\"NRXN3\"",
        "\"RS10146997\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"KCTD15\""
      ],
      [
        "\"BODY SHAPE\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"PHYSICAL ACTIVITY LEVEL\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"MC4R\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS10146997\""
      ],
      [
        "\"ETHNICITY\"",
        "\"RS10146997\""
      ],
      [
        "\"KCTD15\"",
        "\"OBESITY\""
      ],
      [
        "\"COLORECTAL CANCER\"",
        "\"RS4784329\""
      ],
      [
        "\"ADIPOSITY\"",
        "\"MC4R\""
      ]
    ],
    "nodes": [
      "\"MC4R\"",
      "\"NRXN3\"",
      "\"COLORECTAL CANCER\"",
      "\"RS8046502\"",
      "\"PHYSICAL ACTIVITY LEVEL\"",
      "\"RS4784329\"",
      "\"SNP-CANCER ASSOCIATIONS\"",
      "\"RS10146997\"",
      "\"ETHNICITY\"",
      "\"KCTD15\""
    ],
    "chunk_ids": [
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-841b239f43a16869c8effff2954c615d",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-2cfdb37c3e46b12ccadfd4023910be76",
      "chunk-13eed85551aee8769bdd7d566a9388a3",
      "chunk-606e3745887d305085abbdeeda7ea958",
      "chunk-1cc1bb385b2030b386679b552c606643",
      "chunk-9bafd0463858b9e67fde1eaa89761c40"
    ],
    "occurrence": 0.1323529411764706,
    "sub_communities": [
      "76",
      "75"
    ]
  },
  "18": {
    "report_string": "# Genetic and Physiological Interactions in Metabolic Health\n\nThe community revolves around genetic and physiological processes influencing metabolic health, particularly in relation to obesity, type2 diabetes, and metabolic pathways. Key entities include genes such as FTO, GCKR, PACAP, and PPARGC1, as well as physiological processes like energy homeostasis and glucose regulation. These entities are interconnected through their roles in nutrient metabolism, insulin secretion, and disease risk.\n\n## FTO protein's role in physiological processes related to obesity\n\nThe FTO protein is involved in various physiological processes related to obesity, including energy homeostasis and fat metabolism. This suggests that genetic variations in the FTO gene could influence obesity risk and metabolic health.\n\n## GCKR gene and its association with type2 diabetes\n\nThe GCKR gene is associated with type2 diabetes and glucose metabolism. Variants in the GCKR gene, such as rs780093, have been linked to circulating leptin levels, highlighting the importance of genetic considerations in diabetes risk assessment.\n\n## PACAP and PPARGC1 genes in T2DM\n\nThe PACAP and PPARGC1 genes are associated with type2 diabetes. PACAP is involved in pituitary adenylate cyclase-activating polypeptide production, influencing glucose regulation, while PPARGC1 plays a role in peroxisome proliferator-activated receptor-gamma coactivation, affecting glucose metabolism.\n\n## CCNL1 gene and its association with circulating leptin levels\n\nThe CCNL1 gene is associated with circulating leptin levels in women, and variants like rs17451107 have been linked to lower leptin levels. This highlights the importance of genetic factors in regulating energy balance and metabolic health.\n\n## Metabolic pathways and their interaction with genetic factors\n\nThe metabolic pathway associated with MAFLD involves lipid metabolism and glucose regulation. The interaction between genetic factors, such as the FTO protein, and metabolic pathways underscores the complex relationships between genetics, physiology, and disease risk.",
    "report_json": {
      "title": "Genetic and Physiological Interactions in Metabolic Health",
      "summary": "The community revolves around genetic and physiological processes influencing metabolic health, particularly in relation to obesity, type2 diabetes, and metabolic pathways. Key entities include genes such as FTO, GCKR, PACAP, and PPARGC1, as well as physiological processes like energy homeostasis and glucose regulation. These entities are interconnected through their roles in nutrient metabolism, insulin secretion, and disease risk.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and physiological factors on metabolic health and disease risk.",
      "findings": [
        {
          "summary": "FTO protein's role in physiological processes related to obesity",
          "explanation": "The FTO protein is involved in various physiological processes related to obesity, including energy homeostasis and fat metabolism. This suggests that genetic variations in the FTO gene could influence obesity risk and metabolic health."
        },
        {
          "summary": "GCKR gene and its association with type2 diabetes",
          "explanation": "The GCKR gene is associated with type2 diabetes and glucose metabolism. Variants in the GCKR gene, such as rs780093, have been linked to circulating leptin levels, highlighting the importance of genetic considerations in diabetes risk assessment."
        },
        {
          "summary": "PACAP and PPARGC1 genes in T2DM",
          "explanation": "The PACAP and PPARGC1 genes are associated with type2 diabetes. PACAP is involved in pituitary adenylate cyclase-activating polypeptide production, influencing glucose regulation, while PPARGC1 plays a role in peroxisome proliferator-activated receptor-gamma coactivation, affecting glucose metabolism."
        },
        {
          "summary": "CCNL1 gene and its association with circulating leptin levels",
          "explanation": "The CCNL1 gene is associated with circulating leptin levels in women, and variants like rs17451107 have been linked to lower leptin levels. This highlights the importance of genetic factors in regulating energy balance and metabolic health."
        },
        {
          "summary": "Metabolic pathways and their interaction with genetic factors",
          "explanation": "The metabolic pathway associated with MAFLD involves lipid metabolism and glucose regulation. The interaction between genetic factors, such as the FTO protein, and metabolic pathways underscores the complex relationships between genetics, physiology, and disease risk."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 18",
    "edges": [
      [
        "\"FTO PROTEIN\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"GCKR\"",
        "\"RS780093\""
      ],
      [
        "\"PACAP\"",
        "\"T2DM\""
      ],
      [
        "\"GCKR\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"BASOPHILS\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"PPARGC1\"",
        "\"T2DM\""
      ],
      [
        "\"FTO PROTEIN\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"EPINEPHRINE\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ],
      [
        "\"CCNL1\"",
        "\"METABOLIC PATHWAY\""
      ],
      [
        "\"PHYSIOLOGICAL PROCESS\"",
        "\"PPARGC1\""
      ],
      [
        "\"CCNL1\"",
        "\"RS17451107\""
      ],
      [
        "\"PACAP\"",
        "\"PHYSIOLOGICAL PROCESS\""
      ]
    ],
    "nodes": [
      "\"METABOLIC PATHWAY\"",
      "\"BASOPHILS\"",
      "\"FTO PROTEIN\"",
      "\"PPARGC1\"",
      "\"CCNL1\"",
      "\"RS17451107\"",
      "\"GCKR\"",
      "\"RS780093\"",
      "\"PACAP\"",
      "\"EPINEPHRINE\"",
      "\"PHYSIOLOGICAL PROCESS\""
    ],
    "chunk_ids": [
      "chunk-90dc49ded987f15e0a9242fc9bb82297",
      "chunk-ca6b0a71d21533320d52baa951dafe5e",
      "chunk-1e5866d0ecf28a0247051241154861b9",
      "chunk-f1e085cf39d08818835c8a6185977db8",
      "chunk-93c56ba7a18f2822e7e7ef7ca619ad3b",
      "chunk-b45cf2d0f0e7bea50a7e6108dfe0c478",
      "chunk-6e843ea5eb435755d8ec943d9dac487b",
      "chunk-e0aae640e3cd922a59ef48a65b3bd5d8",
      "chunk-120f7b851b271f4dcc7852e52c48e12b",
      "chunk-7c36aa6b71801f70e3b21a56383ca249",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-70430b09782e1fdb643124aa15a06aae",
      "chunk-4ab91070fdebe7e8c402ca2cf9f75848",
      "chunk-7a31a8f3b00d82e12a78688378dd5da0",
      "chunk-e288277c3fa5fa57c6c7f987cf2529af",
      "chunk-31471adcbd695e8173a2d9cb331bc0c3"
    ],
    "occurrence": 0.25,
    "sub_communities": [
      "74",
      "73"
    ]
  },
  "9": {
    "report_string": "# Eating Disorders and Associated Conditions\n\nThe community consists of entities related to eating disorders, specifically EATING DISORDER and AN (Anorexia Nervosa). These entities are connected through their descriptions and relationships, indicating that AN is a type of eating disorder.\n\n## EATING DISORDER and its relationship with AN\n\nThe entity EATING DISORDER is described as a group of psychological conditions characterized by abnormal eating habits. AN (Anorexia Nervosa) is identified as a type of eating disorder, indicating a direct relationship between the two. This relationship highlights the classification of AN as a specific category within the broader spectrum of eating disorders.\n\n## Lack of genetic associations\n\nThe provided relationships do not mention specific genetic factors associated with eating disorders. The mention of 'FTO SNPs' in relation to eating disorders is noted, but it is stated that FTO SNPs are not significantly associated with eating disorder phenotypes. This suggests that, based on the available information, there are no strongly established genetic links to eating disorders.",
    "report_json": {
      "title": "Eating Disorders and Associated Conditions",
      "summary": "The community consists of entities related to eating disorders, specifically EATING DISORDER and AN (Anorexia Nervosa). These entities are connected through their descriptions and relationships, indicating that AN is a type of eating disorder.",
      "rating": 2.0,
      "rating_explanation": "The impact severity rating is low due to the limited information and lack of direct associations with specific genetic or nutritional factors.",
      "findings": [
        {
          "summary": "EATING DISORDER and its relationship with AN",
          "explanation": "The entity EATING DISORDER is described as a group of psychological conditions characterized by abnormal eating habits. AN (Anorexia Nervosa) is identified as a type of eating disorder, indicating a direct relationship between the two. This relationship highlights the classification of AN as a specific category within the broader spectrum of eating disorders."
        },
        {
          "summary": "Lack of genetic associations",
          "explanation": "The provided relationships do not mention specific genetic factors associated with eating disorders. The mention of 'FTO SNPs' in relation to eating disorders is noted, but it is stated that FTO SNPs are not significantly associated with eating disorder phenotypes. This suggests that, based on the available information, there are no strongly established genetic links to eating disorders."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 9",
    "edges": [
      [
        "\"EATING DISORDER\"",
        "\"FTO SNPS\""
      ],
      [
        "\"AN\"",
        "\"EATING DISORDER\""
      ]
    ],
    "nodes": [
      "\"EATING DISORDER\"",
      "\"AN\""
    ],
    "chunk_ids": [
      "chunk-3f4f8136f50b2affe4eba97015885ad2"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "14": {
    "report_string": "# Demographic Differences in BMI\n\nThe community consists of demographic groups 'MEN' and 'WOMEN' and their relationship with 'BMI'. The entities are connected through their influence on body mass index (BMI) and health risks. The relationships indicate that men and women have different average BMIs and body shape scores.\n\n## Demographic differences in BMI\n\nThe community highlights that men and women have different average BMIs, with some cohorts showing men having a lower average BMI than women. This difference is crucial for understanding health risks associated with BMI.\n\n## Influence of demographic categories on health risks\n\nMen and women are demographic categories that can influence the association with BMI and health risks. They have different body shape scores and health risks, indicating that demographic factors play a significant role in health studies.\n\n## Relationship between MEN and WOMEN\n\nThe relationship between 'MEN' and 'WOMEN' indicates they are demographic categories influencing BMI and health risks. Their differences in BMI and body shape scores are essential for personalized health assessments.",
    "report_json": {
      "title": "Demographic Differences in BMI",
      "summary": "The community consists of demographic groups 'MEN' and 'WOMEN' and their relationship with 'BMI'. The entities are connected through their influence on body mass index (BMI) and health risks. The relationships indicate that men and women have different average BMIs and body shape scores.",
      "rating": 3.0,
      "rating_explanation": "The impact severity rating is moderate due to the general influence of demographic factors on BMI.",
      "findings": [
        {
          "summary": "Demographic differences in BMI",
          "explanation": "The community highlights that men and women have different average BMIs, with some cohorts showing men having a lower average BMI than women. This difference is crucial for understanding health risks associated with BMI."
        },
        {
          "summary": "Influence of demographic categories on health risks",
          "explanation": "Men and women are demographic categories that can influence the association with BMI and health risks. They have different body shape scores and health risks, indicating that demographic factors play a significant role in health studies."
        },
        {
          "summary": "Relationship between MEN and WOMEN",
          "explanation": "The relationship between 'MEN' and 'WOMEN' indicates they are demographic categories influencing BMI and health risks. Their differences in BMI and body shape scores are essential for personalized health assessments."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 14",
    "edges": [
      [
        "\"BMI\"",
        "\"MEN\""
      ],
      [
        "\"MEN\"",
        "\"WOMEN\""
      ],
      [
        "\"BMI\"",
        "\"WOMEN\""
      ]
    ],
    "nodes": [
      "\"WOMEN\"",
      "\"MEN\""
    ],
    "chunk_ids": [
      "chunk-8962f590f087ca0056b21a8a98a9cfb5",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e",
      "chunk-d4edb459d74ac18dcf10c2827ae1bdba",
      "chunk-8743fb6113d9382f66ada1dbf201090b"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "11": {
    "report_string": "# Genetic and Pharmacological Influences on HDL-C Levels\n\nThe community revolves around HDL-C, a physiological process crucial for lipid metabolism and cardiovascular health. Key entities include genes such as GALNT2 and PLA2G4A, drugs like atenolol, and genomic variants like rs2144300 and rs10157410. These entities interact through their roles in HDL-C regulation, lipid metabolism, and response to pharmacological interventions.\n\n## GALNT2 gene and its association with HDL-C levels\n\nThe GALNT2 gene is significantly associated with circulating HDL-C levels. Variants in this gene, such as rs2144300, have been linked to changes in HDL-C levels in response to atenolol treatment. This highlights the importance of genetic factors in determining individual responses to pharmacological interventions aimed at modifying lipid profiles.\n\n## Impact of atenolol on HDL-C levels\n\nAtenolol, a beta blocker used to treat hypertension and angina, affects HDL-C levels. The drug's impact on HDL-C is influenced by genetic factors, as evidenced by the association of rs2144300 with atenolol-induced decreases in HDL-C. This underscores the need for personalized treatment strategies that consider genetic background.\n\n## PLA2G4A gene and its role in HDL-C regulation\n\nThe PLA2G4A gene, involved in lipid metabolism, is associated with HDL-C levels. The genomic variant rs10157410 in PLA2G4A is linked to the HDL-C response to atenolol, suggesting that genetic variations in this gene can influence how individuals respond to beta blockers in terms of lipid profile changes.\n\n## Relationship between genomic variants and drug response\n\nGenomic variants such as rs2144300 and rs10157410 are associated with how individuals respond to atenolol in terms of HDL-C levels. These findings highlight the potential for pharmacogenomics to personalize treatment regimens and minimize adverse effects on lipid profiles.\n\n## HDL-C and its inverse association with MAFLD\n\nHDL-C is inversely associated with Metabolic Associated Fatty Liver Disease (MAFLD), indicating that higher HDL-C levels may offer protective effects against MAFLD. This relationship underscores the importance of HDL-C in metabolic health and the potential for therapeutic strategies aimed at enhancing HDL-C levels.",
    "report_json": {
      "title": "Genetic and Pharmacological Influences on HDL-C Levels",
      "summary": "The community revolves around HDL-C, a physiological process crucial for lipid metabolism and cardiovascular health. Key entities include genes such as GALNT2 and PLA2G4A, drugs like atenolol, and genomic variants like rs2144300 and rs10157410. These entities interact through their roles in HDL-C regulation, lipid metabolism, and response to pharmacological interventions.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of genetic and pharmacological factors on HDL-C levels and cardiovascular health.",
      "findings": [
        {
          "summary": "GALNT2 gene and its association with HDL-C levels",
          "explanation": "The GALNT2 gene is significantly associated with circulating HDL-C levels. Variants in this gene, such as rs2144300, have been linked to changes in HDL-C levels in response to atenolol treatment. This highlights the importance of genetic factors in determining individual responses to pharmacological interventions aimed at modifying lipid profiles."
        },
        {
          "summary": "Impact of atenolol on HDL-C levels",
          "explanation": "Atenolol, a beta blocker used to treat hypertension and angina, affects HDL-C levels. The drug's impact on HDL-C is influenced by genetic factors, as evidenced by the association of rs2144300 with atenolol-induced decreases in HDL-C. This underscores the need for personalized treatment strategies that consider genetic background."
        },
        {
          "summary": "PLA2G4A gene and its role in HDL-C regulation",
          "explanation": "The PLA2G4A gene, involved in lipid metabolism, is associated with HDL-C levels. The genomic variant rs10157410 in PLA2G4A is linked to the HDL-C response to atenolol, suggesting that genetic variations in this gene can influence how individuals respond to beta blockers in terms of lipid profile changes."
        },
        {
          "summary": "Relationship between genomic variants and drug response",
          "explanation": "Genomic variants such as rs2144300 and rs10157410 are associated with how individuals respond to atenolol in terms of HDL-C levels. These findings highlight the potential for pharmacogenomics to personalize treatment regimens and minimize adverse effects on lipid profiles."
        },
        {
          "summary": "HDL-C and its inverse association with MAFLD",
          "explanation": "HDL-C is inversely associated with Metabolic Associated Fatty Liver Disease (MAFLD), indicating that higher HDL-C levels may offer protective effects against MAFLD. This relationship underscores the importance of HDL-C in metabolic health and the potential for therapeutic strategies aimed at enhancing HDL-C levels."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 11",
    "edges": [
      [
        "\"HDL-C\"",
        "\"MAFLD\""
      ],
      [
        "\"GALNT2\"",
        "\"RS2144300\""
      ],
      [
        "\"HDL-C\"",
        "\"PLA2G4A\""
      ],
      [
        "\"ATENOLOL\"",
        "\"GALNT2\""
      ],
      [
        "\"GALNT2\"",
        "\"HDL-C\""
      ],
      [
        "\"PLA2G4A\"",
        "\"RS10157410\""
      ],
      [
        "\"ATENOLOL\"",
        "\"HDL-C\""
      ],
      [
        "\"FIGURE1A\"",
        "\"GALNT2\""
      ],
      [
        "\"CHILDHOOD OBESITY\"",
        "\"HDL-C\""
      ]
    ],
    "nodes": [
      "\"PLA2G4A\"",
      "\"ATENOLOL\"",
      "\"FIGURE1A\"",
      "\"RS10157410\"",
      "\"GALNT2\"",
      "\"RS2144300\"",
      "\"HDL-C\""
    ],
    "chunk_ids": [
      "chunk-4fb9131144701073970b486c85c097c3",
      "chunk-54f341ffe1f7911ec2511c600102c4d9",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668",
      "chunk-728d6e8910b1d80980b6bb3f4b124595"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "12": {
    "report_string": "# Statistical Analysis of Genetic Variants and Adiposity Traits\n\nThe community revolves around the analysis of genetic variants and their association with adiposity traits, utilizing statistical methods like the Durbin-Hausman test and concepts such as P value. Key entities include the Durbin-Hausman test, genetic variants, and P value, which are interconnected through their roles in statistical analysis and significance testing.\n\n## Role of Durbin-Hausman Test in Analyzing Adiposity Traits\n\nThe Durbin-Hausman test is a statistical method used to compare the coefficients of different estimation methods in the context of adiposity traits. It plays a crucial role in analyzing the relationship between genetic variants and body mass index (BMI) estimates. This test helps in determining the significance of genetic variants in influencing adiposity traits.\n\n## Genetic Variants and Their Association with Obesity\n\nGenetic variants of the FTO gene are associated with obesity and BMI. These variants can influence adiposity traits, and their significance is often evaluated using statistical methods like the Durbin-Hausman test. Understanding these genetic associations is crucial for developing personalized interventions for obesity management.\n\n## Importance of P Value in Statistical Analysis\n\nThe P value is a statistical concept used to determine the significance of interactions, including those between genetic variants and adiposity traits. It is essential in the context of the Durbin-Hausman test to evaluate the reliability of the estimates. A low P value indicates a significant association, which can help in identifying genetic variants that contribute to obesity risk.\n\n## Interconnection Between Durbin-Hausman Test, Genetic Variants, and P Value\n\nThe Durbin-Hausman test, genetic variants, and P value are interconnected through their roles in statistical analysis and significance testing. The test uses P values to determine the significance of genetic variant associations with adiposity traits. This interconnection highlights the comprehensive approach required to understand the genetic and statistical underpinnings of obesity and BMI.",
    "report_json": {
      "title": "Statistical Analysis of Genetic Variants and Adiposity Traits",
      "summary": "The community revolves around the analysis of genetic variants and their association with adiposity traits, utilizing statistical methods like the Durbin-Hausman test and concepts such as P value. Key entities include the Durbin-Hausman test, genetic variants, and P value, which are interconnected through their roles in statistical analysis and significance testing.",
      "rating": 4.0,
      "rating_explanation": "The impact severity rating is moderate due to the specific but important role of these statistical methods and genetic variants in understanding adiposity traits.",
      "findings": [
        {
          "summary": "Role of Durbin-Hausman Test in Analyzing Adiposity Traits",
          "explanation": "The Durbin-Hausman test is a statistical method used to compare the coefficients of different estimation methods in the context of adiposity traits. It plays a crucial role in analyzing the relationship between genetic variants and body mass index (BMI) estimates. This test helps in determining the significance of genetic variants in influencing adiposity traits."
        },
        {
          "summary": "Genetic Variants and Their Association with Obesity",
          "explanation": "Genetic variants of the FTO gene are associated with obesity and BMI. These variants can influence adiposity traits, and their significance is often evaluated using statistical methods like the Durbin-Hausman test. Understanding these genetic associations is crucial for developing personalized interventions for obesity management."
        },
        {
          "summary": "Importance of P Value in Statistical Analysis",
          "explanation": "The P value is a statistical concept used to determine the significance of interactions, including those between genetic variants and adiposity traits. It is essential in the context of the Durbin-Hausman test to evaluate the reliability of the estimates. A low P value indicates a significant association, which can help in identifying genetic variants that contribute to obesity risk."
        },
        {
          "summary": "Interconnection Between Durbin-Hausman Test, Genetic Variants, and P Value",
          "explanation": "The Durbin-Hausman test, genetic variants, and P value are interconnected through their roles in statistical analysis and significance testing. The test uses P values to determine the significance of genetic variant associations with adiposity traits. This interconnection highlights the comprehensive approach required to understand the genetic and statistical underpinnings of obesity and BMI."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 12",
    "edges": [
      [
        "\"DURBIN-HAUSMAN TEST\"",
        "\"GENETIC VARIANTS\""
      ],
      [
        "\"BMI\"",
        "\"DURBIN-HAUSMAN TEST\""
      ],
      [
        "\"DURBIN-HAUSMAN TEST\"",
        "\"P VALUE\""
      ]
    ],
    "nodes": [
      "\"P VALUE\"",
      "\"DURBIN-HAUSMAN TEST\"",
      "\"GENETIC VARIANTS\""
    ],
    "chunk_ids": [
      "chunk-b655a99ba6fac2e1aa524c660b7bd99b",
      "chunk-2bf3205bb6ba0eb9445f5d33e390051f",
      "chunk-da394b49a7f5393c213d70e9f1a3ce84",
      "chunk-ba2411cc0a5abf8d9834f9769168ac6e"
    ],
    "occurrence": 0.058823529411764705,
    "sub_communities": []
  },
  "1": {
    "report_string": "# Genetic Factors in Obesity: A Community of eQTLs and GWAS\n\nThe community revolves around genetic factors associated with obesity, including genes such as ADCY3, CTSS, and PDZK1IP1, which are linked to obesity GWAS lead SNPs. These genes are involved in eQTL processes, influencing gene expression related to obesity.\n\n## Role of ADCY3 in obesity\n\nThe ADCY3 gene is associated with obesity GWAS lead SNP and functions as an eQTL, influencing gene expression related to obesity. This highlights the importance of genetic factors in obesity susceptibility.\n\n## CTSS gene and obesity\n\nThe CTSS gene is also linked to obesity GWAS lead SNP and is involved in eQTL processes. This suggests that CTSS plays a role in the genetic architecture of obesity.\n\n## PDZK1IP1 and its association with obesity GWAS\n\nPDZK1IP1 is associated with obesity GWAS lead SNP rs977747 and is influenced by eQTL processes. This indicates that PDZK1IP1 is a key gene in the genetic network underlying obesity.\n\n## eQTLs and their role in obesity\n\neQTLs, including those associated with ADCY3, CTSS, and PDZK1IP1, play a crucial role in obesity by influencing gene expression. Understanding eQTLs can provide insights into the molecular mechanisms of obesity.\n\n## Interconnection of genetic factors in obesity\n\nThe relationships between genes like ADCY3, CTSS, and PDZK1IP1, and their associations with SNPs and eQTL processes, underscore the complex genetic network underlying obesity. This interconnectedness highlights the potential for multifaceted approaches to obesity management.",
    "report_json": {
      "title": "Genetic Factors in Obesity: A Community of eQTLs and GWAS",
      "summary": "The community revolves around genetic factors associated with obesity, including genes such as ADCY3, CTSS, and PDZK1IP1, which are linked to obesity GWAS lead SNPs. These genes are involved in eQTL processes, influencing gene expression related to obesity.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant role of genetic factors in obesity susceptibility and the potential for targeted interventions.",
      "findings": [
        {
          "summary": "Role of ADCY3 in obesity",
          "explanation": "The ADCY3 gene is associated with obesity GWAS lead SNP and functions as an eQTL, influencing gene expression related to obesity. This highlights the importance of genetic factors in obesity susceptibility."
        },
        {
          "summary": "CTSS gene and obesity",
          "explanation": "The CTSS gene is also linked to obesity GWAS lead SNP and is involved in eQTL processes. This suggests that CTSS plays a role in the genetic architecture of obesity."
        },
        {
          "summary": "PDZK1IP1 and its association with obesity GWAS",
          "explanation": "PDZK1IP1 is associated with obesity GWAS lead SNP rs977747 and is influenced by eQTL processes. This indicates that PDZK1IP1 is a key gene in the genetic network underlying obesity."
        },
        {
          "summary": "eQTLs and their role in obesity",
          "explanation": "eQTLs, including those associated with ADCY3, CTSS, and PDZK1IP1, play a crucial role in obesity by influencing gene expression. Understanding eQTLs can provide insights into the molecular mechanisms of obesity."
        },
        {
          "summary": "Interconnection of genetic factors in obesity",
          "explanation": "The relationships between genes like ADCY3, CTSS, and PDZK1IP1, and their associations with SNPs and eQTL processes, underscore the complex genetic network underlying obesity. This interconnectedness highlights the potential for multifaceted approaches to obesity management."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 1",
    "edges": [
      [
        "\"CTSS\"",
        "\"EQTL\""
      ],
      [
        "\"EQTL\"",
        "\"PDZK1IP1\""
      ],
      [
        "\"ADCY3\"",
        "\"SNP\""
      ],
      [
        "\"PDZK1IP1\"",
        "\"SNP RS977747\""
      ],
      [
        "\"ADCY3\"",
        "\"EQTL\""
      ],
      [
        "\"CTSS\"",
        "\"SNP\""
      ]
    ],
    "nodes": [
      "\"CTSS\"",
      "\"ADCY3\"",
      "\"EQTL\"",
      "\"PDZK1IP1\"",
      "\"SNP RS977747\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "8": {
    "report_string": "# AMPK Signaling Pathway and Obesity\n\nThe community revolves around the AMPK signaling pathway, which is involved in energy homeostasis. Key entities include the AMPK signaling pathway, CREB1 gene, and FOXO3. These entities are interconnected through their roles in metabolic processes and obesity.\n\n## AMPK signaling pathway and its role in energy homeostasis\n\nThe AMPK signaling pathway is a metabolic pathway involved in energy homeostasis. It interacts with FOXO3, suggesting its role in regulating metabolic processes.\n\n## CREB1 gene and its involvement in obesity\n\nThe CREB1 gene is a transcription factor involved in obesity and is a hub protein. Its interaction with the AMPK signaling pathway highlights its role in metabolic processes.\n\n## FOXO3 and its involvement in the AMPK signaling pathway\n\nFOXO3 is involved in the AMPK signaling pathway, which is crucial for energy homeostasis. This interaction suggests that FOXO3 plays a role in regulating metabolic processes.",
    "report_json": {
      "title": "AMPK Signaling Pathway and Obesity",
      "summary": "The community revolves around the AMPK signaling pathway, which is involved in energy homeostasis. Key entities include the AMPK signaling pathway, CREB1 gene, and FOXO3. These entities are interconnected through their roles in metabolic processes and obesity.",
      "rating": 5.0,
      "rating_explanation": "The impact severity rating is moderate due to the involvement of key entities in energy homeostasis and obesity.",
      "findings": [
        {
          "summary": "AMPK signaling pathway and its role in energy homeostasis",
          "explanation": "The AMPK signaling pathway is a metabolic pathway involved in energy homeostasis. It interacts with FOXO3, suggesting its role in regulating metabolic processes."
        },
        {
          "summary": "CREB1 gene and its involvement in obesity",
          "explanation": "The CREB1 gene is a transcription factor involved in obesity and is a hub protein. Its interaction with the AMPK signaling pathway highlights its role in metabolic processes."
        },
        {
          "summary": "FOXO3 and its involvement in the AMPK signaling pathway",
          "explanation": "FOXO3 is involved in the AMPK signaling pathway, which is crucial for energy homeostasis. This interaction suggests that FOXO3 plays a role in regulating metabolic processes."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 8",
    "edges": [
      [
        "\"AMPK SIGNALING PATHWAY\"",
        "\"CREB1\""
      ],
      [
        "\"CREB1\"",
        "\"OBESITY\""
      ],
      [
        "\"AMPK SIGNALING PATHWAY\"",
        "\"FOXO3\""
      ]
    ],
    "nodes": [
      "\"CREB1\"",
      "\"FOXO3\"",
      "\"AMPK SIGNALING PATHWAY\""
    ],
    "chunk_ids": [
      "chunk-42ad5ef7bfed45076096fabdcce8039a"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  },
  "5": {
    "report_string": "# Haplotype and Obesity Risk in Diverse Populations\n\nThe community revolves around the concept of haplotypes and their association with obesity risk across different populations, including EAS, EUR, and SAS populations. Key entities include haplotypes, genetic factors, and populations, which are interconnected through their roles in genetic risk and disease susceptibility.\n\n## Haplotypes and Obesity Risk\n\nHaplotypes are sets of genetic variants that are inherited together and have been associated with an increased risk of obesity. This relationship highlights the genetic component of obesity and the potential for targeted interventions based on haplotype information.\n\n## Population-Specific Haplotypes\n\nDifferent populations (EAS, EUR, SAS) present specific haplotypes that may influence obesity risk. For instance, EUR populations present the highest-risk haplotype, while EAS and SAS populations also show significant links to specific haplotypes. This population-specific distribution of haplotypes underscores the importance of genetic diversity in assessing obesity risk.\n\n## Haplotype as a Physiological Process\n\nHaplotype is considered a physiological process that affects genomic variants and, consequently, disease susceptibility. This concept emphasizes the role of haplotypes in understanding the genetic underpinnings of obesity and potentially other complex diseases.\n\n## Genetic Factors and Obesity\n\nGenetic factors, represented by genes or sets of genes, contribute to the risk of obesity. The connection between genetic factors and haplotypes suggests that genetic information could be used to predict and manage obesity risk more effectively.\n\n## Role of N3 Identifier\n\nN3 is an identifier for a specific haplotype that is associated with the highest risk of obesity. This highlights the potential utility of specific identifiers in pinpointing high-risk genetic profiles and guiding personalized interventions.",
    "report_json": {
      "title": "Haplotype and Obesity Risk in Diverse Populations",
      "summary": "The community revolves around the concept of haplotypes and their association with obesity risk across different populations, including EAS, EUR, and SAS populations. Key entities include haplotypes, genetic factors, and populations, which are interconnected through their roles in genetic risk and disease susceptibility.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant association of haplotypes with obesity risk across various populations.",
      "findings": [
        {
          "summary": "Haplotypes and Obesity Risk",
          "explanation": "Haplotypes are sets of genetic variants that are inherited together and have been associated with an increased risk of obesity. This relationship highlights the genetic component of obesity and the potential for targeted interventions based on haplotype information."
        },
        {
          "summary": "Population-Specific Haplotypes",
          "explanation": "Different populations (EAS, EUR, SAS) present specific haplotypes that may influence obesity risk. For instance, EUR populations present the highest-risk haplotype, while EAS and SAS populations also show significant links to specific haplotypes. This population-specific distribution of haplotypes underscores the importance of genetic diversity in assessing obesity risk."
        },
        {
          "summary": "Haplotype as a Physiological Process",
          "explanation": "Haplotype is considered a physiological process that affects genomic variants and, consequently, disease susceptibility. This concept emphasizes the role of haplotypes in understanding the genetic underpinnings of obesity and potentially other complex diseases."
        },
        {
          "summary": "Genetic Factors and Obesity",
          "explanation": "Genetic factors, represented by genes or sets of genes, contribute to the risk of obesity. The connection between genetic factors and haplotypes suggests that genetic information could be used to predict and manage obesity risk more effectively."
        },
        {
          "summary": "Role of N3 Identifier",
          "explanation": "N3 is an identifier for a specific haplotype that is associated with the highest risk of obesity. This highlights the potential utility of specific identifiers in pinpointing high-risk genetic profiles and guiding personalized interventions."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 5",
    "edges": [
      [
        "\"EAS\"",
        "\"HAPLOTYPE\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"TABLE4\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"OBESITY\""
      ],
      [
        "\"EAS\"",
        "\"GENETIC FACTOR\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"SAS\""
      ],
      [
        "\"EUR\"",
        "\"HAPLOTYPE\""
      ],
      [
        "\"HAPLOTYPE\"",
        "\"N3\""
      ],
      [
        "\"GENOMIC VARIANT\"",
        "\"HAPLOTYPE\""
      ]
    ],
    "nodes": [
      "\"EAS\"",
      "\"EUR\"",
      "\"N3\"",
      "\"GENETIC FACTOR\"",
      "\"TABLE4\"",
      "\"HAPLOTYPE\"",
      "\"SAS\""
    ],
    "chunk_ids": [
      "chunk-e50a12653611061cb0804f042941c4bc",
      "chunk-bf6975d8a3d2e12929cbcce826523293",
      "chunk-63cd6c597873dc2bc3a6e66bf7138fed",
      "chunk-66262840bddb9d9a2c7a3e725b4a1aee",
      "chunk-3d0d6180e36dc3c20e2bd49c6b33a668"
    ],
    "occurrence": 0.07352941176470588,
    "sub_communities": []
  },
  "19": {
    "report_string": "# Nutritional Intervention and Body Composition\n\nThe community revolves around nutritional intervention and its impact on body composition and metabolism. Key entities include nutritional intervention, weight loss, gynoid body fat percentage, and diet therapy. These entities are interconnected through their roles in managing disease and improving body composition.\n\n## Nutritional Intervention and Weight Loss\n\nNutritional intervention is a dietary pattern that leads to weight loss and improved body composition. This relationship highlights the importance of tailored dietary approaches in managing physiological processes related to body composition.\n\n## Nutritional Intervention and Gynoid Body Fat Percentage\n\nNutritional intervention affects gynoid body fat percentage in individuals. This is significant because gynoid fat distribution is associated with health risks, and nutritional interventions can play a crucial role in mitigating these risks.\n\n## FTO RS9939609 Genomic Variant and Nutritional Intervention\n\nThe FTO rs9939609 genomic variant affects the response to nutritional intervention. This suggests that genetic factors can influence the effectiveness of dietary approaches, emphasizing the need for personalized nutrition plans.\n\n## Diet Therapy and Weight Loss\n\nDiet therapy leads to weight loss and improved body composition. As a treatment approach, diet therapy underscores the importance of dietary patterns in managing disease and promoting health.\n\n## Nutritional Intervention and Total Body Fat\n\nNutritional intervention affects total body fat in individuals. This relationship highlights the role of dietary patterns in managing body composition and metabolic health.",
    "report_json": {
      "title": "Nutritional Intervention and Body Composition",
      "summary": "The community revolves around nutritional intervention and its impact on body composition and metabolism. Key entities include nutritional intervention, weight loss, gynoid body fat percentage, and diet therapy. These entities are interconnected through their roles in managing disease and improving body composition.",
      "rating": 6.0,
      "rating_explanation": "The impact severity rating is moderate to high due to the significant influence of nutritional intervention on body composition and metabolism.",
      "findings": [
        {
          "summary": "Nutritional Intervention and Weight Loss",
          "explanation": "Nutritional intervention is a dietary pattern that leads to weight loss and improved body composition. This relationship highlights the importance of tailored dietary approaches in managing physiological processes related to body composition."
        },
        {
          "summary": "Nutritional Intervention and Gynoid Body Fat Percentage",
          "explanation": "Nutritional intervention affects gynoid body fat percentage in individuals. This is significant because gynoid fat distribution is associated with health risks, and nutritional interventions can play a crucial role in mitigating these risks."
        },
        {
          "summary": "FTO RS9939609 Genomic Variant and Nutritional Intervention",
          "explanation": "The FTO rs9939609 genomic variant affects the response to nutritional intervention. This suggests that genetic factors can influence the effectiveness of dietary approaches, emphasizing the need for personalized nutrition plans."
        },
        {
          "summary": "Diet Therapy and Weight Loss",
          "explanation": "Diet therapy leads to weight loss and improved body composition. As a treatment approach, diet therapy underscores the importance of dietary patterns in managing disease and promoting health."
        },
        {
          "summary": "Nutritional Intervention and Total Body Fat",
          "explanation": "Nutritional intervention affects total body fat in individuals. This relationship highlights the role of dietary patterns in managing body composition and metabolic health."
        }
      ]
    },
    "level": 0,
    "title": "Cluster 19",
    "edges": [
      [
        "\"DIET THERAPY\"",
        "\"WEIGHT LOSS\""
      ],
      [
        "\"NUTRITIONAL INTERVENTION\"",
        "\"TBFAT (KG)\""
      ],
      [
        "\"FTO RS9939609\"",
        "\"NUTRITIONAL INTERVENTION\""
      ],
      [
        "\"NUTRITIONAL INTERVENTION\"",
        "\"WEIGHT LOSS\""
      ],
      [
        "\"GYNOID BFAT (%)\"",
        "\"NUTRITIONAL INTERVENTION\""
      ]
    ],
    "nodes": [
      "\"WEIGHT LOSS\"",
      "\"NUTRITIONAL INTERVENTION\"",
      "\"GYNOID BFAT (%)\"",
      "\"DIET THERAPY\""
    ],
    "chunk_ids": [
      "chunk-6e843ea5eb435755d8ec943d9dac487b"
    ],
    "occurrence": 0.014705882352941176,
    "sub_communities": []
  }
}